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Definitions 
Having autonomy; not subject to control from outside; the 
capacity of a rational individual to make an informed, un-
coerced decisionj central to the concepts of informed consent 
and shared decision making in medicine. 
The local excision of the cancer with a margin of normal 
surrounding breast tissue. 
The local excision of the cancer with a margin of normal 
surrounding breast tissue plus adjuvant ipsilatera l chest wall 
radiotherapy. 
The set of shared attitudes, values, goals, and practices wh ich 
characterises an institution, organisation, or group. 
the imparting or exchanging of information by speaking, 
writing, or using some other medium 
The act of conforming, acquiescing, or yielding . 
Guided, regulated, or managed 
The fundamental and distinctive character of a group, typically 
expressed in attitudes, habits, and belief. 
To make easier or less difficult; help forward (an action, a 
process, etc.) 
Possessing sufficient and sufficiently reliable informat ion or 
knowledge to understand an issue and make appropriate 
judgments or decisions regarding it . 
A patients' agreement to undergo an operation or medical 
treatment after being informed of and understood and 
accepted the risks involved. The provis ion of informed consent 
is contingent on the individua l concerned being in possess ion 
of all relevant facts at the time consent is given and to possess 
adequate reasoning capacity. 
The process of making 'right' choice in accordance wit h the 
authoritative knowledge and experience of clinicians, rathe r 
than being the result of pat ients' cons iderat ion of t he evi dence 
and their personal preferences. 
Mastectomy 
Paternalism 
Patient-centred care 
Shared decision-making 
Refers to simple mastectomy; the removal of the breast alone 
Behaviour which is undertaken regardless of person or group's 
will, by a person, organisation or state, which limits the person 
or group's liberty or autonomy for their perceived good; and 
which can be an expression of an attitude of superiority 
towards the person or group. 
The experience (to the extent the informed, individual patient 
desires it) of transparency, individualisation, recognitio n, 
respect, dignity and choice in all matters, without exception, 
related to one's person, circumstances, and relationships in 
health care. (Berwick 2009) 
The process by which patients are involved as active partners 
with professionals in clarifying acceptable treatment, 
management or support options, discussing goals and 
priorities, and together planning and implementing a preferred 
course of action .(Coulter 201.1.a) 
Abstract 
Background and aims In women with breast cancers up to 5 em diameter, breast conservation 
therapy (BCT) and mastectomy are equivalent for survival and morbidityj although recurrence 
and body image vary. This mixed-method study in a UK region (population 5 million) aims to 
identify reasons for mastectomy rate (MR) variation between units. 
Methods and findings The study comprised five componentsj two in 14 units: 
(1) An audit of the NHS Breast Screening Programme (n=5060 cases from 11 screening units) 
established MR variation was not due to case-mix or caseload (P=O.OOl) . 
(2) A Discrete Choice Experiment (n=68/93) employing multinomial logistic regression 
confirmed clinicians surgical preferences (25 scenarios, n=1695) vary based on cancer (size, site 
and centricity, P<O.OOl), patient (age and breast size, P<O.OOl) and clinician variables (gender and 
clinician role, P=0.015 and P<O.OOl respectively) . 
Three within units representing high, medium and low case-mix adjusted MRs: 
(3) A validated questionnaire established that patients (n=356) preferred and achieved more 
autonomy in treatment selection than beforej particularly among those choosing mastectomy 
(P<O.OOl) . 
(4) Interviews with clinicians (n=26j 13 nurses and 13 doctors) highlighted variation in local 
ethos. Clinicians' focus in the low MR unit was the promotion of BCT and in others, autonomous 
decision-making . Communication strategies and processes optimised this . 
(5) Interviews with patients (n=65) demonstrated varied experiences between breast units . 
While patient factors influenced decisions, breast team factors predominated. Patients from the 
high and medium MR units described more informed autonomous decision-making processes and 
support. 
Conclusions In this study low MRs were associated with clinicians preferring BCT and higher 
MRs with clinicians supporting patients' decision-making . Clinician factors related to treatment 
preferences associated with high MRs were not identified. This does not preclude their existence 
in other regions. Understanding surgical variation factors could facilitate treatment decision-
making equity, but is unlikely to reduce MRs. 
Chapter 1 
Introduction 
LITERATURE REVIEW 
Breast cancer is the most common cancer affecting women worldwide(WHO 2011) and the th ird 
most common cancer diagnosed in the UK; with l in 8 to l in 9 being diagnosed at some po int in 
their lifetime, and approximately 49,000 diagnosed in 2008.(Offlce for National Stat isti cs 
2003;Office of Nationa l Stat ist ics 2011) 
The history of breast cancer surgical options 
Historically breast cancer was treated by the Halsted radical mastectomy, which was first 
performed in 1882. It involved the en-bloc excision of the breast, along with ipsilateral pectoral is 
muscles and axillary contents. This remained the standard of care for all stages of breast cancer 
until the mid-1960s, when aesthetic dissatisfaction, anecdotal reports(Flsher 2005) and new 
evidence about cancer metastases, (Fisher 1980) motivated some to pursue less extensive surgical 
alternatives. Subsequent evidence demonstrated no survival benefit among most treated by 
radical versus simple mastectomy (removal of the breast alone), and simple mastectomy became 
the standard of care .(Flsher 2005) Following this Breast Conserving Surgery (BCS) was 
developed; the local excision of the cancer with a margin of normal surrounding breast tissue . A 
Randomised Control Trial (RCT) commenced in 1976 and published in 1985, produced the f irst 
evidence demonstrating BCS was a suitable alternative to mastectomy among some women with 
breast cancer, and that when followed by adjuvant ipsilateral radiotherapy results were improved; 
so called Breast Conservation Therapy (BCT). (Fisher et al. 1985) 
The initial breast cancer treatment options today 
The mainstays of breast cancer treatment today are surgery, rad iotherapy, chemotherapy and 
endocrine treatments. There has been a recent expansion of treatment options including new 
surgical techniques resulting from the increased adoption of oncoplastic techn iques into breast 
cancer surgery; with breast reconstruction, therapeutic mammoplasty and volume rep lacement 
techniques combined with BCT. (BAPRAS and t he Training Interface Group In Breast Surgery 
200l,Clough et al . 2 0W) The proportion of cancers potentially su itable for BCT has also been 
increased by the utilisation of neo-adjuvant chemotherapy(k au fm ann et al 2003, van der Hage et 
al . 2001;Wolmark et al. 2001) or endocrine treatment(Hlnd et al 2007) t o reduce cancer volume 
prior to surgery. Despite these advances most women undergo surgery as the in it ial therapeut ic 
treatment for the ir breast cancer, and the most common surgica l options rema in mastectomy 
and BCT. 
Neither BeT nor mastectomy are definitively superior options 
Over the last two decades evidence for survival equivalence for cancers treated with BCT or 
mastectomy has increased, with large long term RCTs conclusively demonstrating this in cancers 
up to 4-scm diameter.(B lichert-Toft et al. 1988i CIarke et al. 200s;Fisher et al . 2002;Jacobson et al. 
1995iLichter et al. 1992;Poggi et al. 2003iSarrazin et al. 1989;van Dongen et al 2000;Veronesi et 
al. 2002) Evidence of survival equivalence at five years follow-up first emerged in 1985.(Fisher, 
Bauer, Margolese, Poisson, Pilch, Redmond, Fisher, Wo lmark, Deutsch, Montague, & . 1985) The 
evidence was strengthened in the mid-1990S with the publication of two studies with longer 
foliow-UPi a large RCT - the National Surgical Adjuvant Breast and Bowel Project's Protoco l 
(NSABP) B-06 (n=210s)(Fisher et al. 1995) and a smaller study by the National Cancer Institute 
(n=237)(Jacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatsteln, & 
Okunieff 1995) w ith 12 and 10 years follow-up respectively. These find ings we re based on the 
treatment of cancers less than 4cm diameter (most less than 2cm). The results of the European 
Organisation for Research and Treatment of Cancer (EORTC) trial 10801 corroborated survival 
equivalence evidence in cancers up to scm diameter at 10-years follow up (n=868), (van Dongen, 
Voogd, Fentiman, Legrand, Sylvester, Tong, van der, Helle, van ZIJI, & Barte llnk 2000) as have 
others.(B li chert-Toft, Brincker, Andersen, Andersen, Axelsson, Mouridsen, Dombernowsky, 
Overgaard, Gadeberg, Knudsen, & . 1988;Lichter, Lippman, Danforth, Jr., d'Angelo, Steinberg, 
deMoss, MacDonald, Reichert, Merino, Swain, & 1992,SarrazIn, Le, Am agada, Contesso, 
Fontaine, Spielmann, Rochard, Le, & Lacour 1989) Twenty yea r follow-up resu lts of NSABP B-06 
(n=18S1)(Fisher, Anderson, Bryant, Margolese, Deutsch, Fisher, Jeong, & Wolmark 200 2) and t he 
Milan study (n=701),(Veronesi, Cascinelli, Mariani, Greco, Saccozzl, Lu inl, Aguilar, & Marub ln l 
2002) and eighteen year results of the National Cancer Institute study, (poggl , Danfo rt h, SCiuto, 
Smith, Steinberg, Llewehr, Menard, Lippman, Lichte r, & Altemus 2003) confirm su rv ival 
equivalence is susta ined . 
It is therefore accepted a large proportion of women diagnosed with breast cancer can be safely 
treated with either BCT or mastectomy. BCT is contraindicated when patient safety would be 
compromisedj for example when cancers are large (typically over 4-5cm diameter) or multi-focal, 
or where there are contraindications to radiotherapy which would compromise disease control 
and survival. Relative contraindications to BCT are inadequate breast volume to permit an 
acceptable aesthetic outcome with BCTj typically when over 20% breast volume 
excised. (Bulstrode and Shrotria 2001) Volume excisions beyond this level require oncoplastic 
volume replacement techniques.(BAPRAS and the Training Interface Group In Breast Surgery 
2007jC lough, Kaufman, Nos, Buccimazza, & Sarfati 2010) 
Although survival is equivalent between BCT and mastectomy and most studies demonstrate 
equivalence in their impact on physical(lrwig and Bennetts 1997iMcCready et al 2005,Schain et 
al. 1983)and psychological morbidity(Carlsson and Hamrr n 1994iDorvai et al. 1998iFaliowfie id et 
al. 1986jGanz et al. 2002j lrwig & Bennetts 1997iMoyer 1997iSanger and Reznlkoff 1981iSchain, 
Edwards, Gorrell, de Moss, Lippman, Gerber, & Lichter 1983iStefanek 1993) in most realms, there 
are differences between the two options: Body image(Arndt et al. 2008iCarisson & Hamrrn 
1994jFaliowfield, Baum, & Magu ire 1986j lrwlg & Bennetts 1997iMoyer 1997iSanger & Reznlkoff 
1981iSchover 1994jStefanek 1993) and probably sexuality are superior with BCT, (Arndt, 
Stegmaier, Ziegler, & Brenner 2008iHack et al. 2006,Pozo et al. 1992,Schover 1994) while loco-
regional recurrence rate (LRRR) is statistically significantly higher with BCT. (Clarke, Collins, 
Darby, Davies, Elphinstone, Evans, Godwin, Gray, Hicks, James, MacKinnon, McGale, McHugh, 
Peto, Taylor, & Wang 2005iEarly Breast Cancer Trialists ' Collaborative Group 2002iJato i and 
Proschan 2005ivan Dongen, Voogd, Fentiman, Legrand, Sylvester, Tong, van der, Helle, van ZIJI, 
& Bartelink 20ooiVeronesl, Cascinelll, Marrani, Greco, Saccozzi, Lu inl, AgU ilar, & Marublnl 2002) 
Reflecting differences in extent of resection and radiotherapy doses, studies demonstrate 
different rates, but usually a two-fold increase in LRRR is identified with BCT. (Jatoi & Proschan 
2oo5ivan Dongen, Voogd, Fentiman, Legrand, Sylvester, Tong, van der, Helle, van ZIJI , & 
Bartellnk 2000iVeronesi, Cascmelli, Marranl, Greco, Saccozzl, LUlnl, Aguila r, & Marublnl 2002) 
Most quote LRRR of approximately 2-5% with mastectomy and 10-12% with BCTi (Veronesl, 
Cascine ll i, Mariani, Greco, Saccozzl, Luini, Aguilar, & Marublnl 2002) some quote higher rates of 
around 12% and 20% respectively. (van Dongen, Voogd, Fentlman, Legrand, Sylvest er, Tong, van 
der; Helle, van Zljl, & Bartellnk 2000) 
Despite discrepancies in LRRR, no impact on survival has been demonstrated at 10 yea rs fo llow 
up. (Richards et al. 1995jStewart 1995) However, a recent an overview by Clarke et al. published in 
2005 of the RCTs including a meta-analysis (n=25 000), demonstrated LRRRs exceed ing 10% at 5 
years were associated with statistically significant increased breast cancer mortal ity at 15 
yearsj (Clarke, Collins, Darby, Davies, Elphinstone, Evans, GodWin, Gray, Hicks, James, 
MacK innon, McGale, McHugh, Peto, Taylor, & Wang 2005) and indicate one death for every four 
women diagnosed recurrent breast cancer. Therefore avoiding local recurrence should red uce 
mortality rates. Based on this, it is possible that studies may start to demonstrate survival 
inequality between BCT and mastectomy when the data of longer term follow up is available. 
Patients benefit from being involved in treatment decision making 
The lack of a clearly superior treatment over all realms, and distinct differences between the two, 
led to a call for women diagnosed with breast cancer to be considered eligible for the provision of 
a choice between BeT and mastectomy where possible. Th is call followed evidence emerg ing 
from studies conducted over the same period, demonstrating patients who consulted with 
clinicians providing information and including them in treatment decisions achieved enhanced 
short and long term physical and psychological outcomes, compared with those providing 
treatment direction .(Andersen et al. 2009jDeadman et al. 2001,Faliowfieid et al. 
1994a,Faliowfieid et al 1990jFaliowfieid et al. 1994bjHack, Degner, Watson, & Sinha 
2006iKotwail et al. 1996jMoienaar et al. 2004iMoms and Ingham 1988;Moms and Royle 
1987i Moyer 1997iMoyer and Sa lovey 1998;Schou et al. 2002jStewart 1995,Street, Jr. and VOigt 
1997;Wilson et al. 1988jWolberg 1990) Specifically, patients experienced improved satisfaction 
with the process of care and surgery undertakenj (Deadman, Lelnster, Owens, Dewey, & Slade 
2001jFaliowfield, Hall, Maguire, Baum, & A'Hern 1994aiHack, Degner, Watson, & Sinha 
2006j Moyer 1997jMoyer & Salovey 1998iStewart 1995iStreet, Jr. & VOigt 1997) reduced reg ret 
about their surgeryj (Faliowfield, Hall, Maguire, & Baum 1990,Molenaar, Oort, Sprangers, Rutgers, 
Luiten, Mulder, & de Haes 2004jSchou, Ekeberg, Ruland, & karesen 2002) and improved short 
and long term psychological recovery .(Andersen, Bowen, Morea, Stein, & Baker 2oo9,Deadman, 
Leinster, Owens, Dewey, & Slade 2001iFaiiowfield, Hall, Maguire, & Baum 1990,Kotwall, Maxwell, 
Covington, Churchi ll, Smith, & Covan 1996,Molenaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & 
de Haes 2004,Moms & Ingham 1988,Schou, Ekeberg, Ruland, & Karesen .2 00 2) 
The benefits of good doctor-patient communication and patients' inclusion in decision making 
have been demonstrated, even among those patients with reservations about choosing their 
treatmentj (Fallowfield, Hal l, Maguire, Baum, & A'Hern 1994a) although it is difficult to separate 
the contributions of good communication/information provision and participation in decision 
making to the positive effect. Fallowfield proposed in her follow up study, that optimal 
communication/information was the enhancing factor .(Faliowfield 1997) However evidence from 
a prospective mixed methods study by Deadman et al. investigating the psychological effects of 
breast cancer treatment among women (n=u4), suggest the decisional role provides the 
enhancing impact. Their study comprised questionnaires and interviews a multiple time points 
between preoperative and 15 months post-operatively. Within the subset provided a surgical 
choice (n=80) patients were randomly allocated to take explicit responsibility for their own 
treatment decision (n=41) or receive a strong recommendation from their surgeon after being 
provided with full information about the options (n=39) . Those provided a more autonomy 
exhibited psychological benefit associated with their decision involvement, over and above that 
achieved from undergoing their preferred treatment .(Deadman, Leinster, Owens, Dewey, & 
Slade 2001) 
There is also evidence that partners of women with breast cancer can both benefit from their 
wives' more autonomous involvement in decision making(Ashcroft et al . 1985jMorris & Royle 
1987jMorris and Royle 1988) and experience a negative impact from their partners diagnosis and 
experiencesj (Bigatti et al. 20UjWagner et al. 2006jWagner et al. 2011) with increases in 
depression in this group. (Bigatti, Wagner, Lydon -Lam, Steiner, & Miller 20lljWagner, Bigatti, & 
Storniolo 2006jWagn er, Tanmoy, Bigatti, & Storniolo 2011) Therefore, optimising patients' 
experiences and recovery are an important issue. 
A change in the healthcare provision model 
The culmination of such evidence led to a change in the healthcare provision model of the UK 
National Health Service (NHS) from a paternalistic model where patients were treated as passive 
recipients of a service, to one where patients are considered partners in healthcare decision-
making .(Department of Health 2001ajDepartment of Health 2001c,De partment of Health 
2008j Department of Health 2009jRawling 1992j Royai College Of Surgeo ns Of England 200 2) 
Patients' inclusion in treatment decisions is now enshrined in healthcare . The UK's Department 
of Health (DoH) as NHS funding provider and policy generator, together with doctor's regulatory 
body - the General Medical Council (GMC), clearly state patients should be provided wit h 
adequate time, information and support to make fully informed treatment decisions.(Department 
of Health 2001ajDepartment of Health 2001ciDepartment of Health 2oo9,Generai Medical 
Council 2008i Royal College Of Surgeons Of England 2002) 
The initial therapeutic treatment of primary breast cancer is classic example of a clinical context in 
which preference-sensitive healthcare decision-making is possiblej with patients participat ing in 
treatment decision-making and choosing their preferred options. The adoption of such pract ices 
by specialist breast units preceded the more recent wider adoption of preference -sensitive 
healthcare decision-making by other specialities. The expectation is this approach will improve 
equity in healthcare, as well as optimise patients' satisfaction with both their treatment and the 
delivery of care. (Department of Health 2000iDepartment of Health 2001b, Irw ig & Bennetts 
1997jMcCready, Holloway, Shelley, Down, Robinson, Sinclair, & Mirsky 2005) 
Breast practice guidelines permissive to patient choice but wide variation in practice remains 
With evidence of the benefits of patient involvement in decision making, the optimisation of 
patient involvement in this has become a widespread priority(Assoclatlon of Breast Surgery at 
BASO 2009jB lichert-Toft et al. 1998iDepartment of Health 2001a,Department of Health 
2001CjDepartment of Health 2009jGenerai Medical Council 2008,Kaufmann et al 2010, National 
Collaborating Centre for Cancer 2009iNattinger et al. 1996,Nayfleld et al 1994,Royal College Of 
Surgeons Of England 2002iScarth et al. 2002aiScarth et al. 2002b) which is enshrined within 
law, (Department of Health 2009iNattinger, Hoffman, Shapiro, Gottlieb, & Goodwin 
1996jNayfield, Bongiovanni, Aiciatl, Fischer, & Bergner 1994) international consensus 
statements, (Blichert-Toft, Smola, Catahotti, & O'higgins 1998;Kaufmann, Morrow, von, & Hams 
2010) and national, (Association of Breast Surgery at BASO 2oo9i National Collaborating Centre 
for Cancer 2009iScarth, Cantin, & Levine 2002aiScarth, Cantin, & Levine 2002b) regional and 
breast unit treatment guidelines. Information about treatment variation and survival equality 
between BCT and mastectomy was converted into legislation in US statesj compell ing cl inicians 
to disclose treatment options to breast cancer patients . The first was enacted in 1979·(Nattlnger, 
Hoffman, Shapiro, Gottlieb, & Goodwin 1996, Nayfleld, Bongiovanni, Aictatl , Fischer, & Berg ner 
1994) Treatment guidelines state that when BCT is not contra ind icated on clinical grou nds, 
women with breast cancer should be offered a choice between BCT and mastectomy.(Assoclat lon 
of Breast Surgery at BASO 2oo9;Kaufmann, Morrow, von, & Harris 2010;Scarth, Cant in, & Levine 
2002a) 
It was widely assumed that if breast cancer patients were provided greater patient autonomy in 
treatment selection, the majority would select BCT and practice variation would reduce . 
However, there remains evidence of highly variable practice among hospital breast units, with 
widely varying mastectomy rates (MRs) in the UK(Bates et al 2009,BCCOM 2006,BCCOM 
Steering Group 2007iMoneypenny 2oo4,Sauven et al. 2003,Schooi of Health and Related 
Research 1998) and internationallYi including the US,(Farrow et al. 1992;Mandelblatt et al. 
2000iMorris et al. 2000iMorrow et al. 2001;Nattinger et al. 1992iNattinger and Goodwin 
1994iSamet et al. 1994) Canada, (Goel et al. 1997ilscoe et al. 1994)Japan, (lshlzakl et al. 2002) 
ItalY,(Grilli et al. 1994iScorpigiione et al. 1995) and between countries.(van Nes et al 2010) An 
example of this is illustrated in figure 1.1. The UK DoH expresses concern regarding such images. 
Its documents 'The NHS Cancer Plan'(Department of Health 2000) and 'NHS Performance 
Indicators - A consultation', (Department of Health 2001b) published in September 2000 and May 
2001 respectively, referred to such images as a 'postcode lottery' of treatment, and proposed the 
adoption of breast unit mastectomy to BCS ratios as performance indicators, to discourage 
variation. Thomson's large audit of breast cancer practice variation in Scotland (n=23,786) 
demonstrated an associated between deprivation and MRs; with these being higher among less 
affluent groups. (Thomson et al. 2001) In the US such variation has been associated with race, 
affluence and health insurance. (Goel et al. 2oo5;Morris, Cohen, Sch lag, & Wright 2000,Prehn et 
al. 2002) 
The majority of studies to date demonstrating breast cancer treatment variation conclude that 
significant variation in treatment exists, which cannot be explained by case-mix alone. These 
studies however base their conclusions on aggregated data analysis; amalgamating case 
characteristics across units or hospitals. By combining cases in this way, these studies fail to 
account for the case-mix of individual breast units and thus provide a potentially inaccurate 
representation of practice. They may reflect case-mix variation instead; especially if based on 
small numbers. 
FIGURE 1.1 Variation in MRs between UK Surgeons - BCCOM Project Year 3: The 
management of primary breast cancers diagnosed in 2004 in the UK.(BCCOM 
Steering Group 2007) 
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Practice variation in the Trent region was consistently reported in annual Trent National Health 
Service Breast Screening Programme (NHSBSP) reports produced as part of the Quality 
Assurance (QA) process. A report published in 1998 commissioned by the North Trent Breast 
Cancer Group produced by the School of Health and Related Research (ScHARR), demonstrated 
variation in unit practice among both screen and symptomatically detected breast cancers from 
the Trent region (1995 and 1997); with a similar but exaggerated pattern of variation among the 
symptomatically detected group.(School of Health and Related Research 1998) The report failed 
to include information on primary cancer characteristics, so it is unclear whether this reflects the 
tendency of symptomatically detected cancers to present at a larger size and more advanced 
stage, than screen-detected ones. 
Patients' preferences for treatments vary 
There is strong evidence of the variability of patients' personal preferences fo r the t wo t reat ment 
optionsi some provided with an informed choice electing to have BCT, (Colllns et al 2oo9,Degner 
et al. 1997aiKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996jMastagiia and 
Kristjanson 2001jMoienaar, Oort, Sprangers, Rutgers, Luiten, Mulder, & de Haes 2004,Schou, 
Ekeberg, Ruland, & Karesen 2002) others mastectomy.(Collins, Moore, Clay, Kearlng, O'Connor, 
Llewellyn-Thomas, Barth, Jr., & Sepucha 2009jHack, Degner, Watson, & Sinha 2006jJanz et al 
2004iKeating et al. 2002jLantz et al. 2005jMoienaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & 
de Haes 2004iMoyer & Salovey 1998jSchou, Ekeberg, Ru land, & Karesen 2002,Street, Jr. & VOigt 
1997) Patients' healthcare decisions are subject to many influences. In the context of breast 
cancer, at the t ime of diagnosis women possess pre-existing values, concerns and 
information(Faliowfield, Baum, & Maguire 1986jHughes 1993jLasry and Margolese 1992) which 
can influence their treatment preferencesj including prior information and experience of breast 
cancer, (Hughes 1993jMoienaar, Oort, Sprangers, Rutgers, Luiten, Mulder, & de Haes 2004jNo id 
et al. 2000jSchou, Ekeberg, Ruland, & Karesen 2002) body image values, (Carver et al 
1998;Collins, Moore, Clay, Keanng, O'Connor, Llewellyn -Thomas, Barth, Jr., & Sepucha 
2oo9;Hawley et al. 2oo9;Mandelblatt, Hadley, Kerner, Schulman, Gold, Dunmore -Griffith, Edge, 
Guadagnoli, Lynch, Meropol, Weeks, & Winn 2000;Molenaar, Oort, Sprangers, Rutgers, LU lten, 
Mulder, & de Haes 2004j Moyer 1997;Nold, Beamer, Helmer, & McBoyle 2000,Schou, Ekeberg, 
Ruland, & Karesen 2002jSmitt and Heltzel 1997;Wei et al. 1995) cancer recurrence fears(Colilns, 
Moore, Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr., & Sepucha 2009jFaliowfield, 
Baum, & Maguire 1986,Lasry & Margolese 1992;Molenaar, Oort, Sprangers, Rutgers, LUlten, 
Mulder, & de Haes 2004iSchou, Ekeberg, Ruland, & Karesen 2002,Wilson, Hart, & Dawes 1988) 
and attitudes towards radiotherapy.(Col lins, Moore, Clay, Keanng, O'Connor, Llewellyn -Thomas, 
Barth, Jr., & Sepucha 2009;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 
1996;Molenaar, Oort, Sprangers, Rutgers, Luiten, Mulder, & de Haes 2004,Schou, Ekeberg, 
Ruland, & Karesen 2002) Other issues associated with patients' surgical preferences are soc ial 
responsibilities(Smltt & Heltzel 1997;Wilson, Hart, & Dawes 1988) and inconvenience of 
treatment regimens such as travel for radiotherapy; (Sm ltt & Heltzel 1997,Wdson, Hart, & Dawes 
1988) the latter being amplified in isolated rural areas (Australia (Mastaglla & KrIStjanson 2001 ) 
and Canada(Bathe and Brosseuk 1997;Goel, Ollvotto, Hislop, Sawka, Coldman, & Holowaty 
1997))· 
It has been proposed that during the decision-making process, patients make t rade-offs between 
their values, fears and information, and that the option chosen is governed by wh ich potential 
loss or fear is paramount to the individual. For example, whether fear of breast loss or fea r of 
cancer recurrence or death predominate .(Fallowfleld, Baum, & Maguire 1986iLasry & Margolese 
1992jMoienaar, Oort, Sprangers, Rutgers, Luiten, Mulder, & de Haes 2004iNold, Beamer, Helmer, 
& McBoyle 2000iSmitt & Heltzel 1997) Debate exists regarding whether such a "trade-off 
hypothesis" exists.(Fallowfield, Baum, & Maguire 1986iLasry & Margolese 1992) If it does exist, 
factors within consultations such as clinician's presentation of information and whether or not 
patients' particular concerns or knowledge inaccuracies are addressed, might influence patients' 
trade-offs and impact their decisions. 
The influence of age, (Bleicher et al. 2008jHawley et al 2007iMoienaar, Oort, Sprangers, Rutgers, 
Luiten, Mulder, & de Haes 2004jSingh et al. 2mo) race/culture(Bleicher, Abrahamse, Hawley, 
Katz, & Morrow 2008iHawley, Lantz, Janz, Salem, Morrow, Schwartz, Liu, & Katz 2007iHawley, 
Griggs, Hamilton, Graff, Janz, Morrow, Jagsi, Salem, & Katz 2009) and education(Blelcher, 
Abrahamse, Hawley, Katz, & Morrow 2008jHawley, Lantz, Janz, Salem, Morrow, Schwartz, LIU, & 
Katz 2007jSingh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 
2010) on breast cancer decision making are not clear. Audits of large datasets of treatment 
practice provide a conflicting picture. The evidence for an impact of education is stronger; some 
studies demonstrate when education level is corrected, age and race are no longer associated 
with MR variation. (Singh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & 
Degner 2010) Therefore education may be the key variable influencing these other factors . 
There is also evidence that patients' preferences are influenced by media information 
portrayal. (Collins et a/. 1999,Hughes 1993jKotwall, Maxwell, Covington, Churchtll, Smith, & Covan 
1996jMcKiniay et al. 1997jNattinger et al 1998) For example an epidemiological study from the 
US demonstrated a significant upsurge in MRs following Nancy Regan's mastectomy for breast 
cancer. (Nattinger, Hoffmann, Howell -Pelz, & Goodwin 1998) This was most notable among 
women of a similar age and sustained for several years. 
In recognition of varying patient preferences, lack of superiority of a spec if ic treatment and 
demonstrable benefit of including patients in their treatment decisions, providing women with 
surgical choices for the management of their breast cancer is a recognised priorit y in pat ient ca re. 
Patients' decision-making styles vary 
Patients' preferences for involvement in healthcare decision-making vary. The most common ly 
adopted terms are decision making preferences (DMP) or decision making styles (DMS). Three 
main patient DMS are described in the literaturej active, collaborative and passive . Act ive 
decision-makers want to make their own healthcare decisions, collaborative decision-makers to 
share the responsibility, and passive decision-makers to defer it to others . These are often 
assessed using adapted versions of an instrument designed by Strull (Strull et al . 1984) and 
subsequently popularised(Beaver et al. 1996, Beaver et al 1999, DaVison and Degner 
2002;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Nei l, Bi lodeau, Watson, & Muel ler 
1997a;Hawley, Lantz, Janz, Sa lem, Morrow, Schwartz, Liu, & Katz 2007,Janz, Wren, Copeland, 
Lowery, Go ldfarb, & Wil kins 2oo4;Lantz, Janz, Fagerlin, Schwartz, LIU, Lakhani, Sa lem, & Katz 
2005jSingh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 
2010;Wallberg et al. 2000) by Degner (the Control Preferences Scale) .(Degner and Sloan 1992) A 
version of this five point DMS instrument is illustrated in chapter 4, figure 4.1. 
Studies conducted in the 1990'S reported that women with breast cancer preferred and achieved 
predominantly passive or collaborative roles in the selection of their surgery; with 50 to 70% 
preferring or achieving a passive role, and 20 to 30% a collaborative role. (Beaver, Luker, Owens, 
Leinster, Degner, & Sloan 1996;Bilodeau and Degner 1996;Luker et al. 1996b,Slngh, Sloan, 
Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) The only study 
examining UK breast cancer patients' (n=150) DMS using the Degner card sort technique, 
demonstrated 20% had an active preferred DMS (PDMS), 28% a collaborative and 52% a passive 
PDMS. (Beaver, Luker, Owens, Lelnster, Degner, & Sloan 1996) The literature suggests the 
healthy public tend to possess predominantly active PDMS, (Deber et al 1996;Degner & Sloan 
1992;Levinson et al 2005;O'Donnell and Hunskaar 2007a;O'Donnell and Hunskaar 
2007b;Rothenbacher et al. 1997) and that individuals diagnosed with a chronic(Deber et al 
2007jGiordano et al 2008jLevinson, Kao, Kuby, & Th lsted 200s; O'Donnell & Hunskaa r 
2007a;Rothenbacher, Lutz, & Porzsolt 1997) or life-threatening disease(Beaver, Luker, Owens, 
Leinster, Degner, & Sloan 1996,Butow et al 1997; Deber, Kraet schmer, Urowlt z, & Sharpe 2007) 
their PDMS shifts away from the more autonomous preferences toward more passive 
preferences. Beaver and Degner conducted a series of studies into PDMS among a variety of 
patient and non-patient groups around the same time period . Their stud ies demonstrated the 
predominant PDMS was active (64%) among healthy cont rols,(Degner & Sloan 199 2 
collaborative (46%) among those with benign breast disease, (Beaver, Luker, Owens, Lelnster, 
Degner, & Sloan 1996) and passive DMS (52%) among women newly d iagnosed with brea st 
cancer. (Beaver, Luker, Owens, Leinster, Degner, & Sloan 1996) Butow's study conducted around 
the same time supports this; demonstrating as patients' cancer prognosis worsens their PDMS 
shifts increasingly toward the more passive group.(Butow, Maclean, Dunn, Tattersall, & Boyer 
1997) However, other studies among breast cancer patients exploring DMS in palliati ve 
treatment, fail to demonstrate a passive shift .(Grunfeld et al. 2006,Rothenbacher, Lutz, & 
Porzsolt 1997) 
Recent studies from North America, (Janz, Wren, Copeland, Lowery, Goldfarb, & Wilkins 
2oo4;Lantz, Janz, Fagerlin, Schwartz, Liu, Lakhani, Salem, & Katz 200S,Slngh, Sloan, Atherton, 
Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) Australia (Mastaglia & 
Kristjanson 2001) and Hong Kong(Lam et al. 2003) suggest a reversal in the pattern of 
predominant passivity; with increased proportions preferring and achieving more active roles in 
breast cancer surgery decisions. For example Mastaglia's retrospective survey of consecutive 
women with early stage breast cancer diagnosed over a 6 month period in 1996-1997, who were 
identified through the Western Australia Cancer Registry (n=2so/376), demonstrated 54% 
possessed an active PDMS for their breast cancer treatment, 36% a collaborative PDMS and 8% a 
passive PDMS.(Mastaglia & Kristjanson 2001) Singh et al. performed a meta-analysis on North 
American cancer patient DMS data (n=3276) . They demonstrated a similar but less marked shift 
in DMS away from a predominantly passive PDMS of older studies. The meta-analysis showing 
26% had an active PDMS, 49% collaborative and 25% a passive PDMS.(Singh, Sloan, Atherton, 
Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) 
Patient demographics have been variously associated with PDMS; more active PDMS associated 
with female gender, (Singh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, 
& Degner 2010) younger age(Arora and McHorney 2000;Cassileth et al. 1980, Deber, Kraetschmer, 
Urowitz, & Sharpe 2oo7;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, 
& Mueller 1997a,Hawley, Lantz, Janz, Salem, Morrow, Schwartz, LIU, & Katz 2007,Slngh, Sloan, 
Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010, Wallberg, 
Michelson, Nystedt, Bolund, Degner, & Wilking 2000) higher educat ion (Deber, Kraetschmer, 
Urowltz, & Sharpe 2oo7,Degner, KristJanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, 
& Mueller 1997a,Hawley, Lantz, Janz, Salem, Morrow, Schwartz, LIU, & katz 200l,Slngh, SIOd"", 
Atherton, Smith, Hack, Huschka, Rummans, Clark! Diekmann, & Degner 2010, Wallbe rg, 
Michelson, Nystedt, Bolund, Degner, & Wilking 2000)and affluence .(Hack et al 1994) However, 
not all demonstrate an age association .(Ble lcher, Abrahamse, Hawley, Katz, & Morrow 
2008;Kenne lly and Bowling 200l;O'Connor et al. 2oo3a) The fam ilia ri t y of decision making 
context may also exert an effect. For example Deber demonstrated a reduction in the PDMS of 
patients with chronic diseases, when they were asked to make a treatment decision in unfamiliar 
disease context, as opposed to one in their chronic disease.(Deber, Kraetschmer, Urowltz, & 
Sharpe 2007) 
There is evidence that patients benefit from being involved in treatment decisions; with increases 
in satisfaction with their treatment and the process of its selection .(Bruera et al. 2002; Degner, 
Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,Hack, Degner, 
Watson, & Sinha 2006;Janz, Wren, Copeland, Lowery, Goldfarb, & Wilkins 2oo4,Keatlng, 
Guadagnoli, Landrum, Borbas, & Weeks 2002;Lam, Fielding, Chan, Chow, & Ho 2oo3,Lantz, Janz, 
Fagerlin, Schwartz, Liu, Lakhani, Salem, & Katz 200s;Mastaglia & Kristjanson 2001;Slngh, Sloan, 
Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) The re is 
contention about whether an active achieved OMS (ADMS) per se is benefic ial (Hack, Degner, 
Watson, & Sinha 2006jJanz, Wren, Copeland, Lowery, Goldfarb, & WilkinS 2oo4,Keatlng, 
Guadagnoli, Landrum, Borbas, & Weeks 2002;Lam, Fielding, Chan, Chow, & Ho 2oo3,Lantz, Janz, 
Fagerlin, Schwartz, Liu, Lakhani, Salem, & Katz 2005) or whether achieving congruence between 
ADMS and PDMS provides the most benefit in optimising short and long term recove ry and 
satisfaction, and minimising regret .(Hack, Degner, Watson, & Sinha 2006;Janz, Wren, Copeland, 
Lowery, Goldfarb, & Wilkins 2004jKeating, Guadagnoli, Landrum, Borbas, & Weeks 2002,Lam, 
Fielding, Chan, Chow, & Ho 2003jLantz, Janz, Fagerlln, Schwartz, LIU, Lakhani, Salem, & Katz 
2005) Hack demonstrated improvements in these at three years, among pat ients with breast 
cancer (n=2So) achieving a more active DMS; including statist ica lly sign if icantly better long t erm 
psychological adjustment, quality of life (GoL), and superior physica l and social 
functioning .(Hack, Degner, Watson, & Sinha 2006) Charles demonstrated an ampl ificat ion of the 
positive effect of involvement in decision ma king when congruence was achieved between 
patients' PDMS and ADMS .(Charles et al. 1999a) 
Studies demonstrate cli n icia ns often m isallocate pat ients' decision making preferences . Bilodeau 
& Degner 1996; Bruera et al 2001 Bruera Willey Palmer, & Rosa les 2002,Butow et , , , 
2004jDegner, KristJan son, Bowman, Sloan, Carriere, O'Neil , Bilodeau, Watsol', & Mueller 
1997ai Gyse is and Higginson 2007iHughes 1993iJanz, Wren, Copeland, Lowery, Goldfarb, & 
Wi lkins 2004;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Montgomery and 
Fahey 2001i O'Connor et al. 2003b;Rlchards, Ram irez, Degner, Fallowfle ld, Maher, & Neuberger 
1995jRothenbacher, Lutz, & Porzsolt 1997,Strull, Lo, & Charles 1984) A large Canadian study 
(n=1012) among women with breast cancer found only 42% believed they ach ieved their 
PDMS.(Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 
1997a) This impacts on satisfaction; with dissatisfaction expressed among those who on 
reflection, feel they were excluded from the decision process (B liodeau & Degner 1996,Degner, 
Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,Hack, Degner, 
Watson, & Sinha 2006;Rothenbacher, Lutz, & Porzsolt 1997) or asked to undertake a more active 
role than preferred.(Hack, Degner, & Dyck 1994;Hack, Degner, Watson, & Sinha 2006,Schain 
1980) 
It has been suggested that if women were provided with greater control in the selection of the ir 
surgery, MRs would fall, as women would wish to conserve their breasts. However there is no 
clear evidence to support this supposition : Some studies demonstrate significantly greater 
proportions of those preferring and achieving active roles in the selection of their surgery choose 
BCT, (Collins, Moore, Clay, Keari ng, O'Connor, Llewellyn-Thomas, Barth, Jr., & Sepucha 
2oo9;Degner, Kristjanson, Bowman, Sloan, Carnere, O'Neil, Bilodeau, Watson, & Mueller 
1.997ajKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996, Mastagl la & Kristjanson 
2001j Moienaar, Oort, Sprangers, Rutgers, Luiten, Mulder, & de Haes 2004;Schou, Ekeberg, 
Ruland, & Karesen 2002) others demonstrate more active DMS are associated with an increase 
uptake of mastectomy.(Collins, Moore, Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr., & 
Sepucha 2009iHack, Degner, Watson, & Sinha 2006;Janz, Wren, Copeland, Lowery, Goldfarb, & 
Wilkins 2004iKeating, Guadagno li, Landrum, Borbas, & Weeks 2002,Lantz, Janz, Fagerlin, 
Schwartz, Liu, Lakhani, Salem, & Katz 200s,Mo ienaar, Oort, Sprangers, Rutgers, LUlten, Mu lder, 
& de Haes 2oo4;Moyer & Salovey 1998jSchou, Ekeberg, Ruland, & Karesen 2002,Street, Jr & 
Patients becoming informed 
Three types of support needs have been identified for adaption to occur among ind ividua ls 
experiencing stressful situations; emotional, tang ible and informational. C;chae·e' et al 1981 
When diagnosed with a benign disease(Cassileth, ZUpklS, Sutton -Smith, & March 1980, DavIs et 
al. 1999j Deber, Kraetschmer, & Irvine 1996jJenkins et al. 2001jJones et al 1999, Strull, Lo, & 
Charles 1984) or cancer, (Bliodeau & Degner 1996jBlanchard et al 1988,Butow et al 
1996jCassileth, Zupkis, Sutton -Smith, & March 1980,Chen et al. 2008jDavison et al. 199s,Degner, 
Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,FuJImon and 
Uchitomi 2oo9;Galloway et al. 1997;Graydon et al. 1997jHack, Degner, & Dyck 1994,Jenklns, 
Fallowfield, & Saul 2001;Jones, Pearson, McGregor, Gilmour, Atkinson, Barrett, Cawsey, & 
McEwen 1999iLuker et al. 1996a;Meredith et al. 1996,Sutherland et al 1989jVogei et al 2008a) 
patients often desire extensive information . Miller described two types of patient information 
seeking behaviours and preferences . 'Monitors' were information seekers who gained 
psychological benefit from information. 'Blunters' who were information avoiders who wanted to 
be shielded from pertinent diagnosis and treatment information .(Mlller et al. 1988) Although 
information acquisition IS a prerequisite for more active participation In dec ision 
making,(Bilodeau & Degner 1996;Blanchard, Labrecque, Ruckdesche l, & Blanchard 
1988;Fridfinnsdottir 1997;Hack, Degner, & Dyck 1994) patients' information seeking behaviour 
does not necessarily correlate with their PDMS .(Blanchard, Labrecque, Ruckdeschel, & Blanchard 
1988;Cassileth, Zupkis, Sutton-Smith, & March 1980;Cox et al. 200SjDaVISOn, Degner, & Morgan 
199s;Ende et al . 1989;Fallowfield 2008jHack, Degner, & Dyck 1994,Strull, Lo, & Charles 
1984;Sutherland, Llewellyn -Thomas, Lockwood, Tntchler, & Till 1989) Some seem to adopt it as 
a coping strategy rather than a prelude to more active participation in decision-
making.(Blanchard, Labrecque, Ruckdeschel, & Blanchard 1988jCassileth, ZUpklS, Sutton -Sm ith, 
& March 1980;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Muel ler 
1997ajHack, Degner, & Dyck 1994;Mdler, Brody, & Summerton 1988) 
Some studies demonstrate certain patient demographics are associated w ith higher information 
needs; such as younger age(Cassileth, ZUpklS, Sutton -Smith, & March 1980) higher 
education(Cassileth, Zupkis, Sutton -Smith, & March 1980,Janz, Wren, Copeland, Lowery, 
Goldfarb, & Wilkins 2004) and greater affluence. (Meredlth, Symonds, Webster, Lamont, Pyper, 
Gillis, & Fallowfield 1996) There is a mixed picture regarding associations between info rmat ion 
needs and severity of illness; some demonstrate a reduction with increased severity of il lness, 
others fail to demonstrate and association .(Blanchard, Labrecque, Ruckdeschel, & Blanchard 
1988jDaVIS, Hoffman, & Hsu 1999,Jenklns, Fallowfleld, & Saul 2001) 
Studies demonstrate that patients primarily want their information needs met verba lly through 
communication with their treating clinicians.(Bilodeau & Degner 1996,Cassileth, Zupkls, Sutton -
Smith, & March 1980;Meredith, Symonds, Webster, Lamont, Pyper, Gillis, & Fallowfleld 1996) 
They also show clinicians often underestimate patients' information needstBruera, Willey, 
Palmer, & Rosales 2002;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, 
& Mueller 1997a;Jones, Pearson, McGregor, Gilmou r, Atkinson, Ba rrett, Cawsey, & McEwen 
1999;Laine et al. 1996;Richards, Ramirez, Deg ner, Fa llowfleld, Maher, & Neuberger 199s,Strull, 
Lo, & Charles 1984;Suhonen et al. 2005) and that even when efforts are made to provide 
adequate information, patients' recall is impaired in life threatening situations .(Clmpnch 
1993;Hughes 1993) Information absorption is hindered when individuals are provided information 
they find difficult or unpleasant, (Butler and Hai ley 1996) or when they are overwhelmed by the 
provision of an excess of statements in a single consultation .(Faliowfleld 2000) Despite such 
potential barriers to patients' absorption and recall of information in situations like a new cancer 
diagnosis, the information patients do recall can persist and gain importance over time; patients 
quoting their clinicians verbatim .(Faliowfleld 2000) 
Despite the potential limitations of recall, the provision of treatment information is frequently 
limited to the time of diagnosis, as patients are unable to receive their diagnosis without some 
discussion of management and prognosis. To counter such barriers, Fallowfield proposed 
' ... information needs to be given systematically, at the right time and via several different routes, 
to maximise the chances for patients to understand the implications and make really informed 
choices.'(Faliowfield 1997) The breast care nurse (BCN) role has been developed as an integral 
component of the breast cancer speciality clinical team in the UK, to facilitate the provision of 
information and support to patients follow ing diagnosis. Much of their time is initially spent 
ensuring patients acquire sufficient information to participate in treatment decisions. As options 
and their complexity increase, this is likely to gain importance. 
Clinicians can also benefit from awareness that patients' recall is better with information provi ded 
at the start of a consultation, and if it is related to topics or issues su bject ively priori t ised by the 
patient.(Faliowfi eld 2000) 
How patients' options are decided 
National guidelines state the therapeutic options of UK patients diagnosed wit h breast cancer 
should be routinely discussed and decided at individual case level by Multi-D isc ipl inary Teams 
(MDTs).(Association of Breast Surgery at BASO 2009) Patients are provided opt ions based on 
evidence-based treatment guidelines utilising cancer characteristics, patient characteristics and 
co-morbidities as variables. Guidelines are designed to be flexible, to optimise patient 
involvement in decision-making. In addition to cancer variables known to influence survival (i .e. 
cancer size), the anticipated aesthetic outcome of the options are considered : For instance, BCT 
for a 40mm diameter cancer might be anticipated aesthetically unfavourable in a small breast, 
which could influence the team/clinician's operative preference or recommendation . 
Although groups of clinicians in the form of MOTs determine patients' options, the actual 
presentation of these is by individual clinicians . If presented with options, patients ' decisions are 
based on their personal preferences and knowledgej much of which arises from discussion in 
consultations with their treating clinicians (doctors and nurses). Currently there is limited 
information on these consultations and how they influence patients treatment decisions. It is 
possible clinicians portray their own particular preferences in these consultations. 
What are clinicians' preferences for decision-making and treatment? 
Studies suggest clinicians' preferences and recommendations are associated with cancer 
characteristics, patient characteristics and clinician characteristics .(Col ltns, Kerrigan, & Anglade 
1999jGrill i, Scorpig lione, Nicolucci, Mainini, Penna, Man, Belfi gllo, & Liberati 199 4,L lberatl et al 
1987;McKinlay, Burns, Durante, Feldman, Freund, Harrow, IrISh, Kast en, & Moskowitz 1997) 
However limited information is available on clinicians' preferences; whether they hold spec if ic , 
treatment preferences which might influence their consultations . Most stud ies available are 
based on practice audits or clinicians' stated preferences to clinical vignettes.(Gril ll, Scorplgllone, 
Nicolucci, Mainini, Penna, Mari, Belfigl io, & Liberati 1994, Llberat l, Patterson, Blener, & McNeil 
1987,McKinlay, Burns, Durante, Feldman, Freu nd, Harrow, IrISh, kasten, & Moskowitz 1997) 
These note variability in clin icians' preferences within this theoret ical conte xt, bu t deduce little 
else . 
A large mixed methodology st udy of US breast cli nicians (n=128) suggested considerab le 
variation in clinicians' treatment recommendations, based on their responses to video 
presentations of diagnostic scenarios. In these pat ient characteri st ics such as age, ethn icit y, 
socio-economic status, assertiveness and med ical co morbidit ies varied . Cl inicians' 
recommendations were assocl·ated w·th th· I I f I elr eve 0 experience and medico-lega l 
awareness.(McKinlay, Burns, Durante, Feldman, Freund, Harrow, Irish, Kasten, & Moskowlt: 
1997) The study however did not provide more information than th is, and t he design did not 
permit demonstration of whether such preferences were reflected in cl inic ians' actual pract ice 
patterns. 
Many studies into clinician preferences were conducted among conven ience samples rather th an 
specialists in the field of interest.(Colilns, Kerrigan, & Anglade 1999,Ende et al 1990, Porter and 
McMul kin-Tait 2004) For example Collins et.al. conducted a su rvey among a convenience sample 
of 40 staff and resident surgeons in a single US hospital in 1998; the cl inicians were not breast 
specialists and 26 of the 40 participants were male. They were asked to imag ine t hey were 
diagnosed with breast cancer and 50% said they would have a mastectomy.(Co llln s, ~emgan, & 
Anglade 1999) Such studies may be interesting and highlight a personal or clinician bias toward a 
particular treatment. However, as the sample of clin icians stud ied had no invo lvement in breast 
cancer treatment, any revealed preferences would be unl ikely to impact on actual patient 
decision making . The findings are therefore of doubtful cl inical relevance to understanding 
specialist clinicians' preferences and practice in the f ield of breast cancer.(Co liln s, Kerrigan, & 
Anglade 1999iMcKinlay, Burns, Durante, Feldman, Freund, Harrow, IrISh, Kasten, & Moskowitz 
The hospital influence has been investigated, and a confl ict ing pictu re is seen regarding whether 
surgeons' years of experience and hospital unit itself affect t reatment pract ice . Iscoe's large 
Canadian cohort study conducted in the early 1990S among 14,570 women newly diagnosed with 
breast cancer demonstrated variation in MRs was not related to breast un it workload, pat ient , 
age, presence of on-site adjuvant therapies or size of t own in which t reatment took place . The 
only factor strongly linked with practice patterns, was t he ind ividual hosp ital 's exist ing 
practice. (lscoe, Goel, Wu, Fehringer, Holowaty, & Naylor 1994) Comparing the surgical treatment 
of breast cancer in two Canadian provinces in 1991, Goel demonstrated stat ist ica lly si gnif icant 
lower MRs among patients treated by more recently qualified surgeons or those with an academic 
affiliation .(Goel, Ol lvotto, Hislop, Sawka, Coldman, & HoloV\atv ... Qq7 Portpr M "Iklf 1 a 
2 004) These differences may reflect the ir con duct against a ba ckdrop of changing medical 
evidence; the study was conducted around the time conc lusive evi dence was emerging of survival 
equivalence with BCT and mastectomy. A few studies illustrate higher BCT rates among female 
surgeons.(Gi ll igan et al. 2oo7iMandeibiatt et al 2001iSchou, Ekeberg, Ruland, & Karesen 2002 ) 
Another issue to consider is how patients and clinicians might influence each other's behavi our in 
consultations and decision making. Krupat et .al. conducted a study among US doctors (n=128) 
viewing videotaped consultations with simulated breast cancer patients . Patients had ident ical 
clinical presentations but differed in assertiveness, socio-economic status, education and race . 
Clinicians' preferences varied with disadvantage and race, but moderately assertive behaviour by 
disadvantaged patient groups independently moderated clinician 's behaviour to provide more 
careful diagnostic testing .(Krupat et al . 1999) The study was however conducted among a 
predominantly non-specialist grouPi only 25% having 'some' breast cancer practice in the 
preceding 5 years. 
Communication is more than just words 
Communication is defined as the 'the imparting or exchanging of information by speaking, 
writing, or using some other medium' (Oxford English Dictionary) . Mehrabain demonstrated that 
what is perceived from a communication interaction is more complex than this definition 
suggests. (Mehrabian 1972) The perception of the receiver of communication is not simply a 
duplication ofthe overt verbal articulation of the intended message . According to Mehrabain, the 
vocalised words of communication comprise only a small a component (iVa) of a commun icated 
message. The more substantial impacts on what the receiver perceives comes from the 
nonverbal elements of communication such as positive and negative reinforcing noises (the 
umms, ah-hahs) and tone of voice (38%), and body language (55%). He also demonstrated that 
inconsistencies between the verbal and nonverbal elements of communicat ion, can result in 
confused interpretation of the articulated verbal message.(Mehrablan 1972 ) 
Doctor-patient communication and decision making approaches 
Two broad clinician consultation styles are described in the literaturei doctor-centred and patient -
centred. (Coulter 1999iCouiter et al. 1999iElwyn et al. 1999i Elwyn et al 2000,Elwyn 
2008iMcWhinney 1989iSilverman et al. 1998) The patient-centred style encourages patient 
participation in the consultation, involves the provision of explanations in plain Engl ish and 
focuses on the impact of the disease on the individual patient. In contrast, doctor-centred 
communication focuses on disease pathology, adopts bio-medicallanguage and tends to exclude 
non-disease factors that may be of importance to the patient. Studies demonstrate patient-
centred consultation styles and tailored decision making are preferred by patients(Dowsett et al 
2000iFrederikson 1995i Lerman et al. 1993iMaguire 1999iVIck and Scott 1998) and associated 
with better patient psychological outcomes.(Gnggs et al. 2oo7,Lerman, Daly, Walsh, Resch, Seay, 
Barsevick, Birenbaum, Heggan, & Martin 1993, Roberts et al. 1994) 
There is also a recognised spectrum of decision making approaches. Various terms are used for 
these, but for the purposes of this study we use the terms paternalism, shared decision making 
and informed choice.(Charles, Whelan, & Gafnl 1999a,Charies et al 1999b,Charles et al. 
2000iCouiter 1999,Coulter, Entwistle, & Gilbert 1999,Elit et al 2003, Elwyn, Edwards, Gwyn, & 
Grol1999i Elwyn, Gray, & Clarke 2000;Elwyn 2008iGafni et al 1998,McWhlnney 1989,Silverman, 
Kurtz, & Draper 1998) Paternalism and informed choice lie at the 2 ends of the spectrum. In 
paternalistic decision making, consultations are primarily disease focused and clinicians assume 
the dominant rolei making decisions for patients. At the other end of the spectrum is informed 
choice . In this patients are left without any guidance to make a purely autonomous decision, 
having been provided with what is considered 'sufficient' correct information . Just as paternalism 
uniformly assigns patients a passive role in decision making irrespective of their potential 
preferences, so the informed choice model uniformly assigns patients an active (but unsupported) 
role. Though these approaches suit some patients, their untailored application is not sensitive to 
patients' POMS. Between these extremes lies shared decision making, which theoretically 
enables a more tailored approach. This may involve a number of consultations between pat ients 
and clinicians. Shared decision making comprises a two way exchange of information, a period of 
deliberation by the patient, interspersed with further discussions with their clinicians plus others . 
Following this, patients declare their decision, and patient and clinic ian agree and implement a 
mutually acceptable treatment plan. The three decision making approaches are outlined in figure 
1.2. 
FIGURE 1 . 2 Classic decision making approaches 
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decision making 
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Adapted from 'What do we mean by partnership in making decisions about treatmenfl ' Cathy 
Charles, Tim Whelan, Amiram Gafni BMJ 1999;319;780-782 
UK guidelines regarding informed consent to medical treatment published by the 
DoH, (Department of Health 200la/Department of Health 200lc,Department of Health 200g) 
Royal College of Surgeons on England (Royal College Of Surgeons Of England 2002) and 
GMC, (General Medical Council 2008) are most consistent with the patient -centred consu ltation 
style and shared decision making approach. Although there is an impetus to promote sh ared 
decision making in cancer management, there is currently limited lite rature exploring sha red 
decision making specifically in acute crisis situations like breast cancer diagnosis consu lt at ions; 
where newly diagnosed often distressed patients, are asked to make a high sta kes decision with in 
a relatively short timeframe (often 1 to 2 weeks) . Most studies to date reporting benefit s 
associated with shared decision making have explored this in chron ic stable disease cont exts, 
such as hypertension, diabetes and cardiovascular disease etc. (Ch arles, Gafnl, & Whelan 
1999bjDeber, Kraetschmer, & Irvine 1996jDeber, Kraetschmer, Urowltz, & Sharpe 2oo7,Quili and 
Brody 1996) 
If presented with options, patients' decisions are based on their personal preferences and 
knowledgej much of which arises from discussion in consultations with the treat ing clinicians 
(doctors and nurses). Currently there is limited information on these consultations and how they 
influence patients' treatment decisions. 
Who has the power in consultations? 
The issue of power and communication within consultations is complex. Although patient 
preferences are recognised to influence decision making, the influence of the treating clinician 
cannot be overlooked. The evidence suggests clinicians exert a powerful influence over patients' 
treatment decisions.(G ort et al. 2oo7,Johnson et al 1996,Katz et al 2001,Kotwa ll, Maxwe ll , 
Covington, Churchill, Smith, & Covan 1996j Molenaar, Oort, Sprangers, Rut gers, LUlten, Mulder, & 
de Haes 2004jMorrow et al. 2009iNold, Beamer, Helmer, & McBoyle 2ooo,Schou, Ekeberg, 
Ruland, & Karesen 2oo2,Sm itt & Helt zel 1997) 
In 1974 Lukes theorised the existence of complex power relationships guiding behaviour and 
decisions. He described three potential levels of power relationships .(Lukes 1974) Canter 
transposed Lukes' theory to the clinician-patient interaction in the healthcare setting . He 
suggested that first dimensional power involves clinicians blatantly controlling patients decisions 
or actionsj second dimensional power involves clinicians' exerting their influence in a more subtle 
way by control agendas, deliberately steering interactions and subjugating patients through the 
provision of insufficient clinical time, poor ambience, poor listening skills etc. Canter suggests 
third dimensional power comprises clinicians exerting a more imperceptible influencei clinicians 
supply the medical knowledge underpinning patients' understanding and pe rcept ions, they 
therefore control patients' actions and choices. He argues that suggests third dimensional power 
can be difficult to recognise as it is so pervasive and connected with widely held knowledge itself, 
that patients can falsely believe they are behaving autonomously. -ant er 2(,01 
This theory has not been specifically explored in the context of breast cancer . However the 
evidence suggests patients' decisions are influenced by clinicians' overt recommendations and 
patients' perceptions of their preferences, (Johnson, Roberts, Cox, Relntgen, Levine, & Parsons 
1996jKatz, Lantz, & Zemencuk 2001iKot w all, Maxwell, Covington, Churchill, Smith, & Co, an 
1996iMoienaar, Oort, Sprangers, Rutgers, Lu iten, Mulde r, & de Haes 2oo4;Morrow, Jagsl, 
Alderman, Griggs, Hawley, Hamilton, Graff, & Katz 2009; Nold, Beamer, He lmer, & McBoyle 
2000iSchou, Ekeberg, Ruland, & Karesen 2002;Sm ltt & Heltzel 1997) along with the ir perception 
of treatments' curative potential. (Katz, Lantz, & Zemencuk 2001,Kotwall, Maxwell, Covington, 
Churchill, Smith, & Covan 1996;Smitt & Heltzel 1997) The practice audits and quantitative 
questionnaire studies reporting these findings, attribute a powerful influence to clinicians ' 
preferences, but provide little detail of underlying factors or the mechanism of influence. 
Why variation in breast cancer surgery is an important issue 
Though the incidence of breast cancer is been increasing, mortality rates are reducing (B lamey et 
al. 2007;Coleman et al. 1999;Coleman et al 2oo4, Hack, Degner, Watson, & Sinha 
2006jM andeibiatt et al. 2003,Office of National Stat istics 200s,Rachet et al 2oo9, Street, Jr & 
Voigt 1997) and women are surviving longer following their diagnosis. Based on current 
predictions, 64% of UK women diagnosed with breast cancer at this time point will be alive at 20 
years, compared with 44% diagnosed in the early 1990s.(Coleman, Babb, Damleckl, Gro sc laude, 
Honj o, Jones, Knerer, Pltard, QUinn, Sloggett, & De Stavola 1999;Hac k, Degner, Watson, & Sinha 
2006;Mandelblatt, Edge, Meropol, Sen ie, Tsangans, Grey, Pete rson, Jr., Hwang, Kerner, & Weeks 
2003; Office of National Statisti cs 200s,Rachet, Mannge, Nur, Quaresma, Shah, Wood s, Elli s, 
Walters, Form an, St eward, & Coleman 2009,Street, Jr & VO igt 1997) Optimising patient 
experiences and QoL in survivorship are therefore crucial; as the physical and psycho-social 
impacts of cancer diagnosis and treatment have a more protracted effect. The evidence 
demonstrates patient inclusion in treatment decision making provides patients with short and 
long term psychological benefits.(Andersen, Bowen, Morea , Ste in, & Baker 2oo9,Deadmdl', 
Lern st er, Owens, Dewey, & Slade 2001,Faiiowfi eld, Ha ll , Maguire, Baufl1, & A Her n 
1994a;Faliowfi eld, Hall , Magu ire, & Baum 1990,Fallowfl eld, Hall , Maguire, Bauni, & A'H rn 
1994b; Hack, Degner, Watson, & Sinha 2006, Kot wall , Maxwe ll , Covrngton, (f'urchll, '::>rnlth, 
Covan 1996;Mo lenaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & de Haec, 2004,Morw) '" 
Ingham 1988 jMorris & Royle 1987jMoyer 1997;Moyer & Salovey 1998,Schou, Ekebe rg, Ruland, & 
Karesen 2002jStewart 1995jStreet, Jr. & Voigt 1997, Wilson, Hart, & Daw es 1988, Wo lberg 199 0) 
Therefore the provision and support of this role would seem especially important in the surg ica l 
treatment of breast cancers where patient preferences for different treatments are known to 
vary, (Carver, Pozo-Kaderman, Price, Noriega, Hams, Derhagoplan, Robinson, & Moffat, Jr 
1998jCoilins, Moore, Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr., & Sepucha 
2oo9;Faliowfield, Baum, & Maguire 1986jHawley, Griggs, Hamilton, Graff, Janz, M orrow, Jags l, 
Salem, & Katz 2009jHughes 1993jKotwall, Maxwell, Covington, Churchill, Smith, & Covan 
1996jLasry & Margolese 1992jMandeibiatt, Hadley, Kerner, Schulman, Gold, Dunmore -Griffith, 
Edge, Guadagnoli, Lynch, Meropol, Weeks, & Winn 2000jMoienaar, Oort, Sprangers, Rutgers, 
Luiten, Mulder, & de Haes 2004iMoyer 1997,Nold, Beamer, Helmer, & McBoyle 2000,Schou, 
Ekeberg, Ruland, & Karesen 2002;Smltt & Heltzel 1997, Wei, Sherry, Baisden, Peckel, & Lala 
1995iWilson, Hart, & Dawes 1988) but no single treatment is associated with a definitively more 
favourable outcome, as is found in the treatment in a large proportion of breast cancers (those 
under scm diameter) .(Bllchert-Toft, Brlncker, Andersen, Andersen, Axe lsson, Moundsen, 
Dombernowsky, Overgaard, Gadeberg, Knudsen, & 1988iCIarke, Collin S, Darby, Davie s, 
Elphinstone, Evans, Godwin, Gray, Hicks, James, MacKinnon, McGale, McHugh, Peto, Taylor, & 
Wang 2ooSjFisher, Anderson, Bryant, Margolese, Deutsch, Fi sher, Jeong, & Wolmark 
2002jJacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatsteln, & 
Okunieff 1995jLichter, Lippman, Danforth, Jr, d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & . 1992j Poggi, Danforth, SCiuto, Smith, Steinberg, Llewehr, Menard, 
Lippman, Lichter, & Altemus 2003iSarrazin, Le, Amagada, Contesso, Fontaine, Spielmann, 
Rochard, Le, & Lacour 1989,van Dongen, Voogd, Fentlman, Legrand, Sylvester, Tong, van der, 
Helle, van Zijl, & Bartelink 2000;Veronesi, Casclnelll, Mariani, Greco, Saccozzl, LUln l, Aguilar, & 
Marubinl2002) Yet despite guidelines(Assoclatlon of Breast Su rgery at BASO 2oo9,Department 
of Health 2001a;Department of Health 2001c,Department of Health 2oo9, Generai Medi cal 
Council 2008jNationai Collaborating Centre for Cancer 2oo9,Roya i Co llege Of Su rgeons Of 
England 2002jScarth, Cantin, & Levine 2002a, Scarth, Cant in, & Levine 2002b) and 
laws(Department of Health 2oo9,Nattinger, Hoffman, Shapi ro , Gottl ieb, & GoodWin 
1996jNayfield, Bongiovanni, Aiclati , Fischer, & Berg ner 1994) with a focus on providing choices 
where possible, there remains evidence of persistent highly variable practice among hospital 
breast units, with widely varying MRs.(Bates, Keanrls, Monypenny, L -3qord, L a '\oren e 
2009jBCCOM 2006,BCCOM Steering Group 2007, Fa rlow, Hunt, & Samet 199 2 ,Goe l, 01 ot , 
Hislop, Sawka, Cold man, & Holow aty 1997jGrilli, Scorplgllone, NlcolucCl, Malnlnl Penna Marl 
, , , 
Belfig lio, & Liberati 1994jlscoe, Goel, Wu, Fehringer, Holowaty, & Naylor 1994,Ishlzakl, Imanaka, 
Hirose, Kuwabara, Ogawa, & Harada 2002,Mandeibiatt, Hadley, kerner, Schulman, Gold, 
Dunmore-Griffith, Edge, Guadagnoll Lynch Meropol Weeks & W M 
, , , , Inn 2000, oneypenny 
2004jMorris, Cohen, Schlag, & Wright 2000jMorrow, White, Moughan, Owen, PaJack, Sylvester, 
Wil son, & Winchester 2001jNattinger, Gottlieb, Veum, Yahnke, & Goodwin 199 2 ,Nattlnger & 
Goodwin 1994jSamet, Hunt, & Farrow 1994jSauven, Bishop, Patnlck, Walton, Wheeler, & 
Lawrence 2003iScorpigiione, Nicolucci, Grilli, Angiolmi, Belflgllo, CarinCl, Cubasso, Fdardo, 
Labbrozzi, Mainini, & . 1995ivan Nes, Seynaeve, Jones, Markopoulos, Putter, van, V, Hasenburg, 
Rea, Vannetzel, Diri x, Hozuml, Kerin, Kie back, Meershoek -Klem Kranenbarg, Hille, & Nortler 
201.0) 
The gap in knowledge 
Although the medical literature contains much about the impact of patient factors on treatment 
decisions, (Carver, Pozo-Kaderman, Price, NOriega, Ham s, Derhagoplan, Robinson, & Moffat, Jr 
1.998;Collins, Moore, Clay, Kearrng, O'Connor, Llewellyn -Thomas, Barth, Jr, & Sepucha 
2oo9;Faliowfield, Baum, & MagUi re 1986;Hawley, Grrggs, Hamilton, Graff, Janz, Morrow, Jagsl, 
Salem, & Katz 2oo9; Hughes 1993,Kotwall, Maxwell, Covington, Church ill, Sm ith, & Covan 
1.996;Lasry & Margolese 1992;Mandelblatt, Hadley, Kerner, Schulman, Gold, Dunmore -G riffith, 
Edge, Guadagnolr, Lynch, Meropol, Weeks, & Wlnn 200o,Moienaar, Oort, Sprangers, Rutgers, 
Luiten, Mulder, & de Haes 2004;Moyer 1997,Nold, Beamer, Helmer, & McBoyle 2000, Schou, 
Ekeberg, Ruland, & Karesen 2002, Smltt & Heltzel 1997, Wei, Sherry, Baisden, Peckel, & Lala 
1.995, Wilson, Hart, & Dawes 1.988) it is hard to imagine this can fully account for the differences in 
treatment patterns noted among patients treated by different hospita ls breast un it s. matE's, 
Kearrns, M onypenny, Lagord, & Lawrence 2009,BCCOM 2006,BCCOM Steering Group 
2007iFarrow, Hunt, & Samet 1992,Goel, Ollvotto, Hislop, Sawka, Coldman, & Holowaty 
1997,Grrlll, Scorpigllone, Nlcoluccl, Malnlnl, Penna, Marl, Belflgl,o, & Llberat 199 ,ISlOE', r Jo I, 
Wu, Fehrrnger, Holowaty, & Naylor 1994,Ishlzakl, Imanaka, Hirose, ~ uwabard, ( ga ',d, & Harada 
2002,Mandeibiatt, Hadley, Kerner, Schu lman, Gold, Dunmore-Griff ~r, Edge, GLJdda ]nol ,L .... ( I, 
Meropo l, Weeks, & Wlnn 2ooo,Moneypenny 2004,MoIIIS, Cohen, ScriaC'J, & WI ght L 0 ),Morl :", 
White, Moughan, Owen, PaJack, Sylvester, Wilson, & W nchec,ter ' d t 1 t' J t' p .!. r , 
Yahnke, & Goodwin 1.992jNattinger & Goodwin 1.994,Samet, Hunt , & Fa rrow 1994,Sau en, 
Bishop, Patnick, Walton, Wheeler, & Lawrence 2003,Scorplgiione, Nlcoluccl, Grill, Anglolln', 
Belfiglio, Carincl, Cubasso, Filardo, Labbrozzl, Maln inl, & 1995, van Nes, Seynaeve, Jones, 
Markopoulos, Putter, van, V, Hasenburg, Rea, Vannetzel, Dlflx, Hozuml, Kerin, Kleback 
Meershoek-Klein Kranenbarg, Hille, & Nortier 2010) Clinicians and the breast un it or hosp ita l 
have been demonstrated to exert a powerful influence on patient decisions and practice 
patterns.(Gort, Broekhuls, Otter, & Klazinga 2oo7,Johnson, Roberts, Cox, Re lntgen, Lev ne, & 
Parsons 1.996jKatz, Lantz, & Zemencuk 2001.j Kotwall, Maxwel l, Covington, Churchill, Smit h, & 
Covan 1.996jMoienaar, Oort, Sprangers, Rutgers, LU lten, Mulder, & de Haes 2oo4,Morrow, Jag sl, 
Alderman, Griggs, Hawley, Hamilton, Graff, & Katz 2009,Nold, Beamer, Helmer, & McBoyle 
2000jSchou, Ekeberg, Ruland, & Karesen 2002jSmltt & Heltzel 1997) However, little is current ly 
known about the surgical treatment preferences of specialist breast clinic ians or the extent to 
which individual clinicians' treatment preferences and consultation skills combine with the patient 
factors noted, to contribute to patients' decision-making in breast cancer. Furthermore, stud ies 
at the onset of this programme of research centred purely on doctors and did not include the 
specialist BCN group. The evolving role of the specialist BCN within the breast MDT, in 
educating, informing and supporting patients, makes the inclusion of this occupational group 
mandatory in any study of clinician influences on pat ients' treatment decisions. 
RESEARCH QUESTIONS 
• 
• 
• 
• 
To what extent does inter-unit variation in the su rgical t reatment of breast cancer persist 
after correction for case-mix? 
Do clinician preferences influence patients' dec ision making in breast cancer) 
How do clinicians influence patients' decision making in the light of t reatment guide lines) 
. . . f t · ·th the decision maki ng experi ence influenced by the above) How IS patient satls ac Ion WI 
An inductive process was employed to identify the characteristics of the dec· . k· ISlon ma mg process 
influencing the 2 dependent variables; surgical decision and patient satisfact ion with their 
decision. 
Primary end points 
• To identify the patient and clinician factors influencing choice of surgery in women with 
breast cancer in Trent. 
To identify whether the above, influences patient satisfaction with decision making. 
STUDY AIM AND OBJECTIVES 
Aim 
To identify whether variation in the initial therapeutic treatment of breast cancer, suggested by 
UK NHSBSP reports, persists following correction for case-mix and caseload; and identify 
whether specialist breast clinicians (doctors and nurses) possess particular treatment preferences 
which impact on patient consultations, treatment decisions and therefore MRs. 
Objectives 
• Identify whether inter-unit variation in the surgical treatment of breast cancer persists 
after correction for case-mix. 
• 
• 
• 
Identify whether clinicians possess preferences which inf luence patients ' decision-making 
in breast cancer, and in what way. 
Identify how clinicians influence patients' treatment decisions in t he light of guidelines. 
Identify how patient satisfaction with the decision-making experience is influenced by th e 
above. 
Adaption of the original wording of study research questions & objectives 
At the outset of the studYI the study's research questions and object ives were stated in language 
more consistent with a purely quantitative approachi incorporating the term 'extent' . These 
were modified as the project progressed l to more accurate ly reflect the more qual itat ive 
exploration of the issues conducted within this programme of research . 
The original wording ofthe research questions and objectives are shown below: 
Original research questions 
• To what extent does inter-unit variance in the surgical treatment of breast cancer pe rsist 
after correction for case-mix? 
• Do clinician preferences influence patients' decision making in breast cancer) 
• To what extent do clinicians influence patients' decision making in the light of treatment 
guidelines? 
• To what extent is patient satisfaction with the decision making process influenced by the 
above? 
Original research objectives 
• 
• 
• 
• 
Identify whether inter-unit variation in the surgical treatment of breast cancer persists 
after correction for case-mix. 
Identify whether clinicians' preferences influence patients' decision -making in breast 
cancerl and in what way. 
Identify the extent of clinicians influence on patients' decision-making in the light of 
treatment guidelines. 
Identify the extent to which patient satisfaction w ith the decision-making experience is 
influenced by the above. 
STUDY OUTLINE 
This thesis first explores whether breast unit case-m ix and case load explain variat ion in hospita l 
breast unit MRs in a large UK region . It then goes on to invest igate pe rsistent MR variat ion from 
key stakeholder perspectives (patient, specialist doctor and BCN) employing a combination of 
quantitative and qualitative methodologies; includ ing a Discrete Choice Experiment (DCE) 
among all the regions' breast units to investigate clinic ian preferences. In three un its with 
confirmed high, medium and low MR practice, validated questionnaires are used to explore 
patients' roles and preferences for decision involvement using an information needs and decis ion 
making questionnaire (IDMQ), and patient and clinician beliefs, preferences and interactions are 
explored using one to one semi-structured interviews. Figure 1.3 out lines t he study components. 
STEERING GROUP 
Steering group meetings were held t hree t imes a year over t he period of study design and 
recruitment . The members comprised nine ind ividuals w ith multidisciplinary skill s: 
• 
• 
• 
• 
• 
Two surgeons: M iss Lisa Caldon (LC) and Professor Malcolm Reed (MWR) 
Two qualitative researchers : Dr Karen Coll ins (KC), Mr David Wilde (DW) 
Two health servi ces researchers: Professor Sam Ahmedzai (SA) and Dr Bill Noble (BN) 
A statistician : Professor Stephen Walters (SW) 
And two consumer representatives: Mrs Hazel Marshall -Cork (HMC) and Mrs Gill ian 
Speed (GS) . 
PROJECT DEVELOPMENT 
h did by LC and MWR util ising t he expertise of steering The programme of researc was eve ope , . . 
d h t deve lop specif ic components of the study: SA and BN (Interv iews); group members an ot ers 0 . . 
. . d f t quest ionna ire)' SW (observationa l audit, DCE, patient 
Dr Tony Stevens (interviews an pa len , 
questionnaire)j Professor John Brazier (DCE)j Professor Chris McManus (psycho log ica l sca les 
within the clinician questionnaire). 
CONSUMER INVOLVEMENT 
This research study was developed with the assistance of t wo consumer representat ives from the 
North Trent Cancer Research Network Consumer Research Panel, HMC and GS. In addit ion to 
reviewing and advising on the study design, ind ividual components and documents, they 
participated in the early phase of thematic data analysis of the qual itat ive aspect of t he study. 
SAMPLE 
The study was conducted in the Trent region of the UK, which unt il recently was one of the eight 
National Health Service regions of England and Wales. Si tuated geographicall y in the ce ntre and 
east of England, it has a population of around 5 million, approximately 2,500,000 women. (O ffl ce 
for National StatistiCS 2003) At the time of study design, Trent had one of the con sist ently 
highest overall NHSBSP detected MRs of the UK regions. Over the 3 year period between 1.997/8 
and 1.999/2000 the regions' NHSBSP reports demonstrated a fall in the reg ions' median MR (from 
45% to 33% respectively) to approach the National median (30%) . However, sign if icant inte r- unit 
variation remained (21.% to 46% in 1.999/2000). Th is pattern of inter-un it treatment variat ion 
demonstrated within the region reflected the level of vari at ion observed at Nation al level in 
NHSBSP reports over the same time period . 
STUDY COMPONENTS 
The regions ' spec ialist breast surgery practice was compri sed of 1.4 NHS hospita l breast units and 
1.1. NHSBSP screen ing unitsj some screen ing units covering the geographic area of two hosp ital 
b . Th bast NHS units possessed simi la r routine practice gU idelines and had reast units. e 1.4 re 
similar access to radiotherapy and breast reconstruction . Samp les depended on the specific 
component of the programme of research (see Figure 1.3 and table 1.1): 
• The observational audit sample comprised all National Health Se rvice Breast Screen ing 
Programme (NHSBSP) detected breast cancers detected w ithin the Trent region between 
April 1997 and April 2002 (n=s060). 
• The DCE sample comprised all permanent specialist members of the Trent breast un its 
(doctors and nurses) n=98. 
• The clinician interview, and patient questionnaire and interv iew samples were recru ited 
from three purposively selected hospital breast units reflecting the range of residual 
treatment variation following case-mix correctionj high medium and low MR practice . 
The clinician interview sample represented all permanent members of the three brea st 
units' teams. Patients were purposively identified by their specialist clinicians as having 
been offered a choice of initial therapeutic treatment (BCT and mastectomy). A self-
selected subgroup of patients recruited to the questionnaire phase agreed to participate 
in semi-structured interviews. 
ETHICS AND RESEARCH GOVERNANCE 
The study is Multi-centre Research Ethics (MREC) approved (Trent MREC/02/4/114), and 
underwent Local Research Ethics (LREC) and Research Governance approva l in all participating 
NHS Trusts. LREC approval was granted under the clause 'N o local researcher guidel ines, and 
therefore does not require LREC approval ' for the breast units purely participating in the clinician 
aspects of the research study . The LREC & Research governance reference numbers and approval 
dates are found in appendix 1. 
FUNDING 
h f d d by Cancer Resea rch UK and th e Royal Co ll ege of This programme of researc was un e 
f E I 
d through the award of resea rch trainin g Fell owshi ps . The Royal College of 
Surgeons 0 ng an , 
Surgeons of England part co- fun ded t he observational aud it and cl inici ans ' Discrete Cho ice 
Experiment. Cancer Research UK funded the remainder of the study . 
DISCLAIMERS 
Cancer Research UK and the Royal College of Surgeons of England played no role in study design; 
collection, analysis or interpretation of t he dat a; or the preparation of the thesis . The views 
expressed are those of LC and not necessarily those of Cancer Research UK and the Royal College 
of Surgeons of England. 
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Chapter 2 
Case-mix adjustment audit 
Case-mix fails to explain variation in mastectomy rates: 
management of screen-detected breast cancer in a UK region 
1997-2003 
ABSTRACT 
Background Wide variation in the surgical management of breast cancer exists at hospita l, 
regional, national and international level. To demonstrate whether variation in surg ical pract ice 
observed at aggregate level between breast units pers ists following adjustment for case-mix, 
individual patient-level data from the Trent Breast Screening Programme Qua lity Assurance 
database (1997-2003) was ana lysed . 
Method Expected case-mix adjusted MRs were derived by logist ic regression using the 
variables cancer size, site and grade, patient age and year of presentation, employing the region's 
overall case-mix adjusted practice as the reference population . 
Findings The region's 11 breast screening un its detected 5109 (3989 invasive) surgically 
managed primary breast cancers over the six year period. 1828 mastectomies were performed 
(MR 35.8%, 95% Confidence Interval : 34.5% - 37.1%). Significant variation in MRs observed 
between units (range 25% - 45%, P<0.0001), persisted following case-mix adjustment (P<0.0001). 
Two-fold variation in observed to expected unit MR coefficient is demonstrated overall (range 
0.66 - 1.36), increasing to almost four-fold in cancers less than 15mm diameter (range 0·55 - 1·95) · 
Conclusion Significant variation in surgery for screen -detected primary breast cancer is not 
explained by case-mix. Further research is required to investigate potential patient and clin ician 
causative factors. 
BACKGROUND 
Variation in the surgical management of early breast cancer is widespread (Bates, Kearlns, 
Monypenny, Lagord, & Lawrence 2009iBCCOM 2006iBCCOM Steenng Group 2007, Farrow, Hunt, 
& Samet 1992iGoel, OllvOttO, Hislop, Sawka, Cold man, & Holowaty 1997,Gnlll, Scorplgllone, 
Nicolucci, Mainini, Penna, Mari, Belfigllo, & Liberati 1994ilscoe, Goel, Wu, Fehnnger, Holowaty, & 
Naylor 1994ilshizaki, Imanaka, Hirose, Kuwabara, Ogawa, & Harada 2002,Mandelblatt, Hadley, 
Kerner, Schulman, Gold, Dunmore-Griffith, Edge, Guadagnoll, Lynch, Meropol, Weeks, & Wmn 
2000iMoneypenny 2004iMorris, Cohen, Schlag, & Wright 2000iMorrow, White, Moughan, Owen, 
Pajack, Sylvester, Wilson, & Winchester 2001i Nattinger, Gottlieb, Veum, Yahnke, & Goodwin 
1992iNattinger & Goodwin 1994iSamet, Hunt, & Farrow 1994iSauven, Bishop, Patnick, Walton, 
Wheeler, & Lawrence 2003iScorpigiione, Nicolucci, Grilli, Angiolinl, Belfigllo, Canncl, Cubasso, 
Filardo, Labbrozzi, Mainini, & . 1995ivan Nes, Seynaeve, Jones, Markopoulos, Putter, van, V, 
Hasenburg, Rea, Vannetzel, Dirlx, Hozumi, Kerin, Kleback, Meershoek-Klein Kranenbarg, Hille, & 
Nortier 2010) and viewed as an inequality in healthcare. It has been highlighted in DoH 
documents as a reflection of a 'postcode lottery' of care .(Department of Health 2000,Department 
of Health 2001b) The adoption of mastectomy to BCT ratios as performance indicators of breast 
unit practice have been suggested to discourage variation .(Department of Health 2001b) 
However, most previously published studies highlighting variation base their conc lusions on 
aggregated data analysisi amalgamating case characteristics across units or hospita ls. Utili si ng 
raw treatment rates or combining cases in this way, they fail to account for the case-mix of 
individual units and provide a potentially misleading impression of practicei especially among 
small units. 
Until recently, Trent was one of the eight NHS regions of England and Wales. Situated 
geographically in the centre and east of England it has a population of around 5 million, with 
approximately 2,500,000 females .(Office for National Statistics 2003) The UK NHSBSP was 
established in 1988. At the time of the study it invited all women aged 50 to 64 to attend for 
routine three yearly mammography. The eligible screening population in Trent was 441,000. 
National and regional guidelines exist for the management of breast cancer in the UK now, but at 
the time of the study no national guidelines existed and each unit possessed their own set. These 
were designed to be permissivei their content and wording intended to facilitate optimal 
collaboration between patients and their clinicians in decision -making . Mastectomy was 
indicated where patient safety would be compromised by less extensive surgeryi for example 
where the cancer is large (usually over 4-5cm diameter), multi-focal (multiple areas in more than 
one quadrant of the breast), or where contraindications to radiotherapy exist which would 
compromise disease control and survival with BeT. Relative indications for mastectomy were 
lobular cancer, multi-centric cancer (multiple areas within a single quadrant of the breast), centra l 
cancer, BeT likely to result in an un-acceptable aesthetic outcome, and BeT where radiotherapy is 
likely to be associated with un-acceptably high complication risks . Guidelines also state patient 
preference is an indication for mastectomy, and larger cancers can undergo BeT when cancer to 
breast size ratio permits an acceptable aesthetic outcome and survival and local recurrence risks 
are understood and accepted . 
The aim of this component of the study was to demonstrate whether variation in surgical practice 
observed at aggregate level between units over the Trent region in screen detected and 
symptomatic primary breast cancers, (School of Health and Related Research 1998) persisted 
following adjustment for the characteristics of cases managed by the individual units. 
METHODS 
This observational study analysed OA data collected by the Trent Breast Screening Programme 
on women diagnosed with breast cancer as part of the UK NHSBSP between Aprill997 and April 
2003 . These databases are an established part of the OA process of the NHSBSP, contain 
externally validated data and demonstrate high quality. Individual patient-level data from the 
database was anonymised prior to conversion into an SPSS data file . The password-protected 
database and outputs were stored securely. 
Since the main outcome of treatment data was binary, i.e . whether or not the woman had a 
mastectomy, multiple logistic regression with SPSS for windows version ll .O was employed to 
analyse the dataset at individual patient level to confirm whether observed unit level variations 
persisted following adjustment for case-mix (cancer size, site, patient age) and year of treatment. 
For the purposes of this study, maximum cancer size was defined as the greatest recorded 
diameter (invasive or non-invasive) where cancers comprised both invasive and non-invas ive 
components. Year of treatment was included as a variable to reflect changes in evidence -based 
practice over time . Age, maximum cancer size and year of diagnosis were t reated as cont inuous 
covariates. Cancer grade was categorised into invasive grade 1, 2 and 3, and non- invasive. Cancer 
site was grouped into central and non-central. 
Applying the logistic model at an individual patient level using Trent as the reference populat ion, 
the individuals' probability of undergoing a mastectomy within the region was calculated given 
their clinical covariates. Expected individual screening unit MRs were calculated by the 
summation of individual patient-level probabilities of undergoing a mastectomy across that 
particular unit. The ratio of observed to expected mastectomies for each breast screening unit 
were then calculated for each breast unit. Observed to expected ratios above 1 .0 suggest that 
after adjustment for case-mix, the unit has a higher than expected MR compared to the average 
(using overall case-mix adjusted practice in Trent as the reference population) . Conversely, 
observed to expected ratios below 1.0 suggest a lower than expected MR compared to the 
average. 
Case-mix adjustment was performed twice . The first analysis incorporated the variables cancer 
size, cancer site, patient age and year of screening. The second included cancer grade in addit ion . 
The first analysis reflects information uniformly available prior to surgical decision-making in all 
the region's units, and thus the variables upon which operative options are based . Cancer grade is 
documented pre-operatively in a proportion of cases, and if known, may influence guideline-
based treatment decision-making in certain units. 
FINDINGS 
During the period April 1997 to April 2003, 792,570 women were screened by Trent's 11 Breast 
Screening Units, incorporating 13 static sites and 9 mobile diagnostic units. Over the six-year 
period 5179 primary breast cancers were diagnosed through the programme, 5109 (3989 invasive) 
were managed surgically, 70 did not undergo surgery. Advanced disease or 'other clin ica l factors ' 
were stated as the reason for not undergoing surgery in the majority of cases . These cases were 
distributed evenly over the region's units (p = 0.50) . 
Breast units' performance over the si x-year period was aggregated . Annual fluctuations were 
inherent within most services. 
Table 2.1. describes the characteristics of the cancers detected by the Trent Breast Screening 
Program over the six-year period . Between 1.997 and 2003, 1.828 mastectomies were performed, 
giving an overall Trent region MR of 35.8% (95% CI : 34.5 to 37.1.%). 
TABLE 2.1. Clinical characterist ics of Trent Breast Screening Program Quality Assurance 
database patients 1.997 - 2003 (n=51.09) 
Age at diagnosis (years) 5109 59.1 58.8 6 .2 45 ·3 95.0 
Maximum cancer size (mm) 5062 18·5 15 .0 14·3 0 ·5 220.0 
Financial Year 1997/1998 65 2 12.8 
1998/1999 802 15·7 
1999/2000 799 15.6 
2000/2001 917 17·9 
2001/2002 866 17.0 
2002/2003 1073 21.0 
Total (n) 5109 100 
Overall type of surgery BCT 3281 64.2 
Mastectomy 1828 35.8 
Total (n) 5109 100 
Invasive status Invasive & mixed 3989 78 .1 
Non-invasive only 1120 21·9 
Total (n) 5109 100 
Cancer size (mm) <15 23 29 46 .0 
~15-<20 995 19·7 
~20-<30 1.060 20·9 
~30-<50 480 9·5 
~50 198 3·9 
Total (n) 5062 100 
Cancer site Central/nipple region 288 5.6 
Non-central 4818 94·5 
Total (n) 5106 100 
Cancer grade Non invasive 1120 22 .2 
Invasive grade 1 1209 23 ·9 
Invasive grade 2 1870 37.0 
Invasive grade 3 854 16·9 
Total (n) 5053 100 
Table 2.2 and figure 2.1 illustrate observed unit MRs and those expected following case-m ix 
adjustments for all cancers (n=5060). Table 2 presents the absolute values. Sign if icant variat ion 
in MRs is illustrated across the 11 units, with individual un it MRs rang ing from 25% to 45% 
(P<0.0001). Expected rates derived by logistic regression, using the reg ion's overall case-m ix 
adjusted practice as the reference population, demonstrate a two-fold variation in rat io of 
observed to expected unit MR (range 0.66 to 1.36). Units 6 and 10 demonstrate statist ica lly 
significant lower (34%) and higher (36%) than expected rates respectively. In add it ion Unit 4 
exhibits a 13% higher observed to expected MR ratio, though th is just fa ils to reach stat istical 
significance as the lower 95% confidence interval (CI) is exactly 1.00. 
Figure 2.1 presents the same data graphically as a box and whiskers plot. The observed: expected 
ratios of the 11 individual breast screening units are represented by the boxes and the whiskers 
represent the 95% CI. Boxes located on y=1.0 line demonstrate observed MR equalling that 
expected by the unit's case-mix (based on the overall practice of the Trent region). Boxes located 
above the y=1.0 line demonstrate MRs higher than expected for the case-mix, and boxes below 
y=1.0 line represent lower than expected MRs for the case-mix. Whiskers which do not traverse 
the y=1.0 line are statistically significant. From this graphical presentation it can be seen that two 
hospitals have statistically significantly high and low MRs. 
When case-mix data analysis was repeated including the cancer grade variable, 105/5109 (2%) 
cases were excluded due to missing or incomplete data. Comparison of the results of the two 
forms of data analysis revealed no difference in the ratio of observed to expected unit MRs when 
case-mix adjustment included or excluded cancer grade as a variable. Thus the observed 
variation in MRs across the 11 screen ing units demonstrated in Trent cannot be accounted for by 
cancer size, site or grade, patient age or year of screening. 
TABLE 2.2 Observed vs. Expected MR by screening unit 1997-2003: All cancers 
1 209 89 42.6 77 1.15 (0.93 -1.42) 
2 310 106 34. 2 114 0·93 (0.76 - 1.12) 
3 415 159 38.3 138 1.15 (0.98 - 1·35) 
4 723 250 34.6 221 1.13 (1.00 - 1.28) 
5 367 148 40.3 139 1.06 (0.90 - 1.25) 
6 840 213 25·4 321 0.66 (0.58 - 0.76) 
7 345 118 34.2 124 0·95 (0.79 - 1.14) 
8 253 94 37.2 79 1.19 (0.96 - 1.46) 
9 916 390 42.6 367 1.06 (0.96 - 1.17) 
10 235 106 45.1 78 1.36 (1.11 - 1.64) 
11 447 140 31.3 155 0.90 (0.76 - 1.06) 
Trent 5060 1813 35.8 1813 1.00 
The expected numbers at each Breast Screening Unit are based on adjusting each unit's case-mix for 
age, cancer site, cancer size, year of screening. 
49 patients excluded due to missing data. 
Observed MR range 25-45% 
Mx = mastectomy 
FIGURE 2.1 Observed: Expected MRs all Trent NHSBSP all cancers 1997-2003 
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o RATIO 
The expected numbers of each screening unit are based on adjusting each unit's case-mix for 
patient age, cancer site, and invasive cancer grade and year of screening. 
Mean Trent MR for all cancers (y=1.0) 3S·8% 
n=s060, 49 excluded due to missing data 
Cancer size 87% less than 30mm diameter, 92% less than 40 mm diameter 
TABLE 2.3 Observed vs. Expected MR by screening unit ~997 - 2003 : Cancers < ~5mm 
diameter 
1 96 24 25.0 20 ~ . 22 (0.78 -1.82) 
2 ~48 26 ~7 · 6 30 0.86 (0.56 - 1.26) 
3 ~92 40 20.8 35 ~ · ~4 (0.82- 1.56) 
4 4~7 82 ~9 ·7 79 ~ . 03 (0.82- 1.28) 
5 ~36 28 20.6 25 ~ · ~3 (0·75 - 1.64) 
6 323 33 ~0 . 2 60 0·55 (0.38 - 0·77) 
7 ~42 27 ~9 · 0 27 0·99 (0.65 - 1.14) 
8 ~31 27 20.6 26 ~ . 06 (0.70 - 1·54) 
9 405 87 2~·5 83 ~ . 05 (0.84 - 1.29) 
10 ~~~ 38 34.2 20 ~ · 95 (1.38 - 2.67) 
11 ~92 30 ~5 · 6 37 0.80 (0·54 - 1.14) 
Trent 2293 442 ~9 · 3 442 ~ . oo 
The expected numbers at each Breast Screening Unit are based on adjusting each unit's case-mix for 
age, cancer site, cancer grade and year of screening. 
36 patients excluded due to missing data. 
Mx = mastectomy 
Forty-six percent (2329/5062) of patients had small cancers (less than ~5mm diameter). The 
overall MR in this sub-group was ~9.3% (442/2293); 95% CI : ~7 . 9 to 2~.~%, and practice aga in 
varied significantly (p<o . ooo~) across the n units (MR ~o% to 35%). Within this sub-group, an 
almost four-fold variation in observed: expected MR ratio between breast units was 
demonstrated (range 0.55 to ~ .95) . Although in this sub-group of very small cancers, the majority 
of breast screening units' observed MRs were closer to those expected than was demonstrated in 
the analysis of all cancers. Table 2.3 and Figure 2.2 demonstrate variation in MRs for smal l (l ess 
than ~5mm diameter) cancers. 
FIGURE 2.2 Observed: expected MRs all Trent NHSBSP cancers < :1.smm diameter :1.997- 2003 
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o RATIO 
The expected numbers of each screening unit are based on adjusting each unit's case-mix for 
patient age, cancer site, and invasive cancer grade and year of screening. 
Mean Trent MR for cancers less than :1.smm diameter (y=:1..o) :1.9 ·3% 
n=2293 
36 excluded due to missing data 
DISCUSSION 
The strength of th is component of the study lies in the analysis of a high qual it y externally 
validated database, and the analysis of patient data at an ind ividual level. By co rrecting fo r case -
mix and comparing observed and case-mix adjusted MRs, a unit's MR is effect ively adj usted for 
any variation in the type of cases presenting to them. To our knowledge this is the f irst study of 
this type demonstrating persistent breast cancer surg ica l t reatment vari at ion. The study 
demonstrates that variables other than those included in the case-mix adjustment (cancer size, 
cancer site, cancer grade, patient age and year of presentation) are responsible for the variation in 
treatment observed. 
The conclusions drawn from this study are based purely on breast cancers detected by the breast 
screening programme and do not include those diagnosed through the symptomatic breast 
service. Thus the data analysis only accurately reflects unit practice in the screen-detected 
subgroup, where the majority of women (82%) are aged 50 to 64 and have re lative ly sma ll 
cancers. (BCCOM Steering Group 2007) Although this study does not present information on the 
non-screen-detected breast cancer population, it is probable that symptomatic and screen ing 
practice is similar, as patients are treated by the same team of surgeons and BCNs. However, 
there is a possibility that the inter-unit variation in MR demonstrated by th is study may be 
atypical of women with breast cancerj reflecting variability only within the screened subgroup. 
However a study performed at a similar time, highlighted a comparable pattern of treatment 
variation at breast unit level among cancers presenting to the UK symptomatic breast 
service. (Moneypenny 2004jNHS Cancer Screening Programmes and Association of Surgeons at 
BASO 2004jSaUVen, Bishop, Patnick, Walton, Whee ler, & Lawrence 2003) The Moneypenny 
study included only those cancers presenting symptomatically over a 6 or 12 month period 
(financial year 2001 to 2002), to 85 UK breast units (n=7750 cases primarily surgically treated). The 
study presents raw uncorrected MR data with a MR range of 19 and 100%. Over the group, higher 
MRs were noted among larger cancers, but no correction for case-mix was performed . 
For completeness, further research is ideally needed to determine whether or not un it variation 
exists in the non-screen-detected population. The acquisition of this type of high quality and 
comprehensive data is however a problem. Currently there is no national requirement to collect 
such detailed data on cancer and patient characteristics and treatment . Therefore breast unit 
databases containing this type of data are extremely variable in both the ir data fields and 
completenessj making such ana lyses difficult, if not impossible . 
There are several potential limitations to this type of study and analysis. One is the use of an 
inappropriate data set with large amounts of missing data. We believe the study described uses 
robust dataj the data has been rigorously aud ited by the QA serv ice and val idated both externall y 
and by the surgeons of the originat ing breast units. In areas audited by the study t he data was 
98% complete; 109 cases (2%) were excluded from the analysis due to missing or incomplete 
data. 
Overall cancer size used in the analysis performed was determined histologically, rather t han 
being the radiological cancer size . Evidence suggests histological size and radiological cancer si ze 
correlate well, with good reliability of radiological assessment of cancer size based on ultrasound 
and mammography. (Pa in et al. 1992) It is recognised however that the treatment decision would 
have been based on the radiological cancer size, and that the use of histological cancer size has 
the potential to over or under represent this. 
The present study employed overall Trent screen-detected breast cancer population (1997-2003) 
as the reference population . An argument could be made that the reference population should be 
the overall treated UK NHSBSP population. This would require access to individua l level data of 
the entire treated UK screen-detected population, and though the absolute level of observed to 
expected coefficients may have altered, the degree of variation between un its' coefficients would 
not. 
Another potential limitation of the study is that observations are based on the data of a sing le UK 
region. Trent as a region and its units may be atypical of other UK regions and their units. There 
is however evidence that such MR variation occurs throughout the UK at both regiona l and unit 
level, and in both symptomatic and screen-detected practice,(Associatlon of Breast Surgery at 
BASO 200S;Association of Breast Surgery at BASO 2009,Moneypenny 2004,Sauven, Bishop, 
Patn ick, Walton, Wheeler, & Lawrence 2003;School of Health and Related Research 1998) to a 
similar degree as that identified in Trent. These are explored in the discussion . 
It could be argued that the study concentrated on a small number of cancer characteristics and 
patient's age. Screening year was included as a proxy for time changes in ev idence-based 
practice. It is recognised that clinical factors other than those included in the study's case-mix 
adjustment analysis, could fully or partially explain the pattern of treatment variation observed . 
The variables included within this analysis were chosen to reflect information which is routinely 
available at the time of treatment decision-making. The analysis performed was based purely on 
the information contained within an existing database; patients were not contacted fo r the 
purposes of this study. Therefore other variables of interest wh ich were not recorded on the 
database were not available for inclusion in the analysis . Other variables of interest would includ e 
cancer to breast size ratio, radiological cancer size, and patient information such as educational 
level, family income and decision-making style. Data such as postcode could have provided a 
surrogate measure of socio-economic profile and permit assessment of whethe r distance of 
patient's home to radiotherapy treatment centre influences treatment rates . Th is informat ion 
was however not available due to issues of confidentiality and the requirement for the data to be 
anonymised at source. 
The study was conducted on a screen-detected population where approximately 87% of the 
women diagnosed with primary breast cancer had cancers less than 30mm d iameter. On the 
basis of cancer size alone, the majority of women in this group were eligible for a choice of 
treatment. Within the sub-group with small cancers (total cancer size less than lsmm diameter) 
there is an almost four-fold variation in observed to expected coefficients following case-mix 
adjustment. This finding is concordant with data from another UK study by Sauven et.al. 
illustrating a similar degree of variation in treatment at regional level in the UK in the screen-
detected sub-group with small cancers. (Sauven, Bishop, Patnick, Walton, Wheeler, & Lawrence 
2003) The Sauven study however failed to adjust for case-mix. 
CONCLUSION 
Using a robust, externally validated dataset, this study demonstrates the existence of statistically 
significant treatment variation in the surgical management of early stage breast cancer among 
this UK region's breast screening practice. Variation in observed to expected unit MR coefficie nt 
was two-fold overall (range 0.66-1.36) and increased to four-fold among very small cancers of less 
than lsmm diameter (range 0 .55-1.95). The study conclusively demonstrates that case-m ix can 
be excluded as a causative factor. 
The explanation of wide variation in MRs remains unclea r from both th is component of the study 
and the available literature. Further research is required to investigate the other potential 
influences over the choice of breast cancer surgery . The other components of th is study seek to 
elucidate the reasons fo r variation in the surgical treatment breast can ce r from both t he patient 
and clinician's (specialist doctor and nurse) pe rspect ives . 
FIGURE 2.3 Summary of case-mix audit findings 
• Overall two fold variation was noted after case-mix adjustment 
• Variation between breast units increased rather than reduced among smaller 
cancers ( to four-fold in under 1smm diameter) 
Chapter 3 
Clinician Survey 
What influences clinicians' operative preferences for women 
with breast cancer? An application of the discrete choice 
experiment and psychological profiling of specialist clinicians 
ABSTRACT 
Background Little is known regarding cancer clinicians' treatment preferences. The aim of this 
study was to determine the impact of pre-operative variables over specialist breast cl inici ans ' 
operative preferences using discrete choice experiment methodology. 
Methods Cross-sectional survey of operative preferences to hypothetical scenarios based 
oni patient age, bra cup size, cancer size, site and centricity . 
Results 73% response rate (68/93)· Multinomial logistic regression was used to analyse 
data across scenarios (n=l,69S) with allowance for response clustering, comparing equa l 
preference for mastectomy and BCT, with preference for mastectomy or BCT. Increasing patient 
age, cancer size, central site, multi-centricity and reducing cup size, were all associated with 
preference for mastectomy, over equal preference, over BCT (P<O.OOl) . Doctors preferred 
specific treatments, females and nurses avoided mastectomy (P=O.OlS and P<O.OOl respectively) . 
Conclusions Clinician preferences were predominantly treatment guideline congruent, but 
significantly influenced by patient age, clinician gender and occupation . This methodology is 
capable of elucidating treatment preferences and could be applied elsewhere were treatment 
options and practice variability exist. 
BACKGROUND 
In the UK, the appropriateness of therapeutic surgical options are routine ly discussed and decided 
individual case level within MDT meetings .(Association of Breast Surgery at BASO 2009) 
Decisions about which to offer are based primary cancer characteristics, patient co-morbidity and 
evidence-based treatment guidelines. In addition to cancer variables known to influence su rvival 
, 
I.e. cancer size, (Blichert-Toft, Brincker, Andersen, Andersen, Axelsson, Moundsen, 
Dombernowsky, Overgaard, Gadeberg, Knudsen, & . 1988,Clarke, Collins, Darby, Davies, 
Elphinstone, Evans, Godwin, Gray, Hicks, James, MacKinnon, McGale, McHugh, Peto, Taylor, & 
Wang 2005iFisher, Anderson, Bryant, Margolese, Deutsch, Fisher, Jeong, & Wolmark 
2002;Jacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatsteln, & 
Okunieff 1995iLichter, Lippman, Danforth, Jr., d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & . 1992jPoggi, Danforth, SCiuto, Smith, Steinberg, Llewehr, Menard, 
Lippman, Lichter, & Altemus 2oo3;Sarrazin, Le, Amagada, Contesso, Fontaine, Spielmann, 
Rochard, Le, & Lacour 1989jvan Dongen, Voogd, Fentlman, Legrand, Sylvester, Tong, van der, 
Helle, van Zijl, & Bartelink 2000jVerOnesl, Casclnelli, Mananl, Greco, Saccozzl, LUInI, Aguilar, & 
Marubini 2002) the anticipated aesthetic outcome of the options is also considered :(BAPRAS and 
the Training Interface Group in Breast Surgery 2007;Bulstrode & Shrotna 2001,Clough, Kaufman, 
Nos, Buccimazza, & Sarfati 2010) For instance, BCT for a 40mm diameter cancer might be 
anticipated aesthetically unfavourable in a small breast, which could influence the team/clinician 's 
operative preference or recommendation. Guidelines are designed flexibly to optimise patient 
involvement in decision-making while not compromising survival and recurrencej in recognition 
of the superior patient psychological outcomes associated w ith choice provis ion .(Andersen, 
Bowen, Morea, Stein, & Baker 2oo9;Deadman, Lelnster, Owens, Dewey, & Slade 
2001;Fallowfield, Hall, Maguire, Baum, & A'Hern 1994a,Faliowfield, Hall, Maguire, & Baum 
1990;Fallowfield, Hall, Maguire, Baum, & A'Hern 1994bjHack, Degner, Watson, & Sinha 
2006;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Molenaar, Oort, Sprangers, 
Rutgers, Luiten, Mulder, & de Haes 2004i Morris & Ingham 1988,Morrl s & Royle 1987,Moyer 
1997;Moyer & Salovey 1998;Schou, Ekeberg, Ruland, & Karesen 2002,Stewart 1995,Street, Jr & 
Voigt 1997jWilson, Hart, & Dawes 1988, Wolberg 1990) 
If presented with options, patients ' decisions are based on thei r personal prefere nces(Carver, 
Pozo -kaderman, Pnce, Nonega, Hams, Derhagoplan, Robinson, & Moffat, Jr 1998,Coillns, 
Moore, Clay, Keanng, O'Connor, Llewellyn -Thomas, Barth , Jr, & Sepuc ha 2oo9,Faiiowf ield, 
Baum, & Maguire ~986;Hawley, Griggs, Hamilton, Graff, Janz, Morrow, Jagsl, Sale m, & Katz 
2oo9;Hughes 1993;Kotwall , Maxwel l, Covington, Churchill, Smith, & Covan 1996,Lasry & 
Margolese ~992;Mandelblatt, Hadley, Kerner, Schulman, Gold, Dunmore -Griffith, Edge, 
Guadagnoli, Lynch, Meropol, Weeks, & Winn 2000;Molenaar, Oort, Sprangers, Rutgers, LUlten , 
Mulder, & de Haes 2oo4;Moyer ~997;No l d, Beamer, Helmer, & McBoyle 2000;Schou, Ekeberg, 
Ru land, & Karesen 2002;Smitt & Heltzel 1997;Wei, Sherry, Baisden, Peckel, & Lala 1995iWilson, 
Hart, & Dawes ~988) and knowledge; much of which arises from discussion with the treating 
team's clinicians (doctors and nurses). Clinicians' stated or perceived treatment preferences and 
recommendations have been shown to exert one of the most potent influences over pat ients' 
treatment decisions.(Johnson, Roberts, Cox, Reintgen, Levine, & Parsons 1996;Katz, Lantz, & 
Zemencuk 2001;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996;Molenaar, Oort, 
Sprangers, Rutgers, Luiten, Mulder, & de Haes 2oo4,Morrow, Jagsi, Alderman, Griggs, Hawley, 
Hamilton, Graff, & Katz 2009;Nold, Beamer, Helmer, & McBoyle 2000;Schou, Ekeberg, Ruland, & 
Karesen 2002jSmitt & Heltze l 1997) However, limited information is available on such 
preferences. Most studies are based on doctors' stated preferences to clinical vignettes, and are 
not always conducted among those in the speciality of interest. The information ga ined from 
them is therefore of doubtful value . Also, although the studies note variabi lity in doctors' 
preferences, they but deduce little else and they fail to include the BCN occupational 
group. (Collins, Kerrigan, & Anglade 1999;McKinlay, Burns, Durante, Feldman, Freund, Harrow, 
Irish, Kasten, & Moskowitz ~997) 
Establishing preferences - Discrete Choice Experiment methodology 
The Discrete Choice Experiment (DCE) is a member of the stated preference techn ique family; a 
rigorous survey methodology capable of establishing stakeholder (provider and consumer) 
preferences in controlled experimental conditions, through responses to hypothetica l scenari os. 
The vast majority of DeE applications in healthcare up until the time of th is study, focused upon 
eliciting the preferences of consumers for alternative treatments and service 
configurations.(Lancsar et al. 200 7; Seston et al. 2007) The techn ique has stead ily gained 
importance in the healthcare setting through the impacts their preference info rmat ion has had on 
service planning and provision .(Lancsar, Hall , King, Ke nny, Louviere, Fiebig, Hossai n, Thien, 
Reddel, & Jenkins 2oo7; Ryan and Gerard 2003) 
The superiority of the DCE over other stated preference techniques lies in its abil ity to establ ish 
the relative importance individuals or groups place on different attributes (variables) defining a 
good or service, (Ryan and Farrar 2000) and its ability to disaggregate tota l value (ut ility); 
permitting the estimation of individual attributes/variables impact on total value .(Longworth et 
al. 2001.) 
Examples of the application of DCEs to elicit the preferences of clinicians till now have rema ined 
relatively rare and, to our knowledge this was the first study to use the technique to assess the 
preferences of cancer clinicians for alternative treatment regimens. 
To effectively capture preferences, the DCE design and scenario content must be plausible to 
potential respondents; containing realistic hypothetical scenarios comprised of variables 
individuals are willing to trade between to arrive at decisions. The majority of healthcare DCEs to 
date, have effectively forced respondents to choose between two or more options. However, it is 
recognised that such a design does not reflect all decision-making in healthcare. An opt-out 
response is sometimes necessary to improve realism and response rates. The opt out response 
commonly employed is a non-participation (prefers 'neither') response, (Ryan & Gerard 2003, Ryan 
and Skatun 2004) but equally could include an equivalent preference (prefers both equally) 
option. 
The aim of this component of the study was to employ a cross-sectional postal questionnaire 
survey designed using DCE methodology, to determine the impact of key variables available pre -
operatively, over specialist breast clinicians' (nurses and doctors) therapeutic operative 
preferences for the management of primary breast cancer. It was also designed to determine 
whether particular clinician psychological profiles were associated with their stated preferences. 
The psychological scales included the masculinity/femininity index,(Zeldow 1976) tolerance of 
ambiguity scale, (Budner 1962) Physician's Reactions to Uncertainty (PRU) Scale,(Gemty et al 
1990) GHQ-6 (a subgroup of the GHO-1.2), (Goldberg et al 1997) and the Maslach Burnout 
Inventory. (Mas lach and Jackson 1.986) 
METHODS 
Sample 
All ~4 hospitals' specialist breast teams comprising the Trent breast service were recruited to the 
study. Ninety-seven eligible specialist clinicians (48 doctors and 49 nurses), were identified, 93 
were invited to participate, as 4 were on long term sick leave during study recruit ment . Eligibility 
was defined as a permanent specialist member of the breast team (nurse or doctor), routinely 
discussing surgical treatment options with patients diagnosed with breast cancer. Surg ical 
trainees were ineligible due to their transitory role within teams. 
Instrument 
The questionnaire comprised three sections; background information (age, sex, occupation, 
experience etc.), the DeE (25 hypothetical case scenarios) and a series of five psycholog ica l sca les 
measuring parameters potentially influencing decision behaviour. Space was also provided fo r 
clinicians to provide additional comments. 
DeE scenario development 
The chosen DeE design comprised the presentation of single scenarios and the incorporation of 
an opt-out or equivalent preference option (prefers both equally).(Ryan & Gerard 2oo3,Ryan & 
Skatun 2004) This less commonly adopted design was used in preference to the more 
conventionally applied pair-wise choice design, (Ryan & Gerard 2003) t o more close ly reflect the 
clinical decision-making context of interest, and therefore enhance response rat es and elucidate 
clinicians' treatment preferences. It could be argued, respondents should be forced t o make 
specific choices rather than defer to the perhaps easier decision of selecting the equivalent 
preference option. However, a number of clinical situations exist, e.g. breast cancers up to 4 and 
scm in diameter, where no clearly superior surgical treatment has been established in t erms of its 
impact on mortality rates(B ll chert-Toft, Bnncker, Ande rsen, Andersen, Axelsson, Moundsen, 
Dombernowsky, Overgaard, Gadeberg, Knudsen, & 1988,C larke, Co l/ inS, Darby, DalJles, 
Elphlnstone, Evans, Godwin, Gray, Hicks, James, Mack Innon, McGale, MCHugh, Peto, Taylor, 
Wang 200s,Flsher, Anderson, Bryant, Margolese, Deutsch, Fisher, Jeong, & ol'l)dr~ 
2002iJacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatsteln, & 
Okunieff 1995iLichter, Lippman, Danforth, Jr., d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & . 1992iPoggI, Danforth, Sciuto, Smith, Steinberg, Llewehr, Menard, 
Lippman, Lichter, & Altemus 2003iSarraZln, Le, Arriagada, Contesso, Fontaine, Spie lmann, 
Rochard, Le, & Lacour 1989i van Dongen, Voogd, Fentiman, Legrand, Sylvester, Tong, van der, 
Helle, van Zijl, & Bartelink 2000iVeronesi, Cascinelli, Mariani, Greco, Saccozzl, LUlnl, Aguilar, & 
Marubini 2002)or morbiditY, (Carlsson & Hamrin 1994iDorval, Maunsell, Deschenes, & BrISson 
1998iFallowfield, Baum, & Maguire 1986iGanz, Desmond, Leedham, Rowland, Meyerowitz, & 
Belin 2002ilrwig & Bennetts 1997iMcCready, Holloway, Shelley, Down, Robinson, Sinclair, & 
Mirsky 200Si Moyer 1997iSanger & Reznlkoff 1981jSchain, Edwards, Gorrell, de Moss, Lippman, 
Gerber, & Lichter 1983jStefanek 1993) while evidence exists fo r the posit ive psycholog ica l 
influence of providing choices to patients.(Andersen, Bowen, Morea, Stein, & Baker 
2009jDeadman, Leinster, Owens, Dewey, & Slade 2001iFaiiowfield, Hall, Maguire, Baum, & 
A'Hern 1994aiFallowfield, Hall, Maguire, & Baum 1990,Fallowfield, Hall, Maguire, Baum, & A'Hern 
1994biHack, Degner, Watson, & Sinha 2006iKotwall, Maxwel l, Covington, Churchill, Smith, & 
Covan 1996jMoienaar, Oort, Sprangers, Rutgers, LU lten, Mulder, & de Haes 2oo4,Moms & 
Ingham 1988jMorris & Royle 1987iMoyer 1997;Moyer & Salovey 1998,Schou, Ekeberg, Ruland, & 
Karesen 2002jStewart 199s;Street, Jr. & VOigt 1997, Wilson, Hart, & Dawes 1988, Wolberg 1990) 
Therefore, failing to provide respondents with the option to select the equ ivalent preference 
option and defer decision-making to the patient, would to be inappropriate in this context . 
The conduct of a DCE can be divided into stages :(Ryan et al 1998) Identificat ion of key variables, 
assignment of levels to variables, combination of variables and the ir levels into scenari os f or 
presentation, reduction of combinations to a practical number for presentat ion, the 
establishment of preferences and data analysis. 
As the number of variables and their levels increases, the number of potent ial scena ri os increases. 
Where there are V variables each with L levels the number of scenarios generated is: 
V~ V2 L V3 L Vn L l X L 2 X 3 . . . x n 
Where Ln is the number of levels of the nth variable (V n).(M Ichaels et al 2000) 
The greater the number of variables and levels, the greater t he information obtained, but the 
greater the size and complexity of the exercise. To m inimise respondent cognitive fatigue and 
optimise response and complet ion rat es, it is necessa ry to present individuals wit h a manageable 
number of scenarios. This is achieved by limiting the number of included variables and levels and , 
the application of fractional factorial design (software package Speed)i (Bradley 1991) which 
reduces the number of scenarios while retaining the ability to infer preferences for all. Its 
application assumes minimal significance of some or all interactions between variables .(Mlchaels, 
Brazier, Pa lfreyman, Shackley, & Slack 2000) 
The crucial stage of DCE design is the identification of key variables capable of defining the 
subject of interest. By peer consensus, 5 variables routinely available pre-operatively were 
selected for inclusion and subdivided into plausible levels capable of being traded against each 
other in deciSion-making. Table 3 .1 illustrates the variables and levels of the final applied DCE . 
The questionnaire's 25 scenarios were randomly generated from the reduction, by fractional 
factorial design (Speed)(Bradley 1991) of all possible combinations (1700 potential scenarios) of 
the orthogonal array of variables and levels generated by SPSS 'Orthoplan' software. The DCE 
questionnaire design considered the properties of orthogonality, and was balanced in terms of 
the number oftimes each level of an attribute was represented in a scenario. Table 3.2 shows the 
DCE scenario dimension levels generated by the SPSS 'Orthoplan' software for the applied DCE . 
The numbering of the assigned scenario dimension levels are shown in blue in the lower right in 
table 3.1'S cells. 
A pilot study with a group of experienced surgical trainees with a declared interest in breast 
surgery and BCNs employed outside the regional breast service, exposed the presence of a 
dominant variable level (multi-centric, multi-quadrant cancer centricity) in the init ial set of cancer 
centricity variable levels. This skewed the results; making it impossible to interpret the influence 
of the other variables. It was therefore excluded from the final instrument. 
Discrete choice experiment variables and levels 
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Blue numbers in the lower right of the cells represent assignment numbers for the SPSS 
generated scenarios noted in table 3.2 
TABLE 3.2 DeE scenario dimension levels generated SPSS 'Orthoplan ' 
1 4 4 4 1 
3 5 2 4 2 
5 5 4 3 1 
5 4 3 2 2 
4 4 2 5 1 
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1 2 2 2 1 
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5 1 1 4 1 
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3 3 1 2 1 
1 5 1 5 2 
Psychological scales 
The five psychological scales incorporated into the questionnaire were chosen for their potential 
to influence medical decision-making : 
Masculinity/femininity index :(Zeldow 1976) The eight item masculinity-feminity index generates a 
score between -24 and +24. Interpretation of the scale is dependent on the cultural context in 
which it is applied. In the UK, low negative scores indicate more traditionally feminine (nurturing ) 
attributes and high positive scores more masculine (asserti ve) ones . 
Tolerance of ambiguity scale :(Budner 1962) Budner's sixteen item tolerance of am bigu it y sca le 
generates a score between 16 and 112, where a higher score implies greater tolerance of 
ambiguity and a lower score the converse. Individuals intolerant of ambiguity perceive 
ambiguous or uncertain situations as threatening. 
Physician's Reactions to Uncertainty (PRU) Scale :(Gemty, DeVellis, & Earp 1990) Gerrit y's 
twenty-four item scale comprises two subscales measuring affective reactions to uncerta inty 
specific to healthcare situations; the stress from uncertainty subscale (generating a score 
between 13 and 78) and reluctance to disclose uncertainty subscale (generating a score between 9 
and 39). Higher scores respectively indicate greater stress from, and reluctance to disclose, 
uncertainty. 
GHO-6: A subgroup ofthe GHO-12(Goldberg, Gater, Sartorius, Ustun, Plccmelli, GureJe, & Rutter 
1997) were included in the questionnaire, consisting of the more 'external' or revea led 
representations of anxiety & depression (items 1,3J4,7,8 and 12), possessing greater potential to 
influence communication, than the more 'internal' or concealed items of the scale . Using this 
scaling system the six-item GHO generated a score between 0 and 6. Higher scores indicate 
greater levels of anxiety and depression. 
Burnout Inventory.(Maslach & Jackson 1986) The nine item abbreviated Maslach Burnout 
Inventory comprises subscales evaluating three components of burnout; emotional exhaustion, 
depersonalisation, and personal accomplishment; each generate a score between 0 and 18. 
Burnout is indicated by high scores in emotional exhaustion and depersonalisation and low scores 
in personal accomplishment. 
Three of these comprise part of the UK GMC's performance procedures assessment of doctors; 
the GHO-6, PRU Scale and the Maslach Burnout Inventory. 
Theoretically it could be suggested clinicians would be more likely to favour and portray specif ic 
recommendations rather than favour greater patient autonomy if they demonstrated higher 
masculinity/femininity scores (more assertive) and PRU scores (more reluctant to disclose and 
more stressed by uncertainty), and lower tolerance of ambiguity scores (less tolerant) . It cou ld 
also be supposed that those with higher levels of depression (GHO-6) and burnout (Maslach 
Burnout Inventory) could be less likely to provide optimal consultations for shared decision 
making . 
Establishment of Preferences 
Clinicians were asked to indicate their operative preferences to hypothetical scenarios . Figure 3.1 
illustrates a scenario example. It was emphasised clinicians should respond with their individual 
preferences, rather than with those of their breast team. They were also asked to base the ir 
responses purely on presented information, as other aspects of the cases were equal or 
insignificant. Three treatment options were presentedj mastectomy, BCT, or equal preference 
for both mastectomy and BCTj equal preference representing providing patients with open 
choices. Extended treatment options (neo-adjuvant chemotherapy, primary breast 
reconstruction etc.) were excluded from the exercise . 
FIGURE 3.1 Scenario example 
Patient Age (years) 60 - <70 
Total cancer size (mm) <20 
Bra cup size C 
Site LI 
Centricity Uni-centric 
Please indicate your preferred choice of surgery in this case by ticking the relevant box 
below. If you prefer both equally, please tick both boxes. 
Mastectomy 
D 
Breast Conservation Surgery 
D 
. f d ho'lce of surgery was a 3-level nominal categorical variable Since the outcome, pre erre c , 
(mastectomy, BCT, prefers both options equally), multinomial (polytomous) logistic regression 
(MLR) was used to look for associations between the outcome variable and the various clinical 
characteristics given in the scenarios (age, bra cup size, cancer size, cancer site and centricity) and 
clinician characteristics (including age, experience, gender and psychological scale responses . A 
multinomial logistic model in STATA version 8 was fitted using the mlogit procedure, with 
'prefers both options equally' as the reference or base category.(Stata Corporation 2003) 
With a 3-level nominal categorical outcome, the multinomial logistic model will estimate, using 
maximum likelihood, two sets of regression coefficients for the explanatory variables: One for 
the effect of choosing mastectomy versus prefers both options equally, and a second set for BCT 
versus prefers both options equally. The regression coefficients, from the MLR model, 
correspond to the probability of each outcome category (mastectomy versus both options 
equally; BeT versus both option equally) relative to the base category . The exponentiated value 
of a regression coefficient, from this model, is the relative risk ratio (RRR) for a one unit change in 
the corresponding explanatory variable, where risk is measured as the risk of the category relative 
to the base category. The cluster option was used to take into consideration the lack of response 
independence (each responder valued up to 25 scenarios). This alters regression coefficient's 
estimated standard errors, p-values and confidences intervals, but not coefficient values 
themselves. 
FINDINGS 
Sixty-eight of the 93 clinicians approached from the 14 hospital breast units of the Trent region, 
returned completed questionnaires (73% response rate) : 34% male, 66% female, 48% nurses, 
52 % doctors (25 consultants, 3 Associate Specialists, 1 Staff Grade and 4 Clinical Assistants), 
mode age 41 -50 (range 26 to 65), with a median 22 years post qualification experience (range 5 to 
39 years) and 7 years specialist experience (range 0 to 26 years) . Table 3·3 presents the 
characteristics of the 68 responders to the survey. 
DeE findings 
The impact of clinical factors on clinicians' preferences 
The 68 responders answered 1.695 of 1.700 (68 x 25) scenarios . In 890 (53%) scenari os responders 
preferred mastectomy, 397 (23%) BeT, and 408 (24%) preferred both equa lly . Overall 56/68 
(82%) of responders demonstrated a preference for mastectomy in the majori t y of t he scenarios 
they rated, 7 (1.0%) a preference for BeT and 5 (8%) an equal preference for mastectomy and BCT. 
Table 3·4 summarises the results by scenario . Scenarios are displayed as ind iv idua l rows . This 
form of data presentation highlights a lack of consensus in clinicians' preferences; for example in 
scenario 1.9, in a woman over 80 with a single 30 to <40mm diameter focus of cancer in the upper 
outer quadrant of her B cup breast, 32% of clinic ians would prefer she had a mastectomy, 28% 
prefer she had BeT and 40% would leave the choice to her. The table also illustrates, some 
clinicians adhere rigidly to their preferences despite potentially consequent compromised 
recurrence and survival rates; for example, clinicians retaining their preference for BCT in 
scenarios 1.3 and 25, where cancers are over 50mm diameter and in scenario 25, the cancer is also 
multi -centric. 
TABLE 3.3 Demograph ic data of clinician responders 
Clinician age 26-30 2 (3 .0%) 
3~-35 5 (7 .6%) 
36-40 13 (19·7%) 
41-45 14 (21.2%) 
46-50 ~ (21.2%) 
51-55 8 (12.1%) 
56-60 9 (13 .6%) 
61-65 1 (1·5%) 
Total 66 (100.0%) 
Clinician gender Male 23 (33.8%) 
Female 45 (66 .2%) 
Total 68 (100.0%) 
Clinician occupation Doctor 33 (48.5%) 
Nurse 35 (51.5%) 
Total 68 (100 .0%) 
• 
Year of qualification 64 1982 (8 ·4) 1982.5 1965 1999 
Year commenced as a special ist 65 1995 (6 .6) 1996.0 1977 2003 
No. of years as specia list 65 8 (6 .6) 7.0 0 26 
No. of years' experience (since 63 22 (8-4) 22.0 5 39 
qualification) 
TABLE 3.4 DeE results by scenario 
. . 
. . 
< 40 40- to <50 D LI Uni-centric 45·59 19.12 35 .29 
60-to <]0 2:50 B LI Multi-centric 95·59 0.00 4·41 
2: 80 2:50 D LO Uni-centric 70.59 7·35 22 .06 
2: 80 40- to <50 C UI Multi-centric 80.88 2·94 16.18 
70- to < 80 40- to <50 B Central Uni -centric 94·12 0 .00 5.88 
40-to <60 20- to <30 C LI Uni -centric 1·49 71.64 26.87 
40- to <60 <20 B LO Multi-centric 22 ·39 40.30 37.31 
<40 20- to <30 B UI Uni-centric 5·97 64.18 29 .85 
40- to <60 40- to <50 A UO Multi -centric 91.04 0.00 8.96 
60- to <70 20- to <30 D UO Multi-centric 19·4 46 .27 34 ·33 
40- to <60 ~50 A UI Uni -centric 92.65 0.00 7·35 
40- to <60 30- to <40 D Central Uni -centric 44.12 17.65 38.24 
70- to < 80 ~50 C UO Un i-centric 83 .82 4.41 11.76 
70- to < 80 30- to <40 A LI Multi -centric 89.71 1·47 8 .82 
< 40 <20 A UO Uni -centric 1·47 66 .18 32.35 
< 40 30- to <40 C LO Multi -centric 41.18 25 .00 33.82 
60- to <70 40- to <50 A LO Uni -centric 86 .76 2· 94 10.29 
2:80 20- to <30 A Central Multi -centric 79.41 1·47 19.12 
~ 80 30- to <40 B UO Uni -centric 32.35 27·94 39 .71 
60- to <70 <20 C Central Uni -centric 27·94 42.65 29 ·41 
70- to < 80 <20 D UI Multi -centric 17. 65 45 59 36.76 
~80 <20 A LI Uni -centri c 11.76 50.00 38.24 
70- to < 80 20- to <30 A LO Uni -centri c 13. 23 39 .71 47 06 
60- to <70 30- to <40 A UI Uni-centric 67.65 8 .82 23 ·53 
< 40 ~50 A Central Multi -centri c 94.
12 1·47 4.41 
Responses were analysed across scenarios, to establish the impact of individual vari ab les over 
clinicians' operative preferences. Equal preference, representing the provision of an open choice 
of surgery to the patient, was treated as the reference therapeutic option, and compared wit h 
preference for mastectomy and preference for BCT, using univariate (variables analysed as 
independent of the other variables) and multivariate analysis. 
All 5 scenario variables independently demonstrated statistically significant association with 
preference both on their own and when combined together (p<O.OOl). The results of mult ivariate 
analysis are summarised in Tables 3.5 and 3.6. The RRR for the regression coefficients in Tab les 
3.5 and 3.6 are from the same model, but shown in separate tables for ease of understanding. 
Preference for mastectomy over choice, and choice over BCT, correlated positive ly with 
increasing patient age and cancer size, central cancer site, multi rather than uni-centric cancer, 
and reducing bra cup size . For example, other factors being equal, clinicians are over three times 
more likely to prefer mastectomy rather than choice, if a woman is aged between 60 and 70, than 
if she is under 40 (P=<0.001) . Consistent with evidence-based treatment guidelines, cancer size 
appears to exert the greatest influence over preferences: Clinicians are nearly 36 times more 
likely to prefer mastectomy rather than choice if a cancer is greater than 50mm in diameter, than 
if it is less than 20mm (P=<0_001), and likewise, they are 92% less likely to prefer BCT over choice, 
if a cancer is over 50mm in diameter, than if it is less than 20mm (p=<O.OOl) . The goodness of fit 
of the model in Tables 3-5 and 3.6 was assessed by the pseudo R2. The pseudo R2 value of 0. 29 
suggests the model with five covariates is about 29% better than the model with no covariates 
(the "constant-only" model), but is about 71% worse than the theoretical perfect fitting or 
predicting model (with a pseudo R2 value of 1.0). 
TABLE 3.5 
Patient age 
(years) 
Total cancer 
size (mm) 
Influence of DCE variable over operative preferences: Relat ive Risk Rat io (RRR) 
Equal preference for both BCT and mastectomy vs. mastectomy preference 
' . " . . Equal ~reference 
. vs. Mx ~reference 
I 1.58-3.86 
0 .93- 2.89 
--'''----
<0.001** 
<0 .001** 
0.088 
0.680 
<0.001** r---~--~----------------~-~----------~~~~~---;---
<0.001** 
-- -~ 
61 <0.001** ----+-----~~------------------~~---------Bra cup size A vs. B 0 .76 0 .225 
----1 
A vs~_ 1 0 .46 0.001** 
A vs. ~ D 0 .35 0 .22 -0 .57 ---< -'::: 0.001 ** 
Cancer site Central vs. UO 0 .25 . 0 .14-0.44 <0.001** 
Central VS. LO 0 .28 L 0 .15-0 .50 L <0.001** 
Centralvs. LI 1 0 .37 0 .23-0 .61 1 <0.001** 
I Central vs. UI _ _ 0 ·33 I 0 .19-0.56 <0 .001** 
Centric Uni vs. Multifocal single quadrant 3.22 1.98-5.26 <0 .001** 
Multivariate RRRs after adjustment for the other clinical factors (patient age, cancer size, cancer size, bra 
cup size and centricity). 
* p:s 0.01 
** S 0.001 
------
TABLE 3.6 Influence of DCE variable over operative preferences : 
Equal preference for both BCT and mastectomy vs BCT f 
. pre erence 
Total cancer 
size (mm) 
Bra cup size 
Relat ive Ri sk Rat io (RRR ) 
0 . 215 
0 . 0 
< 0 .001** 
<0 .001** 
0 .001** 
Cancer site 1r::::=i=-;-;:::-- -------+.1:2~----!. 1 .4 2 -7.68 0 .006* 
0 .018 
0 .001** 
0 . 036 
Centric Uni vs. Multifocal si uadrant o. 9 0 . 2 1 -0 .7 1 0 . 002 
Multi~~riate RRR after adjustment for clinical factors (patient age, cancer size, cancer size, bra cup size and 
centnclty). 
* p S 0.01 
** S 0.001 
Effect of patient age on preferences 
Figure 3.2 and tables 3.5 and 3.6 il lustrate how cl inici ans' preferences are influenced by a patient's 
age . The upper section of figure 3.2 compares clin icians who prefer choice w ith t hose w ho prefer 
mastectomYi the lower section, clinicians who prefer choice with those preferring BCT. 
Descending the vertical axis in each section preferences among for the youngest patients are 
compared with preferences among pat ients of increasing age. Boxes represent the ratios, 
whiskers the 95% CISi those not cross ing the vert ical line at 1 are statistically sign ifi cant . At the 
vertical 1 l ine, cl in icians are just as likely t o prefer choice as mastectomy (i n the uppe r section ) or 
BCT (in the lower sect ion). To the left of 1 they prefer cho ices, to the ri ght th ey prefer t he spec ific 
treatment opt ion. Figure 3. 2 demonstrates other factors being equal, age stati st ically 
sign ificantly influences preferences (P <O.OOl) : Clin ician s increasingly prefer mastectomy m ore as 
age increases, but not in the over 80S. Among those preferring BeT, cl inicians sh ift f rom 
preferring BeT to choices with increasing patient age, but the effect is less exaggerated th an 
when choice and mastectomy are compared . The preference for choice over BeT on ly reac hes 
statistical significance in the 70-80 year group. 
FIGURE 3.2 Effect of patient age on preferences 
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Effect of cancer size on preferences 
Cancer size significantly influenced preference (p<O.OOl). With increasing cancer size, clinicians 
increasingly preferred mastectomy rather than cho ices, or cho ices rather BCT. However, there 
was a 10mm diameter difference in thresholds for clinic ians' shift ing the ir preferences depend ing 
on whether they preferred mastectomy or BCT. Those preferring BCT shift toward choice when 
cancers exceed 20mm (size <20 vs. 20-<30mm RRR equal vs. BeT preference 0.70, 95% CI 0.51.-
0.98, P=0.035) and among cancers less than 30mm cl inicians start to shift f rom a preference for 
mastectomy to choice (equal preference vs. mastectomy preference in size <20 vs . 20-<30mm 
RRR 1.10, 95% CI 0.69-1.77, p=0.680, size <20 vs . 30-<40 RRR 4.92 CI 3.17-7. 65, P<O.OOl) . Tables 
3.5 and 3.6, and figure 3.3 illustrate the effect of cancer size on cl inicians' preferences. 
Figure 3.3 Effect of cancer size on preferences 
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Effect of bra cup size on preferences 
Bra size significantly influenced preference (P<0.001). With increasing cup size, clinicians 
demonstrated an increasing preference for choice rather than mastectomy (A cup vs. ~D cUPi 
RRR=0·38, p 2:0.001) and BeT rather than choice (A vs . Ci RRR=1.43, P 0.025). However, when cup 
size was analysed as a factor in isolation, in the largest size (~D) cl inicians prefe r BCT and choice 
equally, rather than preferring BCT (RRR=0.95, P=0.78). Tables 3.5 and 3.6, an d fi gure 3.4 
illustrate the effect of bra cup size on preferences. 
FIGURE 3.4 Effect of bra cup size on preferences 
-.."'-~~- ~~.:;..,.- --,. ..... ~ 
Choice vs Mx 
!l...~ol:!~'I-'._~f'~.:.;g'"'=L · """" 
Choice vs. BCS 
<l.I 
N 
V\ 
0.. 
::J 
u 
ru 
L.-
eo 
Avs B 
A vs( 
A vs >/=D 
Avs B 
A vs ( 
A vs >/=D 
-B-
H 
r 
,..., 
I 
-.-
- 1 o 1 2 
0 
,..., 
w 
-
3 4 
I 
I 
5 6 
upper 95% (I 
lo we r 95% (I 
mu lt lvar odds ra t io 
Effect of cancer site on preferences 
The cancer site within the breast sign ificantly influenced cli nicians' preferences (P<O. OOl )j 
peripheral location was associated with clinicians more likely to prefer choices than mastectomy 
(i .e. central vs. UOj RRR=o.25, p<o . oo~) or BeT rather than cho ices (i .e. cent ral vs. UOj RRR=3 .30, 
p=o.oo6) . All results were highly statistically Sign ificant (p<O.OOl) in the choice versus 
mastectomy analyses for all non-central sites. However sign if icance levels of this magnitude 
were only reached in the central versus LI quadrant . Tables 3.5 and 3.6 and Fi gure 3.5 illustrate 
the effect of cancer site on preferences. 
FIGURE 3.5 Effect of cancer site on preferences 
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Effect of cancer centricity on preferences 
Other factors being equal, cancer centricity sign ificant ly inf luenced preferences (p < 0 .001) . Mult i-
centric cancers were associated with an increasing preference for mastectomy rathe r t han giving 
choices; multi-centric versus un i-centric cancers cho ice versus mastectomy RRR =3.22 p ~ 0.001 . 
Multi-centricity was also associated with a preference for giving cho ices rather than prefe rring 
BCT; multi- rather than un i-centric cancers cho ice versus BeT RRR=0.39, p 0.002 . However, the 
preference for choice over BCT was only statistically significant in multivariate ana lysis . Tables 3.5 
and 3.6, and Figure 3.6 illustrate the effect of cancer centric it y on preferences . 
FIGURE 3.6 Effect of cancer centricity on preferences 
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The impact of clinic ian characteri stics on preferences 
When clinician factors were incorpo at d· t I ·· .. . 
re in 0 mu t lvanate an alysIs alongside the other vanables, 
clinician gender and occupation demonstrated independent associat ion with surg ical preferen ces . 
The findings are presented in table 3.7 and 3.8. Other factors being equal, female responders 
were twice as likely as male responders to prefer cho ice than mastectomy (female vs . male 
clinician gender, RRR equal preference vs . mastectomy preference 0.51, 95% CI 0.29-0.87, 
P=0.0~5)· Occupational role was also associated w ith preferencesj BCNs were more likely to 
prefer choice than mastectomy or BCT (nurse vs. doctorj equa l preference vs. mast ectomy 
preference RRR=0·37, 95% CI 0 . 2~-0 . 64, P<O.OOl, and equal preference vs. BCT preference 
RRR=0·52, 95% CI 0.26-1.03, p=0.06) . In contrast, doctors were more directivej t hey tended to 
prefer specific operations (BCT or mastectomy) over more open choices . 
However neither clinicians' age nor yea rs of experience were associated with their treatment 
preferences; Age; choice vs . mastectomy RRR=1.0, P=o.77, choice vs. BCT RRR=1.0, P=0.29, 
experience; choice vs. mastectomy RRR=0.98, P=0.10, choice vs . BCT RRR=1 .0, P=0.99. 
The self-reported psychological scores of the respondents ind icate t hat as a group the specialist 
breast clinicians possess conventionally feminine or nurturi ng attri butes (gentleness, kindness, 
empathy etc.), tolerate ambiguity well both in hea lthcare and non-healthcare contexts and 
exhibit low levels of anxiety and depression, and high personal accomp lishment However they 
also demonstrate low to moderate burnout : Specifica lly, low levels of depersona lisat ion and 
moderate emotional exhaustion . Table 3.9 summari ses t he respondents psychological scale 
responses. 
When clinicians' psychological scale respon ses were incorporated into mult iva riate analysIs 
alongside the other va riables, they were not associated with clinicians ' treatment preference s. 
See tables 3.7 and 3· 8. 
TABLE 3.7 Influence of clinic ian characteristics over operat ive preferences : Re lat ive Risk 
Ratio (RRR) Equal preference fo r both BeT and mastectomy vs. mastectomy 
preference 
Gender Female vs . male 0 . 29 -0 .8 7 0 .01 5 * 
Occupation Nurse vs. doctor 0·37 0 . 21-0 .64 <0 .001** 
Age 1 .0 0 0 .97- 1 .02 0 ·77 
Experience (years) 0 .9 8 0 .95 - 1 .00 0 .10 
---Masculinity/femininity index 1 .0 5 0 .9 6 - 1 .1 4 0 . 22 
r- ---Tolerance of ambiguity scale 1 .05 0 .97- 1 .1 4 I 025 PRU Scale, Stress scale i 1 .0 2 099 - 1 .0 4 0.31 
- --
PRU Scale, Disclosure scale 1 .0 0 0 .93- 1 .0 7 0 ·99 
--- ---
GHQ-6 0 ·99 0 .75 - 1 . 2 9 0 . 9 1 
>----
Burnout Inventory, Emotional Exhaust ion 0 .89 0 7 4 - 1 .06 0 .19 
----
Burnout Inventory, Depersonalisation 1 .0 0 0 .89 -1 .1 3 0 ·94 
Burnout Inventory, Personal Accompl ishment 0 ·94 0 .85 - 1 .0 5 0 . 3 0 
----
Multivariate RRRs, after adjustment for clin ical factors (patient age, cancer size, cancer 
size, bra cup size and centricity), 
*P$o.o5 
**P$O.OOl 
TABLE 3 .8 Influence of cl inician characteri stics over operative preferences : Re lat ive Risk 
Ratio (RRR) Equal preference fo r both BCT and mastectomy vs . BCT preference 
Gender Female vs. male 0 .64 
Occupation Nurse vs. doctor 0 .5 2 0 . 2 6 -1. 0 3 0 .06 
Age 1 .02 
----t 98 106 ~ 
Experience (years) 1 .00 0 .9 6 -1 .0 4 0 ·99 
----
I 0 .9 1 -1 .10 Masculinity/femininity index 1 .00 0 . 9 6 
Tolerance of ambiguity scale 1.00 I 0 .92 -1 .09 1 0 . 99 
PRU Scale, Stress scale 1.01 I 0 .9 8 -1 .0 4 0 . 61 
PRU Scale, Disclosure scale 1 .03 0 .9 6 -1 .0 9 l044 
--
GHQ-6 0 ·9 9 1 0 .77 -1 . 26 0 . 9 2 
Burnout Inventory, Emotional Exhaustion 0. 9 2 I 0.79-1 .08 0.31 
Burnout Inventory, Depersonalisation 0 ·99 0 .85 - 1 .1 4 0 .85 
Burnout Inventory, Personal Accomplishment 1 .0 2 0 .88 -1 .17 0 .83 
-
Multivariate RRRs, after adjustment for clinical factors (patient age, cancer size, cancer 
size, bra cup size and centricity) 
**pso.Os 
I ***PSO.001 
i 
TABLE 3.9 Clinicians psychological scale responses 
-12·9 -13.0 
Tolerance of ambiguity scale 67 44·0 44·0 33 .0 55.0 
PRU Scale, Stress scale 65 39·7 (11 ·9) 43.0 16.0 64. 0 
PRU Scale, Disclosure scale 65 18.4 (6·3) 18.0 9.0 35.0 
GHQ6 66 0·9 (1·4) 0.0 0.0 5.0 
Burnout Inventory, Personal Accomplishment 66 14.8 (2 .6) 15.0 7. 0 18.0 
Burnout Inventory, Depersonalisation 66 1.2 (2 .1) 0.0 0.0 9.0 
Burnout Inventory, Emotional Exhaustion 65 (2 .8) 5.0 1.0 15.0 
CONCLUSION 
To our knowledge, this is the first study to use the DCE technique to assess the preferences of 
cancer clinicians for alternative but equipoise treatment regimens. This study adopted the less 
commonly utilised single scenario with equivalent preference option DCE design(Ryan & Gerard 
2oo3iRyan & Skatun 2004) for greater realism to the specific clinical decision-making context of 
interest. The findings substantially increase our understanding of special ist breast clinicians' 
surgical preferences. 
Three of the DCE variables were cancer characteristics available pre-operatively (cancer size, 
cancer site and centricity) which are included in treatment guidelines and therefore should 
influence practice. In addition, bra cup size is a surrogate measure of breast volume which is used 
alongside cancer size to permit the clinicians' evaluation of whether BCT will be aesthetically 
acceptable «20% volume resection) or not.(Bu lstrode & Shrotna 2001) The majority of cl inicians' 
preferences were congruent with evidence-based guidelines: Preference for mastectomy rather 
than choice, and choice rather than BCT demonstrated positive correlations with increasing 
cancer size, central site, multi rather than uni -centric distribution, and reducing bra cup size i all to 
the P < O.OOl level. The overall preponderance toward mastectomy most likely reflects evidence-
based decisions to scenario content (larger and multi-centric cancers), rather than signify ing a 
particular bias in the clinician group. The main findings are summari sed in fi gure 3-7-
Although the responses were generally consistent with guidelines, these are permissive to w ide 
ranging responses, and the DCE uncovered several novel insights into specialist breast cl inicians ' 
operative preferences. For example, other factors being equal, clinicians increasingly preferred 
mastectomy with increasing patient age (P<0.001), but less so in the very old (over 80S). Age was 
also less influential among those preferring BCTj only achieving statistical significance in the 70-
80 year group. 
Cancer size significantly influenced preference (P<0.001)j as cancer size increased, clinicians 
increasingly preferred mastectomy rather than choice, or choice rather than prefer BCT. But the 
DCE results also highlight that choice dominates over mastectomy and BCT at different cancer 
size levels: there was a 10mm diameter difference in clinicians' thresholds fo r their preferences, 
depending on whether they preferred mastectomy or BCT. Those preferring BCT start to shift 
toward choice when cancers exceed 20mm (Cancer size <20 vs. 20-<30mm RRR equal vs. BCT 
preference 0.70, 95% CI 0.51-0.98, P=0.03S). Whereas clinicians start to shift from a preference 
for choice to mastectomy when cancers exceed 30mm (Cancer size <20 vs. 20-<30mm RRR equal 
preference vs. mastectomy preference 1.10, 95% CI 0.69-1.77, p=0.680, size <20 vs. 30-<40 RRR 
4.92 CI 3.17-7.65, p<0.001) . Such detail is unlikely to have been detected with other 
methodologies used to establish preferences in healthcare decision-making. 
Some individual clinician variation was noted and occasional outlying responses identified . Some 
demonstrated preferences which lay outside evidence-based practicej for example, preferring 
BCT In cancers over scm despite clinical trial data demonstrating a survival 
disadvantage.(Blichert-Toft, Brincker, Andersen, Andersen, Axe lsson, Mouridsen, 
Dombernowsky, Overgaard, Gadeberg, Knudsen, & 1988jClarke, Co ll ins, Darby, Davies, 
Elphinstone, Evans, Godwin, Gray, Hicks, James, MacKinnon, McGa le, McHugh, Peto, Taylor, & 
Wang 200SiFIsher, Anderson t Bryant, Margolese t Deutsch, Fisher, Jeong, & Wolmark 
2002;Jacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatstein, & 
Okunieff 1995iLichter, Lippman, Danforth, Jr., d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & . 1992iPoggi, Danforth, SCiuto, Smith, Steinberg, Liewehr, Menard, 
Lippman, Lichter, & Altemus 2003iSarrazin, Le, Arnagada, Contesso, Fontaine, Spielmann, 
Rochard, Le, & Lacour 1989ivan Dongen, Voogd, Fentlman, Legrand, Sylvester, Tong, van der, 
Helle, van ZIJI, & Bartelink 2000iVeronesi, Cascinelli, Mariani, Greco, Saccozzl, LUInI, Aguilar, & 
Marublnl 2002) Translated into practice, such preferences could compromise LRRR and mortality . 
Clinician gender and occupational role were associated with preferences. Female gender and 
BCN role were associated with preference for choice and mastectomy aversion . The gender-role 
impact is difficult to separate. What might be interpreted as a gender effect may instead reflect 
occupational role; as BCNs were an all-female group, and participating doctors predominantly 
male. The occupational influence may reflect the role clinicians are often required to undertake in 
clinical practice; specific recommendations for doctors and supportive roles for nurses. No 
association was demonstrated between clinicians' psychological scale responses and preferences. 
Another finding of the DCE was that, although the five DCE variables included in t he DCE 
significantly influenced clinicians' treatment preferences (P<O.001), the low pseudo R2 value of 
0 .29, suggests these variables only account for 29% of the clinician responses. The majority (71%) 
were due to other factors not examined in the DCE. 
Achieving greater understanding of clinicians' preferences and what influences these are 
important steps to understanding clinicians' impact over patient treatment decisions. DCE 
methodology holds promise for elucidating practice variation in wider healthcare contexts, where 
treatment variation and contention regarding best practice coexist. 
FIGURE 3.7 Summary of findings of the specialist breast clinician DCE survey and 
psychological scale responses 
Clinicians preferred mastectomy over choice & choice over BCT with: 
Increasing patient age 
Increasing cancer size 
Reducing bra cup size 
Central rather than peripheral cancer site 
Multi- rather than uni-centric cancers 
• Specialist clinicians' treatment preferences vary, but most are congruent with 
evidence-based treatment guidelines 
• Some clinicians' possess preferences incongruent with guidelines, which if 
translated into a patient treatment, could compromise patient outcomes 
• Clinicians stop preferring BCT over patient choice in cancers over 2omm, and 
start preferring mastectomy in cancers over 30mm 
• Clinicians prefer mastectomy for aging women, independent of cancer 
characteristics 
• Doctors are more likely demonstrate preferences for specific operations, whereas 
nurses prefer to provide women with more open choices 
• Nurses and female specialists are more likely to avoid mastectomy 
• Clinician age, experience and psychological profiles were not associated with 
their preferences 
Chapter 4 
Patient information needs and decision-making 
questionnaire (IDMQ) 
Changing trends in the decision-making preferences of UK 
women with early breast cancer 
Abstract 
Background Women with early stage breast cancer are frequently offered a choice between BCT 
and mastectomy. Previous studies indicate a predominance of passive OMS among these UK 
patients. Study aim: To determine current UK OMS (preferred and achieved), OMS congruence 
and establish whether OMS are associated with operative choice and breast unit MR. 
Methods This MREC approved study was conducted in three special ist breast units of a 
single large UK region, representing high, medium and low case-mix adjusted MRs. A postal 
questionnaire survey design was adopted utilising previously validated instruments. 
Results Purposive sampling of 697 consecutive eligible patients (offered a choice 
between BCT and mastectomy), 356 (51%) completed questionnaires: Mean age 58.5 years 
(range 30.4-89.0), mean 6.9 weeks from surgery (range 1.3-48.6). Operation: 74% BCT (n=262), 
26% mastectomy (n=94). Strikingly high proportions of active OMS demonstrated, particularly 
among the mastectomy (83% vs. 58%, P<0.001) and high MR unit (80% vs. 54% and 52%, 
P<0.001) groups. High concordance established between preferred and achieved DMS 61% 
(218/356); highest among active OMS (91%), and those choosing mastectomy (67% vs. 59%, 
P=0.070). 
Conclusions Greater proportions of active OMS were identified than in previous UK studies, 
especially among women choosing mastectomy and women from high MR units. The findings 
imply that providing greater autonomy in treatment selection to women suitable for BCT, may 
not reduce MRs. 
BACKGROUND 
Over the past two decades healthcare provision has shifted from a paternalistic model towards a 
model where patients are viewed as partners in shared decision-making, (Department of Health 
200lai Department of Health 200lciDepartment of Health 2008iDepartment of Health 
2009iRawling 1992i Roya i College Of Surgeons Of England 2002)and providing patients with 
choices has become a recognised priority. (Association of Breast Surgery at BASO 2009, Bllchert -
Toft, Smola, Cataliotti, & O'higgins 1998,Department of Health 200la/Department of Health 
200lcjDepartment of Health 2oo9,·General Medical Council 2008 Kaufmann Morrow von & 
I I I I 
Harris 20loiNationa i Co llaborating Centre for Cancer 2009iNattinger, Hoffman, Shapiro, 
Gottlieb, & Goodwin 1996iNayfield, Bongiovanni, Aiciati, Fischer, & Bergner 1994iRoyai Co llege 
Of Surgeons Of England 2002iScarth, Cantin, & Levine 2002aiScarth, Cantin, & Levine 2002b) 
Patients' preferences for involvement in healthcare decision-making vary. Three main DMS are 
describedi active, collaborative and passivei wanting to take control, share or defer making 
healthcare decisions. These are often assessed using adapted versions of a simple five point scale 
often attributed to Sutherland, (Sutherland, Llewellyn -Thomas, Lockwood, Tntchler, & Till 1989) 
but originally designed by Strull for use in a hypertensive outpatient study. (Stru ll , Lo, & Charles 
1984) Its use was subsequently popularised by Degner who independently developed a tool with 
almost identical wording, but adopted a different administration technique .(Beaver, Luker, 
Owens, Lelnster, Degner, & Sloan 1996,Beaver, Bogg, & Luker 1999,Davison & Degner 
2002iDegner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 
1997aiHawley, Lantz, Janz, Sa lem, Morrow, Schwartz, Liu, & Katz 2oo7,Janz, Wren, Copeland, 
Lowery, Goldfarb, & Wilkins 2004iLantz, Janz, Fagerlln, Schwartz, LIU, Lakhani, Salem, & Katz 
2005iLuker, Beaver, Lelnster, & Owens 1996aiWaliberg, Michelson, Nystedt, Bolund, Degner, & 
Wilking 2000) Degner's version (the Control Preferences Scale) published in 1992, involves a card 
sort technique : Participants are shown a series of paired cards depicting the sca le options, from 
which they prioritise their PDMS and ADMS.(Degner & Sloan 1992) The various tools above 
utilise wording of the Control Preferences Scale, which is similar to the s-po int scale used in th is 
study, and illustrated in figure 4.l . By convention the five items are collapsed into three for 
analysisi first two options are considered to represent an act ive DMS the th ird a collaborat ive 
DMS and the fourth and fifth passive DMS.(Beaver, Luker, Owens, Lelnster, Degner, & Sloan 
1996,Beaver, Bogg, & Luker 1999,Davison & Degner 2002,Gopai et al 200s, Hawley, Lant z, Jam, 
Salem, Morrow, Schwartz, Llu, & Katz 2007,Janz, Wren, Copel an d, Lowerv, Go ldfarb, & Wilkins 
2004;Luker, Beaver, Le inster, & Owens 1996a;Singh, Sloan, Atherton, Smith, Hack, Huschka, 
Rummans, Clark, Diekmann, & Degner 2010;Waliberg, Michelson, Nystedt, Bolund, Degner, & 
Wi lking 2000) Some use the convention of the first and fifth respectively active and passive OMS, 
and the middle three items coliaborative .(Strull, Lo, & Charles 1984) 
Studies conducted in the 1990'S, reported women with breast cancer preferred and ach ieved 
predominantly passive or collaborative roles in the selection of their surgery. (Beaver, Luker, 
Owens, Leinster, Degner, & Sloan 1996;Bilodeau & Degner 1996;Luker, Beaver, Leinster, & 
Owens 1996b;Singh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & 
Degner 2010) This included the only previous UK breast cancer patient study (n=150) of 
treatment preferences. Using Degner's card sort technique, Beaver et.al. demonstrated 20% 
active, 28% collaborative and 52% passive PDMS. (Beaver, Luker, Owens, Leinster, Degner, & 
Sloan 1996) More recent literature suggests a probable shift in this groups PDMS toward more 
autonomous preferences; (Janz, Wren, Copeland, Lowery, Goldfarb, & Wi lkins 2004,Lam, 
Fie lding, Chan, Chow, & Ho 2oo3;Lantz, Janz, Fagerlin, Schwartz, Liu, Lakhani, Sa lem, & Kat z 
2oo5;Mastaglia & Kristjanson 2001) more in keeping with levels seen in earlier studies among the 
healthy population. (Deber, Kraetschmer, & Irvine 1996,Degner & Sloan 1992;Levinson, Kao, 
Kuby, & Thisted 2005;O'Donnel l & Hunskaar 2oo7a;O'Donnell & Hunskaar 2007b;Rothen bacher, 
Lutz, & Porzsolt 1997) However, the recent studies were conducted in other countries, therefore 
they may reflect geographic variation in preferences rather than a genuine shift in DMS over time. 
No recent UK data is available for comparison . 
Improved satisfaction and reduced decision regret are identified among those achieving a more 
active DMS (even if it is not their PDMS), but the greatest benefits were demonstrated among 
those achieving their PDMS .(Bruera, Willey, Palmer, & Rosales 2002;Degner, KristJanson, 
Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,Hack, Degner, Watson, & 
Sinha 2006;Janz, Wren, Copeland, Lowery, Goldfarb, & Wilk ins 2oo4,Keatlng, Guadagnoll, 
Landrum, Borbas, & Weeks 2002;Lam, Fielding, Chan, Chow, & Ho 2oo3,Lantz, Janz, Fagerlln, 
Schwartz, LIU, Lakhani, Salem, & Katz 2oo5,Mastagha & Kristjanson 2001,Slngh, Sloan, Atherton, 
Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) Many studies however 
demonstrate clinicians often misallocate patients' PDMS;(Bilodeau & Degner 1996,Bruera, 
Sweeney, Calder, Palmer, & Benisch-Tolley 2001,Bruera, Willey, Palmer, & Rosales 2002,Butow, 
Devine, Boyer, Pendlebury, Jackson, & Tattersall 2oo4,Degner, KrIStJanson, Bowman, Sloan, 
Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,Gyseis & Higginson 2oo7,Hughes 1993,Janz, 
Wren, Copeland, Lowery, Goldfarb, & Wilkins 2004 'Kotwall Maxwell Covington Churchill I J I I , 
Smith, & Covan 1996;Montgomery & Fahey 2001;O'Connor, Stacey, Entwistle, Llewellyn -
Thomas, Rovner, HolmeS-Rovner, Tait, Tetroe, Fiset, Barry, & Jones 2003b;Rlchards, Ramirez, 
Degner, Fallowfield, Maher, & Neuberger 199s;Rothenbacher, Lutz, & Porzsolt 1997;Strull, Lo, & 
Charles 1984) which increases dissatisfaction among those who feel excluded from the decision 
process(Bilodeau & Degner 1996;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, 
Watson, & Mueller 1997ajHack, Degner, Watson, & Sinha 2006;Rothenbacher, Lutz, & Porzsolt 
1997)or asked to undertake a more active role than preferred .(Hack, Degner, & Dyck 1994;Hack, 
Degner, Watson, & Sinha 2006;Schain 1980) . A large Canadian study (n=1012) among women 
with breast cancer found only 42% believed they achieved their PDMS .(Degner, Kristjanson, 
Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a) There remains contention 
about whether an active ADMS per se or achieving congruence between ADMS and PDMS is 
preferable in seeking to optimise short and long term recovery, satisfaction and minimise regret. 
Hack's study among patients with breast cancer (n=2So) suggests that achieving a more active 
DMS per se is beneficial; with statistically significantly better long term psychological adjustment, 
OoL, and superior physical and social functioning (at 3 years) .(Hack, Degner, Watson, & Sinha 
2006) 
Information is a prerequisite for informed decision-making.(Bilodeau & Degner 1996;Blanchard, 
Labrecque, Ruckdeschel, & Blanchard 1988;Fridfinnsdottlr 1997iHack, Degner, & Dyck 1994) and 
Extensive information needs are often reported among patients with benign diagnoses(Cassdeth, 
Zupkis, Sutton-Smith, & March 1980;Davis, Hoffman, & Hsu 1999;Deber, Kraetschmer, & Irvine 
1996;Jenkins, Fallowfield, & Saul 2001;Jones, Pearson, McGregor, Gilmour, Atkinson, Barrett, 
Cawsey, & McEwen 1999,Strull, Lo, & Charles 1984) and those with cancer.(BIIodeau & Degner 
1996;Blanchard, Labrecque, Ruckdeschel, & Blanchard 1988;Butow, Kazeml, Beeney, Griffin, 
Dunn, & Tattersall 1996;Cassileth, ZUpklS, Sutton -Smith, & March 1980,Chen, Tao, Tlsnado, 
Malin Ko Timmer Adams Ganz & Kahn 2008,'Davison, Degner, & Morgan 1995,Degner, 
I I I I I 
Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a;FuJlmOri & 
Uchitoml 2oo9;Galioway, Graydon, Harrison, Evans-Boyden, Palmer-Wic kham, Burleln -Hall, 
Rich -van der Bij, West, & Blair 1997;Graydon, Galloway, Palmer-W ickha m, Harrison, Ri ch-van der 
Bij, West, Burleln -Hall, & Evans-Boyden 1997;Hack, Degner, & Dyck 1994,Jen kln s, Fallowflel d, & 
Saul 2001;Jones, Pearson, McGregor, Gilmour, At kinson, Ba rrett, Cawsey, & M cEwen 1999, Luker, 
Beaver, Leinster, & Owens 1996a,Meredlth, Symonds, Webster, Lamont , Pyper, Gill iS, & 
Fallowfleld 1996,Sutherland, Llewellyn -Thomas, Lockwood, Trl tchler, & Till 1989,Vogel, Bengel, 
& Helmes 2008a) However, these are not necessarily associated w ith either the severity of 
iliness(Davis, Hoffman, & Hsu 1999)enkins, Fallowfield, & Saul 2001) or PDMS .(Blanchard , 
Labrecque, Ruckdeschel, & Blanchard 1988jCassi leth, Zupkis, Sutton -Sm ith, & March 1980,Cox, 
Jenkins, Catt, Langridge, & Fallowfield 2ooSjDavison, Degner, & Morgan 1995jEnde, Kazls, Ash, & 
Moskowitz 1989jFaiiowfieid 2008jHack, Degner, & Dyck 1994,Strull, Lo, & Charles 
1984jSutheriand, Llewellyn -Thomas, Lockwood, Tntchler, & Till 1989) Some employ information 
acquisition as a coping strategy, rather than a prelude to more active participation in decision -
making.(Blanchard, Labrecque, Ruckdesche l, & Blanchard 1988jCassileth, ZUpk lS, Sutton -Smith, 
& March 198ojDegner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 
1997ajHack, Degner, & Dyck 1994jMiller, Brody, & Summerton 1988) 
It has been suggested that if women provided with more decision control MRs would fallj as given 
the choice most women would chose BCT. The evidence is however conflicting .(Coll ins, Moore, 
Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr., & Sepucha 2oo9;Degner, Kristjanson, 
Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a;Janz, Wren, Copeland, 
Lowery, Goldfarb, & Wilkins 2004jKeating, Guadagnoli, Landrum, Borbas, & Weeks 2002jKotwa ll, 
Maxwell, Covington, Churchi ll, Smith, & Covan 1996jLantz, Janz, Fagerlln, Schwartz, LIU, Lakhani, 
Sa lem, & Katz 2005jMastagiia & Kristjanson 200ljMoienaar, Oort, Sprangers, Rutgers, Luiten, 
Mulder, & de Haes 2004jMoyer & Salovey 1998;Schou, Ekeberg, Ruland, & Karesen 2002) Some 
studies demonstrate a significant preponderance to active ADMS and PDMS among patients 
having BCT, (Collins, Moore, Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr, & Sepucha 
2oo9;Degner, Kristjanson, Bowman, Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mueller 
1997a;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Mastaglla & KrIStjanson 
2001; Molenaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & de Haes 2004;Schou, Ekeberg, 
Ru land, & Karesen 2002) others report the opposite .(Collms, Moore, Clay, Kearlng, O'Connor, 
Llewellyn-Thomas, Barth, Jr., & Sepucha 2009jHack, Degner, Watson, & Sinha 2006jJanz, Wren, 
Copeland, Lowery, Goldfarb, & Wilkins 2004,Keating, Guadagnoli, Landrum, Borbas, & Weeks 
2002; Lantz, Janz, Fagerlln, Schwartz, LIU, Lakhani, Salem, & Katz 200 5, Molenaar, Oort, 
Sprangers, Rutgers, LUlten, Mulder, & de Haes 2004,Moyer & Salovey 1998,Schou, Ekeberg, 
Ruland, & Karesen 2002jStreet, Jr. & VO igt 1997) 
The objectives of this component of the study were to establ ish t he current nat ure of the DMSs of 
women recently diagnosed with breast cancer in the UK w ho were offered a choice of surgery . To 
establish how f requently w omen achieved the ir PDMS, and analyse how these were associated 
with women's operative choices and their treating breast units' MR . The other objective was t o 
investigate patterns of patient information needs and identify whether these were associated 
with patients' PDMS and ADMS, surgical treatment choice, or breast unit MR . 
METHODS 
Setting 
The identification and recruitment of three breast units demonstrating practice variation 
The audit phase of over 5,000 NHSBSP detected cancers presented in chapter 2, established that 
units case-mix and case load did not account for the region's surgical variation . It also permitted 
the MR categorisation of hospital breast units for the in-depth phase of the study. The regions' 
specialist breast practice comprised ~4 NHS hospital breast units and n NHSBSP screening units. 
All ~4 breast units possessed similar practice guidelines and had similar access to radiotherapy 
and breast reconstruction . Following correction of their raw MRs for case-mix, three were 
purposively invited to participate in the in-depth components of the study; one each to represent 
the range oftreatment variation - high, medium and low MR. 
The audit phase of the study was conducted in two phases; an initial unit recruitment phase (using 
three years of data ~997-200~), and a subsequent full audit phase (~997-2003) which increased the 
case numbers and provided the power of the study; the findings of which are presented in chapter 
2 . The biphasic approach was necessitated by the time lag between audit data collection and 
availability and the attainment of project funding, and ethics and research governance processes 
involved in conducting the overall study in ~4 hospital breast units. 
Unit Inclusion criteria for the in-depth phase of the study 
Specialist hospital breast units demonstrating high, medium or low MR practice, and with a 
consistent and stable specialist workforce over the period of the study (aud it to completion); ~997 
to 2004). 
Exclusion criteria Unit for the in-depth phase of the study 
Units undergoing substantial changes in workforce between the recruitment phase of the aud it 
(1997-2001) and unit recruitment to the in-depth phases of the study. 
The exclusion criteria meant that unit 10 was not invited to participate in this phase, despite 
demonstrating the highest case-mix adjusted MR among all cancers and those in the less than 
lsmm diameter subgroup. Between the audit and in-depth unit phases ofthe study, the unit had 
undergone dramatic workforce changes; with approximately half the clinicians changing. The in-
depth study could therefore not be considered reliably representative the high MR pract ice 
pattern being investigated. 
The observed: expected MRs of the participating high (unit 4), medium (unit 3) and low (unit 6) 
MR units were 1.30 (95% (I 0.88-1.85), 1.03 (95% (I 0.78-1.35) and 0-48 (95% ( I 0.28-0 ·75) 
respectively; based on the case-mix adjustment of cancers less than lsmm diameter (n= 1399) 
diagnosed through the region 's NHSBSP (1997-2001); and 1.13 (95% (I 1.00-1.28), 1.15 (95% (I 
0.98-1.35) and 0.66 (95% (I 0.58-0.76) respectively for all cancers diagnosed through the region's 
NHSBSP (1997-2001). The full data (1997-2003) are presented in chapter2. 
All units had similar treatment guidelines and served a mixed rural and urban population . The low 
MR unit was based in a teaching hospital with 1,963 beds, NHSBSP population of 120,000 women 
per year, 5 full time consultants, 6 non-consultant grade breast doctors and 6 B(Ns. Their 
radiotherapy services were located in a different hospital of the same city 3·4 m iles away. The 
medium MR unit was based in a district general hospital with 609 beds, NHSBSP population of 
40,000 women per year, 2 full time consultants and 2 B(Ns. Their radiotherapy services were 
located in the adjacent city 14.3 miles away. The high MR unit was based in a district general 
hospital with 1,101 beds, NHSBSP population of 78,000 women per year, 3 full time consu ltants 
and 7 B(Ns. Their radiotherapy services were located in a different hospital of the same city 3·7 
miles away. The demographics of the three breast units recruited to this phase of the study as 
shown in table4·1 
TABLE 4.1. Breast unit demographics 
Hospital type 
No. hospital beds1 
Breast screening population 
Team size 
Total permanent specialist 
clinicians (n) 
Consultants (n) 
BCNs (n) 
BCN (Full Time Equivalent) 
BCN : screening population 
Distance and approximate 
journey time breast unit to 
radiotherapy unit2 
Recruitment period (months) 
No. patients approached for 
IDMO 
No. approached/month3 
No. cancers diagnosed treated 
by surgery in 2004 
% patients approached from 
no. treated by surgery 
Teaching 
1.,963 
1.20,000 
large 
1.7 
5 
6 
3-4 miles 
Time: 6min 
Same city different 
hospital 
21. 
235 
1.1..20 
1.9·9% 
District general 
609 
40,000 
small 
4 
2 
2 
2 
1.:20,000 
1.4.3 miles 
Time: 22 min 
Adjacent city 
22 
1.39 
6.32 
District general 
1.,1.01. 
78,000 
medium 
1.0 
3 
7 
3.8 
3.7 miles 
Time: 7 min 
Same city 
different hospita l 
27 
1 Average daily number of available beds by ward classification, NHS organisations in England, 
2007-08. Published 26 September 2008, from 
http://www.performance.doh .gov.uk/hospitalactlvity/data requests/download/beds open over 
night/bed 08 detail.xls 
2 calculated breast unit site to radiotherapy unit site by http.llwww.theaa .com/route -planner 
3 mean calculated on total no. patients approached and recruitment period 
Questionnaire setting and sample 
The questionnaire sample size was based on published literature available at the time of study 
design: Assuming a collaborative OMS of 50% at each breast unit, to estimate this proportion 
within +/- ~o% (i.e. 95% confidence interval, 40 to 60%) required approximately ~oo responders 
per breast unit. To gain ~oo completed responses per unit, it was estimated 200 patients wou ld 
need to be approached from each breast unit; allowing for a 50% response rate and a clustering 
effect, whereby women treated by a specific breast unit are expected to be more sim ilar to other 
women treated by that particular breast unit, than they are to women treated by other breast 
units. If there were ordering across the three (high, medium and low MR) breast units with 
respect to the proportions of collaborative OMS at each unit, then w ith a sample size of ~oo per 
unit, a 0.05 two-sided Chi-square test of trend in proportions would have 80% power to detect a 
difference in proportions characterised by this trend, assuming collaborative OMS proport ions of 
0.39, 0.50 and 0 . 6~ respectively in the three breast units for an average collaborative OMS 
proportion of 0.50 across the 3 sites. 
Purposive sampling was adopted: Consecutive eligible women were purposive ly recruited from 
three breast units purposively recruited to reflect the spectrum of surgical management variat ion; 
high, medium and low case-mix adjusted MRs. 
Patient eligibility criteria 
Eligibility for inclusion in the study was defined as any female breast cancer patient within one 
month of diagnosis of breast cancer, capable of providing informed consent to participate in a 
research study, who had been offered a choice of initial therapeutic surgery (BCT and 
mastectomy) by a specialist surgical consultant or a doctor of longstanding involvement (i. e. Staff 
Grade, Associate Specialist or General Pract ice Clinical Assistant) in the recru iting breast un it . 
The wording 'offered a choice of initial therapeutic surgery (BCT and mastectomy), was assumed 
synonymous w ith patients who did not require mastectomy on clinical grounds. However, duri ng 
the recruitment phase, very low recru itment rates w ithin the low MR prompted exploration of th e 
eligibility criteria wording with the unit's clinicians . The el igib ility crite ria wording was 
subsequently amended to 'any female breast cancer patient w ith in one mont h of diagnosis of 
breast cancer, capable of providing informed consent to part icipate in a research study, offe red 
surgery, who did not requ ire a mastectomy on clinical grounds'. 
Exclusion criteria included patients advised to have mastectomy on cl inical grounds and those 
diagnosed with a current acute psychiatric illness liable in the opinion of the patient' s doctor t o 
affect the patient's ability to give fully informed consent. While it could be argued all newly 
diagnosed patients should be included in the study, it was considered inappropriate to explore 
patients' involvement in decision making, when on clinical grounds this particular group were 
advised to have a mastectomy and not provided an opportun ity to part icipate in the decision 
making experience being explored. There was concern this could potentially cause psychologica l 
distress. 
Patients were not excluded on the basis of language, and arrangements were made for 
conversion of the study documents into the 5 main community languages (i .e. Arab ic, Benga li, 
Cantonese, Somali, Urdu) if required . 
Patient identification and recruitment 
Eligible women were identified prior to initial therapeutic surgery by members of the ir treating 
breast team, and invited to participate in the study as soon as possible following the ir initial 
therapeutic surgery, either in person or by post. The recruitment pack contained an introductory 
letter from their consultant surgeon, a patient information leaflet, a study reply form to indicate 
their preference for participating and a freepost envelope. 
Those agreeing to participate completed a consent form and study reply form ind icating whether 
or not they wished to participate in the study. Once a positive response was received, patients 
were posted the questionnaire and consent form to confirm partic ipation in the study and perm it 
access to their medical record (to determine their surg ical treatment deta ils). Patients were 
asked to return the completed documents to the researchers in the enclosed freepost envelop. 
See Appendix 6. 
Instruments 
A self-report postal information needs and decision making questionnaire (I OMQ) was ut ili sed to 
identify patients' OMS and information needs. Adapted versions of two validated instrument s 
used widely and internationally among cancer patients were utilised . A f ive-po int sca le fo r rat ing 
patient's preferences for participation in treatment decision-making wh ich was adapted f rom 
Strull's original tool (Strull, Lo, & Charles 1984) was used to identify patients' POMS and AOMS . 
Cassileth's 12-item information styles questionnaire(Cassileth, Zupkls, Sutton -Smith, & March 
1980) was used to document patients' information needs. Figure 4.1 and tab le 4.8 illustrate t he 
respective instruments. A further section of the questionnaire captured information on pat ient 
age, the patients' dates of diagnosis and surgery, type of initial therapeutic surgery undertaken 
and the surgical options discussed, plus the clinician role of the doctor providing information and 
options. 
In the OMS section, patients were asked to separately indicate which particular statements most 
accurately described the role they preferred in deciding their breast cancer surgery, and the role 
they achieved. By convention the first two responses are considered active, the th ird 
collaborative, and the last two passive. 
In the information needs section of the instrument, patients were asked to indicate the level of 
their information need on a three-point scale regarding each of the 12 items at the t ime of 
decision-making; I absolutely need this information, I would like this information, I do not want 
this information . 
All data collected were anonymised and stored securely in password-protected databases. The 
data were analysed in SPSS version 12.0, using frequency, Ch i-square, and one way ANOVA. 
FIGURE 4 .1 Decision-making styles instrument 
Preferred DMS version 
I 
I prefer to make the final selection about which treatment I will have. 
I prefer to make the final selection of my treatment after seriously considering 
my doctor/nurse's opinion. 
~--------------------------------------------------------
I prefer that my doctor/nurse and I share responsibility for deciding which 
I treatment is best for me. . _ 
; I prefer that my doctor/nurse makes the final decision about which treatment 
will be used, but seriously considers my opinion . 
I 
I prefer to leave all decisions regarding my treatment to my doctor/nurse . 
Achieved DMS version 
I made the final selection about which treatment I had . 
- - ----
I made the final selection of my treatment after I had seriously considered my 
doctor/nurse's opinion. 
My doctor/nurse and I shared the responsibility for deciding wh ich treatment 
was best for me. 
My doctor/nurse made the final decision about which treatment was used, but 
seriously considered my opinion . 
My doctor/nurse made all the decisions regard ing my treatment . 
A = Active DM S 
C = Collaborative DMS 
P = Passive DMS 
Classification convention 
!1 most commonly adopted 
a less common ly adopted 
a 
A 
C 
P 
a 
A 
C 
C 
• C 
P 
FINDINGS 
Between September 2003 and December 2005, 697 eligible women were ident ified and 
approached to participate in the study, 373 patients agreed to part icipate, 356 completed 
questionnaires were received (5~% response rate) . The mean age of the respondents was 58.5 
years (range 30.4-89.0), n% were over 70. The mean t ime between initial therapeut ic surgery 
and return of completed questionnaire was 6.9 weeks (range ~.3-48 . 6 weeks); although the 
majority (98.9%, 352/356) returned the questionnaire with in 24 weeks of the ir surgery. Overa ll, 
within the three breast units 74% (95% CI : 69-78%) of the responders underwent BCT (n=262) and 
26% (95%CI 22-3~%) mastectomy (n=94) . Two ofthose undergoing mastectomy had immed iate 
breast reconstruction; one from the high and one from the low rate unit (age 62.5 and 60.4 years 
respectively) . Reconstruction was equally available in all the units at the t ime of the study. But 
over the study period few reconstructions were performed and these were almost exclusively 
done by plastic and reconstructive surgeons. Table 4.2 demonstrates the cancer size distribution 
of low and high MR unit IDMQ participants; demonstrating the patient populations had simi lar 
cancer size characteristics . Table 4.3 demonstrates the number of patient participants by age and 
type of initial surgery. 
TABLE 4.2 IDMQ patients' cancer size characteristics by unit (low and high MR units) 
S10 33 29·7% 4~ 29·3% 
10-1 9 49 44·~% 62 44·3% 
20- 2 9 ~9 ~7 · 1% 28 20 .0% 
30 -39 7 6·3% 8 5·7% 
40 -49 ~ 0·9% 1 0·7% 
2 ~ . 8% 0 0% >50 
Missing data 2 ~7 
Range 0-55, Mean 30.69, Median Range 0-40, Mean 15-49, Median 
~4 ~5, mode 30 
mode 20 
TABLE 4.3 
Initial 
therapeutic 
treatment 
Total n (%) 
Number of patient participants by age and type of init ial surgery 
BeT n (%) 45 (1.7 .2%) 1.93 (73·iVo) 24 (9·1.%) 
Mastectomy n (%) 23 (24·5%) 57 (60.6%) 
68 (1.00.0%) 250 (J.Oo.o%) 38 (1.00.0%) 
Mean age of women having BCT = 58.3 (range 30.4 - 89.0 years) 
Mean age of women having mastectomy = S8.S (range 33.7 - So.oyears) 
94 (26%) 
356 (100%) 
Decision -Making Styles 
Table 4·4 demonstrates patients' preferred versus achieved DMS, and the concordance between 
their PDMS and ADMS. Overall, 6~% (2~8/356) agreement was observed between pat ients' 
PDMS and ADMS (kappa 0.39 p=o . oo~) . When women failed to achieve the ir PDMS, they tended 
to adopt more active (29 .5%, ~05/356) than passive roles (9 .3%, 33/356) . The atta inment of 
patients' PDMS was associated with their PDMS; the greatest concordance being demonstrated 
among those preferring active roles (9~ . 0%, ~3~/~44) . Those preferring either collaborative or 
passive roles were less likely to achieve their PDMS; 53 .0% of those preferring a collaborative ro le 
in the selection of their surgery actually had an active role, and 3~ . ~% of those preferring a passive 
role had an active role. 
TABLE 4.4 Preferred versus achieved decision-making styles 
Achieved Active n (%) 
decision- Collaborative n (%) 4 (2 .8%) 61 (17.1%) 
making style 
65 (18·3%) Passive n (%) 9 (6·3%) (ADMS) 
Total n (%) ~44 (~oo . o%) ~51 (~oo .o%) 356 (100%) 
The black shaded cells on the diagonal indicate perfect agreement between the PDMS and 
ADMS. 
Kappa statistic for agreement = 0.39, P<0.001. 
------- -- ---------
Concordance between patients preferred and ADMS was independent of operation choice 
(P=0.070) and breast unit MR (P=0.533). However there was a non-significant a t rend t oward 
greater concordance between PDMS and ADMS among those choos ing mast ectomy (6t Vo vs . 
59%), and the achievement of more passive roles than preferred among the BeT group (11% vs . 
3%). Table 4.5 illustrates patients' PDMS versus ADMS by operat ion cho ice, and demonstrates 
these trends . 
TABLE 4.5 Preferred versus achieved decision-making styles by operation choice 
Table 4.6 summarises patients' AOMS by operation choice, and case-mix adjusted breast unit MR . 
Overall, 64.6% (231/356, 95% CI : 60 to 70%), of the sample achieved an active OMS. Act ive 
decision-making was particularly predominant among those women choosing mastectomy 
(83.0%), rather than those choosing BCT (83.0% vs . 58.0%, 25% difference, CI 14 to 34%, 
P<0.001), and those from the high MR unit than those from the low & medium MR units (79 .6% 
vs . 52 .2% and 53.5% respectively, p<0.001). Women choosing mastectomy and those from the 
high MR unit, also preferred a significantly more active OMS compared with those choosing BCT, 
and those from the medium and low MR units (P<0.001 and P=0.015 respectively). 
TABLE 4.6 Summary of achieved decision-making style (ADMS) by operat ion choice, and 
case-mix adjusted breast unit MR 
Overall achieved OMS (n=356) 64. 6% :lI~% ~8 · 3% P=0.001 
Operation choice and achieved OMS 
BeT choice (n=262) 58.0 % ~9 · 5% 22 ·5% 
Mx choice (n=94) 83.0% ~0 . 6% 6·4% 
P<0.001 
Breast Unit MR and achieved OMS 
Low MR (n=113) 52.2% 23.0% 24.8% 
Medium MR (n=86) 53 ·5% 22 . ~% 24·4% 
High MR (n=157) 79.6% ~0 . 2% ~0.2% P<0.001 
P-values from chi-squared test . 
Table 4.7 illustrates patients' ADMS by operation choice and case-mix adjusted un it MRj 
highlighting the predominance of the active DMS among patients choos ing mastectomy treated 
at the high MR breast unit. Those choosing mastectomy and those from the high MR un it , a lso 
preferred a significantly more active DMS compared with those choosing B(T, and those from 
the medium and low MR units (p<o . oo~ and P=0 . o~5 respectively). 
TABLE 4.7 
Breast 
unit MR 
Achieved decision-making style (ADMS) by operation cho ice and case -mix 
adjusted breast un it MR 
5 (18 ·5%) 6 (22.2%) 27 (1000% ) 
surgery 
BeT 43 (50 .0%) 21 (24 .4% ) 22 (25 .6%) 86 (100 .0%) 
Total 59 (52 .2%) 26 (23 .0%) 28 (2 4 .8%) 113 (100 .0%) 
Medium Type of Mx 26 (89 .7%) 3 (10·3%) 0(0%) 29 (100 .0%) 
surgery 
BeT 20 (35 .1% ) 16 (28 .1%) 21 (36.8%) 57 (1000%) 
Total 4 6 (53 ·5% ) 19 (22 .1%) 21 (24 .4%) 86 (100 .0%) 
High Type of Mx 36 (94 ·7%) 2 (5.3% ) 0 (0%) 38 (100 .0%) 
surgery 
BeT 89 (74 .8% ) 14 (11.8% ) 16 (13 .4%) 119 (100.0%) 
Total 125 (79 .6% ) 16 (10 .2%) 16 (10 .2%) 157 (1000%) 
The percentage figures with in the brackets correspond to the proporti ons across each row of the table 
The study was not designed to look at age as an independent variable/ however younger women 
were found to prefer more active roles in decision-making (P=0.041)/ as illustrat ed by t he mean 
age of the DMS groupSj active 57.4 years/ collaborative 58.4 years and passive 61.1 yea rs . 
However/ age was not associated with the ADMS (P=O.252)/ operat ion cho ice (p=o·716) or breast 
unit MR (P=0.371) . Table 4.8 illustrates the mean ages of the PDMS and ADMS styles . 
TABLE 4.8 Achieved and preferred decision-making style (DMS) by patient age. 
Active Collaborative Passive p= 
Achieved OMS (n=356) 58.0 (g.1) 58.5 (8.g) 60.2 (12 .0) P=0.252 
Preferred OMS (n=356) 57·4 (g .g) 61.1 (11.0) P=O.041 
Information needs 
Consistent with previous studies among cancer patients, the patients participating in this study 
expressed high information needs. The majority stating they 'absolutely needed' (items 1. to 6 
and g) or 'would like' (items 7, 8, and 10 to 12 to 6) all the information items presented in the 
instrument. The only item where the need for information was expressed less consistently was 
item 12; examples of cases where the surgery has not been effective. 
There was however a trend toward the desire for greater information related to specific 
information items among those who preferred an active decision-making style (items 1 and 3; 
possible side effects and whether or not the diagnosis was cancer, P=0.051. and p=0.028 
respectively), those choosing BCT (item 6; exactly how the surgery will affect their body, P=0.049) 
and a possible trend among those from the higher MR units (items 11 and 12; examples of cases 
where the surgery has been or not been effective p=0.060 and p=0.066 respect ively). The full 
results are presented in full in table 4.9· 
TABLE 4.9. Information needs questionnaire items, responses and associations with breast un it MR, 
treatment, and preferred and achieved Decision-Making Style (OMS). 
INFORMATION ABOUT. .. 
1. What all the possible side 
effects are. 
62·4 36 .8 0.8 0 0.452 0.245 0 .05l 0·377 
2. What the surgery will 77·5 
accomplish. 
2l·9 0.6 0 0.6l4 0.68l 0.069 0.l69 
3. Whether or not it is 88 .2 ll.2 0 .6 0 ·3 0·4l4 0·740 0.028 0.l30 
cancer. 
* 
4. What the likelihood of 78 .l 20·5 l .l 0 ·3 0.227 0·979 0.336 0.20l 
cure is. 
5. Which parts of the body 77.2 2l·9 0 .6 0 ·3 0 .6l5 0.74 2 0 .088 0.29 2 
will be involved? 
6. Exactly how the surgery 73.0 26·4 0.6 0 0 .720 0.049 0·1l4 0·553 
will affect my body. 
* 
7. What the daily (or 4l ·9 55.6 2.2 0·3 0 .626 0.l82 0·459 0.983 
weekly) progress is. 
8. What the specific 36 .5 58.4 4.2 0 .8 0.202 0.288 0.l82 0.2l 3 
medical name of the 
-+-illness is. -----9. Whether it is inherited. 57·3 40 .7 2.0 J:4 0·30l 0.727 0 .25 l 
10. How effective the 38 .2 57. 0 4. 8 0 0 ·38l 0 .l40 0.l84 0.626 
surgery has been for 
-1 other patients 
- - ---
-
- ---
11. Examples of cases 28 .l 58 .7 l3 ·2 0 0 .060 0 .9 25 0 .646 0· 757 
where the surgery has 
been effective. 
12. Examples of cases 19·9 47. 8 32.0 0·3 0 .066 0 ·911 0 .2l7 0 ·9
11 
where the surgery has 
not been effective. 
---- --
*p<o.oS 
CONCLUSION 
Using validated tools with a track record in this context, (Ca ssdeth, Zupkls, Sutton -Smith, & March 
198ojStrull, Lo, & Charles 1984) this study demonstrates a significant sh ift in the DMS of UK 
women with breast cancer eligible for surgical choices. They indicate the maj ori t y women want 
to be comprehensively informed about their diagnosis and options, and over 80% want to 
participate in selecting their breast cancer surgery (active or collaborative). Only a m inority 
wanted clinicians to make decisions on their behalf. This group of participants preferred and 
achieved more active roles than demonstrated in previous UK (Beaver Luker Owens Lelnster 
, , I I 
Degner, & Sloan 1996) or international studies. (Janz, Wren, Copeland, Lowery, Goldfarb, & 
Wi lkins 2004jKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Lantz, Janz, Fagerlin, 
Schwartz, Liu, Lakhani, Salem, & Katz 200SjMastagiia & Kristjanson 2001) The act ive shift was 
amplified among those choOSing mastectomy (P<O.OOl) and those from the high MR un it (act ive 
PDMS P=O.OlS, active ADMS P<O.OOl respectively) . Most previous studies demonstrate more 
active DMS among the BCT group.(Degner & Sloan 1992iMastagiia & Kristjanson 2001) But a 
more recently published study report findings analogous with oursi (Davlson & Degner 2002) 
indicating mastectomy will continue to be chosen by a subgroup of women given choices . 
The evidence suggests when patients achieve their preferred or an active role in decision making 
they are more satisfied with both their treatment and the decision making process, and possess 
less regret, {Bruera, Willey, Palmer, & Rosales 2002, Degner, Kristjanson, Bowman, Sloan, 
Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997ajHack, Degner, Watson, & Sinha 2006,Janz, 
Wren, Copeland, Lowery, Goldfarb, & Wilkins 2004iKeatlng, Guadagnoll, Landrum, Borbas, & 
Weeks 2002iLam, Fielding, Chan, Chow, & Ho 2003iLantz, Janz, Fagerlln, Schwartz, LIU, Lakhani, 
Salem, & Katz 2oosJv1astagiia & Kristjanson 200l,Singh, Sloan, Atherton, Smith, Hack, Huschka, 
Rummans, Clark, Diekmann, & Degner 2010) and that this is amplified when cong ruence between 
PDMS and ADMS is achieved.{Charles, Whelan, & Gafnl 1999a) The majority of patients in th e 
study either achieved their preferred or a more active role . Only 9·3% ach ieved more passive 
roles than preferred . Highest rates of concordance were demonstrated among those preferring 
active roles. Where discrepancies existed, passives were shifted toward more act ive ro les, and 
collaboratives shifted in either direction. The latter finding is consistent wi t h other studies 
published since the onset ofthis study.(Vogel et al 2008b) 
In accord with other studies among cancer patients, ou r partic ipants displayed high information 
needs. These were predominantly unrelated t o the ir PDMS or ADM S, their unit s' MR and 
treatment decision. A few exceptions were noted : the BeT group wanted more info rmation 
about the impact of surgery on their body (P=0.049), and there were trends for act ive dec ision 
makers to want more information on possible side effects (P=0.051) and high MR un it pat ients to 
want examples of where surgery had been effective or not (p=o.060 and 0.066 respect ively). The 
findings are summarised in figure 4.2. 
The limitations of the questionnaire include its administration after the decision -making episode 
and the overall response rate of 51%. These are explored in the discussion chapter. Our respon se 
rate is however comparable with similar studies. Such limitations may affect the general izability 
of the study; as with all research, the findings may be characteristic only of those part icipating in 
the research study. 
FIGURE 4.2 Summary of OMS and information need findings 
. ~. It. 
Preferred and achieved DMS were most active in: 
The high MR unit 
Women from all units choosing mastectomy 
• The majority of patients (80%) wanted to participate in deciding the ir breast 
cancer surgery (active or collaborative) 
• Women were more likely to achieve their preferred role in decision making than 
in previous studies (61%, n=218/356) 
• Active decision makers and those choosing mastectomy were more likely to 
achieve the role preferred in decision making (67% vs. 59%, P=0.070 ). 
Chapter 5 
Clinician semi-structured interviews 
Why do hospital mastectomy rates vary? A qualitative study 
of clinicians' attitudes to surgical decision making for women 
with early breast cancer 
Abstract 
Background Widespread variation exists in hospital breast unit MRs. Clin icians are known to 
exert a prominent influence over treatment, but the mechanism and intent are poorly 
understood. The aim of this component of the study was to explore the possible associat ion 
between MRs and clinician beliefs and decision making approaches. 
Methods Semi-structured interviews were conducted with 26/3~ specialist clinicians from 
three hospital breast units with high, medium and low (case-mix adjusted) MRs from a single UK 
region; 1-3 BCNs and ~3 doctors. Interviews were recorded, transcribed verbatim and analysed 
using 'Framework'. 
Findings Four key themes defined breast units' decision making culture and were 
associated with variation in hospital breast unit MRs; breast unit ethos, definition of eligibility for 
choices, clinician beliefs and routine processes. 
The four themes were mutually interdependent, with the overall ethos dominant. Clinicians from 
the different breast units described an ethos central to their practice at individual and unit level. 
These were either primarily outcome-based with a focus on mastectomy avoidance (low MR unit) 
or primarily process-based, focussed on patient involvement in decision making (medium and 
high MR units). These defined the group of patients clinicians identified as suitable for cho ices. 
The ethos was associated with specific clinician beliefs (regarding clinician-patient roles in 
decision making, optimum management, patient preferences and dec ision making capacity); and 
were reinforced by the units' routine processes (offering options, providing information and 
recommending treatment) . Their effects were either exacerbated or tempered by decision 
support and timescales provided. 
Conclusions This chapter reports new findings which elucidate some of the overt and subtle, 
interdependent clinician and breast unit factors associated with variation in hospital MRs. 
Although some individual variat ion was noted, consistent distinct differences were observed 
between different breast units' clinicians. In the units studied, lower MRs were associated with a 
preference for BCT and a more paternalistic approach to consultations and decision making 
dominated by recommendations, and less provision and support of shared decision making, 
which was compounded by rapid timescales to consent . 
BACKGROUND 
The UK's DoH, (Department of Health 200la;Department of Health 200lc,Department of Health 
2009) Royal College of Surgeons on England(Royal College Of Surgeons Of England 2002) and 
GMC guidelines(General Medical Council 2008) regarding informed consent t o medical treatment 
are most consistent with a patient-centred consultation style and shared dec ision making 
approach. Evidence -based breast cancer treatment gu idel ines state clin icians should offer a 
choice of BCT and mastectomy to patients, when BCT is not cont raindicated; (Assoclatlon of 
Breast Surgery at BASO 2oo9;Kaufmann, Morrow, von, & Harris 2010, Scarth, Cantin, & Levine 
2002a) reflecting the shift from paternalism to partnersh ip .(Department of Health 
2001ajDepartment of Health 2001c;Department of Health 2008;Department of Health 
2009jRawling 1992jRoyai College Of Surgeons Of England 2002) Such gu idelines were des igned 
to facilitate maximal patient control over decisions without compromising mortal ity and 
morbidity.(Fisher, Anderson, Bryant, Margolese, Deutsch, Fisher, Jeong, & Wolmark 2002, van 
Dongen, Voogd, Fentlman, Legrand, Sylvester, Tong, van der, Helle, van ZIJI, & Bartellnk 2000) 
This is usually interpreted as choice for uni -focal or multi-centric cancers up t o 4-5cm diameter 
with no contraindications to radiotherapy. 
Despite this, the surgical treatment of this common cancer remains highly vari able(Bates, 
Kearins, Monypenny, Lagord, & Lawrence 2009;BCCOM 2006,BCCOM Steering Group 
2007jFarrow, Hunt, & Samet 1992,Goel, Ollvotto, Hislop, Sawka, Coldman, & Holowaty 
1997jGrilli, Scorpiglione, Nicoluccl, Malninl, Penna, Marl, Belflgllo, & Liberati 1994,Iscoe, Goel, 
Wu, Fehringer, Holowaty, & Naylor 1994;lshizaki, Imanaka, Hirose, Kuwabara, Ogawa, & Harada 
2002jMandelblatt, Hadley, Kerner, Schulman, Gold, Dunmore -Griffith, Edge, Guadagnoli, Lynch, 
Meropol, Weeks, & Wlnn 20ao,Moneypenny 2004,Morrls, Cohen, Schlag, & Wright 2000, Morrow, 
White, Moughan, Owen, Pajack, Sylvester, Wilson, & Winchester 2001,Nattinger, Gottlieb, Veum, 
Yahnke, & Goodwin 1992jNattinger & GoodWin 1994, Samet, Hunt, & Farrow 1994, Sauven, 
Bishop, Patnlck, Walton, Wheeler, & Lawrence 2003, Scorplgl,one, Nlco luccl, Grilli, Ang,olln', 
Belflgllo, Cannci, Cubasso, Filardo, Labbrozzl, Maln lnl, & 1995,van Nes, Seynaeve, Jones, 
Markopoulos, Putter, van, V, Hasenburg, Rea, Vannetzel, Dlrl x, Hozuml, Kerin, Kleback, 
Meershoek-Klein Kranenbarg, Hille, & Nortler 2010) wit h no clear expl anation for it . Patients' 
healthcare decisions are subject to many influences related t o patient concerns and fears (( drYer, 
Pozo -Kaderman, Price, NOriega, HarriS, Derhagop,an , RoblnsOl, & Moffat, Jr 19 !;,(l IIIn , 
Moore, Clay, Kearing, O'Connor, Ll ewe llyn -Thomas, Barth, Jr., & Sepucha 2oo9,FalloV\f leld, 
Baum, & Maguire 1986i Haw ley, Grigg s, Ha m ilton, Graff, Janz, Morrow, Jagsl, Salem, & Katz 
2009i Hughes 1993iKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Lasry & 
Margolese 1992jMandeibiatt, Had ley, Kerner, Schulman, Gold, Dunmore -Griffith, Edge, 
Guadagnoli, Lyn ch, Meropol, Weeks, & Winn 20ooiMoienaar, Oort, Sprangers, Rutgers, LUlten, 
Mulder, & de Haes 2004i Moyer 1997i Nold, Beamer, Helmer, & McBoyle 2ooo,Schou, Ekeberg, 
Ruland, & Karesen 200 2,Smitt & Heltzel 1997,Wel, Sherry, Baisden, Peckel, & Lala 1995,Wilson, 
Hart, & Dawes 1988) The evidence also suggests patients' decisions are influenced by cl inici an s' 
overt recommendat ions and patients' perceptions of their preferences, (Johnson, Robe rts, Cox, 
Reintgen, Levine, & Parson s 1996jKatz, Lant z, & Zemencuk 2001,Kotwall, Maxwe ll, Covingt on, 
Churchill, Smit h, & Covan 1996, Moienaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & de Haes 
2004iMorrow, Jagsl, Alderman, Griggs, Hawley, Hamilton, Graff, & Katz 2009,Nold, Beamer, 
Helmer, & McBoyle 2oooi Schou, Ekeberg, Ruland, & Karesen 2002, Sm ltt & Heltze l 1997) along 
with patients' perception of treatments curative potential. (Katz, Lantz, & Zemencuk 
200liKotwall, Maxwell, Covington, Churchill, Sm ith, & Covan 1996, Sm ltt & Heltzel 1997) 
Although limited detail is available from these predominantly audit-based stud ies. At the onset 
of this study, limited information was available about clin icians' preferences and 
recommendations. Most was based on quantitative methodolog ies and theoret ical question ing . 
Iscoe suggested a 'hospital affect'(lscoe, Goe l, Wu, Fehringer, Holowaty, & Naylor 1994) and 
quantified its degree of impact, but did not define the factors causing it . Some have suggested 
clinician preferences are associated with clinician characteristicsj such as experience 
level, (M cKinlay, Burns, Durante, Feldman, Freund, Harrow, Irish, Kasten, & MoskOWitz 1997) time 
since qualification, (Goel, OllVOttO, Hislop, Sawka, Cold man, & Holowaty 1997) gender,(Gilllgan, 
Neuner, Spa rapanl, Laud, & Nattlnger 2007,Mandeibiatt, Berg, Meropol, Edge, Gold, Hwang, & 
Hadley 200liSchou, Eke berg, Ruland, & Karesen 2002) academic affiliat ion (Goel, Oil vOttO, Hislop, 
Sawka, Coldman, & Ho lowaty 1997,Porter & McMu lkln -Talt 2004) and med ico-legal 
awareness .(M cK inlay, Burns, Durante, Feldman, Freund, Harrow, Irish, Kasten, & MoskOW itz 
1997) However, most provided little detail and insufficient information, t o permit underst anding 
of the factors or mechanism underlying the influence. Also, most stud ies were conducted among 
convenience clinician samples rather than specialists.(Coliln s, k erri ga n, & Angl ade 1999, Ende, 
Kazls, & M oskOWitz 1990,Porter & McMulkln -Talt 2004 So although interest ing, they are of 
limited value, as revealed preferences are unlikely to affect speci alist practice. Olllf''>,,, err lCjcW, & 
Ang lade 1999, M cKinlay, Burns, Durante, Feldman, Fre und, Harrow, If I<;h, r., asten, & Mosko' It : 
1997) Additionally, studies to date investigating clinicians' impact on pat ient treatment have 
focussed on doctorsj BCNs been neglected, but represent a potentiall y key cl inic ian group in t hi s 
decision making context . 
As well as limited information on the relevant clinician stakeholders ' preferences, there is m inimal 
information about the mechanism by which clinician preferences and influences are med iated . 
The evidence suggests clinicians' consultations are the key encounters through w hich an 
influence is mediated. But there is sparse specific relevant information on how prefe rences 
manifest within them, or how they impact on patient decisions in the context of wider non -
clinician/unit influences. 
Much has been written about different styles of communication (doctor vs. patient-centred) and 
healthcare decision making (paternalism, shared and informed choice), (Coulter 1999,Coulter, 
Entwistle, & Gilbert 1999jDeadman, Leinster, Owens, Dewey, & Slade 2001,Elwyn, Edwards, 
Gwyn, & Grol1999jElwyn, Gray, & Clarke 2000,Elwyn 2008;Fallowfleld, Hall, Maguire, Baum, & 
A'Hern 1994ajHack, Degner, Watson, & Sinha 2006; McWhlnney 1989,Moyer & Sa lovey 
1998jSi lverrnan, Kurtz, & Draper 1998/Stewart 1995jStreet, Jr. & VOigt 1997) and pat ients are 
recognised to prefer patient centred consultation styles .(Dowsett, Saul, Butow, Dunn, Boyer, 
Find low, & Dunsmore 2000jFrederrkson 1995,Lerman, Daly, Walsh, Resch, Seay, Barsev lck, 
Birenbaum, Heggan, & Martlll 1993,Magulre 1999, Vlck & Scott 1998) However, the impact of 
these on patients' decisions especially in situations where there is no globally superior treatment 
(like the surgical treatment of breast cancer), are not well understood or documented . Patient-
centred consultations encourage patient participation and seek to tailor explanations and 
discussion of the impact of the disease and treatment. Doctor-centred consultations and 
paternalistic decision making involve clinic ians assuming the dominant role, are primarily d isease 
focused and tend to exclude non-disease factors of potential importance to patients .(Charles, 
Gafni, & Whelan 1999b;Charles, Gafnl, & Whelan 2000iCouiter 1999,Coulter, EntWistle, & Gilbert 
1999jEllt, Charles, Gold, Gafnl, Farrell, Tedford, Dal Bello, & Whelan 2003,Elwyn, Edwards, Gwyn, 
& Grol1999,Elwyn, Gray, & Clarke 2000/Elwyn 2008,Gafnl, Charles, & Whelan 1998,McWhllllley 
1989jSilverman, Kurtz, & Draper 1998) At the other end of the spect rum of decision making 
approaches is informed choice, where patients are given 'suffic ient ' information t o make a choice 
but no guidance, and assumes patients play an active decisional role. These approaches suit 
some patients, but tend to be applied irrespective of patient PDM S. Betw een these extremes is 
shared decision-making where patients and clinicians participate In two way information 
exchanges, the patient deliberates, has further discussions with their clin icians and others, they 
then declare their preference, and the parties agree a treatment plan . This form of dec ision 
making seems more patient-centred and suited to tailoring . 
Lukes' theorised the existence of complex power relationships guiding behaviour and decisions, 
which Canter transposed into the clinician-patient interaction in healthcare.(Canter 2001, Lukes 
1974) Three levels are suggested; first dimensional power involves clinicians blatantly controlling 
patients decisions or actions; second dimensional power involves clinicians' exerting their power 
in a more subtle ways by control agendas, deliberately steering interactions and subjugating 
patients through the provision of insufficient clinical time, poor ambience, poor listening skills 
etc.; and third dimensional power comprises clinicians exerting a widely pervasive, more 
imperceptible influence: As clinicians supply the medical knowledge underpinning patients' 
understanding and perceptions, they control patients' actions and choices, so patients can false ly 
believe they are behaving autonomously. 
There is little published knowledge regarding treatment preferences of clinicians as individuals or 
as members of specialist teams within hospital breast units. There is also limited information 
regarding the beliefs and motivations underlying them, and how they are communicated to 
patients and influence decisions and therefore both hospital treatment rates and practice 
patterns, in the wider context of other non-clinician/unit influences. Other issues include; a lack 
of understanding of the message clinicians intend to communicate in these contexts; how overt 
or subtle do recommendations or preferences have to be for patients to perceive or comply with 
them; how systematic and intentional are recommendations or preference communications; and 
do clinicians working as part of a breast unit team hold similar preferences? This chapter 
describes the findings of interviews with specialist breast clinicians (doctors and nurses) explo ring 
their treatment preferences and the breast cancer treatment decision making process from 
clinicians' subjective perspective, to identify the key themes associated with vari ation in breast 
unit practice patterns. 
METHODS 
Study design 
Semi-structured qualitative interviews were chosen to explore how spec ialist clinicians influenced 
patients' choice of surgery (BCT or mastectomy). Th is methodo logy was chosen as it permits the 
acquisition of targeted rich data on pre-determined topics of interest, wh ile synchronously 
permitting sufficient flexibility to capture all ied emergent themes. 
Setting and sample - Breast unit recruitment 
This component of the study was conducted in the same three purposively select ed specialist 
hospital breast units as the patient questionnaire and interview components of the study, which 
are described in chapters 4 and 6; i.e. units representing high, med ium and low case-m ix adj ust ed 
MRs. 
Clinician inclusion criteria: Any specialist BCN, surgical consultant or doct or of longst an ding 
involvement in the breast unit (i .e. Staff Grade or Associate Special ist) 
Clinician exclusion criteria: Non-specialist and non-permanent members of the breast team 
(including trainee surgeons who play only a transient role in the unit). 
All 31 permanent specialist clinicians of the three breast units ' were invited to part icipate in t his 
component of the study. Potential participants were contacted via post, fo llowing an init ial study 
recruitment meeting. The study invitation pack contained a covering letter, information sheet, 
study reply form and freepost envelope. Those indicating a wi llingness to part icipat e in one to 
one interviews were contacted by the research team to arrange an interview at a t ime and place 
to suit the clinicians' convenience. Interviews were conducted with the 26 ag ree ing to part icipate. 
This group comprised 13 specialist doctors and 13 BC Nsj of which 19 were female (13 BCNs, 3 
consultant surgeons, 2 associate specialists and one GP cl inical ass istant) and 7 male (6 consultant 
surgeons and one GP clinical assistant). Non-responders included 2 BCNs, and 3 male doctors . 
Only one was a consultant surgeon who (at the onset of t he study) gave his recent retirement as 
the reason for not participating . Table 5.1 outl ines th e occupational role, gender and breast un it 
of responders and non-responders. 
TABLE 5.1 Breast unit and clinical role of responders and non-responders 
Medium MR unit 
6 (6) 6 2 (2) 2 
Consultant 4 (2) 5 2 2 
surgeon 
2 (2) 2 
2 (1) 4 
(17) 
Data 
Interviewed 
(female) 
5 (5) 
3 (1) 
8 (6) 
7 
3 
(10) 
The interview schedule was developed by the research team comprising experienced qua litative 
researchers, two surgeons, one BCN and two consumer representatives who had previously been 
diagnosed and treated for breast cancer. The interview schedule was piloted on one special ist 
consultant breast surgeon and one BCN from other breast units from the region . The final 
interview schedule was developed following minor amendments . The schedule was designed to 
explore the breast unit guidelines, structure and processes; including the process from 
assessment to diagnosis and consent at individual clinician and breast un it level. Quest ions were 
focussed on how decisions about patients' options were made, the content and styl e of 
information presentation in consultations; clinician thoughts about t he su rgical treatment of 
breast cancer and patient involvement in decision making in th is context; and what they felt had 
the greatest influence over patient decision making . It also conta ined a crit ica l incident 
technique, where clinicians were asked to describe interact ions with act ive, collaborat ive and 
passive patients. The interview schedule and consent form are located in appendix 5· 
Interviews lasted between 44 and 120 minutes (median 73 minutes), were digitall y recorded and 
transcribed verbatim. Field notes of the interviews and communication with the cl inicians were 
also kept. 
Qualitative data analysis options 
At the time of study development, two forms of data analysis were commonly used in health and 
social services qualitative researchj 'Framework' and computer assisted approaches such as OSR 
NUD*IST. Computer assisted approaches were more commonly used and offered greater speed 
of analysis, but in our view offered less potential depth and flexibility of data analysis. Although 
more labour intensive and time consuming, it was felt Framework would permit us to remain 
grounded in the data throughout analysisj retaining the voice of the individual while crystallising 
their message. It would also assist the subsequent triangulation of the study data from the 
different methodologies and stakeholder perspectives. This was felt crucial to optimising 
understanding of a complex issue such as decision making . A comparison of the two potential 
analytical approaches considered (OSR NUD*IST and 'Framework') is summarised in table 5.2 . 
Analytical approach (the 'Framework' approach) 
'Framework'(Pope et al. 2000jRichie et al. 2003,Rltchie and LewIs 2003) was used to analyse the 
interview transcripts and field notes generated by the study. This method of data analysis was 
chosen for both the clinician and patient interviews of the study in view of its capacity tO j analyse 
large volumes of qualitative textural data in a rigorous, comprehensive and systematic but flexible 
waYj synchronously permit the extensive exploration of the data within and across both themes 
and caseSj and retain the link between each comment and the source data to perm it deeper 
analysis in the context ofthe interview flow. See table 5.2. 
TABLE 5.2 Comparison ofthe two potential analytical approaches OSR NUD*IST & 'Fram ework' 
aSR NUD*IST 'Fra'mework' 
Breaks up the original transcripts by themes ~echanism to condense data w hile reta ining the 
identified by the researcher (after initial individual respondent characterist ics . 
manual coding) . 
Pulls out information coded manually Manually ident ified themes and code to plot in the 
(initia lly) Framework matrix 
Data extracted in one dimension Data extracted in two dimensions from the outset . 
Theme vs. participant (characteristics etc. ) 
---
Does not condense the data to a manageable Condenses data to a more manageable size fo r 
size needed to analyse a large number of subsequent analysis - while retain ing the 
interviews respondents 'voice' (if summarise in their language) 
Permits within & between respondent analysis 
Dissociates data from the source Retains link with source data throughout f ; r ease of 
comparison in data analysis & permits comparison 
on different levels/groups i.e. decision-making & 
different MRs, etc. 
Permits ready identification of pages data 
summarised from (rigor) and quotes_ Links 
-- --
Very good when looking at complex relational data 
Less time and labour intensive! More laborious and time consuming !1 
The research focus and nature of the questions of applied and policy-relevant research means, it 
is by definition more structured than is the norm among other forms of qualitative research _ A 
priori needs strongly inform both the data collection and analysis of health services research, it 
therefore tends to be more targeted and explicit in its focus . The Framework approach was 
developed in the UK by the National Centre for Social Research, as a structured approach to 
qual itative data analysis. It was specifically designed to accommodate these needs. The data 
management/summarising phase of the analysis, leads to the development of a grid structure or 
matrix constructed of themes (in columns) and participants in (in rows). Th is fac ilitates t he 
exploration of complex relational data, while retain ing the link to the ori gina l data _ The red uct ion 
and matrix arrangement of these extensive textural datasets into summari sed versions f acilitate s 
exploration of the data in a flex ible way; enabling both wit hin and between exploration at many 
different levels; thematic, individual participant, breast unit, operation choice etc. Framework 
was therefore the appropriate choice for the analysis of the qualitative data of t his study. 
Five stages of Framework are traditionally described, although the process can be halted at any 
point after the completion of stages two to five . Figure S.l outlines the steps involved in 
Framework analysis. 
Stage one: Data management 
This stage of the Framework approach traditionally consists of five steps of data analysis, 
resulting in the construction of a matrix in which all the qualitative data is summarised by theme 
and participant into individual cells. The steps comprise: 
I. Familiarisation and Identification of a thematic Framework 
The familiarisation phase and generation of the thematic structure involve the researchers 
becoming immersed in the raw data by studying the research proposal 's aims and object ives, 
published literature, interview schedule, and listening to the interviews, reading identica l random 
subsets of interview transcripts and field notes. Through this process of focuss ing on a prio ri and 
recurring issues, views and experiences emerging from the participants ' data; permitting the key 
ideas, concepts and recurrent themes of the research to be identified . The identification of these 
lead to the construction of a detailed index which will permit the data to be subsequently 
examined and referenced in a systematic way; labelling the data into manageable chunks fo r 
subsequent retrieval and exploration . 
This step was conducted by three researchers (LC, DW and KC) and two consumer 
representatives (HMC and GS). The main column head ings of the Framework matri x were 
developed from subsequent discussions of their interpretations. Appendix 8 provides a clinician 
Framework matrix example. 
II. Index & code individual transcripts 
The thematic framework or index created was then appl ied systematically to the fu ll textua l 
dataset. Individual transcripts were analysed and annotated with numerical codes and short 
textural descriptors from the index in the margin of the transcript . Single passages of text often 
encompass a large number of different themes; each was documented . Most (65 .2%, 45/69 
patient interviews) were facilitated by listening to the particular interview aud io recording while 
analysing the verbatim transcript. 
III. Pilot charting and adapt the thematic index 
A number of individually charted transcripts which were coded and charted by more than one 
researcher (LC , DW and KC). They were then examined and discussed and the themat ic 
framework adapted in light of gaps and overlaps identified through the piloting process. At the 
end of this phase the final version of the thematic index was created which was subsequently 
applied to the full set of qualitative data. Figure 5.2 illustrates the final version of the Framework 
patient data analysis theme headings & code numbers of the thematic index applied to the 
participant interview transcripts . 
IV. Charting 
The indexed verbatim interview transcript data were then rearranged grouped and distilled into 
summaries of the views and experiences documented within the transcripts of the ind ividua l 
participants. Figure 5.3 outlines the agreed charting conventions and abbreviations employed 
during the charting process. The distilled summaries were then incorporated into the relevant 
part of the thematic framework . At the end of the charting phase fo r each partic ipant, the 
competed charting was re-examined to ensure it accu rately reflected the patient's account . 
During this process attempts are made to reta in the patient 's language within the d ist ill ed 
summary. In this way the final Framework matrices were constructed by the repet it ion of the 
process for all the participant transcripts and data . Some themes overlap and t he refore the data 
occasionally appear in more than one thematic column . The final ve rsion of the mat ri x st ructure 
was therefore comprised of individual rows representing indi vidual pa rticipa nts, and columns the 
different themes and subthemes. An example of a clinician interview Framework matrix is found 
in appendix 8. 
v. For inter-rater reliability; different raters code and chart a random overlap sample 
As an on-going process to minimise bias and improve the reliabil ity of the data ana lysis, 30 % 
(n=8/26) of the interviews conducted were independently coded, charted by one clin ical (LC) and 
one non-clinical (DW) researcher. The provisional chartings were subsequently discussed 
between the researchers and any discrepancies in analysis resolved. The information gained 
through this process was utilised to inform subsequent data analysis. 
Stage two: Exploring descriptive accounts. 
Following completion of the coding and charting phase, the Framework matrices were explored 
within and across themes, clinicians and breast units. In this stage the descriptive summaries of 
patients' views and experiences contained within the Framework matrices were explored fo r 
similarities and discrepancies, to understand why the accounts from the individual participant 
interviews and breast units were different or similar, and investigate the reasons for variation in 
experiences and views. This led to identification of factors describing clinicians' beliefs, 
motivations and practices. Only those related to the remit of understanding variation in practice 
were analysed further. Once identified, emergent themes, subthemes and factors were 
developed using the Framework matrix. The structure of the thematic matrices facilitated the 
process and depth of data exploration and analysis. The findings are presented below. 
Stage three : Investigating explanatory accounts 
Exploring the data for similarities and differences between groups; seeking to identify 
explanations for the findings of data analysis . 
Stage four: Developing explanations. 
Traditionally two types of explanations are developed through a process of stepwise abstraction, 
categorisation and refinement of the data. Explicit or stated explanations are where conc lusions 
drawn from the data are based on participants explicit and clear statements. In contrast, imp licit 
explanations are based on researchers' interpretations of participant views or experiencesj the 
latter being less reliable than explicit explanations. 
Stage five : Seeking wider applications. 
The fifth and final phase of Framework which can be completed, consists of looking at how the 
explanations generated by the data analysis could be applied more widely. 
FIGURE 5·l. Steps involved in Framework analysis 
Data 
analysis 
proceeds 
up & down 
Framework 
steps 
l.. 
2. 
3· 
4· 
Data management: 
Reduction & sorting, 
data interrogation & 
conceptual processing 
Exploring descriptive 
accounts 
Investigating 
explanatory accounts 
Develop explanations 
5. Seek wider application 
I. 
II. 
III. 
iv. 
Familiarisation to identify recurrent themes 
Index & code individual transcripts 
Pilot charting and adapt framework in light of 
gaps and overlaps identified by piloting 
Chart: Read through, summarise & synthesise 
individual participant data from verbatim 
transcripts into the thematic matrix (for all 
data). At the completion of the participant's 
charting each is reviewed to ensure charting 
accurately reflects the story. 
v. For inter-rater reliability different raters to chart 
a random overlap sample and discuss plus 
amend . 
Charting tips: 
Retain the individual's language . 
conventions & abbreviations 
Use agreed 
Reference all charted data (use multiple page references 
if applicable) 
Interrogate the data for similarities and discrepancies . Try to 
understand why the messages are different or similar . 
Exploring the data for similarities and differences between 
groups; seeking to identify explanations for the findings of 
data analysis 
2 Types of explanations 
Explicit explanations - that base conclusions on & make 
obvious when write up whether the explanation given is 
implicit or explicit In nature . " ... the respondents state 
clearly .. . " 
Implicit explanations- = researchers interpretations - don't 
rely on. " .. . there seems to be an association between ... " 
While maintaining the richness ofthe data . 
Through a stepwise abstraction through categorisation and 
refinement ofthe data. 
Make sure remain aware and document which of the data 's 
explanations are explicit (stated) and implicit . 
Avoid over-interpretation of data 
Adapted from 'The Analytic Hierarchy' by Richie and Lew is .(Rltchle & LeWIS 2°°3) 
FIGURE 5.2 Final Framework Clinician data analysis theme headings 
COMMUNICATION 
& 
INTERPERSONAL 
SKILLS 
Information about 
time spent in unit, 
work in other units, 
MOTs, structure of 
pathway, etc. 
4) SELF 
Communication & 
interpersonal skills, 
self-perceptions, work 
ethos. 
7) PATIENTS'PRIOR 
INFORMA TlON 
Patients' knowledge, 
information, 
perceptions prior to 
meeting them. 
12) ACTIVE DECISION 
MAKER 
Summary of incidence, 
characteristics of 
decision maker, how 
soon recognized and 
did it change the 
consultation approach 
15) UNDERSTANDING 
Clinicians perception 
of patient 
understanding of 
information . 
18) FEELINGS ABOUT 
CHOICE GIVING 
Pressures of job, 
dealing with bad news, 
etc. 
5) DOCTORS 
Communication & 
interpersonal skills, 
perceptions of 
doctors, thei r work 
ethos. 
8) INFORMA TlON 
RELA YED & GIVEN BY 
TEAM 
Manner in which 
information is 
delivered, what tools J 
strategies used in 
delivery, inviting 
questions. 
13) COLLABORATIVE 
DECISION MAKER 
Summary of 
incidence, 
characteristics of 
decision maker, how 
soon recognized and 
did it change the 
consultation 
approach. 
16) OPTIONS 
Clinician and patient 
actors underlying 
options given . 
19) ClINICIAN 
ADVICE 
What Clinicians advise 
- replies & reactions 
when asked for their 
preference. 
What colleagues 
working styles are like, 
how they get on with 
them, work 
environment, 
atmosphere, physical 
characterist ics, etc. 
6)~ 
Communication & 
interpersonal skills, 
perceptions of nurses, 
their work ethos. 
9) CONSISTENCY I 
INCONSISTENCY OF 
INFORMA TlON 
RELA YEO & GIVEN BY 
TEAM 
Differences and 
similarities of 
information deli very . 
14) PASSIVE 
DECISION MAKER 
Summary of 
incidence, 
characteristics of 
decision maker, how 
soon recogn ized and 
did it change the 
consultation approach 
17) TIME 
Clinician perceptions 
of how much time & 
patients' feelings & 
feedback about 
amount of time given 
to make decision . 
20)MNORfTY 
PATIENT DECISION-
MAKING STYLE 
PERCEIVED BY 
CLINICIAN 
Bullet pointed choice 
vs. perceptions of 
10) INFORMA TlON 
CONTENT 
What was actually 
said to the patient, 
questions asked to 
patient . 
1.1) PRIORITY 
INFORMA TlON 
NEEDS 
What Clinicians 
perceived patients 
wanted or needed to 
know about their 
cancer and its 
treatment 
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23) ONE THING TO CHANGE 
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FIGURE 5.3 Adopted Framework charting conventions and abbreviations 
--
Font format Meaning _ 
- -
.. . . 
- . Notes ' 
, 
,- , .. 
. . .. . • 'r , • 
Regular Summarised verbatim text Summarise in respondents language 
'quote' Direct quote Pertinent & short, can part quote and 
summarise to retain mean ing whil e 
condensing text 
(number) Page number referral Use all 
CAPS Charters comments/data analysis I.e. INCONSITENT MESSAGE, 
CONTINUED IN COLUMN Z, REFER 
TO COLUMN X ETC. 
Q 0 = good quote Be very choosy. Only use the 0000 if 
00 it warrants it. 
000 
0000 = must use quote 
<CAPS> 3rd person views 
--
(i) Implicit data Everything else = explicit 
Abbreviations 
-
BCN Breast care nurse 
-
HCP Health Care Professional (Clinician) 
CONS Clinician 
Rx Treatment 
Mx Mastectomy 
-
-
BCS Breast conservation surgery 
FHx Family history 
-
PMHx Past medical history 
-
-- -
---
OM Decision-making 
--
-- ~ OMS Decision-making style . OCiS Ductal carcinoma in situ ~ 
1-- Interpersonal skills IP 
--! 
-
T20 Tamoxifen 
--
---
Transcription conventions 
Quotations in the findings section appear indented. Words appearing between two square 0 
brackets indicate where notes of clarification have been added by the author(s). Ell ips is po int s 
indicate where a quotation has been abridged. Italics indicate words stressed by interviewees. 
Following each quotation, the participant's identification number will be reported along with their 
gender, clinical role, and breast unit MR classification. This is followed by the page number(s) 
identifying the extract within the flow of the interview. 
FINDINGS 
Four key themes emerged from the clinician interviewsj breast team ethos, elig ibility for cho ices, 
clinician beliefs and routine processes. These themes were overlapping and mutually 
interdependent. The breast team ethos was the central theme dominating and interlinking the 
others, and driving the decision making culture in each unit. This was associated with specific 
beliefs, which determined who was eligible for choices and reinforced many of the routine 
processes adopted by the units; which reinforced attainment of the unit ethos. Some variation 
was noted between clinicians of the same unit. Clinicians were aware of diversity within their 
unit. However this diversity and their understanding of it were framed in terms of the unit ethos. 
Consistent distinct differences were observed between the units; w ith the low MR unit find ings 
being dissimilar to those of the more concordant medium and high MR un its . Some of the 
differences noted were more obvious among particular clin icians and in certain contexts, others 
were more subtle. 
BREAST TEAM ETHOS 
'Ethos' refers to the fundamental and distinctive character of a group, t yp ically expressed In 
attitudes, habits, and belief'. Clinicians acknowledged the existence of a predominant sh ared 
ethos within their breast units, which developed out of close working rela t ionships, and was 
central to their practice . 
I think what happens with time is that people who work in a team somet imes get a simi la r 
style or a similar way of approaching things ... . people influence one another. .. t he t eam, 
so it's likely that we have the same feelings about how th ings should be done ... after long 
discussions you get closer in your beliefs and your styles ... [BS037, f emale consultant 
surgeon, low MR unit, p2] 
The focus of the ethos was either the attainment of a particular treatment (outcome-based ethos) 
or form of decision making (process-based ethos) . These defined and dominat ed t he dec ision 
making culture of the units. The low MR unit clinicians' outcome-based ethos focussed on 
mastectomy avoidance where possible . See Table 5.3 . 
.. . it's fairly cut and dried the recommended treatments, you know, ... we have a protocol 
and we all do the same for the first recommendation ... the type of surgery ... [GPAoo3, 
female GP clinical assistant, low MR unit, p12-13] 
Contrastingly, the prevailing ethos of the medium and high MR unit clinic ians was primarily 
process-based, focused on the facilitation of more autonomous patient involvement in decision 
makingj with the provision of treatment choices where possible, and active support of shared or 
informed decision making . 
... the surgeons and the nurses as a team ... sing from the same hymn-sheet ... explaining 
the options ... the information ... they need to make the decision ... 1 wouldn't say anybody 
says, \\1 think this is best .. . it's my opinion ." [BCNo02, female nurse, med ium MR un it , pl] 
TABLE 5.3 Breast unit ethoses and MR unit 
I Outcome-based ethos; focussed on the 
maximisation of a particular treatment (BCT) 
Process-based ethosj focussed on fac ilitation 
of more autonomous pat ient dec ision making 
ELIGIBILITY FOR CHOICES 
One of the most prominent and fundamental differences between the low MR unit and others 
was their interpretation of which patients were eligible for choices . Units possessed sim ilar 
guidelines, but clinicians' interpretation varied by unit; therefore patients wi th sim ila r cancers 
could be offered different options in the different units. Medium and high MR un its conside red 
the overwhelming majority eligible for genuine treatment options and offered them to those not 
requiring a mastectomy on clinical grounds . 
.. . once you've excluded those to whom you're gonna say 'You should have a 
mastectomy,' everybody else gets the choice . ... 1 would still say to a woman with a 3mm 
tumour there are two choices: one is wide excision, the other ... mastectomy. I wouldn 't 
say, 'You shouldn't have a mastectomy because it's so small .. .' [B501.5, male consultant 
surgeon, high MR unit, P1S-6] 
Contrastingly, most low MR unit clinicians felt a small proportion were suitable for genuine 
choices; and found the concept of offering choices to those who were suitable for BCT perplexing . 
.. . personally ... I've always tried to conserve breasts for people, I find the concept of open 
choice when it's perfectly possible to do a simple breast conserving operation with 
radiotherapy giving the same results as mastectomy .. . rather peculiar. [B5029, male 
consultant surgeon, low MR unit, p26] 
They reserved options for a narrower subgroup; those with cancers cons idered less definitive 
cases for BCT (i.e. larger or central cancers). Patients with screen-detected or small cancers (up to 
30 or 4mm diameter) were typically only offered BCT rather than options . 
... Who would get breast conservation? .. . smallish tumours with regard to the size of the 
breast: now this might include a tumour perhaps as big as 3cms or even 4cms ... if it was a 
big enough breast.. . But usually tumours around less than 2 or 3cms, one quadrant, not 
multi-focal. [B5020, male consultant surgeon, low MR unit, P1 3] 
On occasions all clinicians discussed options strictly outside breast unit gu idelines. This invariably 
meant choices for multifocal, multi-centric or larger cancers, which were less ideal for this opt ion . 
They did this to accommodate strong patient preferences (all units) and avoid being direct ive 
(medium and high units) . 
.. . 1 think ... [we] offer wide local [BCT] for some larger tumours than ot her unit s . ... t hat's 
one of my suspicions as to why we do have a higher rate here. [B5028, ma le associate 
specialist, low MR unit, p8] 
TABLE 5.4 Eligible for choices and MR unit 
Only offered BCT for small (up to 3-4cm Cho ices offered to all In whom BCT IS not 
diameter) peripheral cancers (most clin icians). contraind icated 
Choices reserved for cancers 'borderline ' for 
mastectomy 
CLINICIAN BELIEFS 
Five clinician belief subthemes underlay the different breast teams'/clinicians ' particular ethos; 
beliefs regarding clinicians' role in deciding treatment, opt imum management , pat ient 
preferences, patients' decision -making capability and reflexivit y rega rding deci sion making 
beliefs . Table 5.5 summarises these subthemes and factors . 
Beliefs about the clinicians' role 
The various units' clinicians perceived the ir role in t reatment decisions different ly among pat ients 
suitable for BCT. Medium and high MR unit clinic ians bel ieved the ir role was facil itating more 
autonomous informed patient decision making. To them it encompassed provid ing t ime, 
information and support, so patients' gained sufficient knowledge and confidence t o explo re and 
make preference-based decisions based on the ir individual concern s and circumsta nces. 
I'm pleased .. . [ if] we've encouraged her to make decisions ... and t ake her time rather than 
rush ... and bully her into one decision or another... [B5003, mal e con sult ant surgeon, 
medium MR unit, p12] 
In contrast, the vast majority of low MR unit doctors believed t heir rol e was the provi sion of the 
specialist 's expert opinion regard ing opt imum t reatment . Th ey vol unteered th ese wi th varying 
strength from more permissive recom mendat ions to a clear forceful opin ion . 
... we just push it quite, quite, quite hard and say that "th is lesion is pe rfectly co mpatible 
with doing a local operation ... " [BS029, male consultant surgeon, low MR unit , P24] 
.. . 1 usually go straight to the point to discuss which is the optimal opt ion when I see 
somebody, but if I know somebody has had trouble accepting things then I ... try to be 
more helpful with giving them options and helping them decide . [BS037, low MR un it, 
pu] 
Clinicians' role beliefs affected their feelings about consultations with patients possessi ng 
different OMS. They were most ease in consultations with patients who reinforced their clinician -
patient role beliefs. Low MR unit surgeons often found the passive sub-group the most 
comfortable. Those with a process-based ethos preferred two way discussions with patients 
engaging in decision making . 
.. . [a] passive ... makes it easier ... because I don't need to go into al l the rigmarole and be 
swirling around on a hook the whole time. At the same time, I wouldn 't short change 
them, I'd give them the same information ... and ... would emphas ise ... I'm trying to do the 
best for them by doing the least mutilating surgery that's possible . [BS029, male 
consultant surgeon, low MR unit, P24-2S] 
' ... you can take collaborative to a different level. .. in general. .. those ... are the eas iest ... it 's a 
shared dialogue back and fore ... you discuss the pros and cons of each and she comes to a 
decision in consultation with you, as opposed to 'I'm having this,' or 'I haven't got a 
clue, ' ... you give ... information .. . it's acted upon ... sensible questions are 
asked ... you .. .feel. .. if she decided ... mastectomy ... or ... wide excis ion it was for good 
reasons ... [BSo~S, male consultant surgeon, high MR unit, p 21] 
As with most themes, subthemes and factors, some variation was seen; some from the low MR 
unit clinicians shared beliefs more in common with those of the other units . These expressed 
satisfaction about consultations with their more active patients; especially when they chose BCT. 
I like it when the re are puzzles, I li ke it when you have to t hin k, 'Yeah, I understa nd her 
decision,' and I think I'd have understood it both ways, but 1 felt that she had listened, 
taken everything on board, and .. . worked it out for herself what was best . [BS023, low MR 
unit, P~9] 
Beliefs about optimum management 
Clinicians we re united in the ir motivation to 'take ca re' of t he ir pat ients and provi de what they 
perce ived was the optimum management; to min imise the negat ive im pact of d iag nosis and 
optimise recovery. Discrepancies were noted however between the diffe re nt tea ms in what they 
felt the optimum management was and the app roaches adopte d t o achieve it . 
... most ofthe time ... 1 feel sorry for them .. . the majority are go ing to be knocked for six ... so 
you feel. .. apprehensive and sorry ... 1 suppose .. . my discussion about treatment reall y st arts 
from a presumption that the patient probably doesn't want a mast ectomy... [B 5020, 
male consultant surgeon, low MR unit, PS-6] 
... you just want to make sure that you've done your best fo r them really ... you want to 
ensure that whatever you tell them is going to add to their care rathe r than detract fro m 
it .. . give them plenty of support ... Because ultimately you want the best care for you r 
patients ... and I think the better informed they are, [the). .. bette r recovery, whateve r 
surgery you're having. [BCN026, female nurse, high MR unit, pll] 
Clinicians had different opinions of mastectomy as an option . None portrayed a prefe rence for it 
per se, but almost without exception low MR unit clinicians were particula rly negat ive about it; 
and used adjectives like 'horrible' [B5022, female consultant surgeon, low MR un it , pll] and 
declared it should be avoided where possible . Low MR clinicians believed BCT was the opti m um 
management and it should be performed where feasible . In contrast med ium and high MR unit 
clinicians firmly believed that only informed patients could decide what the optimum treatment 
was based on their individual preferences, concerns and circumstances . They focussed on the 
literature demonstrating the positive impact of patient involvement in decision ma king; 
optimising psychologica l recovery a nd m inim ising regret. They therefore dec lared optimum 
management was patients making informed treatment dec isions. 50 although they could vo ice a 
personal dislike of mastectomy, they felt this should not be permitted to bias patients' decisions . 
They felt the important issue was individual patients' determination of t reatme nt acceptabi lity; 
and they should be permitted to freely undergo their prefe rred treatment without persuas ion or 
pressure. They recognised this could result in some patients with cancers su itable fo r BCT, 
choosing mastectomy . 
.. . if ... a lesion is su itable for breast conservation su rgery ... 1 don 't thin k that we would tell 
the women [what to do). .. 1 don't think it's fair ... women choose breast conse rvation ove r 
mastectom y or mastectomy over breast co nservation fo r different reasons . ... 1 often te ll 
the pat ients .. . "You have to choose what is right for you, what you fee l. .. you .. . cou ld live 
with ... and ... wouldn't have any regrets about it.' ... as a woman they do tend to say, 'What 
if it was you?' and I turn around and say, 'I don 't kn ow how I' m goi ng t o react sitting on 
that side, ... so I cannot tell you ... you must choose what is right [fo r yo u], not yo ur 
daughter ... your mother ... your husband ... " [B5014, female consultant su rgeon, h ig h MR 
un it , P13] 
Although these clinicians felt that patient involvement in dec ision ma king was optimum, t hey 
recog nised that some expe rie nced discomfort or difficulty in the short term wh ile ma ki ng 
decis ions. They however weighed th is against the ir be lief t hat t he lo nger t e rm positive benefit of 
patients undergoing the treatment which is right for them, was the more important issue. They 
sought to alleviate short term discomfort with the provision of information, time and support . 
Beliefs about patients' treatment preferences 
Clinicians recognised patients possessed different motivations and preferences for specific 
treatments. These varied in complexity and extent, often by unit . Most low MR unit clinicians 
described more simplistic impressions of most patients' motivations; the primacy of breast 
preservation and impressions of patient passivity dominated other potential considerations . In 
contrast, medium and high MR unit clinicians' described patients' treatment preferences in a 
more detailed and complex way. They discussed the frequent coexistence of numerous issues 
and preferences within individual patient considerations, and how these could vary in relative 
importance as patients weighed up their preferences against treatment facts during deliberation . 
... [some people say] 'It can't be as bad if I'm being given a choice ... so I'll have a wide 
excision,' and then other people say for the tiniest cancer of 3 mms, 'I want a 
mastectomy.' ... they're so different and they've got different reasons . [BCNo22, female 
nurse, high MR unit, P17] 
Typical issues included those relating to body image, recurrence, radiotherapy, social 
circumstances and responsibilities, travel issues etc. Some described some (especially younger) 
patients with large or multi-centric cancers wishing to preserve body image against potentially 
increased mortality risks . 
.. . on a couple of occasions a couple of ladies have said to me, 'I would rather die than lose 
my breast,' ... [BCN025, female nurse, high MR unit, p2] 
While others possessed more fatalistic attitudes; focussing on recurrence and patients describing 
sacrificing what they perceived as the 'vanity' of breast preservation for maximised disease 
freedom . 
... sometimes, there's two things: one is 'Cut it off, doctor, and then it's gone' 
and ... another .. . underlying thing .. . people feel ... if they don't have a mastectomy, they're 
chickening out.. .this is the price they've got to pay for being cured ... for ... some .. . there IS a 
sense that, ' .. . if I have a mastectomy everything'lI be all right, if I go for the vain option 
then it'll come back and it'll be my fault because I've been vain ... ' [BCNo01, female nurse, 
medium MR unit, p22] 
Beliefs about patients' decision making capability 
Clinicians recognised that in order to make treatment decisions patients needed to be able to 
assimilate and weigh up complex, often new information . However they held different 
impressions about patients' capability of doing this . These were linked to their impressions about 
patients' decision making preferences. Clinicians of individual units tended to hold simila r 
impressions, although some variability was noted. 
Clinicians unanimously reported that many patients requested recommendations in the f irst 
treatment consultation. However their interpretation of these and their responses varied . Most 
low MR unit clinicians fairly uniformly believed these recommendation requests reflected 
patients' overwhelming unease about decisions making and an inability to assume this role . 
... very often ... they say, " ... hang on a minute, you're the surgeon ... Why are you giving me 
a choice, I don't know anything about this ... you tell me ... 1 don't know." ... choice is a very 
difficult issue. And .. . it's all been drummed into us ad nauseum ... everybody has to be 
given a choice but they find it ... a difficult concept.. . [85029, male consultant surgeon, 
low MR unit, pl6] 
Medium and high MR unit clinicians recognised that many patients seemed initially surprised by 
the offer to choose their treatment and that some found this role difficult or challenging; patients 
seemed to feel a responsibility to make the 'right' decision; and often they needed to be 
reassured that there was no 'right' or 'wrong' option . 
... they feel. .. because they're given this choice, they have to make the right choice, and I 
say to them that whatever you decide is the right choice ultimately... I think patients 
often say that's the hardest thing, having a choice .. . [8CN026, female nurse, high MR 
unit, P9] 
But they felt these initial reactions and requests for recommendations represented an automatic 
response to a fear-provoking diagnosis and ignorance of the options and process, rather than 
necessarily reflecting patients' ability or willingness to engage in decision making . 
.. . we get.. .quite a lot of.. .patients who ... say, we'll have whatever you recommend ... [but 
a] vanishingly small number .. . who ... think ... doctor knows best ... [85003, male consultant 
surgeon, medium MR unit, Pl 3] 
They believed that if they explained the rationale behind providing a choice and provided tailored 
consultations with sufficient reassurance, time, information and support; such requests usually 
became superfluous, and the majority demonstrated thei r decision making capability . 
.. . our job as nurses really is to go through the choices ... give them t he pros and the cons of 
b~th ... and ... sometimes have to go through that severa l times . . ... they' re so 
dlfferent ... you have to be sure .. . when they're given a choice that they ... kno w both sides 
of the coin so that they can make an informed decision . And hopefu lly they w il l. 
[BCN022, female nurse, high MR un it, P17-18] 
Clinicians described a spectrum of patients' desire for involvement in treatment decisions . 
... it's an individual reaction. You get some people who can't cope with the cho ice and 
they'd rather that the doctor just said to them, 'This is what you need, ' and then you get 
people who are so indecisive it's awful. ... and equa lly othe r people are qu ite relieved t hat 
they're given a choice .. . [BeNon, female nurse, high MR unit, P1 7] 
Deciphering patients' decision making capability varied; active decis ion-makers were genera lly 
easier to recognise, collaborative patients could take much longer and differentiating between 
these and passive patients could take until the day of surgery . 
.. .. it can be difficult ... you know when you've got an active one because they' ll tell you .. . a 
collaborative one or a passive you may not know before they leave the room ... the 
collaborative one may take a little while ... but will be taking on board what you've sa id, 
will listen to what the breast care nurse has said and come to a dec ision ... passive ones 
remain undecided ... you realise it's passive later on when they haven't made a dec is ion . 
... the passive ... tend to be the ones that will come ... bouncing back ... [8S015, ma le 
consultant surgeon, high MR unit p 21-22] 
They also recognised their initial impressions could be incorrect; falsely based on patients' acute 
reaction to their cancer diagnosis, rather than their decision making des ire or capability . 
... quite a lot of patients will fit into this [passive] group : they' ll either posit ively fit into this 
group by saying, 'What do you think? .. you 're the doctor, you decide,' or wi ll just not 
really be part of the discussion ... they'li just sit there and soak up the information ... not 
take much part in it, possibly because they're a bit shell-shocked in what 's going on . Now 
it could be that they should be seen again to make sure that they aren 't a more act ive 
person anaesthetised at the time by the information that they've been gi ven, but I 
suppose I tend to rely on them coming back ... for more informat ion.. . [8S020, ma le 
consultant surgeon, low MR unit, P17-18] 
However clinicians often based their approach to consultations treatment plann ing and 
presentation of information on these in itial impressions. The low MR cli n icians recognised it 
could also influence the choices they offered; they might not disc uss opt ions if t he patient 
seemed passive even ifthey were eligible for a choice. 
I think what they're li ke to start with influences you ... if they are withdrawn and 
an xious ... you may go a bit more carefully ... if they're parti cula rly art icu late yo u m ig ht go 
into more detail. .. what you 're doing and w hy ... I'm influe nced by how t hey seem to 
me, .. . patients who don 't seem to be part icula rly worried or concerned might not 
get ... much ... if I thought they were this group of [pass ive] pat ients ... 1 p ro bably would not 
try to get to the position to say, 'We could do this and this, the cho ice is you rs, ' ... 1 th ink ... 1 
would try and point out what seemed to be the most obvious, app ropriate proced ure .. . 
[B5020, male consultant surgeon, low MR unit, P17-18] 
Patients' decision making capability seemed a non-issue to some of the more d ire ct ive low MR 
unit doctors; as they explained most seemed happy with the treatment plans they prov ided . 
I would never over-ride their wishes ... patients do tend to make a final decision, or at least 
they're happy with the decision that's made shall we say, which I suppose mea ns 
something similar though not quite the same . [B5020, male consultant surgeon, low MR 
unit, P15-16] 
50me seemed articulated inaccurate understandings of the collaborative DM5 and shared 
decision making . They focused on the gravity of diagnosis d ictating pat ients' desi re for the expert 
to assume this responsibility, this eclipsed other considerations . 
... most ... seem to accept .. . what you suggest, that, if it's small enough ... just have the lump 
out ... if they're collaborative they're agreeing, you 're sort of making the decisions 
together ... they want you to ... recommend, and ... say that's fine . But ... passive ... you tell 
them what you recommend .. . they say, 'Well you're the doctor ... just do what .. .' there's 
not that much between them . ... they take it much more seriously if it's someth ing li ke 
breast cancer, they don't want to mess around ... they want to get on and do the right 
thing at this early stage ... so ... usually, they go along with you ... accept what you 
recommend ... [GPAo03, female GP clinical assistant, low MR unit, p12] 
They believed only the minority who actively requested more information o r discussion wanted to 
decide their treatment, and if patients genuinely wanted this role they felt it wou ld become 
obvious. 
I get a lot of passive patients .. .. they say, "Whatever you thin k, docto r. We don 't know 
anything ... if you think that's the best thing for me ... do whatever you thin k to cure it ... " 
They've looked nothing up, ... perhaps haven 't spoken to an ybody, and they' re qu it e 
prepared to go along with it. [B5029, male consultant su rgeon, low MR un it , P24] 
Reflexivity regarding decision making beliefs 
Reflexivity was noted among clin icians of the units . They recognised alte rnatives t o the ir beliefs 
or consultation approach and decision making behaviour; recogn is ing a m inority with these in 
their own unit . The minority with these incongruences of bel iefs a nd dec isio n ma ki ng behaviou r 
(in low MR unit) or consultation styles (high MR un it ) however re main ed subject to the 
predominant ethos of the unit; their view coloured by the unit culture . In the high MR un it a 
single consultants' consultation style was recognised to be incons istent wi th their beliefs and the 
unit culture/ethos. To harmonise their patients' experience they developed a compe nsatory 
approach . 
... we're .. . much the same age group but there 's probably a Is-year sp read with m e ... the 
oldest and I think the way they have developed ... means that they do spend more t ime 
talking to patients whereas I try and judge how the patient's ta king things or accept ing 
things, and go on as appropriately .. . with sympathy or fact, to a certa in point and t he n I 
think I can go no further ... that's when I move them on to the breast care nu rses to p ick up 
the pieces, so there are different styles ... they do spend twice as long ... as I do so I assume 
they're saying more . ... 1 generally confer with the nurse ass istants who ... have been with 
us for a long while and I might say ... 'Do you think she unde rstood / .. . Did I put my foot in it 
.. . ?' ... Did I get it wrong?' ... if I don't think it's gone well it ... gets it off you r chest .. . and they 
may say 'well you've done better, ah well - that's one in a hundred or one in fifty.' But of 
course there's a let-out clause, if I've done badly is the breast care nurse go ing to do badly 
as well? ... unlucky both of us having a bad day ... (B5013, male consultant surgeon, high 
MR unit, pI & p6) 
.. . one of my colleagues ... he's very good with his patients, but he is much more m atter-of-
fact, gives the basic information and ... might spend less time with an indiv idual 
patient .. . and ... a lot of the ... extra will be filled in by the breast ca re nurses . ... that 's a 
different style. I personally spend probably longer .. . I think we've developed a style in _ 
... the .. . guidelines and protocols of the unit tend to be what we tend to say and we a ll t ry 
to sing from the same hymn sheet . ... in some ways that cramps st yle, as it doesn 't allow 
individuality, and I think probably across the board the breast care nu rses a re ve ry good at 
reinforcing our team message and ... 1 personally don 't thin k that they .. . ma ke a g reat dea l 
of difference to decisions because I think they just sing with the sa me hym n sheet as we 
do . (B5015, male consultant surgeon, high MR unit, pl-2) 
A minority of individual low MR un it doctors expressed personal bel iefs more cons ist with the 
process-based ethos of the other units and incongruence with the predom inant bel ief syste m and 
culture of their particular unit . The degree to which they d iffered from the ir unit co lleagues 
varied . The consultant of the group adapted the units ' rout ine processes of ca re to de live r the ir 
own patients a process more consistent with the atta in me nt of t he ir perso nal process-based 
preferences . Both the clinician and their colleagues recog nised these d iffe ren ces . 
... personally, I thin k that we should tal k abo ut mastecto my for an y pat ient ... even if 
they've got the tiniest small tumour ... ideal fo r wide loca l. .. . 1 a lways say that there 's t wo 
options: we can either remove the whole breast or we can just ta ke the tumour and sma ll 
t issue around where the tumour is and , if.. .1 t h in k a wide local is by fa r prefe rable, I wo uld 
say ' ... in your case, this is probably the better opt ion ... ' a nd 9 t imes out of 10 they' ll go for 
a wide local, but I think we're still obl iged to tal k about either o pti o n ... I ce rt ai nl y kno w 
one of the consultants [here] does say ... 'we ' ll be a ble t o t re at th is, just t ake t he lump 
away, ' and not really tal k fully about the other option, ... a lt hough I t hi nk they t ry and 
remember .. . they should mention mastectomy ... anothe r one pro ba bly does t hat.. .t oo . 
[BS028, male associate specialist, low MR unit, p8-9] 
.. . one or two of the consultants here a re more into givi ng pat ients fre e cho ice, havi ng 
long discussions .. . than I probably am. Not that I don't g ive them a cho ice but , .. . some a re 
less directive ... and virtually ... prepared to sit there and say, "Well, we 'll do what you want 
and I'm not going to tell you what to do ." [BS029, male consultant su rgeon, low MR unit, 
p2] 
There might be slightly different attitudes in terms of w hat you say to t he pat ie nt , what 
the degree of choice that you might offer, or the deg ree of advice .. . you might 
offer .. . probably minor differences between people .. . [BS020, ma le consulta nt surgeon, 
low MR unit, P3] 
BCNs recognised such differences and some described a preference for t he less d irected proceSSj 
but accepted operating with the confines of their unit or clinicians' constraints . 
... some .. . will bring them back the following wee k follo wing d iscuss io n of 
treatments .. . they're given .. . written information so they can go awa y home and t hink 
about it and read the information and then they come bac k . .. . 1 t hink that' s a good way of 
doing it because at ... diagnosis they can't always thin k straight.. .they don 't ta ke on boa rd 
everything ... and I think they need that week to get their head round everyth ing ... And 
you often find that when women do come back the followin g week t hey a re very much 
more focused, they've obviously had time to think, .. . tal k to people, get o n the website, 
get information .. . they want.. .then .. . we can plan surgery . ... Some [consu lta nts] .. . don 't do 
that : they see them at the t ime of diagnos is ... and .. . a re not seen aga in by the consult ant.. . 
[BCN038, female nurse, low MR unit, P3-4] 
TABLE 5.5 Clinician beliefs associated with differing unit ethos 
Beliefs regarding clinicians' role 
The clinicians' provide an expert opinion The clinicians' role is to fac ilitate pat ients 
regarding optimum treatment selecting their preferred treatment 
Beliefs about optimum management 
Optimum management is BCT and its uptake 
should be maximised 
Mastectomy should be avoided where possible 
Optimum management is patients choosing 
their own treatment wherever possiblei to 
optimise psychological recovery and minimise 
regret 
Only patients can determine their preferred 
treatment 
Beliefs about patients' treatment preferences 
Most patients prefer BCT Individual patient preferences vary depending 
on multiple pre-existing subjective factors, 
including experiences and concerns 
Beliefs about patients' decision making capability 
- --------
Most patients want expert guidance from their 
specialists, or are unable to make treatment 
decisions due to lack of knowledge and 
experience 
-------
Patients' preferences for deciding their own 
treatment vary, but most are capable of making 
treatment decisions, given the appropriate t ime 
and support resources 
Reflexivity regarding decision making beliefs 
ReflexivitYi some incongruence in beliefs of a 
minority of clinicians in context of unit ethos 
recognised by clinicians . But ethos 
predominates 
ReflexivitYi some incongruence in consultat ion 
styles of a minority of cl inicians in context of the 
unit ethos recognised by cl inicians. But eth os 
predominates 
ROUTINE PROCESSES 
Breast units' routine processes were underpinned by the ir bel ief s and concord ant with the ir ethos. 
They also reinforced the units' decision making culture . These were defined by four subthemes; 
the process of offering options, the process of communication, the process of recommend ing 
treatments, and the process of decision making and establish ing consent. Table 5.6 summarises 
the process subthemes and factors. 
The low MR unit's processes differed from the generally more analogous medium and high MR 
processes. Although inevitably some variation was seen among cl inicians f rom the same breast 
unit; a minority of mainly low MR unit clinicians with more process-based pe rsonal be liefs, were 
selective about which of their units' routine processes they adopted . 
Process of offering options 
Clinicians described entering consultations with a treatment discussion plan. As described above, 
the group considered eligible for choices varied according to the ir clin icians' interpretat ion of 
established breast unit guidelines. Patients' treatment options were decided at diffe rent levels in 
the different units. Standard practice in the medium and high MR un its was t o discuss and 
determine these options at MDT level, prior to the results appoint ment. Clinicians described 
reassurance stemming from the team nature of decisions; especially complex ones. The high MR 
unit also employed an additional step. During init ial cl inica l assessment t hey routinely 
documented patients' suitability for surgical options (based on cance r size : breast vo lume and 
site) on a standardised proforma which was used in conjunct ion with the more widely utilised 
radiology and histopathology information, to guide MDT decisions. 
I feel very, very confident that it 's not my judgement, it is our judgement ... not a un ilateral 
decision, it's a consensus of opinions... The straight-forward ones are no problem .. the 
complicated ones .. . you don 't feel ' ... have I made the ri ght decision ... )' (B5014, femal e 
consultant surgeon, high MR unit, P3] 
The low MR unit did not routinely discuss cases preoperative ly in t he MDT. Opt ions were instead 
determined by individual doctors, based on the ir triple assessment find ings . 
.. . 1 will have seen the result and ... aim ... t o te ll t hem t he result and then try and formulate a 
t reatment plan ... I'1i already have decided what I th ink ... probably serves them 
best ... before I go in ... it ' l l either f all int o a group where they need to have a mastectomy 
because it's big or ... multi-focal, or they need to have, or ... can have a wide exci sion ... that 
would be the preferential treatment ... or it could be either [opt ion). .. fro m its position 
or ... size . [B5020, male consultant surgeon, low MR unit, p6-7] 
They explained this approach was partly dictated by the high volume work load of t he unit, which 
necessitated prioritisation of MDT cases to those most likely to benefit from discuss ions between 
surgical and non-surgical cliniciansj for example post-operative results and adjuvant t reatment 
planning . Most considered routine pre-operative MDT case discuss ion superfluous, as clear 
guidelines indicated the obvious recommendation . The approach was also partly necessitated by 
'hot' pathology reporting in some clinics, which meant, some patients could be given the ir 
diagnosis and treatment options on the day of initial assessment . 
... we try and do a one-stop clinic where possible . 50 patients would expect on t he whole 
to go out with a diagnosis at the end of that session . It is very, very occas iona l that we 
ever wait for an MDT discussion before letting the patient know the diagnosis ... [GPAooS, 
female GP clinical assistant, low MR unit, P3] 
BCNs from the different units talked about their participation in dete rmining pat ient s' t reatment 
options. Those from the medium and high MR units described a less hierarch ica l relationship 
between the two occupational groups and greater contribution to this both in clin ics and MDTs . 
Process of communication 
Clinicians recog nised patients' view of the ir cl inicians (particula rly the ir doctors) as experts; meant 
patients arrived expecting to listen . 
.. . the surgeons ... they are the person that the pat ient is coming to see; .. . th e GP's said, 
'I'm going to refer you to ... Mr _ ... They'll be able to help you .' And that 's the person 
they're expecting to see ... the person who they listen to ... the ir consultant ... t he expert . 
[BCNool, female nurse, med ium MR unit, p26- 27] 
These expectations meant clinicians possessed the power to influence pat ient decisio ns not only 
by determining patients' options, but their commu nicated of t hem . 
... 1 think in general the breast team must have the biggest influ ence because partly 
it's .. . dec iding who isn 't suitable for choice .... And the re are ways, and means; .. . 1 like to 
think that I give a very balanced view ... and 1 t hink other people don t ... 1 think .It s almost a 
case of, ' .. . there 's a choice you can have ... breast conservation therapy or If you really 
want ... you can have a mastectomy,' ... 1 th ink th is is where you can tell It and how you sell 
it . [B50l5, male consultant surgeon, hig h MR unit, P2 5] 
Some reflected on the tendency of developing a replicable way of 
commun icat ing, but 
emphasised the importance of retaining sensitivity to individual pat ient needs and ta ilo ring 
communication accordingly . 
... having done it for a long time .. . you do tend to have set speeches .. . it is hard to avoid 
tha~. But...I ... ~ope that I am sensitive to the needs of an individual pat ient ... some 
patIents you will need to spend longer and go into more detail and others .. . do n't want 
that. detail ... Having ... broken the ice with the introductions .. . the cruc ial th ing is to .. . go 
straIght for the fact that unfortunately .. . this is cancer and try and avoid euphem ism s and 
skirting around it.. .. I would obviously try and be gentle, factually correct... and then I 
think you really have to assess what the response is .. . and .. . often it will be yeah, I 
know .. . that's what you implied last week .. . we've got our head around that. Where do we 
go from here? 50 you can then move on to treatment options and I suppose my usual 
spieL I would try and emphasise the positives, overall breast cancer has a good prognosis 
compared to many cancers, most ladies are successfully treated and then ente r into the 
different treatment modalities .. . [85003, male consultant surgeon, medium MR unit, P4-
S] 
• Consultation style 
Clinicians' consultation styles were consistent with their personal and un it beliefs about pat ients' 
decision making capability and preferences, and patient-clinician roles in treatment 
determination . There was a spectrum observed between the directive presentation of 
predetermined specific treatment plans, to the more facilitative presentation of open options. 
These gave the impression of varying degrees of patient- versus doctor/clinician-centred 
consultation styles. Consultation styles of clinicians of the same units tended to lie predom inantly 
around one region of the spectrum . Low MR unit clinicians clustered predominantly toward the 
more directive end of the spectrum, and the others toward the less d irect ive, more facil itat ive 
end . Some were more overt examples of these approaches and cl inicians also described d iffe re nt 
adherence to their usual style . The less informing consultat ion styles, with less opportun it y for 
patient-directed discussions were often expressed alongS ide the bel ief that cl in ici ans ' rol e was t o 
provide recommendations . 
... I'm rightly or wrongly, usually very an xious not t o ta ke ladies breasts off at a ll if I can 
avoid it so I tend to be directive towards doing as little as poss ib le consistent with cur in g 
the disease, .. . personally I don 't give them a cho ice really in terms of saying ... we can 
remove your breast or ... 1 don 't give them ... carte- bla nc he and say, " ... we can do th is or 
that, you decide ." .. . some .. . [surgeons] are reall y quite non -prescript ive . . [8502 9, mal e 
consultant surgeon, low MR unit, P2 4- 2 S] 
They believed most patients did not want options or the deta ils of treatme nts, so did not 
routinely volunteer this information . They usually reserved less d idactic, more compre hens ive 
options and consultations for patients actively see ki ng more informatio n a nd de monstrat ing an 
obvious desire for involvement in decision making . 
... 1 think [it is important] to try and get the message over to t hem ... it' s ... cancer .. . they 
need an operation .. . though of course many won't really be interested ... t hey'l l swi t ch off 
somewhere along the line and just want to get on with it really. . .. some will wa nt a bit 
more detail about the operation that's on offer, some ... will just be ha ppy t o know the 
diagnosis, happy to know what you offer .. . and leave it at that ... but some that will want to 
know a little b it more ... and ... be part of the decis ion ma king ... ' I th ink they form quite a 
small group ... because obviously they are go ing to have to as k fo r more informat io n abo ut 
what a mastectomy is, what the benefits are ... the d isadvantages a re, and ... with the wide 
excision ... radiotherapy and th ings.' [B5020, male consultant surgeo n, low MR unit , plO 
and p1.6-1.7] 
They relied on patients to disagree with proposed treatment plans and seek more d iscuss ion or 
other options if they desired this . 
... he tends to explain ... we could .. . remove this lum p without re moving th e whole of the 
breast, and ... explain his reasons why. . .. some ... he ' li as k .. . how they fee l abo ut that 
and ... the majority are quite comfortable with that decision ... but some .. . might want t o 
discuss the option of mastectomy and so ... generally ... they are given that opt io n to ha ve 
alternative surgery if they feel strongly about that . [BCNo4l , female nurse, low MR unit, 
p1.2] 
In contrast most medium and high MR clinicians sought to communicate in a way t hat was mo re 
conducive to patient participation in treatment dec ision ma ki ng . They recogn ised that t ime -
pressure could hinder th is and emphasised the importance of creating an unrushed, open 
environment from arrival to leav ing, where patients felt at ease; to facil itate the explorat ion of 
information and development of decis ion making confidence . 
. .. 1 just don't know how they do it ... I've seen them whe n they [the cons ulta nts] ... must be 
feeling really frustrated .. . and ... patients come in and they greet t he m as if t hey're th e only 
person they've got to see and give them a ll the t ime a nd ma ke them feel that this is all 
they've got to do and it's their time and they've got as long as t hey want . [BCNoOl, 
female nurse, medium MR unit, P5] 
I'll spend as little or as long as I need to and the cloc k is irre levant to me, if a patient needs 
five minutes to be told the diagnos is of breast cance r, t heir choices, that's fine, if a patient 
needs 45 minutes that 's f ine, and I won't be th rowing t hem out the door because I've got 
the next patient waiting ... they' II. .. get the ind ivi dua l amount of time they need . . And if 
that means over-running ... th at m eans ove r-run ning ... , but eve rybo dy knows that If the y 
see me they' ll get the t ime they need ... [B50l5, male consultant surgeon, high MR unit , 
p2] 
The vast majority ... come through the fast-track clinic. .. They know ... it is go ing to be qu ite 
a long. afternoon. .. The other person .. . in clinic is ... our Health Care Ass ista nt ... pat ients 
come In, we try and keep things as relaxed and unhurried and friendly as poss ible, and 
since ... we've had this new building, it's ... quieter, ... more relaxed, and that seems to have 
filtered through to the patients .. .. 1 think .. . that environment ... matters as much as how 
you greet them and how you are with them ... ' [BCNo01, female nurse, medium MR unit 
p2] 
'I like to take the patient away from where they've been [for their diagnosis and]. .. use the 
quiet rooms ... and .. . give .. . a bit of time-I don't come straight in-... sometimes they just 
want a hug, ... a bit of quiet time, ... a drink, ... and then I'll come ... ask ... if they want to go 
through everything again now or ... at a later point ... quite a lot ... want to go through it 
again then, because they've not always understood and quite often ... if you've managed 
leave the patient a little while, they might have gone through a very tearful moment and 
then sat down and discussed it with whoever they're with, and ... have some questions . 
... And if the patient really can't cope at all, I won't go through anything .. . at that particular 
time, I'll just sit with them ... just let them cry or be angry ... whatever they need ... 
[BCN037, female nurse, low MR unit, p12-13] 
Those adopting more facilitative approaches described a more extensive exploratory aspect to 
their consultationsj including carefully checking and rectifying patients' understanding and 
knowledge. 
I hope ... 1 leave it to them to make the decision .. . that I don't push them in any particular 
direction. . .. there are some who in the first instance will say, ' I want a mastectomy' 
... [and] I will say ... let's just go through ... why you're choosing one over the other,' and if 
they have this preconceived idea that, ' ... if I have the mastectomy I'll get rid of the disease 
and it'll never come back,' ... re-educate them ... [BS014, female consultant surgeon, high 
MR unit, P13] 
Those seeking engage their patients in decision making expressed pat ients often had difficulty in 
absorbing and assimilating information initially, and they wanted to ensure they were informed 
but not overloaded or overwhelmed with information . 
I think assimilation of [that] kind of information is difficult and you only know over the 
time what's been taken in and what hasn't. . .. 1 . . . think, if you 're told you've got breast 
cancer, for an awful lot of people that's enough, anything else sa id after is just, goes way 
over their head, and is forgotten or ... not taken in, because .. . when you 're told you'~e got 
cancer you think, ' .. . am I gonna die? What does this mean ) Am I. .. gonna see my children 
grow up?' ... that kind of stuff ... [BCNo02, female nurse, med iu m MR unit, p10] 
They recognised information provision had to be tailored; var ied in pace and pitch according to 
patients' needs and explained the informing process often needed to be slowed; res ist ing the urge 
to relay too much on the first day. 
... if somebody's getting really upset I will stop and say, 'Do you want us to finish here 7 ' . . . 1 
think we all make mistakes over the years .. . and you've felt it 's part of your job to give 
them all the information before they leave, and don 't let them go until they've got it all 
but, ... 1 go with my instincts [and stop for now]. ... [BCN023 female nurse high MR uni~ 
p~ , , 
Those adopting more facilitative approaches also sought to discuss issues which might impact on 
decision making, and described identifying potential barriers and attempting to overcome them. 
Typical barriers to BCT included inconvenience or travel for radiotherapy. They also described 
trying to focus patients on the longer term physical and psychological consequences of the ir 
decisions, not just immediate reactions . 
... she said, ' ... 1 want .. . a mastectomy, I don't want to have to .. . travel [for radiotherapy] ... ' 
So Mr _ said, ' ... travelling doesn't have to be a problem .. . we can provide transport.' 
... And ... he went through ... each step of both options and [said]. .. you may well decide to 
have a mastectomy because it means ... you can avoid the five weeks of treatment .. . yes, 
it's a difficult five weeks, there's lots of travelling, [but] it does come to an end . If you 
have the mastectomy that's fine and ... it's often a gut reaction to say, 'Just cut it off, get 
rid of it' but ... you've [also] got to think how you're going to feel afterwards ... [BCNoOl, 
female nurse, medium MR unit, p20] 
Clinicians' approaches to identifying and overcoming of potential barriers varied from informative 
countering to insistent direction. The transition point between them could be overt or subtle; 
related to the degree of direction employed and adoption of active listening skills with the timely 
provision of appropriate responses . 
... if I think ... they're going towards a mastectomy when they have .. . got a tumour which is 
suitable for a wide local excision, I would try and find out their reasons why they were 
bothered about the other operation and try and put the fact straight if they still th ink, 
'Oh, that must be more risky, ... ifyou don't remove all the breast,' .... [I] try and make sure 
they do have all the facts as clearly as possible to try and help them make their decision . 
[B5028, male associate specialist, low MR unit, Pl-3-1.4] 
.. . 1 will create a ... a scenario where I will say, ' ... you choose a mastectomy and three years 
from now you get a recurrence, you may turn around and say, " ... 1 could have had a bre ast 
for three years ... why did I choose a mastectomy? .. On the other side, you choose for 
breast conservation surgery and three years from now you have ... a recurrence and you 
have to have a mastectomy, "Well, I should have had the mastectomy then, " but the 
positive side ... is that for three years you would have had a breast.' .. . You have to choose 
what is right for you, what you feel that you would, could li ve with, ... that you wouldn't 
have any regrets about ... ' And I think that ... helps them to decide one way or the other. 
[B501.4, female consultant surgeon, high MR unit, P9] 
Even clinicians who tried to tailor the ir consultations described fairly rigid adherence to their usual 
more di rective or facil itative consultation style; even when it did not necessarily suit their 
patients. However if patients' unease (vocal or non-vocal) was pers istent ly evident, t hey cou ld 
alter their style . There were differences however in when cl inic ians would do t his . Medium and 
high MR unit clinicians tended to reserve a more directive style for much later in the dec ision 
making journey; concerned genuinely passive patients could be difficult to diffe rent iate f rom 
those merely anxious and shocked around diagnosis. By deferring directedness, they sought t o 
avoid biasing decision making in the non-definitively passive group. Low MR un it doctors 
described responding to very clear active preferences, and more experienced low MR unit BC Ns 
were willing to adopt consultation styles responsive to perceived patient preferences; but if t his 
meant countering the doctor's treatment plan, would usually first seek their approval. 
Patients' clinical and cancer characteristics, and clinicians' perceptions about pat ients ' POMS 
could influence consultation styles. Even those believing strongly in patient choice could descri be 
struggling to present truly unbiased options to patients with very small cancers of a few 
millimetres, and could describe being more directive in these circumstances. They emphasised 
cancer characteristics (small size, impalpable) and patients' presentation (screen-detected or 
\earl{ diagnosis), in addition to providing the usual reassurance about BCT safety, whi le trying t o 
avoid overriding patients' sense of decision making autonomy. There may however, have been 
differences in when clinicians employed this form of emphasis; as some low MR unit cl inicians 
referred to cancers up to 3-4cm diameter as small and unsuitable for options . 
... screen-detected cancers ... of a few millimetres. We'll put the emphasis strong ly on 
breast conservation ... [emphasising] the size of the tumour, method of diagnosis, size in 
relation to the breast .. . [BSo04, male consultant surgeon, med ium MR unit, P17] 
However a few medium and high MR unit clin icians felt it was unfa ir to selectively bias decision 
making even among those with the smallest cancers . 
.. . ifs very hard when you're in the thick of it to sit back and look objecti vely at the kind of 
information thafs being given and how ifs put ... it does ki nd of conce rn me that smaller 
cancers that are picked up on screening I think there is a tendency t o subtly steer th ose 
patients towards breast conservation rather than a symptomatic lump cance r where we 
may not push them so much towards conservation ... [BS003, male consu ltant surgeon, 
medium MR unit, P1 4] 
Consultation styles also seemed to be associated with docto( s age among the male subgroup. In 
particular the three older male consultant su rgeons (one from the hig h MR and t wo f rom the low 
MR units) seemed less comfortable using words li ke 'cancer' w ith the ir pat ients and prov ided less 
. . f t ' The 'lr level of di rectedness however remained consistent with the others extensive In orma Ion . 
from their unit. The high MR unit doctor described their self-awareness that the ir consu ltat ion 
style was sub-optimal for their process focussed beliefs and ethos. They t he refo re 
counterbalanced this with heavy reliance on BCNs to go through everything in more deta il and 
provide patients with sufficient opportunities to explore the options . They provided pat ients wit h 
a brief discussion of the options available and ensured they knew more extensive d iscussion wit h 
their BCN would follow. 
Clinicians recognised to aid absorption, information often needed reiterating . 
... our job as nurses really is to go through the choices ... the pros and the cons of both ... and 
they sometimes have to go through that several times . ... you pitch it at the level that that 
patient wants, you sometimes do have to use diagrams .... especially at that first 
consultation, because their mind's just whizzing round and ... you need written 
information, you need pictures, they need to take that home to get the ir heads round it ... 
[BCN022, female nurse, high MR unit, P17-18] 
As well doing this verbally, many employed tools to emphasise salient points, explore information 
needs and reinforce the clinicians' message. Some used the patient's mammograms or 
histopathology reports . 
It would depend thing on .. . what message I was trying to get across. .. .in screening 
patents ... mostly they're very tiny tumours, .. . I. .. probably subconsciously try to emphasise 
... this is a .. . tiny thing .. . within the breast: .. . if I want to emphasise the smallness of the 
cancer I'll often show them on the x-ray and ... say, 'You ' ll need to come really close to thi s 
because it's so small' to get that positive message over. [BS004, male consultant 
surgeon, medium MR unit, pn] 
Others produced freehand drawings and wrote down salient points as they discussed the options; 
this way information was reinforced with an individualised concrete too l. Th is was used to focus 
discussion and taken home for later reiteration. Many felt these were the most valued tools . 
I draw little diagram of the breast and the axi lla .. . show where the lymph glands a re, why 
we're removing them .. . 1 think one of the useful things is that rather than keep it as an 
abstract thing, that you've got wide excision versus mastectomy and the pros and con s of 
each, if you've written it on a piece of paper and then ... they can point that the th ing, ' If I 
have that treatment.. . what about radiotherapy etc.?' And it just acts as a kind of 
freehand for both of us, particularly since some of the terms they may not ... know .. . [or] 
understand .. . to start with .. . [BS004, male consultant surgeon, med ium MR unit, pn] 
BCNs also used printed leaflets and provided the opportun ity to view t reatment outcome photos. 
• Information content 
There was a range seen in the comprehensiveness and extent of consu ltat ions content; incl ud ing 
the options discussed, detail provided and emphasis placed on individua l informat ion 
components. This was influenced by clinicians' predominant beliefs, and po int on the fac ilitative-
directive spectrum described earlier. Most low MR un it rout ine consultation inform ation content 
comprised a greater emphasis on general reassurance but a briefer and less comprehensive 
provision of clinical information focussed on their preferred treatment. In contrast, t he other 
units' consultations, though providing reassurance, did so as a component of more extensive, 
comprehensive detailed factual information set; aware that restricted information could hinder 
and bias decision making . These provided the impression of different degrees of cl inician 
directedness in consultations and decision making . 
.. . 1 think they need ... a lot of information on the two types of surgery really. And kn ow that 
equally, there is no better surgery, long-term outcomes, it's what you live with, or wh at 
you feel you can live with afterwards [that is important]. [BCN026, female nurse, high MR 
unit, p12] 
... my own views ... it'li either fall into a group where they need to have a mastectomy ... or 
they can have a wide excision ... if it could be either or it's better treated by wi de excision, 
I'd usually go along those lines and say, 'We'd recommend removal of the lump and t his 
can be done by a wide excision - we remove the lump and we take a marg in round it that 
is adequate. . .. There is an alternative option to that and that is removal of t he whole 
breast, but in your case this isn't absolutely necessary but it is something you m ight want 
to consider - some ladies do ... so ... w ide excision ... would be an ent irely reasonable and 
safe way forward .' ... and we'll fix a date .. . for your surgery and you 'll have a bit of t ime with 
the breast care nurse to go through what I've said .' Then I'll go t hrough t he operat ion and 
sign a consent form with you .' [BS020, male consultant surgeon, low MR un it , p6] 
Many low MR unit clinicians routinely recommended what they cons idered the most suitable 
treatment, which they normalised; expla ining most pat ients underwent th is standard option . 
... I. .. usual say ... "Look, you have a small lump, it 's two cent imetres ... in thi s un it ... about 
sixty per cent of patients end up having a conserving operation, forty per ce nt 
or ... less .. . end up having a mastectomy ... We 're t ryi ng to do a safe operat ion ... saving the 
breast ... Course, we respect your view if you .. .feel more comfortable having everything 
removed ... [BS029, male consultant surgeon, low MR unit, P24- 2S] 
If the cancer was considered suitable or borderline for BCT, mastectomy was often mentioned to 
acknowledge and discount it rather than provide it as an opt ion . Some neglected to mention it 
unless patients raised, it and when it was discussed it was often character ised it as excessive. 
They could also skirt over the possibility of further surgery for insufficient margins and t he 
inevitability of radiotherapy with BCT . 
... in g.eneral, I think that as surgeons we maybe don't talk about radiothe rapy after a wide 
~ocalln enough detail and what that actually involves .. . we often say to pat ients, ' ... we can 
Just take some of the breast but you will need radiotherapy afterwards .' I al ways t ry and 
say to patients, 'Well it does involve coming up for ... treatments once a day for f ive 
weeks,' and I think often we .. . pass over on that ... [BS028, male assoc iate spec ia list, low 
MR unit, P7-8] 
Clinicians often stressed the importance of uSing clear unequivocal language to minimise 
misinterpretation. But some low MR clinicians seeking to provide reassurance, underplayed 
diagnostic and treatment information, used equivocal language or adopted euphemisms. 
some people .. . say, 'Gosh, you do use the word cancer a lot/ and I say, ' ... at the end of the 
day ... people know what cancer is, ... if you say ... tumour, tumours can be benign, 
... harmless, ... serious ... different implications ... [to] different people ... whereas a cancer is a 
cancer ... [BCNo02, female nurse, medium MR unit, pn] 
.. . 1 say to the patient .. . though initially .. . there was some feeling that this was not serious, 
the x-rays have suggested that it was suspicious and ... the needle tests have drawn off 
some abnormal cells and so it is something that isn't just an ordinary lump, it is a bit more 
serious and probably does mean that it's a malignant lump, a little cancer ... or a cancer. 
[BS020, male consultant surgeon, low MR unit, p6] 
Clinicians expressed patients were often surprised by the offer to choose thei r treatment and that 
patients' lack of knowledge and confidence, as well as understanding about why they we re g iven 
a choice could act as barriers to involvement. 
I think sometimes they don't get the options - 'Well he sa id I can have the smalle r 
operation or a mastectomy, why)' Why have they got choice) And some people say, ' ... 1 
don't ... know, he's the doctor,' - I don't think that tends to happen much now, [but] there 's 
certainly some people say - 'How am I expected to choose when I don 't know anyth ing 
about it?' and I feel it's our responsibility to actually inform the patients ... , there is a 
choice and why there's a choice, and ... [sayl yes the doctor does know best but if t he re 
was a best option the doctor would be saying 'You should have this because it is th e best 
option,' whereas the two options he's described to you both are equal in terms of yo u 
living to be a hundred, for example, therefore .. . your own pe rsonal choice comes into it . 
... sometimes you have to reiterate that, but most people understand . [BC No02, fema le 
nurse, medium MR unit, pn] 
Clinicians felt survival equivalence was the key issue to most patients g iven a choice . They 
recognised patients often possessed concerns about the safety of t reatments, and t hat t hey could 
have difficulty grasping the concept of the equal safety and su rviva l eq uivale nce of BCT and 
mastectomy. This information was therefore prov ided clea rly and emph asised, 
I think some patients ... find it difficult to understand that just do ing the wi de excis io n is as 
~afe as .. . mastectomy, and I always try and emphasise ... the t wo options a re just th e same 
I~ t~rms of the cancer coming back. . .. 1 think some patie nts do st ill fin d th at concept 
difficult because they think surely taking ... all of the breast, is ... safer . [B50 28, ma le 
associate specialist, low MR unit P9] 
Therefore also explained and emphasised why options were being offered early in the ir 
consultations, and stressed the importance of patients deciding their own treatment . They 
reassured them that no treatment was superior or ' right' . 
.. . I've had to say quite categoricaliy .. .' lt's not what I would do .. . 1 can g ive you t he 
information .. . the good and the bad ... , but I'm not the one that's got to wake up eve ry 
morning to the surgery ... get dressed and undressed with the surgery. You are, ... that 's 
why it's got to be your decision ... [BCN022, female nurse, high MR unit, p26-27] 
... when patients are struggling for example about, how can one be the same as the other, 
I do bring in the fact that there has been a lot of research and wide local excisions, as long 
as you get clear margins plus you give the radiotherapy, is the same in terms of surv ival as 
a mastectomy. That's why there is a choice and that's why it comes down to personal 
preference because at the end of the day any decisions that are made, the women are 
going to live with them for the rest of their lives, and it's not my breast and it's not my 
decision, ... it's how they feel and what they want . And ... some people say, 'Well, my 
husband would want this,' or '5uch-and-5uch would want that,' and I say, ' ... d iscuss these 
things with your family, but at the end of the day it's your breast, it's your decision , and 
you are the only one that will live with the consequences of.. .the decision .. ' [BCNo0 2, 
female nurse, medium MR unit, P9] 
Those encouraging patient participation in decision making also described reassuring patients 
they had time to make a decision; that it was not expected today and specifically outlined the 
timescales for decision making and what would be happening in the interim . 
... you ... stress ... I've just told you ... upsetting news, I don't expect you to make a decis ion 
now .. . [B5015, male consultant surgeon, high MR unit, p 21-22] 
.. . when you talk to ladies, they just, they really want to know when are they havi ng it 
done ... 1 think [it's]. .. very important for them, to know exactly when they're hav ing the 
surgery. I think the choice ... just adds to an xiety somet imes on that in it ial consultat ion 
because they've just been told they've got cancer, they need an ope rat ion, the re 's t wo 
things we can do. And that just sends them off in a ... 'Oh, God, what would yo u do)' 
... obviously you don't ever say, 'You need to make a decis ion' on the da y of d ia gnosis ... 
[BCN026, female nurse, high MR unit, p12] 
Recognising there was a lot of information to impart and absorb, some provided a n initi a l brief 
summary, and then built on that framework in a stepwise ma nn er with in the consultat ion . 
Providing, exploring and reiterating information and encourag ing quest ioning . They beli eved t his 
assisted information absorption and patients ' acqu is it ion of a firm kno wledge ba se and 
confidence from which they could consider their options and preferences. They explored t he 
options, the pros and cons, provided clear information on issues which different iated between t he 
two; for example the possibility of requiring further surgery if resect ion marg ins were inadeq uate, 
and that radiotherapy was an integral part of BCT and this involved 4 to 5 weeks of outpat ient 
treatment . 
... 1'11 sit down and ... say, 'OK, there is a lump here, it 's a small lu mp and it 's abo ut 1 112 
centimetres,' ... That's about that [demonstrates] size,' and [to]. .. a patient with a choice, I 
will say "you need an operation ... there are choices .. . and you will have that choice . I wi ll 
give you all the information I can to try and make the cho ice . The first opt ion is an 
operation where we remove the lump with a margin of tissue all the way around it, the 
important thing being that we get the lump out with a nice safety margin of normal t issue 
all the way around .' And I might say to them, 'From ... what we can feel and what we can 
see on mammograms and scans, you look perfectly suitable for that operation .' After the 
operation the pathologist will check down the microscope that we've got the ... area out 
with a nice safety margin all the way around . Nine times out of ten ... there's not a 
problem -.. . occasionally they .. . see something .. . we can't predict before the operation, in 
which case we have to think again, and that's an important built-in safety guard .... And I'll 
explain ... 'You will require radiotherapy following that operation, ' .. . then I will say, 'The 
alternative to that would be to remove all the breast tissue, what we call a mastectomy. 
Those two operations are equal : one isn't better than the other - if one was better than 
the other I wouldn't give you a choice ... but in this situation there are two equal 
options ... 'In a minute I'm going to get you to see one of the breast care nurses, who 's 
going to go through what I've said in some more detail, put a plan together about you 
coming into to hospital and give you a lot of information to go home with . .. . and .. . 1 will 
usually say, 'I've already said to you that after the local ope ration you will need 
radiotherapy: you could still require radiotherapy after a mastectomy but it 's less li kely . 
.. . and you may end up with another quarter of an hour of different questions or .. . one 
minute of further questions, depending on individual ladies and the ir informat ion needs . 
... the last thing I always advise women is .. . when they go home they'll thin k of lots of 
things they meant to ask, and to write them down on a piece of paper so when they next 
come and see us they've got a checklist of questions to ask us .' [B5015, male consultant 
surgeon, high MR unit, P9-] 
All units tended to use vague terms which covered local recurrence and survival. Medium and 
high MR unit clinicians tended to distinguish between local recurrence and survival; adopt ing 
phrases that informed patients that survival was equivalent, but there was a sl ightly higher 
chance of local recurrence with BCT - while not quantifying this . Wh ile the low MR clinicians 
typically grouped them, rather than disengaging the concepts; using phrases like the 'treatment 
outcomes' were the same or there was the same risk of the 'cance r comi ng back'. 
Those adopting more facilitative approaches encouraged pat ients to spend t ime considering the 
options and emphasised the specialist support availab le fo r t hi s process . 
••• 1 reiterate .. . it is not my decision, it is for them to dec ide, an d t hat th ey don 't have to 
decide today, they can think about it and take away all the informat ion ... see th e breast 
car~ nurse ... the.y have time to think, spea k to the ir fam ily a nd then ma ke th e ir 
declslon ... [and] It should be their decis ion . [BS014, fema le consulta nt surgeon, high MR 
Unit, PI3-I4] 
Clinicians explained patients' pre-existing level and accuracy of knowledge about breast cance r 
and its treatment varied g reatly. BCNs in particula r spent a substant ial pro port ion of the ir 
consultations checking, correcting and bUilding patients' knowledge; recog ni s in g pat ie nt 
involvement required the possess ion of sufficient accurate knowledge . 
... it really does vary tremendously. Some people know absolutely noth ing about breast 
cancer ... about options. A lot of people have heard about mastectomy but some ... haven 't 
got a clue .. . or they've got information but they're not co rrect ... I th ink the m ajo rity ... fall 
in between... . .. you need to assess their level of knowledge and if it 's not so 
great .. . inform .. . and ... lf it's incorrect .. . correct it.. .because at the end of the day 
their ... decisions are .. . based on thei r ... informat ion so it does need t o be co rrect . [BCNo02, 
female nurse, medium MR unit, pI0] 
.. . patients'li tend to come thin king, ' If I've got breast cancer I'll need to have a 
mastectomy.' .. . depend[ing] on ... personal experiences, whethe r they've got a family 
member ... sometimes there's myths ... you need to put straight and it's bu ilding that 
trust ... relationship ... that you are dispelling myths rather than trying to say, ' ... no, that 's 
not right' .. . [BCN037, female nurse, low MR unit, PI7-18] 
Over the three units, clinicians expressed a desire to provide a consistent message to patients. 
BCNs reiterated and reinforced the intended message of the doctor -patient consultation . The ir 
consultation topics and content therefore echoed those of the docto rs . 
... [the BCNs] go through what we've meant by the opt ions and re ite rate th ings ... [BS020, 
male consultant surgeon, low MR unit, P19] 
If the particular unit ethos was not being followed, BCNs tended to refocus thei r consultat ion in 
line with their units' ethos (choice or BCT) . For example, if medium o r high MR unit pat ients fe lt 
they had been recommended a treatment plan rather than genuine options, BC Ns refocused 
patients on making thei r own dec isions and provided info rmation t o do so . 
.. . sometimes ... [there is] the sense of ' ... 1 haven't really co nside red a m astectomy because 
the surgeon's advised ... wide local excision' and I would just elaborate on t hat a litt le 
bit .. . emphasising ... there is always a cho ice ... l'd neve r t ake a decision from t he m t here 
and then ... don't need to ma ke a decision today ... ' [BC N025, fe ma le nurse, high MR unit, 
pIS] 
Even when patients wanted decisions made for them, med ium and high MR un it cl inic ians tri ed to 
ensure patients possessed and understood the info rmation pe rti nent t o the t reatme nt options . 
.. . patients .. .from that era where the doctor knows best and you do n't as k questions, 
.... where ~heY're given a choice [and] ... they just want it decided for them . .. . [we spend 
time] trying to get them to think about the different aspects of it ... in some cases .. [the 
doctors] saYI 'Well, ... it is up to you ... to decide what you [want,' but] .. . on occasion some 
may saYI ' ... 1 think x is best' ... 50 .. . 1 just try to make sure they understand the implications 
of.. .what is being done . For example ... with ... conservative surgery ... the possibil it y .. . they 
might need another operation if the margins aren't clear ... And [I] probably would again 
point out that there is a choice, but try to ascertain that they are comfortable with what 
they've [having] done and know ... the implications of that particular ... decision ... 
[BCN0391 female nurse, low MR unit, p1S] 
On occasions the clinicians from all three units described discussing options strictly outside breast 
unit guidelines at the patients' request; BeT when the cancer was multifocal, multi-centric, or 
large . They described outlining options in a similar way to normal but highlighted why BeT was a 
less clinically appropriate option in this contextl and emphasised the potential consequent 
problems . 
... [even] when you feel strongly that ... the best recommendation would be a mastectomy . 
... we might say that .. .'lf you feel strongly that you would like to preserve as much breast 
tissue as possible ... we will try and work round that ... my job is just to make sure you're 
aware ofthe pros and cons of any decision . [BS023, low MR unit, P9] 
... we would never paint it as a 'you must have this or ... that ' ... it's not a problem .. . if a 
woman says 'I won't have a mastectomy' I will explain ... the reasons why we think she 
should .. . but would never make her feel that somehow she was being .. . silly .. . [BS003, 
male consultant surgeon, medium MR unit, p8] 
Process of recommending treatments 
All doctors provided treatment recommendations sometimes when patients' cancers were 
suitable for BeT. But one of the most notable differences between the low versus other units' was 
their clinicians' attitude and practice regarding the provision of recommendations (reluctance 
versus inclination or enthusiasm) and the stage of the decision making journey they wou ld 
provide them (early versus late) . 
Reflecting their beliefs about decision making, most low MR unit clinicians ta lked comfortably 
about providing their expert opinion of the most appropriate treatment in response to patients' 
requests for recommendations. Self-reflection could contribute to this practice 
... quite a lot of patients will fit into this group [passive pat ients] .... 1 suspect I'd fit into that 
group .. . if I was given a load of options by somebody who I consldered ... kn owledgeable In 
the field, ... l'd have to ... ask them .. . what they thought was the best ... [BS020, male 
consultant surgeon, low MR unit, p~9-20] 
The forcefulness of recommendations varied with their strength of belief in their unit ethos . 
Some described providing forceful recommendations when cancers were suitable for BCT. 
... we just push it quite, quite, quite hard and say that \\this lesion is perfectly compat ible 
with doing a local operation ... " If they ... want a mastectomy for various reasons, ... 1 
suppose you might go along with that ... if they were desperate .. . [BS029, male consu ltant 
surgeon, low MR unit, P24] 
Their impression of patient desire for recommendations was often so predominant, that many 
volunteered them early in the first treatment discussion rather than waiting for their request . 
... some patients will just be happy to know the diagnosis, happy to know what you offer, 
whatever it is, and leave it at that, 'You know best, doctor' .. . which is I suppose why I try 
and pre-empt that a little bit by giving them a bit of an inkling to start with ... what would 
be easy to choose, and then back off if they say, 'Well actually, I want a mastectomy ... ' 
[8S020, male consultant surgeon, low MR unit, pl1-12] 
Most medium and high MR unit clinicians however described trying to avoid the provision of 
recommendations in all but the most definite exam ples of passive patients and deferring direction 
to a later stage: The reasons provided being concerns they correctly identified true passive 
decision-makers who needed these, and concern that once given recommendations, patients 
ceased to consider options and risked experiencing later regret . 
.. . often ... they want to be told what to do. So ... listen ... But you try not to be influential, I 
... say, it's, ultimately it's your choice ... [BCN026, female nurse, high MR unit, P9] 
.. . some ways these are the hardest people to deal with because they ... expect you to just 
decide what is best for them ... in ... mastectomy versus wide excision, one of the most 
important things is their own concern about cosmesis, which I cannot know . .. . the pat ient 
I've got in mind ... presented with a screen-detected cancer and I think she probably only 
said about five words during ... the whole consultation, and just ... nodded and 
looked ... blank at everything we said, .. . it was very difficult to know how much she'd taken 
in, ... and at the end she .. . said, 'Well, what should I do? What do you think! and it was 
almost, because of the way that we approach it and explain that there is a treatment 
choice and that it's different from one individual to another, [she] seemed not to even 
have heard that ... I find that the hardest group to deal with because I want them to at 
least have some input into it, I want to get a feel ing from them how important the 
cosmetic issue is for that individual. .. Part of the problem of course is that you have a 
limited timeframe in which all this can happen, ... people are often coming in quite quickly 
and ... have a limited time in which these choices a re made . And ... we need to kn ow that 
they've had suffici ent time, that ... they're making, or ... we're making the right decis ion on 
their behalf. [BS003, male consultant surgeon, medium MR unit, p18-19] 
Rather than provide recommendations, this group persisted trying to inform, engage and support 
patients in decision making; adapting their usual stepwise process of information prov ision, to do 
so; reiterating information, encouraging self-reflection and consideration in the context of 
patients' subjective preferences. They also emphasised the individuality and long term nature of 
such a decision and the time available for the process. If this did not assist patients, they sought 
to identify patients' preferences, concerns and fears and encouraged patients to consider the 
information in the context of these. Typical discussion foci were breast loss, rad iotherapy, the 
possibility of further surgery and cancer recurrence . 
The other thing that comes in ... is the possibility of a second operation .. . how would you 
feel about the possibility of a second operation if it needed)' 'How would you feel about 
having, definitely having radiotherapy ... just go through and pick up the reasons why they 
might choose one orthe other. [B5015, male consultant surgeon, high MR unit, p 24] 
Using this process these clinicians recalled few instances where patients were unable to make 
decisions . They however recognised this process could require substantial time commitment. 
I can't ever remember a case where I had to say, 'OK, then, I'll decide, we'll do blah-blah.' 
At the end of the day you usually get it from the patient.. . It can take a lot of work and 
effort sometimes and, occasionally it does mean ... on the morning of the operation .. . 1 go 
round and do the final consent...and if they've got any indecision .. . 1 would usually ... get 
one of the breast care nurses to come ... and chat to the patient.. .and then come back to 
see them .. . to give them even more chance to, not just have me,. .. somebody else talking 
to them . [B5015, male consultant surgeon, high MR unit, p 24] 
Clinicians from all units who readily volunteered or reluctantly provided recommendations, 
expressed concern patients could subsequently regret decisions made for them because of 
unidentified concerns or preferences. Despite this, most low MR unit clinicians still described a 
readiness to universally recommend BCT; believing it more acceptable to patients . 
... the people you're least sure you've done the right job for are the [ones] ... you've made 
the decisions for ... it really only may turn out afte rwards that that might not be the 
decision that they would have made ... if they'd been given time or the ability .... they're 
totally shocked as a result of being told ... that they've got cancer and .. . they appea r 
passive .. . the patients who tell you what they want, even though it might not be want you 
want to offer .. . at least it's their preferred option . 50 I think you feel a bit more ... certain 
that you're doing the right operation for that person .. . [B5020, male consultant surgeon, 
low MR unit P20-21] 
To minimise this risk, some described adopting a tailored approach to their recommendat io ns . 
With ... passive decision makers it's a bit difficult because I have to make the decision for 
them ... 1 have to fish out all the details that would enable them to dec ide .. . and make the 
decision ... knowing how they would feel on certain aspects of their life or what is 
important to them ... the fact that they're saying, 'You can make the dec ision for me,' 
doesn't necessarily mean that they will be happy with it . So [Il .. have to ma ke sure t hat 
they're going to be happy ... [BS037, low MR unit, Pl3] 
However, if any doubt remained, clinicians recommended BCT to passive patients; as it cou ld be 
converted to mastectomy if necessary, but the reverse was not possible . 
... one of the things I' ll often say to ... this kind of [passive] person is ... 'Some people 
find ... they cannot come to a decision.' ... where there 's a clearly a choice I usually sa y, ' If 
you're still in two minds ... you're often better going for the wide excision ... because .. . a 
mastectomy's an irreversible thing, once a breast's removed that 's it . [BS004, med ium 
MR unit, p 19] 
The unit's ethos was usually reinforced by one or both specialist clinician groups. In the low MR 
unit this usually meant emphasising direction toward BCT; sometimes if the doctor had not 
promoted it. 
Some low MR unit BCNs described feeling constrained and uncomfortable limiting the ir 
discussion extent to the doctor's treatment plan if patients wanted to explore wider options than 
those offered by the doctor. Many adhered to the doctors' remit, but some more senior BCNs 
more freely and extensively followed the patients' lead; but described a tension between the ir 
desire to reinforce the doctor's message and not confuse patients, with the desire to provide 
patient support and advocacy . 
... 1 think we can be there to help them through how they .. . make their decision ... discuss 
it, ... making sure that they understand what the consultant said to them and giving them 
the right information ... support them while they make that dec ision . [BC N042 , fema le 
nurse, low MR unit, P32-33 
Process of decision making and establishing consent 
Variation was seen between the units in clinicians' perception of t he process of deci sion making 
and (establishing) consent. As with the other subthemes and factors, vari at ion was mainly un it 
dependent; with low MR unit descriptions differing from those of the more simil ar medium and 
high MR units . Some from the low MR unit seemed to view consent as an isolated event, 
establish ing permission to treat according to a t reatment plan determin ed and recommended by 
the treating specialist clinician. Clinicians from the med ium and high MR units consistently 
viewed establishing consent as a process requiring a variable period of time, governed by and 
requiring patients' acquisition and consideration of appropriate and adequate informat ion . This 
was reflected in the journey timescales and processes clinicians described from diagnos is to 
confirming treatment and establishing consent. This process was generally much swifte r in the 
low MR unit . The organisational structure of clinics meant patients usually had fewer rout ine 
consultations in the timeframe between assessment and consent . 
... once they've been told [their diagnosis] .. . 1 won't routinely arrange to see them aga in . 
... there are exceptions ... But they are the minority and I'm prompted to do that in pat ients 
who I can see is not taking in it or just being knocked for six by a diagnos is .. . or by the 
breast nurse who'd picked up that...1 don't tend to .. . bring them back because the clinics 
are busy enough, and I'm not sure they need it really ... [85020, male consultant surgeon, 
low MR unit, p8] 
This rapidity was exacerbated within the one-stop clinics of the low MR unit; which could mean 
some patients were assessed, diagnosed, had treatment discussed and were consented on the 
same day. Some also used the BeN consultation immediately after the diagnosis, to establish 
treatment consent . 
... 1 say to the patient ... 'You came with a lump in your breast today ... it.. .isn't just an 
ordinary lump, it is a bit more serious and probably does mean that it's a mal ignant lump, 
a little cancer ... or a cancer. Now we need to recommend some treatment.. .we'li fi x a date 
for you to come in for your surgery and you'll have a bit of time with the breast care nurse 
to go through what I've said .' Then I'll go through the operation and sign a consent form 
with you. [85020, male consultant surgeon, low MR unit, p6] 
This was the only preoperative doctor-patient consultation for many of those patients . The sense 
of process rapidity could be compounded by patients' lack of preparedness for their diagnosis . 
.. . it's ... largelya Single visit clinic .. . So .. . they're not prepared ... Some patients are utterly 
shocked, had no idea at all that it could be [cancer] .... because of the .. . comp ressed t ime 
scale of the whole system .. . there 's not much warning ... [85029, male consultant surgeon 
, pS] 
Some BCNs also expressed discomfort regarding the time-pressured decis ion making processes 
which could rush patients . They were particularly uncomfortable about the pract ice of consent ing 
on the day of diagnosis; believing patients had insufficient time to make cho ices . 
.. . the ladies can be diagnosed and consented all on the same da y .. .. it st ill doesn't sit 
comfortably with me .. . that somebody can be diagnosed and be a ble t o m a ke a dec ision 
about surgery all on the same day. It doesn 't always happen but it ha ppen s qu ite a 
lot, ... there's two particular consultants that work that way. And ... 1 t hink it' s d iff icu lt for 
us .. . breast care nurses and the patient's advocate , and .. . 1 ha ve t en ded to say [t o the 
patient] at t~at point, ' ... you don't have to make a decision today, you can go away and 
think ab~ut It, ,and come back.' And some of them will say, 'Oh, no, it 's, I'm qu ite happy,' 
but...1 still don t feel comfortable about that, and that's something ... 1 th ink we [nurses] all 
feel that way .. ' [BCN042, female nurse, low MR unit, p8] 
Some low MR unit clinicians adopted a comparatively slower approach, with an add itional docto r-
patient consultation a week following diagnosis, to permit additional discussion . This was 
preferred by the BCNs . 
.. . some consultants will bring them back the following week following discussion of 
treatments ... they're given ... written information so they can go away home and think 
about it and read the information and then they come back ... . 1 think that's a good way of 
doing it because at...diagnosis they can't always think straight.. .they don't take on board 
everything .. . and I think they need that week to get their head round everything .. . And 
you often find that when women do come back the following week they are very much 
more focused, they've obviously had time to think, .. . talk to people, get on the website, 
get information ... they want.. .then .. . we can plan surgery . ... Some [consultants] .. . don't do 
that: they see them at the time of diagnosis ... we ... sit down and talk to them, and .. . some 
are not seen again by the consultant.. . [BCN038, female nurse, low MR unit, P3-4] 
The other units described routinely incorporating more consultations between assessment and 
consent, and routinely consented patients closer to the time of surgery; in pre-assessment clinic 
or on admission . 
... we'li go through the results, plan, ... a date for surgery .. . negotiate it directly with them ... 
they'll usually go and have a chat with the breast care nurse alone in a quiet 
room .. . immediately after that . ... anyone having surgery will come to a separate [pre-
assessment] clinic ... and we ... almost always get to see them again on that day which is 
quite useful as well because it's an opportunity for the questions that they didn't think of 
the first time ... And .. . that'li be the time when we tend to make that f inal cho ice between 
us and we do the consent forms at that stage .. .. there will of course be some people who 
haven't made their mind up by then; ... they need .. . more time so we'd .. . [consent] when 
they're admitted . [BS004, male consultant surgeon, medium MR unit, p2] 
BCN consultations immediately following diagnosis was routine practice in all units . But the 
medium and high MR had more routine consultations a few days after diagnosis, prior to 
consenting. Their rationale being that most patients required sufficient time and opportunities to 
gain adequate knowledge confidence, and explore their preferences . Th is slight delay also 
allowed patients a little time to take in their diagnosis and perm itted the resumption of 
information exploration and discussion, without the time constra ints o r acute pat ient d ist ress of 
the first meeting . 
It varies tremendously, ... the re are some pat ients who are so gobsmacked by the 
diagnosis that they can't think or ask anything and it may be the partne r who is doing a ll 
th~ questioning or it may be that they are both gobsmac ked and I thin k we a ll accept th at 
It IS a ... gradual process and that very often you won 't cover half the ground at the first 
visit. . .. they ... go with the breast care nurses ... and consolidate what has bee n sa id 
and .. . may have .. . subsidiary questions ... which ... the breast care nurses may deal wit h it . 
... pre assessment clinic. .. is another opportunity to meet the surgeon and ... go over in 
more detail and do the consent. [BS003, male consultant surgeon, med ium MR unit, P5] 
High MR unit patients were offered the opportunity to have these additional consultations in the ir 
own home rather than at the hospital. BCNs believed the home environment fac ilitated greate r 
patient confidence and freedom exploring their needs and agenda . 
... a lot of [home] visits ... tend to be ... a newly-diagnosed ... patient [who] didn 't want to 
stay or I felt that they haven't totally understood what has been said ... the home visit ... will 
give the woman and her family an opportunity to be on their own ground and .. . that 
sometimes helps, they feel more secure in their own home ... more comfortable to open up 
to you ... Most of the time ... it's a much easier interview, they have settled down by that 
stage, they are starting to think a little bit more and question, but it's on their time not 
yours .... Ied by the patient, not by us. [BCN023, female nurse, high MR unit P7] 
Clinicians from all units described a sense of time-pressure in their consultations as a result of 
high workloads . 
... the most I've probably had in one clinic is 9 patients diagnosed in one afternoon . Now 
to see them one after the other, if I'm not ready to see the next patient for diagnosis, that 
slows the clinic down, it makes the patients' waits longer, and it increases patient anxiety . 
.•. 1 think ... we do see an awful lot of cancers : ... more than the recommended number ... that 
should be seen by a breast care nurse ... [BCN037, female nurse, low MR unit, P4] 
... sometimes .. . you've got three, four patients to see, ... it's a bit like a conveyor belt and 
even though ... you're delivering the same information ... you don't perhaps get as 
involved ... as ... when you've got more time ... [BCN025, female nu rse, high MR unit, P4] 
BCNs in particular described difficulties balancing consultation workloads and desire to not keep 
anxious patients waiting, with the desire to provide ind ividual patients with sufficient t ime . 
.. . the more time you've got to spend with the patient the better. If you know when you 
come into work on the Tuesday that, somebody might be on holiday so there might be 
only three of you, so ... you've got to see three women yourself t hat morni ng, you just 
know you're not going to have that [time]. .. well you make t ime but you fe el unde r 
pressure because you're aware that there might be somebody else wait ing t o be seen . 
.. . there's that sense of .. . l've got people waiting. [BCNo26, fe male nurse, high MR unit, 
P4] 
... some of the difficulties are the numbers of pat ients com in g t hrough, and that's always 
going to be the problem, .. , it's a high turnover .. . outpat ient work load, and sometimes if 
you're in a busy ... clinic and there's a lot of patients out the re wait ing and you can see 
that the waiting room's packed, seeing people and spending t ime with them can be quite 
difficult. Some people might take half an hour of your time, if they've got a lot of 
questions or they're very upset, and you do feel under pressure. [BS004, ma le consu ltant 
surgeon, medium MR unit, P4] 
They also described how the emotional nature of their work could compound time -wo rk load 
pressures to impair their ability to support individual patients. 
To be honest, I'm going from one patient diagnosis of cancer to another .. . thinking, ' .. . 1 
need to get organised ... ready for the next .. . [sometimes]. .. 1 just need to stop,' .. . l'm only 
human, ... I. .. wasn't ready to take the next patient on board ... 1 wouldn 't be able to g ive to 
that patient the right bit of me, the right bit of information . [BCN037, female nurse, low 
MR unit, P14] 
Clinicians recognised that patients required different time-spans for decision making; some 
volunteering swift decisions, others taking longer. But medium and high MR clinicians almost 
always discouraged quick decisions and encouraged patients to thoroughly consider the 
treatment facts and their decision before committing to a treatment and being consented . They 
were concerned rushing decisions could lead to regret . 
... we do sometimes see people who appear to ... jump to a decision and then may change 
it, so even in that situation ... we wouldn't make the final decision until they'd seen the 
breast nurse and then we'd seen them in the pre-assessment clinic. .. [BS003, male 
consultant surgeon, medium MR un it, plO] 
Low MR unit clinicians in contrast often consolidated decisions early by consenting . Some BCNs 
felt this could have negative consequences . 
... personally I prefer them to come back the following week ... because ... on the rare 
occasion that there is a problem ... you have to pick up the pieces ... and start from scratch . 
. .. that has happened a couple of times and it's caused us qu ite a few problems ... 
[BCN038, female nurse, low MR unit, P3-4] 
TABLE 5.6 Routine processes and decision making culture subthemes and factors . 
Individual clinicians decide eligibility for options 
based on interpretation of breast unit guidelines 
MDT decides eligibility for options based on 
interpretation of breast unit guidelines. 
Standard documentation of suitability for options 
at initial clinical assessment (high MR unit) 
Consultation style 
Consultations more consistently directive and 
focused on clinician preferences 
Less routine checking of understanding 
Consultation style consistent with their belief that 
most patients are passive 
Consultations more consistently focused on 
facilitating decision making 
Often comprehensive checking understanding 
Consultation style consistent with the view that 
most patients are capable of treatment decision 
making with support 
Information 
Content more focused on BCT. Mastectomy Content focused on BCT & mastectomYi including 
mentioned to discount it the pros, cons and possible outcomes 
Provide less comprehensive information set 
dominated by reassurance 
Emphasise BCT as the best/standard option 
Most routinely volunteer recommendations of the 
'standard' /optimum treatment. 
Most provide early in the initial consultation 
• • • •• • • 
Increased time pressure in clinics and decision 
making, due to workload, consultation styles, 
routine appointment system & timeframe to 
establishing consent 
Timeline from 1 st assessment to diagnosis & 
consenting usually shorter (at diagnosis or 1 week 
later) 
BCNs consent for some doctors. 
BCNs have one routine consultation prior to (and 
sometimes incorporating) consenting . 
Provide reassurance as part 
comprehensive information set 
of a more 
Emphasise choices and safety of BCT. 
--------------~ 
Most reluctant to provide recommendat ions. 
Instead adopt a stepwise process to promote 
decision making 
Tend to defer till for late in the decision making 
journey if patients cannot decide 
-----------...,j 
Often adopted strategies minimise t ime pressure 
in clinics and decision making through 
consultation styles, add itiona l routine 
appointments and emphasising t ime for consent 
Not same day diagnosis and longer j ou rney to 
making decision & consentingi routinely at pre -
assessment clinic or on the day of surgery 
Doctors always consent patients. 
BCN consultation immediate ly following diagnosis 
and one or more routine additiona l BeN 
consultations. 
CONCLUSION 
This component of the study reports new findings of the interface between patients and cl inicians 
engaging in treatment discussions and decision making, and offers potential explanat ions fo r 
variation in practice . A number of interdependent key differences were observed between the 
breast units in whom case-mix was excluded as a cause of variation . Some were overt, others 
more subtle . These created a decision making culture within each unit which provided the 
backdrop for patients' experiences of decision making . These are summarised in table 5-7- As 
reflecting any real life Situation, many of the qualitative findings expose a spectrum of beliefs, 
attitudes, and behaviours. Some variation was noted between clinicians of the same unit. 
Clinicians were aware of diversity within their unit. However this diversity and their 
understanding of it were framed in terms of the unit ethos. Like the third dimensional power in 
Lukes' power theory, (Lukes J.974) this culture was so pervasive, there were certain things 
clinicians believed, described and accepted, which other units might question . Despite this 
diversity, distinct and consistent differences were noted between the units; with the low MR unit 
differing from the more comparable medium and high MR units . 
There was a cohesive and specific ethos within each breast unit regarding the management of 
women with breast cancer suitable for BCT. Clinicians, as individuals and as members of a breast 
unit team, described the central focus of their ethos on the provision of the optimum 
management to patients, in order to optimise well-being and minimise the negative impact of a 
potentially life-threatening diagnosis. However two notable differences existed between them . 
They differed in what they believed optimum management was. As teams, they either viewed 
this as either a particular outcome (BCT where possible in the low MR unit) or a particular process 
(the facilitation of more autonomous patient decision making in the medium and high MR un its). 
This impacted the patient groups they identified as suitable for options; which resulted in a much 
smaller subgroup of patients in the low MR unit being provided with genuine options . They 
described not providing choices, but rather BCT as a treatment plan, to women with what they 
considered small (up to 3-4cm) and/or peripheral cancers. The other units described providing 
choices to this patient subgroup. 
Underlying and concordant with the ethos, the groups of clinic ians from the different units 
tended to hold a particular set of beliefs. These included not on ly what t hey be lieved was 
optimum management, but what they felt patients wanted in terms of part icular t reatments and 
whether they believed patients wanted a role in choos ing t heir t reatment and had t he capabili ty 
to do so. They possessed different beliefs about the roles of patients and cl inicians in the decision 
making process; predominantly believing clinicians role was either to provide the expert op inion 
(low MR unit) or provide patients with the tools to facilitate them making their own choices 
(medium and high MR units) . The unit ethos, beliefs and preferences also influenced the opt ions 
and information routinely presented to patients, and the way they were communicated; directive 
versus facilitative . This was reinforced by the routine processes adopted within units. The effect 
of these various factors were either amplified or diminished by the time clin icians provided for the 
process. For example, patients' journey from initial assessment to diagnosis and consent was 
usually swifter in the low MR unit and did not afford as many routine consultations prior to 
consent; some had one-stop clinics where assessment to consent all happened on the same day. 
There was considerable overlap between the four key themes identified from the clinic ian 
interviews. None were mutually exclusive, all were interdependent; though ethos was the 
strongest theme and could steer even those who were less committed to it . In terms of the 
relationships between the four themes; clinician beliefs fed into the ethos which was central and 
dominant within the individual units, the ethos governed who was considered elig ible for options 
and who was considered too definitively suitable for BCT that no options were provided. The 
ethos and beliefs fed into the units' process of what information was presented and how it was 
presented, and the process of how decisions and consent were made. These individual factors 
contributed toward the differing decision making culture of units. The result clinic ians tended to 
describe was, decision making by varying degrees of informed consent or informed/uninformed 
compliance; depending on the clinician and unit. Despite such notable differences between 
them clinicians and teams within units had identical motivations; they wanted to provide what , 
they considered the optimum management of their cancer to patients and minimise the negative 
impact of this diagnosis. 
Among the study population from this UK region, the uptake of BCT reduced when clin icians 
provided and supported greater patient knowledge acquisition and promoted greater pat ient 
decision making autonomy. 
This component of the study is based on self-report interview data, rathe r than direct observation 
of clinicians' consultations with patients . This could be viewed as a potent ly li mitat ion . This is 
explored in the general discussion . 
TABLE 5·7 Summary of the key similarities and differences identified by the clin ician interviews 
Primary motivation to provide their patients with breast cancer optimum management and 
minimise the negative impact of this diagnosis . 
. ' , ".' , ."" '~ ' .. '~.': ')T~,~~'; ": :,: -':"'::', -:~ ~;;:'j~:: ,':- ',:i:,c~,' ~;~(~:>:: '~' ", f: .::;:<~n:;,~~S,:, ':~:::- :,~, " '?L " :":' '-:.-
, Key dl'ffer~,nces " ".,.- ',,' ';"<" '.-: ,,:,' , " ;.!" ' d ,':,' "£ ,;' " .,- :', _. " ' 
rJ:~I:~" 'i'~: , . . :!~.~.",~«:,/:~;,:'~'~~.J,.t~,.:;~I .. ~;~~:l~'·~'·:·-: ~:\.lJ··":':·~~_·r:~;~ ~ 'q '::~~,~.'I;::' '~~~"~~~ ',':: .. ".~. '" .~.~ 
1. Which patients teams/units/clinicians identify as suitable for treatment options/choices 
2. Breast unit ethos' central focus; outcome-based (a specific treatment) or process-based 
(more autonomous patient decision making) 
3. Clinician/units' central belief; optimum management is a specific treatment determined 
by the expert clinician (BCT where possible at the low MR unit) vs. the treatment 
preferred by the patient (more autonomous patient decision making at the medium and 
high MR units) 
~----------------------------------------------
4. Depth and extent of information provision (options, language and comprehensiveness) 
5, Directive vs. facilitative approach & recommendations (reluctance vs, inclination or 
enthusiasm, and early vs. late) 
6. Mechanisms of patient decision making support vary In comprehensiveness and 
whether or not routine part of the process 
7. Timescales and process of establishing consent for treatment 
Chapter 6 
Patient semi-structured interviews 
Why do hospital mastectomy rates vary? A qualitative study 
of the decision-making experiences of women with breast 
cancer 
ABSTRACT 
Background UK national guidelines state when BCT is not contraind icated, women with breast 
cancer should be offered a choice between BCT and mastectomy. Despite th is, surg ica l 
treatment variation between hospital breast units is widespread . The aim of this component of 
the study was to determine the relationship between breast unit MRs and patients' experience of 
information provision, consultations with their treating clinicians and decision-making 
experiences. 
Methods This MREC approved study was undertaken in three purposively selected breast 
units from a single UK region identified to have high, medium and low case-mix adjusted MRs. 
Semi-structured interviews were conducted with 65 women the breast unit clinicians identif ied as 
having been provided with a choice of breast cancer surgery (BCT or mastectomy). Interviews 
were digitally recorded, transcribed verbatim and analysed using the Framework approach. 
Findings The decision-making experiences of women from the medium and high MR 
breast units were similar, and these were dissimilar to those of the low MR unit. Treatment 
variation was associated with patients' perception of the most reassuring and least disruptive 
surgical option; the content and style of consultation information (equipoise or directed); level of 
patient participation in decision-making; and the time and process of decision-making. The 
provision of more comprehensive less directive information, together with greater autonomy, 
time and support of independent decision-making were associated with a lower uptake of BCT. 
Interpretation Variation in MRs between units was associated with clin icians' information 
provision and consulting style, and patients' treatment decision-making experiences. More 
comprehensive information provision and the promotion of greater patient autonomy were 
associated with higher MRs. The findings suggest that improving informed decision -making and 
increasing patient autonomy in the selection of the treatment, is unl ikely to increase the uptake 
of BCT among women suitable forthis option. 
BACKGROUND 
Research demonstrates neither BCT nor mastectomy are superior in the ir impact on morta lity (in 
cancers up to 4-scm diameter), (Blichert -Toft, Brlncker, Andersen, Andersen, Axelsson, 
Mouridsen, Dombernowsky, Overgaard, Gadeberg, Knudsen, & . 1988i CIarke, Collins, Darby, 
Davies, Elphinstone, Evans, Godwin, Gray, Hicks, James, MacKinnon, McGale, McHugh, Peto, 
Taylor, & Wang 200SiFisher, Anderson, Bryant, Margolese, Deutsch, Fisher, Jeong, & Wolmark 
2002iJacobson, Danforth, Cowan, d'Angelo, Steinberg, Pierce, Lippman, Lichter, Glatsteln, & 
Okunieff 1995iLichter, Lippman, Danforth, Jr., d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & . 1992iPoggi, Danforth, SCiuto, Smith, Steinberg, Llewehr, Menard, 
Lippman, Lichter, & Altemus 2003iSarrazin, Le, Arriagada, Contesso, Fontaine, Spielmann, 
Rochard, Le, & Lacour 1989ivan Dongen, Voogd, Fentlman, Legrand, Sylvester, Tong, van der, 
Helle, van Zijl, & Bartelink 2ooojVeronesi, Cascillelli, Mariani, Greco, Saccozzi, Luinl, Aguilar, & 
Marubini 2002)or morbidity(Carlsson & Hamrin 1994iDorval, Maunsell, Deschenes, & Brisson 
1998jFa liowfie ld, Baum, & Maguire 1986jGanz, Desmond, Leedham, Rowland, Meyerowitz, & 
Belin 2oo2jlrwig & Bennetts 1997jMcCready, Holloway, Shelley, Down/ Robinson, Sinclair, & 
Mirsky 2ooSjMoyer 1997jSanger & Reznlkoff 1981,Schain, Edwards, Gorrell, de Moss, Lippman, 
Gerber, & Lichter 1983jStefanek 1993) (except body image) .(Arndt, Stegmaier, Ziegler, & Brenner 
2008iCarisson & Hamrin 1994jFaliowfield, Baum, & MagUire 1986jlrwlg & Bennetts 1997,Moyer 
1997jSanger & Reznikoff 1981jSchover 1994jStefanek 1993) Therefore guidelines state, when 
BCT is not contraindicated on clinical grounds, women with breast cancer should be offered a 
choice between BCT and mastectomy.(Associatlon of Breast Surgery at BASO 2oo9,Kaufmann, 
Morrow, von, & Harris 2010jScarth, Cantin, & LeVine 2002a) Despite th is w idespread 
emphasis, (Associatlon of Breast Surgery at BASO 2009;Bllchert -Toft, Smola, Cataliottl, & 
O'higgins 1998jDepartment of Health 2001a;Department of Health 2001c,Department of Health 
2009iGenerai Medical Council 2008iKaufmann/ Morrow, von, & Hams 2010,Nat ionai 
Collaborating Centre for Cancer 2009; Nattlnger, Hoffman, Shapiro, Gottlieb, & Good Win 
1996; Nayfleld, Bongiovanni, Aiclatl, Fischer, & Bergner 1994, Royal College Of Surgeons Of 
England 2002jScarth, Cantlll, & Levine 2002a;Scarth, Cant lll, & LeVine 2002 b) pract ice rem ains 
variable. (Bates, Kearins, Monypenny, Lagord, & Lawrence 2009,BCCOM 2006iB CCO M Steering 
Group 2oo7;Farrow, Hunt, & Samet 1992,Goel, OllVOttO, Hislop, Sawka, Co ld m an, & Holowaty 
1997,GrllIl, Scorplgllone, NlcolucCl, Malll III I, Penna, Marl, Belf lg llO, & Liberati 1994,Iscoe, Goel, 
Wu, Fehringer, Holowaty, & Naylor 1994,lsh lzak" Ima naka, Hirose, Kuwabara, Ogawa, & Harada 
2002jMandeibiatt, Hadley, Kerner, Schulman, Gold, Dunmore-Griff it h, Edge, Guadagnoll yne h, 
Meropo l, Weeks, & Winn 2000iMoneypenny 2004iMorrls, Cohen, Schlag, & Wright 2000,Morrow, 
White, M oughan, Owen, Pajack, Sylvester, Wilson, & Winchester 2001,Natt inger, Gottlieb, Veum, 
Yahnke, & Goodwin 1992;Nattinger & Goodwin 1994,Samet, Hunt, & Farrow 1994,Sauven, 
Bishop, Patnick, Walton, Wheeler, & Lawrence 2003iSchooi of Health and Related Research 
1998;Scorpig lione, Nicolucci, Grilli, Angiolinl, Belfigllo, CarinCl, Cubasso, Filardo, Labbrozzl, 
M ain ini, & . 1995;van Nes, Seynaeve, jones, Markopoulos, Putter, van, V, Hasenburg, Rea, 
Vannetzel, Dirix, Hozumi, Kerin, Kieback, Meershoek-Kleln Kranenbarg, Hille, & Nortler 2010) 
It was widely supposed that if women were given more choice over the ir surgery, the m aj ority 
would select BCT. The evidence regard ing this is confl icting .(Colllns, Moore, Clay, Kearing, 
O'Connor, Llewellyn-Thomas, Barth, Jr, & Sepucha 2oo9;Degner, Kristjanson, Bowman, Sloan, 
Carriere, O'Neil, Bilodeau, Watson, & Mueller 1997a,Hack, Degner, Watson, & Sillha 2006)anz, 
Wren, Copeland, Lowery, Goldfarb, & Wilkins 2oo4,Keatlng, Guadagnoll, Landrum, Borbas, & 
W eeks 2002;Kotwall, Maxwell , Covington, Churchill, Smith, & Covan 1996, Lantz, Janz, Fagerllll, 
Schwartz, Liu, Lakhani, Salem, & Katz 2oo5,Mastagiia & KrIStjanson 2001,Molenaar, Oort, 
Sprangers, Rutgers, Luiten, Mulder, & de Haes 2oo4;Moyer & Salovey 1998,Schou, Ekeberg, 
Ru land, & Karesen 2002;Street, Jr. & Voigt 1997) 
Patients' breast cancer surgery decisions are subject to numerous influences, ((arver, Pozo -
Kaderman, Price, Noriega, Hams, Derhagopian, Robinson, & M offat, Jr 1998; ( 011111 5, Moore, 
Clay, Kearing, O'Connor, Llewellyn -Thomas, Barth, Jr., & Sepucha 2009iFallowfleld, Baum, & 
M aguire 1.986;Hawley, Griggs, Hamilton, Graff, Janz, Morrow, Jagsl, Salem, & Katz 2oo9,Hughes 
1.993; Kotwa ll, Maxwell, Covington, Churchill, Smith, & Covan 1996, Lasry & Margolese 
1.992;Mandelblatt, Hadley, Kerner, Schulman, Gold, Dunmore-Griffith, Edge, Guadagnol" Lynch, 
Meropol, Weeks, & Winn 2000;Molenaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & de Haes 
2004iMoyer 1997;Nold, Beamer, Helmer, & McBoyle 2000;Schou, Ekeberg, Ruland, & Karesen 
2002iSmitt & Heltzel 1997, Wei, Sherry, Baisden, Peckel, & Lala 1995, Wil son, Hart, & Dawes 1988 ) 
and impacts from age, (Blelcher, Abrahamse, Hawley, Katz, & Morrow 2008, Haw ley, Lant z, Jan z, 
Salem, Morrow, Schwartz, Liu, & Katz 2007iMoienaar, Oort, Sprangers, Rutgers, LUlten, Muld er, 
& de Haes 2004iSingh, Sloan, Atherton, Smith, Hack, Huschka, Rum m an s, Cl ark, Diekmann , & 
Degner 2010) race/culture(Blelcher, Abrahamse, Haw ley, k atz, & Morrow 2008,Hawley, Lantz, 
Janz, Salem, Morrow, Schwartz, Llu, & Katz 2007, Haw ley, Gr iggs, Hamilton, Graff, Jam, Morro"" 
Jagsl, Sa lem, & Katz 2009) and education (Blel cher, Abra hamse, Hawley, r atz, & Morroli'. 
2008, Hawley, Lantz, Janz, Sa lem, Morrow, Schwartz, Llu , & katz 2007, SII~gh, Sloan, Atherton, 
Smith, Hack, Huschka, Rumman s, Clark, Diekmann, & Degner 2010) have been demon strated . 
The media has an influence, (Collins, Kerrigan, & Anglade 1999,Hughes 1993,Kotwall, MaxVvell, 
Covington, Churchill, Smith, & Covan 1996iMcKinlay, Burns, Durante, Feldman, Freund, Harrow, 
Irish, Kasten, & Moskowitz 1997iNattinger, Hoffmann, Howell -Pelz, & Goodwin 1998) as do 
patients' social responsibilitiesj leading some to opt for more simplified t reatment package.(Smltt 
& Heltzel 1997j Wilson, Hart, & Dawes 1988) 
However, clinicians and units have been shown to exert an influence over pat ients ' t reatment 
decisions, by recommending a particular treatments or commun icating preferences,(Johnson, 
Roberts, Cox, Reintgen, Levine, & Parsons 1996iKatz, Lantz, & Zemencuk 2001iKotwall, Maxwell, 
Covington, Churchill, Smith, & Covan 1996iMolenaar, Oort, Sprangers, Rutgers, LUlten, Mulder, & 
de Haes 2004jMorrow, Jagsi, Alderman, Griggs, Hawley, Hamilton, Graff, & Katz 2009,Nold, 
Beamer, Helmer, & McBoyle 2ooojSchou, Ekeberg, Ruland, & Karesen 2002,Smitt & Heltzel 1997) 
and through women's perception about the curative potential of treatments.(Katz, Lantz, & 
Zemencuk 2oo1jKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996, Smltt & Heltzel 
1997) Limited data are available on how patient and clinician/unit facto rs combine to influence 
treatment decisions, or what impact different consultation styles (pat ient vs. doct or -cent red ) or 
decision making approaches (paternalistic, shared and informed choice)(Charles, Whelan, & Gafnl 
1999ajCharles, Gafni, & Whelan 1999biCharles, Gafnl, & Whelan 2000,Cou iter 1999,Coulter, 
Entwistle, & Gilbert 1999,Elit, Charles, Gold, Gafnl, Farrell, Tedford, Dal Bello, & Whelan 
2003jElwyn, Edwards, Gwyn, & Grol1999,Elwyn, Gray, & Clarke 2000iElwyn 2008, Gafnl, Charles, 
& Whelan 1998jMcWhinney 1989jS ilverman, Kurtz, & Draper 1998) have over dec isions . However 
patients are demonstrated to prefer patient-cent red consultat ion styles(Dowsett, Sau l, Butow, 
Dunn, Boyer, Flndlow, & Dunsmore 2000,Frederikson 199s,Lerman, Daly, Walsh, Resch, Seay, 
Barsevick, Birenbaum, Heggan, & Martin 1993iMaguire 1999;VICk & Scott 1998) and decision 
making approaches, (Charles, Whelan, & Gafni 1999a) and these have been associated wit h better 
information recall (Faliowfield 2000) and patient outcomes.(Gnggs, Sorbero, Mallinger, QUinn, 
Waterman, Brooks, Yirlnec, & Shields 2oo7,Hack, Degner, Watson, & Sinha 2006,Irwig & Bennetts 
1997jLerman, Daly, Walsh, Resch, Seay, Barsevlck, Birenbaum, Heggan, & Martlll 
1993;Mandelblatt, Edge, Meropol, Sen Ie, TsangaflS, Grey, Peterson, Jr , Hwang, Kerner, & Weeks 
2003iMcCready, Holloway, Shelley, Down, Robinson, Sinclair, & Mirsky 200s,Roberts, Cox, 
Relntgen, Baile, & Glbertinl 1994;Street, Jr & VOigt 1997) 
As the interaction between the two groups takes place in consultations, understandi ng pat ients' 
experience of consultations with their clinicians and how these influence their treatment 
decisions is important. The aim of this component of the study was to explore the consultat ion 
and treatment decision-making experiences of women newly diagnosed with breast ca ncer, to 
identify key themes associated with variation in breast unit MRs. The study was conducted 
among patients eligible for a choice of surgery (BeT or mastectomy), from three breast units of a 
single UK region identified as having high, medium and low case-mix adjusted MRs. 
METHODS 
Study design 
Qualitative research methodology was employed to explore how specialist cl inicians influenced 
patients' choice of surgery (BeT or mastectomy). Semi-structu red interv iews were chosen t o 
capture rich data on the topics of pre-determined interest, while provid ing sufficient flexibil ity to 
capture emergent themes in allied areas of interest. 
The interview schedule (see appendix 7) was developed by the research team; includ ing 
experienced qualitative researchers, two surgeons, one BeN and two consumer representatives 
who had previously been diagnosed and treated for breast cancer. The interview schedule was 
piloted on one breast cancer patient. 
Setting and sample 
This component of the study was conducted in t he same three purposively se lected specialist 
hospital breast units from the Trent region of the UK, as the pat ient questionnaire and interview 
components of the study described in chapters 4 and 5; i.e. units represent ing high, medium and 
low case-mix adjusted MRs. 
Reports of similar stud ies suggest t hat interviewing approximately twenty patients per breast unit 
ach ieves response saturation .(Marshall 1996) A sampl ing frame (figure 6.1) was employed to 
purposively recruit women from the questionnaire phase of the study balancing treatment choice 
and breast unit. Potential participants were identified by their unit as having been offered a 
choice between BCT and mastectomy, and able to provide informed consent to participate . 
Patients were approached following their surgery. The recruitment process and eligibility criteria 
are fully described in the patient questionnaire section of the thesis (chapter 4) . Partic ipa nts self-
selected to participate in both the questionnaire and interview phases (n=274/3 57). Interviews 
were restricted to a defined eight month period by the employment of a single interviewing 
researcher. Ninety eligible participants were recruited during the eight month interview period. 
Two withdrew, leaving a potential eighty-eight eligible participants. Limited recruitment of 
patients choosing mastectomy meant the sampling frame could not be filled in the timeframe of 
this component of the study. However, response saturation was achieved with the interview of 
sixty five patients. 
FIGURE 6.1 Patent interview sampling frame 
;rtlIJi:"rui1o.: ,~,~,!!..'>. .. ~~)i~.·,~~i iI~ ~ ,," , . 
. . 
. '. Low Medium High 
. , MR unit MR unit MR unit 
. . , 
, - .-
Initial BeT (n) 10 10 10 30 
therapeutic 
treatment Mastectomy (n) 10 10 10 30 
Total (n) 20 20 20 60 
The participants were aged median 58 years (range 33-73 years) . The mean time between surgery 
and interview was six weeks (range 1.9-20.6 weeks). Overall, 75% of participants underwent BCT 
(n=49) and 26% mastectomy (n=16) . Twenty patients were interviewed from the low and 
medium MR units, and 25 from the high MR unit. Seven, seven and two patients had undergone 
mastectomy respectively from the high, medium and low MR breast units. The interviewed 
patient characteristics are summarised in tables 6.1, 6.2 and 6·3· Tables 6.1 and 6.2 illustrate the 
groups characteristics. Table 6.6 provide information at individual participant level on age 
t · PDMS ADMS breast unit and time between operation and interview. opera Ion, , , 
TABLE 6.1 Characteristics of patients interviewed (n=65) 
Time surgery 
interview (weeks) 
Operation BCT 49 
Mastectomy 16 
PDMS Active 29 
Collaborative 25 
Passive 11 
ADMS Active 44 
Collaborative 12 
Passive 9 
Patient operation by Mastectomy (n 7 7 2 
breast unit r----
BCT (n) 13 
Total (n) 20 20 
TABLE 6.2 Interview patients by initial therapeutic treatment and age 
<50 yrs 50-70 yrs >70 yrs 
Initial BCT (n) 10 37 2 49 
therapeutic 
treatme~l_ Mastectomy (n) 6 9 1 16 
-- L~ Total _ _ J (n) 16 3 65 
--'--
-== -=- -
median age 58 years (range 33 to 73 years) 
TABLE 6·3 Summary of Interview participant characterist ics by breast unit and time of interview 
Medium 2 Mx 3 2 34 MRunit 3 Mx 45·2 3 1 53 4 BeT 58 .1 4 4 29 
5 BeT 62 .1 3 3 28 6 BeT 56.8 2 3 32 
7 Mx 46.1 2 2 29 8 Mx 58.2 2 2 25 
9 Mx 50.8 2 2 35 10 BeT 54 ·7 2 2 15 11 BeT 47·0 5 1 35 12 BeT 69 ·4 4 3 18 
13 BeT 70 ·7 2 2 49 
14 BeT 60.2 3 3 15 
15 BCT 43 .1 3 3 115 
16 Mx 73 ·4 4 3 60 
17 BeT 50 .0 4 4 90 
18 BeT 62 .0 3 3 63 
19 BeT 58 .5 2 5 39 
20 BeT 2 2 2 21 
21 BeT 54·5 4 2 144 
22 BeT 58.9 2 2 109 
23 Mx 62.6 2 2 49 
24 BeT 43.0 2 2 35 
25 Mx 60·9 4 1 86 
26 BeT 57.8 3 2 90 
27 BeT 61.6 3 1 55 
28 BeT 60 .6 3 2 58 
29 Mx 48 .6 2 1 38 
30 Mx 62.6 2 2 31 
31 Mx 64·7 3 1 38 
32 BeT 61·5 2 2 47 
33 BeT 57·5 3 1 66 
34 BeT 55 ·5 3 2 37 
35 Mx 65·5 2 2 37 
36 BeT 57.8 3 2 26 
37 BCT 67.6 2 2 40 
38 BeT 57·9 1 1 51 
39 BeT 71.7 2 2 36 
40 BeT 57·4 2 3 41 
41 BeT 4 2.5 2 2 49 
42 BeT 60 .8 4 1 28 
43 BeT 61.1 5 5 38 
BeT 57·9 2 5 38 
Mx 6.0 2 
BeT 59·4 2 1 64 
Low 47 BCT 68 .6 3 2 63 
MR unit 48 BeT 38.8 3 3 48 
49 Mx 59 .6 3 3 32 
50 BCT 55.8 2 2 24 
51 BCT 51.8 3 2 22 
52 BeT 53 ·3 2 ]. 13 
53 BeT 4~·7 4 4 ~6 
54 BeT 60 ·7 2. 2 ~3 
55 BeT 44 · ~ 3 3 3~ 
56 BeT 33 ·0 ~ 2 24 
Sl BeT 44. 2 2 ~ 14 
58 BeT 58 .2 3 2 22 
59 BeT 60 .1 3 2 13 
60 BeT Sl·6 2 2 25 
6~ BCT 55 ·~ 3 4 45 
62 BeT 44.6 3 5 30 
63 BeT 59 ·9 3 5 48 
64 BeT 59.8 3 3 29 
65 Mx 44 ·4 4 2 21 
OP = operation; Mx = mastectomy, BeT = breast conservation therapy 
OMS: 1= most active, 2= shared active, 3=collaborative, 4=shared passive, 5= most passive 
Data 
The interview schedule was designed to provide a description of the pat ient's surgical treatment 
decision-making experience. Gathering information about consultations with multi-disciplinary 
breast team members; focussing on the content and style of consultations, patients' 
understanding of the information provided, and how these influenced treatment decisions. 
Contextualising information was sought on patients' treatment, their preconceptions, and pre-
existing information and experiences of breast cancer, information from other sources and other 
factors influencing their treatment decisions. The interview schedule is found in Appendix 7, 
along with patient letters. Interviews took place between 23/03/2004 and 19/11./2004. All except 
one interview was conducted in the patients' home. Interviews were digitally recorded and 
transcribed verbatim. An example of a verbatim patient interview transcript is found in Appendi x 
10. Field notes were also kept. 
Data analysis (the Framework approach) 
As described more fully in chapter 5, verbatim transcripts and the intervi ewer's f ield notes were 
analysed using the Framework approach, which provides a rigorous, comprehens ive, systematic 
approach to manage and analyse the large volumes of textural data generated by qualitat ive 
studies; but permits extensive data exploration within and across both t hemes and cases, while 
retaining the link between each comment and the source dat a. In it ial themat ic analysis was 
conducted by one clinical researcher (LC), two non-clinician researchers (DW and KC), and the 
study's consumer representatives (HMC and GS). The majority of clin ician interview ana lyses 
(79.9%, 20/26 patient interviews) were facilitated by listening to the particular interview aud io 
recording while analysing the verbatim transcript . To minimise bias and optimise consistency of 
data analysis 12/65 (20%) interview transcripts were independently coded and charted by two 
researchers (LC and DW) and then discussed, as an on-going process throughout data analysis . 
The development of the theme, sub-theme, and factor structure utilised the same process as 
described in chapter 5. The final Framework patient data analysis theme headings and code 
numbers are illustrated in figure 6.2. An example of a patient interview Framework matrix is 
found in appendix 9. The adopted charting conventions and abbreviations shown in chapter 5, 
figure 5.3. The transcription conventions are also found in chapter 5· 
FIGURE 6.2 Final Framework patient data analysis theme headings & code numbers 
1) UNIT 10 CODE . 
2) PATIENT 10 
DECISION-MAKING 
& CLINICIAN STYLE 
DECISION-MAKING , 
PROCESS 
CHOICE 
FINDINGS 
I.e . age, marital status, 
ethnicity employment, 
PHMx 
8) DOcrORS 
Communication & 
interpersonal skills, 
perceptions of doctors. 
10) INFO SEEKING 
BEHAVIOR 
How, when and in 
what ways did patients 
look for (or were given 
info (not info from 
clinic) . 
15) 
I,l.NDERSTANDING 
Patients perception of 
clinicians information 
& IDwho. 
18) FEELINGS 
ABOUT HAVING A 
CHOICE 
How did patient feel 
about being diagnosed 
& living with cancer, 
family I social aspects 
of having cancer, etc. 
Inc. sources of these . 
9) NURSES 
Communication & 
interpersonal skills, 
perceptions of nurses. 
11) ACCESSIBILITY 
General perception of 
team vs. other (who 
and what info) . 
16) OPTIONS 
Options given & 
implications of 
options. 
19) CLINICIAN 
ADVICE 
What did clinicians 
advise if or when 
asked for their 
24) FEELINGS 
ABOUT 
OPERATIONS 
Thumbnail sketch of 
joumey through clinic, 
who they saw, when, 
etc. 
12) INFORMATION 
RELA YED & GIVEN 
BY TEAM 
Manner in which 
information was 
delivered, what tools I 
strategies used in 
delivery, inviting 
questions. 
17) TIME 
Patient perceptions of 
how much time they 
had to make decision 
& feelings about the 
amount oftime . 
Treatment 's 
Chemotherapy, 
Radiotherapy & 
endocrine . 
13) INFORMA TlON 
CONTENT 
What was actually 
said to the patient, 
questions asked to 
patient> 
14) PRIORITY 
INFORMA TlON 
NEEDS 
What patients w anted 
or needed to know 
about their cancer and 
its treatment, what 
they actually asked 
about . 
There was heterogeneity of women's experiences within the units . However, the deci sion-
making experiences of women from the medium and high MR units were similar, and were 
dissimilar to those of the women treated by the low MR breast unit. The themes ident ified were 
clustered into two main groups; patient-specific themes and breast unit-specific themes . Table 
6·4 summarises the themes and sub-themes associated with variation in patients ' treatment 
decisions. 
TABLE 6.4 Themes and sub-themes associated with variation In patients ' treatment 
decisions. 
• Most reassuring treatment option 
• Least disruptive treatment option 
Breast unit-specific themes " 
• I nformation content 
• Information content style 
• Time and decision-making process 
f----------
---------------- ----------------------------------~ 
• Patient autonomy in decision-making 
PATIENT-SPECIFIC THEMES 
The patient-specific themes were heterogeneous with in and across the breast units, and most 
seemed innate to patients; and predominantly independent of the breast teams' influence. 
However, two sub-themes were more influenced by patients ' interactions with the ir breast 
clinicians and were associated with variation in patients ' treatment choices , These were patients' 
perception of the most reassuring treatment option, and thei r perception of the least disruptive 
treatment option. Table 6.5 summarises the patient-specific sub-themes and factors , 
Most reassuring treatment option 
Although patients were aware of and accepted the equivalence of surv ival with BeT and 
mastectomy and seemed to accept this, the extensiveness of surgery often influenced their 
perception of the safety of the treatment option . Many choosing mastectomy said this more 
surgically extensive treatment option reduced their anxiety about the completeness of cancer 
excision . 
... [1 could] never have ... had as much peace of mind if I'd just had the lump removed, 
... what if they've missed a little bit round it ... [Patient 1, mastectomy, age 42, medium 
MR unit, PS] 
Many of this group also talked about minimising the local recurrence risk . This was expressed as 
important in reducing patients' anxiety about the need for further treatment at a later date . 
Some also felt it must confer a better long-term outcome . 
••• 1 didn't contemplate just [BeT] ... when you have the lumpectomy [BeT] you're worried 
all the time, every time it's your appointment at the breast clinic you ... get anxious ... worry 
all the time .... at least having a mastectomy a good part of the worry is gone . I know you 
can still get it [recurrence], this has been explained .. . but ... it gives me a greater chance ... 
[Patient 23, mastectomy, age 62, high MR unit, p6] 
Reassurance regarding their surgery was expressed in a different way by many of those choosing 
BeT. Some of this group felt because they were offered BeT, their cancer was not as bad or 
harmful as it might have been. A few also believed this inferred they were more likely to be cured . 
This was particularly predominant among patients of the low MR Unit who described the 
provision of a treatment plan or strong recommendations, rather than a more open choice of 
treatment. 
Total mastectomy ... conjures up ... you are riddled with cancer. . .. wide local 
excision ... contains your thoughts that it's not as bad as your brain 's telling you. [Patient 
27, BeT, age 61, high MR unit, P9] 
... [1] realised with having the choice, it must be small, because ... 1 know there are instances 
where you're not given the choice, you've got to have the mastectomy, so I thought, 
"Well, it won't be very big, it hasn't spread much" [Patient 35, mastectomy, age 65, high 
MR unit, Ps] 
While most patients in this group based their dec is ions on correct information, some expressed 
the incorrect beliefs about the safety of the option they had chosen . 
Mastectomy ... much bigger operation, but feel that the problem 's gone, it's not go ing to 
recur in the breast tissue because it's not there anymore . [Patient 31, mastectomy, age 
64, high MR unit, pll] 
I was told if you'd had the mastectomy .. . the cancer could still have come bac k on t hat 
side. ...and then I thought...if you had a mastectomy you don't [have] radiotherapy do 
you, so ... if there had been any [cancer] cells possibly then in the tissue [left] that co ul d 
have come back, I don't know whether they would have been cleaned up . [Patient 42, 
BeT, age 60, high MR unit, P17] 
While most patients based their decisions on information provided by the clin icians, some util ised 
anecdotal experiences to decide their treatment and based their decisions on health beliefs with in 
their family or community, as to which treatment was more reassuring or safer. 
I do know several people who've had just the lump removed and in a year or two they've 
had to go back and have a mastectomy. [Patient 35, mastectomy, age 65, high MR un it, 
P9] 
My best friend that had it [BeT] ... she'd been given 't choice and she said ... "I'm having 't 
lump out ... because if it comes back and you've had your breast off ... where 's it gonna 
go?" .. . and that's always stuck in my mind . [Patient 19, BeT, age 58, medium MR un it , 
P39-40 ] 
Least disruptive treatment option 
Patients also chose their surgery based on what seemed the least disruptive treatment option . 
For some it meant choosing the option which they felt would cause least disruption to their wider 
life and commitments during treatment. For those choosing BeT this often meant the treatment 
associated with a shorter hospital inpatient stay for surgery. Wh ile many of those choos ing 
mastectomy talked about wishing to minimise the overall treatment process and the potent ial 
need for further treatment, which might include further surgery or radiotherapy . 
.. . 1 didn't fancy the radiotherapy ... 1 just d idn't want the hassle of go ing t hrough t hat a nd I 
know a few people who've had the lump and had to go back . So I thought if I've got to 
have one orthe other I might as well get it all done at once . .. . 1 think that was probably my 
fear of operations as much as anything. [Patient 7, mastectomy, age 46, med ium MR 
unit, p22] 
I don't want to be coming back every day for radiothe rapy for six wee k ... 1 ha d goL .my 
son and his two children here ... And .. . 1 take my duty as a surrogate pa rent ser ious ly and I 
thought, it's time-consuming, I've got to give the time up to go down to the hospita l 
every day, [and I]. .. knew people that had had it and they sa id how t ired and ho w wea ry [it 
makes them feel]. .. you 've got to weigh up what your lifestyl e is like . I di dn't wa nt to run 
the risk of having to have two operations, that was the major, major issue for me ... if I'd 
had a lumpectomy and for whatever reason it didn't have a clear marg in and then I had to 
go back for a further lumpectomy or a mastectomy .. . [Patient 25, mastectomy, age 60, 
high MR unit, P7-8] 
For others, the least disruptive treatment option was determ ined by the potent ial impact of 
surgery on their body image or sexual relationships . For some the preservation of their breast per 
se was extremely important either to themselves or to their partner. 
When she said ... that there really was a choice and that either way just as good, then my 
next thought was my husband, that it would be so much easier for him physically, to look 
at.. [Patient 25, B(T, age 60, high MR unit, p8] 
I d idn't get upset until the point where it was losing the whole breast.. .1 hadn't had a 
sexual partner for three years ... but I'm not on the shelf, I've not given up hope, [i thought] 
do I have to lose my full breast, is there any way you can just keep part of it . [Patient 48, 
B(T, age 38, low MR unit, p1.6] 
My tits are precious ... they've always been my asset, even though they're .. . a bit saggy 
now .. . it's a feminine thing. [Patient 50, B(T, age 55, low MR unit, P7] 
While for others having a mastectomy would act as a constant physical reminder that they had 
had cancer. 
If you're disfigured ... it's a constant reminde r that you 've got, had or in remission of 
cancer ... every time you look at yourself...it's never going to be anything you can forget 
because every time you take your clothes of it shouts at you . [That's] how I would have 
felt had I now had a full mastectomy.. . I can dress and it wouldn't be noticeable to the 
outside world but.. . [Patient 42, B(T, age 60, high MR unit, P23] 
A small number had witnessed the result of surgery of relatives and wished to avoid a similar 
physical appearance . 
.. . [all] I could see was my Mum's scar, all gathered up, and I thought, 'I don 't want to look 
like that .... 1 thought...[a mastectomy] will ruin my life . [Patient 1.2, B(T, age 69, high MR 
unit, p2] 
Although body image concerns predominated among those choosing B(T and fea r of recurrence 
predominated among those choosing mastectomy, when cons idering the ir options many 
vacillated between the tWOj trading between their concerns regarding safety and recurre nce, and 
the disruption of normality and body image. 
I thought I'm going to have to have a serious think about whethe r I' ll cope with losi ng it 
[her breast]. 00 .1 listened to both and I didn't fancy the radiothe rapy... [Pat ient 7, 
mastectomy, age 46, med ium MR un it , p22] 
There was also a small highly specific group of patients who expressed the ir safety concerns and 
body image considerations in a different way. This particular group were younger women with 
breast cancer and a co-existing family history of breast cancer who were cons ideri ng geneti c 
testing and the possibility of risk reducing surgery in the future . This group also incorporated 
these issues into their consideration of the treatment options . 
.. . [I knew the radiotherapy part of BeT would be] automatica lly lessen ing my chances to 
have reconstruction surgery if I feel like I need it ... 1 still don't know whether I wou ld go 
through that [risk reducing mastectomy and reconstruction] or not but [as I chose 
mastectomy] my chance now is st ill there . [Patient 45, mastectomy, age 46, high MR 
unit, P10,16,26] 
Although these themes have been classified as patient-specific themes, some of the sub-t hemes 
were influenced by the information provided by the patients' breast team. For example, the 
decision-making considerations of those undergoing BeT from the low MR un it were less likely t o 
include the possibility of post-operative re-excision or the need for rad iotherapy. In some 
instances patients described this information as being down-played, while others implied it was 
only provided in conjunction with the results of their therapeut ic surgery . 
.. . he [surgeon] told me that it was actually a small ca ncer [2cm invasive ca ncer] and .. . he 
went on to explain how best to deal with it, explained the lumpectomy .. . the fact that I'd 
probably need a bit of radiotherapy .. . depending on what they found .. " [Patient 55, BeT, 
age 44, low MR unit, p6] 
One of my biggest fears in life fo r some reason ... is having a mastectomy. On the other 
hand, if it's gonna save my life .. . then it wouldn 't bother me .. . 1 wouldn 't have hesitated -
or even if I'd been told, "You can have [BeT]. .. but there was a possibil ity .. . it can recur" ... 1 
would have then gone forthe mastectomy. [Patient 54, BeT, age 60, low MR unit , pl.?] 
In contrast, medium and high MR un it patients voiced such information read ily and descri bed 
utilising it when making their treatment decisions. 
He [surgeon] sat and drew diagrams and said that it was a lump, it was cancer. He went 
through the various options that I could take . He also had the mammogram up on t he 
board 50 he was showing me that. He .. . gave me t he options of eith er having the lump 
removed and going for follow-up treatment rad iotherapy at --t and which wou ld be a 
five-week [course]. .. or the mastectomy. [Pat ient 9, mastectomy, age 50, med ium MR 
unit, P4] 
TABLE 6·5 Patient-specific sub-themes associated with variation in patients l treatment cho ice 
Safety and fears 
• Cancer fully removed 
• Survival 
• Local recurrence 
• Minimise the psycho-physical impact of diagnosis (implication of better prognosis with 
less extensive surgery) 
Anecdotal information/experiences 
• Positive or negative anecdotal experiences of others 
Minimise impact on life, relationships and social commitments 
• Social commitments 
• Family (especially partners and dependants) 
Minimise hospital treatment experience 
• BCT - shorter in-patent stay 
• Mastectomy - shorter overall treatment (minimise need for radiotherapy and re -
excision) 
-- -----
Minimise the psycho-physical impact of surgery 
• Body image disruption min imised with BCT 
• Potential impact on partners and relationships 
• Mastectomy as a constant reminder of cancer 
BREAST UNIT-SPECIFIC THEMES 
The experiences of patients from the medium and high MR units were similar, and dissimilar to 
those of the low MR unit. The breast unit-specific sub-themes related to treatment variation 
were; information content, information style; time and decision-making process; and patient 
autonomy in decision-making. These are summarised in table 6.6. 
Information content 
The content and style of information patients received from their breast units influenced the 
treatment choices they made. Table 6.6 summarises the information content sub-themes and 
factors emerging from the data. 
Patient accounts from the low MR unit focussed on their clinicians' reassurance regarding their 
cancer and its treatment, along with treatment recommendations. Patients from the low MR unit 
were also more frequently only openly offered BCT, even when they requested information about 
mastectomy or expressed a preference for it. 
I went in and ... [the consultant] said what they wanted to do, this operation and take it 
away [BCT] ... And I just said to her "Well why don't you just take the whole lot off ... and 
she said ... she didn't think there was any need whatsoever to go to those extremes. 
[Patient 60, BCT, age 57, low MR unit, P13] 
In contrast patients from the medium and high MR units typically recounted much more detailed 
descriptions of the information about both BCT and mastectomy as treatment options available 
to them, what undergoing each would involve, the potential consequences and the amount of 
time they had for decision-making. 
He went through the various options that I could take . ... having the lump removed and 
going for follow-up treatment radiotherapy, and which would be a five-week [course]. .. or 
the mastectomy. He also went through the pros and cons of each one .. . and wrote this 
down. [Patient 9, mastectomy, age 50, medium MR unit, P4] 
Patients described different roles clinicians played in providing information for making decisions. 
Doctors were viewed as primary information providers, while BCNs reiterated, reinforced, and 
explored information needs. Patients of the high MR unit described discussions with their BCN 
and the extensive process of check ing understanding. The low MR unit patients felt BCNs were 
happy discussing the topics covered by the consultant's consultation, but were generally 
uncomfortable extending the scope of the consultant's consultation . This was most notable when 
patients expressed a preference in conflict with doctors' recommendat ions' or request ed 
information and a discussion regarding alternative surgical options. In instances where pat ients' 
desire for such information was persistent, BCNs tended to refer patients back to the consulta nt 
for further discussion. 
I said, "Well what happens if I just have the whole breast off," and she [BCN] said, "We ll 
that's something you'll have to discuss with your surgeon, I can't tell you that. [Patient 60, 
BCT, age 57, low MR unit, P7] 
Information style 
Within the information style sub-theme, four factors were associated with pat ients' choices; 
contextual ising informationj emphasis and minimisationj accessibility of information; and 
treatment recommendations. Table 6.6 summarises the information style sub-themes and 
factors. 
Contextualising information 
Patients being involved in the choice of their surgery were contextualised differently. The 
medium and high MR units tended to introduce the concept and explain the rationale for 
providing options early within the consultation, leading patients to expect involvement in 
decision-making . 
He was saying ... some women like the choice ... . some ... prefe r one to the other ... they're 
equal, there is no better option. The choice is yours. [Patient 42 , BCT, age 60, high MR 
unit, P5] 
Most patients at the low MR unit did not describe the provision of such information . 
He said, \\I'm sorry, it is malignant, but it is ve ry, very sma ll, you wi ll need to have an 
operation . I think it would be appropriate for you to have a lumpectomy ... [Pat ient 63, 
BCT, age 59, low MR unit, P7] 
The other type of contextualisation observed was how individual t reatment options were framed; 
whether this was in an open, directive or dismissive manner. 
They were very clear that this was going to be my choice and that they wouldn't push one 
against the other. They just simply presented all the facts about the t wo . [Pat ient 33, 
BCT, age 57, high MR unit, p6] 
[The surgeon] said, "Normally people with one that 's as small as you have th is incision 
[BCT], and at the end she mentioned mastectomy, but you got the impression she d idn't 
think you should go along that line . [Patient 64, BCT, age 59, low MR un it, p16] 
.. . a mastectomy would be like using a sledgehammer to open a nut. [Patient 43, BCT, age 
61, high MR unit, P9-1O] 
Patients who receive a message framed in a directive manner, perceived the clinician to have a 
treatment preference or to be offering a treatment recommendation . 
.. . he [surgeon] didn't actually say, 'Which would you prefer? ' but I mean I, he 's the 
professional, he knows ... 1 didn't question it because .. . 1 thought, 'Well, he knows what he's 
doing,' and he of course was the second person who'd said what the course of act ion 
would be .. . so I was quite happy to take his word, I mean you 've got to trust in them, 
haven't you? [Patient 63, BCT, age 59, low MR unit, P7] 
Emphasis and minimisation 
Clinicians often stressed certain cancer characteristics (small size and the early nature) which 
influenced patients' perceptions of the extent of their disease and which treatment they should 
undergo . 
[The surgeon] said it was only a diddy [very small] one, that it hadn 't grown very big and, 
it had started to invade slightly but they hoped it wasn 't in the lymph nodes ... the way 
[they]. .. explained the cancer made me feel a mastectomy wasn't necessary. [Patient 52, 
BCT, age 53, low MR unit, p6] 
When patients received treatment recommendations which we re emphasised they could also 
assume the recommended option was more likely to be successful in treating the ir disease, 
especially ifthe message was reite rated . 
.. . that [BCn was likely to be the most successful type of operation to have and that the re 
was no need to have anyth ing more drast ic. [Patient 53, BCT, age 41, low MR unit , P1S] 
If a treatment option was emphasised, almost universally it was BCT. This option was genera lly 
the first to be mentioned and discussed, and in some instances it was the on ly o pt ion d iscussed . 
Some patients received information about BCT and had no recollect ion of a pre limina ry 
introduction of a choice of treatments be ing ava ilable . In th is context they tended to assume it 
was either the only option available, or the recommendation of the clinician or unit. If 
information about mastectomy was then subsequently introduced by the clinician, it cou ld cause 
the patient surprise and alarm. 
He [surgeon] said, "This is the size of the cancer." Then he drew a circle round it and sa id 
"This'll be the area that we would remove." ... and you try to actually take in what he ' ~ 
saying as he's drawing this thing, and sort of except it and then the next thing he adds is, 
"This is what we'll do, or you can have a mastectomy." And at that point inside ... you're 
screaming, "What? Why? Why?" I'm sort of just coming to terms with the whole thing and 
accepting that, I'm going to have this [BCTl .. and then he said, "Or .. . " and you thinkl 
"Why?" if I need a mastectomy tell me I need one!11 [Pat ient 421 BCT
I 
age 601 high MR 
unit, P4-5] 
Accessibility of information 
The language and consultation styles adopted by clinicians influenced the accessibility of 
information to patients. Language varied from every day to bio-medical. Those who received 
information in an easily understandable format ,felt better able to understand and assimilate the 
information they were given. 
She explained extremely well, quite a lot of detail and in simple terms which were quite 
easily understood ... and asked us if we had any questions to ask ... [Patient 36, BCT
I 
age 
57, high MR unit, P5-6] 
Clinicians' consultation styles also varied between an openl tailored, two-way dialogue which 
encouraged interaction between the patient and clinicianl to a more prescriptive style . 
He [the surgeon] accepted the fact that I had a brain, I'd been looking at things and .. . took 
my background into account [andl .. we talked about things as a coup le of adults . [Pat ient 
61 BCT, age 56, medium MR unitl P7] 
[The consultant] wasn't really listening to what I was saying . ... Rather than it be a 
discussion between us, I felt it was a one-sided discussionl that's the best way I can 
describe it. [Patient 62, BCT I age 441 low MR unitl plO-11] 
The approach adopted influenced how patients felt about the consultation and their potentia l 
level of autonomy in the decision-making experience. These were often expressed more 
positively among those experiencing a more patient-centred consultation approach; where they 
were provided with clear, understandable, tailored information and the opportun ity to express 
and explore their needs, concerns and preferences. 
Treatment recommendations 
There was a tendency for low MR breast unit clinicians to volunteer a clear treatment plan 
containing recommendations based on what the clinician felt was most appropriate. These we re 
often given early within the consultation . 
I think it would be appropriate for you to have a lumpectomy ... 50 he didn 't actually say, 
"Which would you prefer?/I ... and he of course was the second person who'd sa id what the 
course of action would be. [Patient 63, BCT, age 59, low MR un it, P7] 
In contrast, the medium and high MR clinicians tended to provide patients with more open and 
comprehensive information and the opportunity to choose. 
They were very clear that this was going to be my choice and that they wouldn 't push one 
against the other. They just simply presented all the facts about the two . [Patient 33, 
BCT, age 57, high MR unit, p6] 
Some patients, immediately after diagnosis, felt underprepared for a role in decision-making and 
asked their clinician's recommendation . At this point the medium and high MR cl inicians usually 
spent more time discussing options and emphasising the time and support available; wh ile low 
MR clinicians tended to recommend a treatment; if they had not done so already. 
The force of clinicians' recommendations varied in a spectrum between encouragement to 
consider both options with a gentle steer toward a specific treatment option (almost invariably 
BCT), to a form of recommendation where patients felt they were denied their preferred 
treatment. 
I was, "Get it off, cut it off." And she was ... very kind, very understand ing but ... ve ry 
gently steering me to the outcome that she wanted . [Patient 48, BCT, age 38, low MR 
unit, p16] 
Mr _ said to me ... /Il don't like doing mastectomies" ... So ... the re was no d iscussion reall y 
on having my whole breast off .. . And every time I brought up the subject ... he wasn 't re all y 
listening to what I was saying . [Patient 62, BCT, age 44, low MR unit, p12] 
Patients from the medium and high MR breast units sometimes felt they we re g ive n treatment 
recommendations in some instances. Howeve r, whe n t his occ urred they tended to be more 
temperate and deferred to a later point in the dec ision- ma ki ng journey; usua lly in response to 
patients e xpressing a consistent desire to be d irected . These exceptions t ended to occur among a 
small subgroup of clinicians when cancers were described as particularly small in size . More ohen 
patients perceived a preference, based on the way information was portrayed, as although they 
we most often given information on both treatment options there was a strong emphas is on 
things like a small cancer size and safety of B(T, and occasionally mastectomy was described as a 
more extensive option than that required . 
... 1 think he would have preferred me to have the lump removed . He said it was a very big 
operation having a full mastectomy, ... 1 got the impression he thought 1 didn't need to 
have the whole mastectomy ... [Patient l, mastectomy, age 42, medium MR unit, P4] 
TABLE 6.6 Information content and style sub-themes 
• Options 
• Treatment details 
• Potential consequences 
• Comparison of treatments 
• Time for decision-making 
Contextual ising information 
• 
• 
Framing of involvement in decision-making 
Framing of the options: Open/d irect ive/d ism issive 
Emphasis and minimisation 
• Cancer size 
• Implication of 'early cancer' 
• Mastectomy as more a more extreme option 
Accessibility 
• Language & terminology: Everyday language vs. bio-medical 
• Consultation style: Two way dialogue vs. prescriptive; tailored vs. universa l 
Recommendations 
• Provided or not 
• Overt vs. perceived 
• Volunteered vs. provided on request 
• Timing of recommendation : Early vs. delayed 
Time and process of decision-making 
The decision-making experiences of pat ients from the breast unit s varied fair ly cons istentl y 
according t o t he breast un it they we re treated by . The process was genera lly more rap id in the 
low MR unit and patients fairly consistently reported pressure to make a decision immed iately . 
This was reinforced by all but one consultant from the low MR unit consenting patients on the day 
of diagnosis, immediately after their initial discussion about their diagnosis and treatment. 
I found it a very hard decision [I]. .. couldn't decide at all. .. I'd got to decide there and then 
w~e~her . 1 had a mastectomy or a lumpectomy ... so I decided on the lumpectomy and 
within minutes all the paperwork was there. [Patient 51, BeT, age 51 low MR unit, P7] 
It had to be a fairly quick decision; I wasn't allowed to go away and think about it . I could 
go back the next week, ... and say 'I want to change my mind' if I want to. [Patient 46, 
BeT, age 59, low MR unit, pIS] 
Among this group, many recalled being told if they signed their consent form at this stage, they 
could 'rip up the consent form and sign another one' if they changed their mind before their 
surgery. 
I was told all the way through that that could be ... ripped up half an hour before the 
operation . [Patient 62, BeT, age 44, low MR unit, Pll-l2] 
In practice, a signed consent however sometimes seemed to be a barrier to further discussion or a 
subsequent alteration in decision, for a small minority who were uncertain about the treatment 
they had initially chosen and wanted to do re-discuss or alter their decision . 
At this point [one day before surgery] it might not be a good idea to change your mind . 
[Patient 57, BeT, age 44, low MR unit, pll] 
50 after thinking long and hard .. . 1 rang up the breast care nurses the week before my 
operation was due, and I made an appointment to go and speak to Mr_ ... to talk through 
with him ... because I'd decided by then I wanted the whole thing off .. . .so I went to see 
him .. . and I felt I was talked out of the mastectomy ... there was no discussion really on 
having my whole breast off ... And every time I brought up the subject.. . I felt that, because 
Mr - didn't want to do it ... he wasn't really listening to what I was saying . ...1 feel that 
I. .. went with what he said, rather than what [I wanted] 'cos I'd gone in there to tell him I 
wanted a mastectomy and to rip up the consent form and sign anothe r one .... and even 
when I came out I still wasn't 100 one hundred per cent that I'd done the right thing . 
[Patient 62, BeT, age 44, low MR unit, pll-12] 
In contrast, the medium and high MR unit's patients found the process of decision-mak ing less 
rushed. They were almost universally provided with clear information early in the consultation 
about the date of their surgery and were told they had until then to make a decision . Pat ie nts 
who expressed an immediate preference for a specific option were often encouraged to spend 
time considering the options to ensure they were making the right choice for them . The amount 
of time patients had for exploring information and going through the dec ision-ma ki ng proce ss, 
affected how prepared they felt for the task. Most felt they were given a sufficient and realist ic 
timeframe and this knowledge provided a sense of security and reassurance that more 
autonomous decision-making was achievable. 
I was thinking from one to the other ... thinking \\My God, what a decision .. . " but knowing 
I'd got this fortnight ... and being told two or three times I didn't have to make a decision 
there and then, I could leave it right 'til the morning of the operation ... helped . So I didn't 
panic. [Patient 3:1., mastectomy, age 64, high MR unit, p8] 
When patients were given choices and were either only given a short time for decision-making or 
not given clear information on how much time was potentially available for the process, they 
tended to feel making a choice was unachievable. They often felt overwhelmed and 
underprepared for such a task, and were more likely to ask the opinion of their clinicians. 
I found it a very hard decision ... just couldn't decide, couldn't decide at all. .. I'd got to 
decide there and then. [Patient 5:1., BCT, age 5:1., low MR unit, P7] 
Given only 24 hours to decide: \\[It was] like ... dropping you out of an airplane with no 
parachute." [Patient 38, BCT, age 57, high MR unit, P:1.7] 
Patients often expressed they needed to spend time away from the clinical environment 
following their diagnosis, to recover from shock of diagnosis before they could meaningfully 
engage in decision-making. 
All that information ... gets crammed in your head and you have everything just swinging 
round and ... you're awash with it until you can come home and then you've got that time 
to relax and chill and just let your mind unwind and then think about everything that's 
been said. [Patient 48, BCT, age 38,Iow MR unit, P33] 
I bet it was a good ten days before I actually calmed down and just thought, qu ite 
calmly ... this is what I'm going to do . [Patient 42, BCT, age 60, high MR unit, P:1.5] 
Patient autonomy in decision-making 
A surprisingly large proport ion of women had a preconception that they would be told wh at their 
treatment plan would be, and expressed surprise when offered choice of treatment. 
Giving me this option ... without giving me any advice as to which one he thought would 
be good ... came as a real shock, I wasn't expecting it. [Patient 33, BCT, age 57, high MR 
unit, P4] 
All my life if I've needed to go to a doctor, I've followed instructions: "Ta ke these tablets" 
or \\00 nothing" and whatever I've been advised I've always followed those direct ions. 
[Patient 57, BCT, age 44, low MR unit, P4-5] 
Breast units had a substantial impact on the level of autonomy patients desired and were wi lli ng 
to assume in the selection of their treatment. This impacted on the extent to which women's 
decisions were clinician-opinion or patient choice-based. When patients received an explanation 
about why a choice was offered, most wanted to participate in making a treatment choice. 
I think it's nice that you do have the choice . ... better than somebody just saying to you, 
"Right, we're going to do this," or "We're going to do that.. .1 think it's important.. . 
[Patient 37, BCT, age 67, high MR unit, p21] 
The level of autonomy patients felt it was possible for them to achieve in decision-making was 
influenced by the gap they perceived between their knowledge and experience, and that of the ir 
clinicians. It was also influenced by whether patients felt this gap could be narrowed or bridged . 
Feeling positive about participating in decision-making was more often expressed among those 
experiencing a more patient-centred consultation approach (especially by their consultant 
surgeons), and when patients described the provision of clear, understandable, tailored 
information and the opportunity to express and explore their needs, concerns and preferences. 
The amount of time patients believed they had for decision-making also exerted an effect. The 
availability of time and this approach often allowed patients feel they had suffic ient knowledge 
and confidence to participate more autonomously in deCiSion -making. 
Patients also described benefitting from receiving an individualised description and diagram of 
their cancer's characteristics and a synopsis of pertinent treatment option information by their 
clinicians. If provided, such tools were utilised by patients as a method to simulate their recall of 
the consultation discussion during the decision-making process. 
She drew diagrams to show me, she'd also got the callipers to show me how big the 
tumour was . She explained extremely well, quite a lot of detail and in simple terms which 
were quite easily understood ... She then gave me options as to t reatment .... we spent 
quite a bit of time with [the BCN] .. . and she was explaining all sorts of things ... and asked 
us if we had any questions to ask .. .. nothing that we didn't already understand I don 't 
think. It's hard to take in all at once ... (Patient 36, age 57, high MR unit, BCTpS-6) 
Most patients needed support and encouragement of their clinicians to more comfortably engage 
in more autonomous decision-making . This assisted in the acquisition of the knowledge 
necessary for decision-making and provided the confidence to undertake this role in an unfamiliar 
but supportive environment. 
I felt a little bit .. . alone ... Not qualified ... to be making this decision myself ·t I·k 
• •• • 1 was 1 e 
stepping out into the unknown ... it was a big thing to take on . .. . But I was aware that 
everybody was there to help me. Everybody was on my side . [Patient 31. mastectomy 
age 64, medium MR unit, P7-S] " 
When such a consultation approach was not adopted, many patients could feel there was such a 
gap in experience, knowledge and power between themselves and their clinicians, that the expert 
was the only person who could assume control of decision-making . 
They were the people who had the knowledge, the information, the sk ill. It was my 
body ... and ... 1 really didn't know what was best for me, so whatever they led me to bel ieve 
would be best, that's what I would go along with . [Patient lS, BeT, age 62, med ium MR 
unit, P30] 
The discrepancies in the power patients perceived between themselves and their cl inicians were 
often more pronounced among the low MR breast unit patients, and were reinforced or 
moderated by clinicians' information provision and consultation skills. 
[The consultant's] not intimidating in that way .. . but you do feel as though you're sl ightly 
walking on eggshells .... the trouble is you're in a very, very vulnerable position ... there are 
some questions you wouldn't ask because you don't want to upset people, because you 
feel they're in charge of your life. [Patient 49, Mastectomy, age 59, low MR unit, P17-18] 
... we were on the same wavelength ... always working together for my benefit. I didn't 
have to think, "Well he knows better than I do so I'll go with what he says, " .. . there was 
never any confrontation, never any 'Well I'm not quite sure, but he must know best ... 
[Patient 1.2, BeT, age 69, medium MR unit, p20] 
Doctors seemed to have the capacity to exert the more disempowering influence within the 
situation and relationship, and the presence of a BeN within a consultation sometimes seemed to 
encourage greater patient involvement in the discussion of options and decision-maki ng . 
Because there was two doctors in the room and I didn't have a [Breast Care] nurse in with 
me .. . when I had a breast care nurse with me before, we were all involved in t he 
conversation so I felt I had my support with me ... 1 just felt a little bit, not intimidated, 
because he's not an intimidating man, I just .. [Pat ient 62, BeT, age 44, low MR un it, pu-
1.2] 
There was variability among patients' descriptions of the ir decision maki ng con siderations and 
the speed of their decision making journeys. Within all units, some made swift decisions based on 
specific strong preferences. However, the differences in information provi sion and consu lt ation 
approach often meant that patients of the low MR unit seemed to experience sim pler and more 
rapid decision-making than patients from the other units . They described the tenden cy of 
clinicians to provide a treatment plan or heavily direct their decision. In contrast, dec ision -m aking 
at the medium and high MR units tended to be more complex, with pat ients often descri bing 
periods of reflection and deliberation . Although some patients of the medium and high MR units 
found the decision-making experience more challenging, on reflection these pat ients ofte n 
expressed feeling proud of the achievement, often expressed their ownersh ip of the dec ision, and 
confidence in the treatment chosen . 
CONCLUSION 
This component of the study provides new information on the interface between clinic ians and 
patients; exploring the clinical consultation and decision-making experiences from the 
perspective of women with breast cancer who are suitable for BCT. The findings may explain the 
reasons why continued variation in MRs is observed . It demonstrates both overt and more subtle 
influences of clinicians over decisions. 
While decisions were influenced by patient-specific themes, breast clinicians exerted a substantial 
influence. Patients described differences in their experiences of decision making related to the 
treatment options offered and how this was communicated (information content and style; 
equipoise to directed) . They described differences in the level of autonomy they were provided 
and the decision support given, along with differences in the t ime allocated for decision-making . 
Among the breast units studied, low MR unit patients tended to describe the provision of less 
comprehensive, more directive information by their clinicians, less autonomy and less t ime fo r 
decision-making . They also described the earlier consolidation of decision making by consenting 
(at diagnosis or a week later). Conversely, high and medium MR units' patients tended to 
describe receiving more comprehensive less directive information, alongside greater support and 
time for decision-making. They also often described a more complex consideration of t he options 
and treatment facts in the context of their preferences; more cons istent info rmed autonomous 
decision-making. The themes associated with differences in breast un it MRs are summarised in 
table 6·7. 
This study adds to information available from others publ ished since the onset of this programme 
of research, increasing the descript ion of the interface bet ween clinicians and pat ients . Providing 
information on what is being communicated, how much actual choice pat ients are be ing given 
and what is influencing patient decisions. The evidence from this study and others demonstrate 
that although patients want to play increasingly autonomous roles in chOOS ing the ir 
treatment, (Beaver, luker, Owens, lelnster, Degner, & Sloan 1996;Bilodeau & Degner 1996,Janz, 
Wren, Copeland, lowe ry, Goldfarb, & Wilkins 2004; Lam, Fielding, Chan, Chow, & Ho 2oo3,Lantz, 
Janz, Fagerlin, Schwartz, li u, l akhani, Salem, & Katz 200s,Luker, Beaver, Lelnster, & Owens 
1996b;Mastaglia & Kristjanson 2001iSingh, Sloan, Atherton, Smith, Hack, Huschka, Rummans, 
Cla rk, Diekmann, & Degner 2010) there is' continued acquiescence to ciinicians .(Gort, Broekhuls, 
Otter, & Kl azi nga 2007i Joh nson, Roberts, Cox, Reintgen, Levine, & Parsons 1996,Katz, Lantz, & 
Zemencuk 2001;Kotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996iMoienaar, Oort, 
Sprangers, Rutgers, luiten, Mulder, & de Haes 2004iMorrow, Jagsi, Alderman, Grtggs, Hawley, 
Hamilton, Graff, & Katz 2009;Nold, Beamer, Helmer, & McBoyle 2000,Schou, Ekeberg, Ruland, & 
Karesen 2002;Smitt & Helt zel 1997) As mortality rates among this patient group falls (64% 20 
year survival now, compared with 44% diagnosed in the early 1990s), (Blamey, ElliS, Pinder, Lee, 
Macmillan, Morgan, Robertson, Mitchell, Ball, Hayblttle, & Elston 2007;Coleman, Babb, Damleckl, 
Grosclaude, Honjo, Jones, Knerer, Pltard, QUinn, Sloggett, & De Stavola 1999, Coleman, Rachet, 
Woods, Mitry, Riga, Cooper, Quinn, Brenner, & Esteve 2004, Hack, Degner, Watson, & Sinha 
2006;Mandelblatt, Edge, Meropol, Senie, Tsangans, Grey, Peterson, Jr., Hwang, Kerner, & Weeks 
2003;Office of National StatistiCS 200s;Rachet, Martnge, Nur, Quaresma, Shah, Woods, ElliS, 
Walters, Forman, Steward, & Coleman 2oo9;Street, Jr & VOigt 1997) patients experiencing a 
positive decision making experience and undergoing a t reatment that is right for them, becomes 
increasingly important in seeking to optimise Qol and psychological morbidity in 
survivorship. (Andersen, Bowen, Morea, Stein, & Baker 2oo9,Deadman, Lelnster, Owens, Dewey, 
& Slade 2001; Fallowfleld, Hall, Maguire, Baum, & A'Hern 1994a,Faliowfield, Hall, Maguire, & 
Baum 1990;Fallowfield, Hall, Maguire, Baum, & A'Hern 1994b,Hack, Degner, Watson, & Sinha 
2006;Kotwa ll, Maxwell, Covington, Churchill, Smith, & Covan 1996,Molenaar, Oort, Sprangers, 
Rutgers, LUlten, Mulder, & de Haes 2004;Morris & Ingham 1988,Morrls & Royle 1987,Moye r 
1997, Moyer & Salovey 1998,Schou, Ekeberg, Ruland, & Karesen 2002,Stewart 1995,Street, Jr & 
VOigt 1997;Wilson, Hart, & Dawes 1988, Wolberg 1990) 
The findings suggest that if the focus rema ins on involving patients in medical dec isions, clinicians 
must be encouraged to adopt a more open, ta ilored, informing and empowering approach In 
consultations, if any but the most active of dec ision -makers are to truly choose their treatment . 
TABLE 6.7 Summary of themes associated with breast unit treatment variation . 
~= .i;': ~ ~ , .. .., II ;Il.imu.'ll", l~.umi.-';;:·':"~~ J!': ""; 
Less comprehensive information More comprehensive information I 
1 
Active direction of choice: Reluctance to direct choice : 
• More directive information • Less directive information 
• More volunteering of opinion • Less volunteering of clinician opinion 
Less active support of autonomous patient Active support of autonomous patient 
decision-making decision-making 
-
Time pressure for decision-making Lack of t ime pressure for decision-making 
• Process factors • Process factors 
• Consent early: At diagnosis or one • Consent later: At pre-assessment 
week after diagnosis clinic or pre-operatively 
--
Chapter 7 
An emergent theme 
Women's views and experiences of choosing their breast 
cancer surgery 
ABSTRACT 
Background: Patients' participation in decision-making is a fie ld of increasing interest, as health 
services become focused on the provision of patient choice . Th is chapter explo res pat ients ' views 
and experiences of choosing their initial therapeut ic t reatment of primary breast cancer. 
Methods: Semi-structured interviews were conducted with 65 patients as part of a study 
exploring variation in treatment rates among three specialist breast units of a UK reg ion . All were 
identified by their clinicians as those offered a choice of therapeutic surgery fo r breast ca ncer. 
Interviews were transcribed verbatim and analysed using the Framework Approach . 
Results: Patients' reactions to their involvement in treatment dec ision-maki ng emerged as a key 
theme within the main study. Three sub-themes defined the theme; init ial responses, late r 
responses, and influence over responses. Many patients initially assumed they would be provided 
a specific treatment plan . Individual preferences and patients' perceptions following interact ions 
with their clinicians, were key in shaping patients' responses and adaptation to treatment cho ice; 
specifically through the way information and decision-maki ng were present ed, encouraged and 
supported, and the time patients were given for the task . 
Conclusions: Clinicians should be aware of pat ients' reactions to part icipation in t re atment 
decisions. This chapter increases our understanding of how cl inicians can influence pati ents' 
expectations and responses to treatment decision-makin g. These fi nd ings may be relevant to 
other healthcare contexts. 
BACKGROUND 
There is increasing interest in patients' part icipat ion in healthcare decisions, and it is wi dely 
assumed patients want increasing autonomy in these . The evi dence t hat patients with cancer 
want to be well informed is irrefutable, (Bliodeau & Degner 1996,Blanchard, Labrecque, 
Ruckdeschel, & Blanchard 1988jButow, Kazeml, Beeney, Gri ffi n, Dunn, & Tattersall 
1996jCassileth, Zupkis, Sutton -Smith, & March 198ojChen, Ta o, Tlsnado, Malin, ko, Timmer, 
Adams, Ganz, & Kahn 2008jDavison, Degner, & Morgan 1995,Degner, KristJanson, Bowman, 
Sloan, Carriere, O'Neil, Bilodeau, Watson, & Mue ller 1997aj FuJ Imon & Uch ltoml 2oo9,Gaiioway, 
Graydon, Harrison, Evans-Boyden, Palmer-Wickham, Burleln -Hall , Ri ch-van der BIJ , West , & Blal! 
1997jGraydon, Galloway, Palmer-Wickham, Hamson, Rich -van der BIJ, West , Burleln -Hall, & 
Evans-Boyden 1997j Hack, Degner, & Dyck 1994,Jenklns, Fallowfield, & Saul 2001, Jones, Pearson, 
McGregor, Gilmour, Atkinson, Barrett, Cawsey, & McEwen 1999,Luker, Beaver, Lelnst er, & 
Owens1996aiMeredith, Symonds, Webster, Lamont, Pyper, GilliS, & Fall owf le ld 1996,Sut herland, 
Llewellyn-Thomas, Lockwood, Tritchler, & Till 1989;Vogel, Bengel, & Helmes 2008a) but t his does 
not necessarily correlate with possessing an active PDMS.(B lanchard, Labrecque, Ruckdesche l, & 
Blanchard 1988iCassileth, ZUpklS, Sutton -Smit h, & March 1980,Cox, JenkinS, Catt, Langridge, & 
Fallowfield 2005jDavison, Degner, & Morgan 1995i Ende, Kazis, Ash, & MoskOWitz 
1989iFaliowfieid 2008jHack, Degner, & Dyck 1994,St rull, Lo, & Char les 1984,Suther land, 
Llewellyn-Thom as, Lockwood, Trlt ch ler, & Till 1989) Some adopt informat ion acquisition as a 
coping strategy. (B lanchard, Labrecq ue, Ruckd eschel, & Blanchard 1988,Cassileth, Zupkls, Sutton 
Smith, & March 198oiDegner, Kristjanson, Bowman, Sloan, Carriere, 0 Neil, Bilodeau, Watson, & 
Mueller 1997ajHack, Degner, & Dyck 1994i Mdle r, Brody, & Summerton 1988) However, there is 
gathering evidence of a shift in patient PDMS toward t he more act ive end of the 
spectrum. (Beaver, Luker, Owens, Lelnster, Degner, & Sloan 199b,Bilodeau & Degner 199b,Janz, 
Wren, Copeland, Lowe ry, Goldfa rb, & Wil k inS 2004,Lam, Fie lding, Chan, Chow, & Ho 2oo3,Lantz, 
Janz, Fagerlin, Schwartz, Liu, Lakhani, Sa lem, & Katz 2005, Luker, Beaver, Leln ster, & Owen s 
1996bj Mastagiia & Kristjanson 2001,Slngh, Sloan, Atherton, Smith, Hack, Husc hka, Rumman s, 
Clark, Diekmann, & Degner 2010) The eviden ce po ints to the beneficial impact of more 
autonomous decision making on patient sat isfact ion, regret and psychological recovery. Br uera, 
Willey, Palm er, & Rosa les 2002iDegner, KrIStJanson, Bowman, Sloan, Carl ere, ()"Ne ll, Bilodeau, 
W at son, & M uell er 1997a,Hack, Degner, Watson, & Sin ha 2006,Ja'lz, Wen, ( opeland, lOWt)r y , 
Go ldfarb, & WilkinS 2oo4,Keatlng, Guadagnol " La ndrum, Borbdc" E'E'k) 1 )02 La 1, ~ Id nq 
Chan, Chow, & Ho 2oo3,Lantz, Janz, Fagerlln, ~c hwalt z, Llu, l akf'dr1l, Salern, 
200SiMastagiia & Kristjanson 2001iSingh, Sloan, Atherton, Smith, Hack, Husch ka, Rummans, 
Clark, Diekmann, & Degner 2010) But separating the contributions of good 
communication/information provision and participation in decision maki ng toward t he posit ive 
effect are difficult. Fallowfield proposed optimal communication/information was the enhancing 
factor. (Fa llowfie ld 1997) However evidence from a prospective mixed methods study by 
Deadman et al. investigating the psychological effects of breast cancer treatment among women 
(n=J.14) suggest the decisional role itself provides the enhancing impact.(Deadman, Lelnster, 
Owens, Dewey, & Slade 2001) Hack demonstrated similar findings .(Hack, Degner. Watson, & 
Sinha 2006) There remains limited understanding of what patients feel about engag ing in 
decision making, and what can enhance or deteriorate their experiences . 
Providing patients with choices has become a recognised priority, (Assoclation of Breast Surgery 
at BASO 2009iBlichert-Toft, Smola, Cat aliottl, & O'higg ins 1998,Department of Health 
2001aiDepartment of Hea lt h 2001ci Department of Hea lth 2oo9,Genera i Medica l Council 
2008iKaufmann, Morrow, von, & Harris 2010i Nationai Co ll abora ting Centre for Ca nce r 
2009i Nattinger, Hoffm an, Shap iro, Gottlieb, & GoodWin 1996,Nayf leld, Bongiovanni, Alelat l, 
Fischer, & Bergner 1994iRoyai College Of Surgeons Of Eng land 2002,Scarth, Cantin, & Levine 
2002a;Scarth, Cantin, & Levine 2002b) as the two main surgical options for cancers under scm 
diameter demonstrate equivalent survival (Bllchert -Toft, Bnncker, And ersen, Ande rsen, Axelsson, 
Mouridsen, Dombernowsky, Ove rgaard, Gadeberg, Knudsen, & 1988,Clarke, Collins, Darby, 
Davies, Elph instone, Evans, GodWin, Gray, Hicks, James, MacKinnon, McGale, McHugh, Peto, 
Taylor, & Wang 200Si Fisher, Anderson, Bryant, Margolese, Deut sch, Fisher, Jeong, & Wo lmark 
2002iJacobson, Danforth, Cowan, d'Angelo, St einberg, Pierce, Lippman, Lichter, Gla tst eln, & 
Okunieff 1995iLicht er, Lippman, Danforth, Jr., d'Angelo, Steinberg, deMoss, MacDonald, 
Reichert, Merino, Swain, & 1992,PoggI, Danforth, SCiuto, Smith, Steinberg, Llewehr, Menard, 
Lippman, Lichter, & Altemus 2oo3iSarrazin, Le, Amagada, Contesso, Fontaine, Spielmann, 
Rochard, Le, & Lacour 1989, van Dongen, Voogd, Fent lman, Legrand, Sylvester, Tong, van der, 
Helle, va n ZIJI, & Bartellnk 2000, Veronesl, Casclnelll, Mariani , Greco, Saccozzl , LUIll I, Aguil r, & 
Marubtnl 2002) and morbiditYi (Carlsson & Hamrin 1994,Dorval, Maunsell, Deschenes, & Bw,son 
1998,Fa ll owfield, Baum, & Mag Ui re 1986,Ganz, Desmond, Leedham, Row land, Meye roN 'tz, & 
Belin 200 2,I rwig & Bennetts 1997,McCready, Hollowav, Shelley, Down, Robinson, Sincla ir, 8.-
Mirsky 2ooS,Moyer 1997;Sanger & Reznlkoff 1981,Schatn, fd ,'3 rr1s Gor rpl, de M oc,,:>, L ,PPrl dn, 
Gerber, & Lichter 1983,Stefanek 1993) w ith the except ion of body image( Ind t , teqn 1dl t>F 
Z iegler, & Brenner 2008,Carlsson & Hamnn 1994,Fallow fteld, Bau'11, &- Ma lJl'e 1)8 ~ II"" j 
Bennetts 1997i Moyer 1997iSanger & Rezn ikoff 1981,Schover 1994,Stefanek 1993 ' and 
recurrence .(Clarke, Collins, Darby, Davies, Elphlnstone, Evans, Godwin, Gray, Hicks, James, 
MacKinnon, McGale, McHugh, Peto, Taylor, & Wang 2oos,Early Breast Cancer Tna llst s' 
Collaborative Group 2002;Jato l & Prosch an 2oo5jvan Dongen, Voogd, Fentlman, Legrand, 
Sylvester, Tong, van der, Helle, van Zijl, & Barte lin k 2000, Veronesl, Casclnelll, Mariani, Greco, 
Saccozzi, Luini, Aguilar, & Marubini 2002) Also patients wit h breast cancer are known t o possess 
varying attitudes to these treatments and place different sign ificance on factors which might 
differentiate between the two in patient decision making. (Carver, Pozo-Kaderman, Price, 
Noriega, Harris, Derhagopian, Robinson, & Moffat, Jr, 1998,Colilns, Moore, Clay, kearlng, 
O'Connor, Llewellyn-Thomas, Barth, Jr., & Sepucha 2oo9, Fa liowfle ld, Ba um, & Maguire 
1986iHawley, Griggs, Hamilton, Graff, Janz, Morrow, Jagsi, Salem, & Katz 2oo9,Hughes 
1993iKotwall, Maxwell, Covington, Churchill, Smith, & Covan 1996,Lasry & Margolese 
1992iMandeibiatt, Hadley, Kerner, Schulman, Go ld, Dunmore-Gri ffit h, Edge, Guadagno ll , Lynch, 
Meropol, Weeks, & Winn 2000i Molenaar, Oort, Sprangers, Rut gers, LU lten, Mulder, & de Haes 
2004i Moyer 1997i Nold, Beamer, He lmer, & McBoy le 2000,Schou, Ekeberg, Ru land, & Karesen 
2002i Smitt & Heltzel 1997i Wei, Sherry, Ba isden, Peckel, & Lala 1995, Wi/son, Hart, & Dawes 1988) 
However it is also recognised that patients possess different preferences fo r being involved in 
decision making. (Beaver, Luker, Owens, Lelnster, Degner, & Sloan 1996,But ow, Mac lean, Dunn, 
Tattersall, & Boyer 1997iDeber, Kraetschmer, & Irvine 1996,Deber, Kraetschmer, Urowltz, & 
Sharpe 2007jDegner & Sloan 1992jGiordano, Mattarozzl, PUCCI, Leone, CaSlnl, Coilimedag lla, & 
Solari 2008i Levinson, Kao, Kuby, & Th ist ed 2005jO'Donne il & Hunskaar 2oo7a,O'Donne il & 
Hunskaar 2007bi Rothenbacher, Lutz, & Porzsolt 1997) Not all want to play an active role in 
choosing their treatment. This chapter explores a strong emergent t hemej pat ient s' react ions t o 
being involved in choosing their treatment, and the facto rs influencing these , The theme arose 
from the patient interviews conducted among women wit h breast cancer, as part of the research 
study exploring surgical treatment variation , All pat ients were identified by t heir clinicians as 
having been offered a choice of su rgery (BCT and mastectomy). 
Breast cancer surg ica l dec ision making is an idea l context in which to explore pat ients ' 
experiences of healthcare decision-making for the reasons outlined above, It is also likely t o 
become increasingly complex, as the range of pot ential treatment options and proport ion of 
patients elig ible for treatment choices increases with the advent and wider adoption of newer 
treatments such as neo-adjuvant chemotherapy to down-size cancers extending the scope of 
BCT, and the more routine incorporation of oncoplastic surgical techniques . 
METHODS 
The study design, setting and sample and data analysis are presented in chapter 6 
FINDINGS 
Patients' subjective views, feelings and experiences of being involved in choos ing the ir t reatment 
emerged as a prominent theme from the patient interviews. Three sub-themes encapsulate the 
theme: initial responses to involvement in decision-makingj later responseSj and influences over 
patients' responses to being given a choice of treatment. These subthemes and factors are 
summarised below and in tables 7.1 and 7.2 . 
INITIAL RESPONSES TO INVOLVEMENT IN DECISION-MAKING 
Patients described a range of initial responses to the inv itation to part icipate In treatm ent 
decisionsj which are defined by six factorsj expected involvement, unexpected involvement, 
overwhelmed by the need to make a decision, acceptance of dec ision-maki ng role, acceptance of 
clinician's recommendation and decision making role unwelcome . Table 7.1 summa rises these . 
Expected involvement 
At diagnosis, a small number of patients had antic ipated be ing involved in treatment decis ion -
making. Those who did often expressed the opinion that they sh ould be provided with suc h an 
opportunity. 
I have the right to choose what happens to me. [Patient 42, BeT, age 60, high MR unit, 
p18] 
Unexpected involvement 
The majority however, assumed that they would be given a clear treatment plan by their 
specialist clinicians, rather than offered a choice. 
Giving me this option ... without giving me any advice as to which one he thought wou ld 
be good ... it came as a real shock, I wasn't expecting it. [Patient 33, BeT, high MR unit, 
age 57, P4] 
Overwhelmed by the need to make a decision 
Patients often described feeling initially 'shocked' on receiving confirmation of their potentially 
life threatening disease, and some felt this impeded their capacity to absorb information provided 
within their consultations. When invited to select their own treatment at this specific t ime po int, 
a number ofthis group felt overwhelmed . 
1 got a mental shutdown ... swamped. [Patient 48, BeT, age 38, low MR unit, p6] 
This was particularly marked among those whose diagnosis was unexpected . 
You're sitting there and the doctor's talking to you, you don't take it all in . Most of it goes 
straight over your head, and you come out afterwards th inking, 'What did he say)' ... 1 
think all I heard at the time was cancer ... that was the only thing that sunk in . [Patient 16, 
mastectomy, age 73, medium MR unit, P7] 
The acuteness of their diagnosis, awareness of their lack of knowledge, and the synchronous 
provision of seemingly large volumes of information on both diagnos is and treatment could 
exacerbate this perception . 
. . . 1 didn't want to be overloaded with too much information ... didn't want to know about 
everything all in one go, ... that was just too much. [Patient 41 , BeT, age 4 2 , high MR unit, 
p6]. 
This could result in patients hav ing difficulty env isag ing their assumption of a decis ion -making 
role and feeling overwhelmed at the prospect; especially init ially . 
They were the peopl~ who had the knowledge, the information, t he skill . It was my 
body ... & ... 1 really dldn t know what was best for me. [Patient 18 BeT 6 d' 
MR ' ] , , age 2, me lum unit, P30 
This group sometimes felt isolated and fearful. 
It was unknown territory, and I don't like being on unknown territory, I like to be in 
control, and I wasn't going to be control, and what was more I'd got to ma ke this decision 
for myself . ... 1 felt .. . 1 was alone .. . not qualified ... it was like stepp ing out into the unknown 
because you're here with this disease, and you don't know which way it's gonna go unt il 
after t~e surgery ... it was a big thing to take on ... [Patient 31, mastectomy, age 64, high 
MR unit, P7-8] 
Acceptance 
Some patients immediately accepted a more autonomous role in decision -making . 
... it surprised me that I'd got to choose ... 1 don't like having to choose ... but ... when he told 
me I didn't find it difficult. [Patient 39, BeT, age 71, high MR unit, p26- 27] 
This group often anticipated participating in the selection of their treatment, and tended to 
describe a form of uncomplicated and instinctive decision-making upon presentation of the 
available options. Decisions among this group were inclined to be based on either pre -existing 
information or strong treatment preferences, and were therefore often swift; occurring 
immediately or within a few days. 
From when he fi rst told me that he was suspicious, I'd al ready made my mind up that, if I 
was offered the lump [Ben or the full mastectomy, it would be the whole ... 1 could never 
have ... had as much peace of mind if I'd just had the lump removed . [Patie nt I, 
mastectomy, age 42, medium MR unit, P4-S] 
Many of these did so recognising the personal nature of such a decision and the importance of the 
individual patients' preferences in this particular context. 
It's nice that you do have the choice ... better than somebody j ust sayin g to you, "Right, 
we're going to do this," or "We're going to do that ... 1 th ink it's important .. ... it 's a very 
personal decision, isn't it . [Patient 37, BeT, age 67, high MR unit, P23] 
Although many described accepting this role in dec ision-making, this cou ld co-exi st w ith a degree 
of anxiety. Such anxiety chiefly arose f rom difficult y concept ua l is ing the ir ro le in decision-
making; patients often felt lacki ng in knowledge (especiall y init iall y), and t he t iming of making 
such a maJ'or decision around the time of thel'r d 'a . Id b I gnosls cou exacer ate the ir sense of 
vulnerability. 
I've found [decision-making] .... really hard . It was nice to have the cho ice but not 
knowing much about it and wondering which one will be the best for me .. . [Pat ient 41 , 
BeT, age 42, P9,l1] 
This was especially evident among those for whom the role or diagnosis was unexpected. 
Acceptance of clinician's recommendation 
Another group who experienced an uncomplicated decision-making process articulated thei r 
acceptance of the clinicians' clear and specific treatment recommendations or treatment plan . 
Some described an element of participation in the process, while others did not . 
[They] gave me the information I needed ... and advised, which you expect a doctor ... to 
do, but I never felt as if I was told what to do . I always felt I had that choice. [Patient 42, 
BeT, age 59, high MR unit, P29] 
He didn't actually say, 'Which would you prefer?' But .. . he 's the professional. .. and 
he ... was the second person who'd said what the course of action would be ... so I was quite 
happy to take his word, I mean you 've got to trust in them, haven 't you? [Patient 63, BeT, 
age 59, low MR unit, p8] 
Decision making role unwelcome 
A minority understood they could choose their treatment, but it was an unwanted role . This 
group wanted their clinicians to issue them with a treatment plan or di rect them towards a 
specific treatment the clinician felt was best, rather than involve them in the decision-ma king 
process. 
I didn't want any choice ... 1 just wanted them to tell me what was th e right t h ing for me . 
.. . whatever they led me to believe would be best, that 's what I wo uld go a long With. 
[Patient 18, BeT, age 62, medium MR unit, P3 0 ] 
LATER RESPONSES TO INVOLVEMENT IN DECISION-MAKING 
For many patients, their responses to involvement in decision making changed over t im e. Th ese 
often seemed adaptive; occurring as a consequence of patients' recovery from the initial shoc k of 
their diagnosis, the acquisition of knowledge, and the provi sion of reassurance and decis ion 
support by their clinicians. A range of later responses were described, which are categorised by 
four factors; positive adjustment to the decision-making role, reluctance to accept the decis ion-
making role, desire for greater participation in the decision-making process, why choices are 
offered. Table 7.1. summarises these . 
Positive adjustment to the decision-making role 
By the time of interview most patients exhibited a good understanding of the informat ion on 
which to base an informed decision, and while a lack of confidence or a reluctance to participate 
in decision-making could persist, this was not the case for the majority. Patients could find the 
experience of decision-making challenging, but most adjusted . 
I kept thinking I've got this decision to make and I can't do it . But ... we did it [patient and 
husband] and we made the right decision . [Patient 37, BeT, age 67, high MR unit, P1.4] 
For some undertaking this role became empowering; they expressed the view that the 
opportunity had helped to restore a sense of control, and ameliorated the feelings of power loss 
experienced at diagnosis. 
The most important thing ... was that I had got the choice .. .. 1 think more women'd 
perhaps .. . feel a bit better able to cope if they realised that the re was more of a choice . 
[Patient 24, BCT, age 43, high MR unit, P23] 
Some experienced an ampl ified sense of ach ievement born from the challenge they exper ienced 
coming to a dec ision . 
I've changed my mind as things have progressed . . initially 1 was angry that 1 was ~i ven a 
choice, I felt let down by the service, I thought they should make th e cho ice, they re the 
experts. But now I'm glad that I had the choice ." \\1 wanted to be In contro l of something . 
1 felt that everything was spinn ing out of my control. [Patient 25, mastectomy, age 60, 
high MR unit, P27-28 and p1.6] 
I d 't " t that the ro le confirmed the impo rta nce of their own opinion, and They a so expresse POSI IVI Y 
permitted them to unde rgo a treatment wh ich felt right for them as an individual. 
I'm glad tha~ I had the choice, because I've made the choice and I've got to live w ith it . 
And I am qUite sure that I made the right choice ... for me . [Patient 25 mastectom a e 
60, high MR unit, p28] , y, g 
Reluctance to accept the decision-making role 
By the time of interview only a small minority of patients expressed persistent dissatisfaction with 
being asked to choose their treatment. This group often described feeling oppressed by the 
enormity of their diagnosis, or unqualified and ill-equipped to undertake the role. Some 
attributed this to an inability to either absorb the information required for decision-making, or 
evaluate the pros and cons of the options. 
I'd got all the information, it was just my head that wouldn't work it out ... my 
brain ... wouldn't make a decision ... weighing up the pros and cons. [Patient 28, BeT, age 
60, high MR unit, pl.?] 
Others feared making the wrong decision. These patients articulated being convinced that their 
expert specialist clinicians must know which treatment would be best for them . They were 
therefore adamant the clinician should determine the most appropriate treatment course. 
How can I make this decision? Th is is my life we're deciding about and I'm not qualified . 
... they're the experts ... I. .. couldn't cope with making that decision . It's so important. 
[Patient 42, BeT, age 60, high MR unit, P4-5] 
If their clinicians retained a non-directive stance, these patients expressed dissatisfaction, and 
described seeking indications of their clinicians' treatment preferences from the way information 
and options were portrayed . A very small minority of this group, felt that undertaking a role in 
choosing their treatment was a worse experience than being diagnosed with cancer . 
I think I spent the next week or ten days [after diagnosis with). .. it causing more grief and 
stress ... trying to come to terms with having to make this decision, than accept ing I'd got 
the cancer in the first place. My mind was just like a rat in a trap . Didn't know which way 
to turn, no escape, ... on the really bad days I really thought I was going mad . [Patient 42, 
BeT, age 60, high MR unit, P5] 
Desire for greater participation in the decision-making process 
Some patients however desired more autonomous dec ision-making experiences than the ir 
clinicians seemed willing to permit. 
I'd have liked them to have said ... we've found a lump, it's ma lignant, it 's a grade th ree 
which means it's fast-growing, these are your options. [Pat ient 62, B(T, age 44, low MR 
unit, p18] 
This group often expressed treatment preferences wh ich confl icted wit h t hose of t heir clinicians . 
When patients felt their clinicians failed to respect or take into consideration their preferences, 
they described a loss of trust and in some cases, frustrat ion and anger. This was particularly 
marked among those who felt their clin icians ignored both the ir treatment preference and desire 
for active participation in decision-making. 
The way he was talking .. . there was no discussion .. . 1 fee l t hat I went with what he said, 
rather than what [I wanted] ... 1 was really angry, ... 1 rea lly wished I'd have stuck to my 
guns. If I could give any doctor any feedback, it's "Listen to wh at your patient's 
saying ... you might think, well, the best thing is th is," but listen to why t hey don't want to 
go with that.. . [Patient 62, B(T, age 44, low MR un it , P9-11] 
Why choices are offered 
A very small minority doubted their cl inicians' mot ivation for involving patients in treatment 
decisions; assuming they provided the role to minimise blame or litigation should something go 
wrong . 
... my first thoughts when t hey .. . [gave] the option of the lumpectomy and the 
mastectomy .. . [were] "Qh that's because of litigation" ... These days everybo~y hasto be 
f I 'If you decide that they've po inted you in the wrong direction they re gOing to so care u .. . . 
litigate .. . 1 thought, is that why t hey're giving you a choice .. . [Patient 42, B(T, age 60, 
high MR unit, p12] 
TABLE 7.1 Patients' responses to be ing g iven a choice of treatment for breast cance r 
Expected involvement 
Anticipated choosing their treatment 
Unexpected involvement 
Anticipated would be given a treatment plan 
Overwhelmed by the need to make a decision 
Overwhelmed by diagnosis & volume of information provided 
Perceived inadequacy of knowledge/capacity for dec ision-ma king 
Acceptance of decision-making role 
• 
Early acceptance &/or a pleasant surprise 
Decisions tended to be made qu ickly 
Pre-existing preferences fo r a treatment 
Acceptance of clinician's recommendation 
Given a clear recommendation by clinic ians which ag ree with 
Options mentioned, but not perceived g iven a real cho ice by clinicia ns 
Decision making role unwelcome 
• Preference for clinician directed treatment (passive PDMS) 
• Perceived lack of knowledge to undertake t he role 
Positive adjustment to the decision -making role 
Transient sense of being overwhelmed ove rco me by clinici ans empowerment strategies 
• Varying degrees of challenge experienced 
Some experience empowerment through invo lve ment in the decision -making process 
Reluctance to accept the decision-making role 
• Perceived insufficient knowledge or expe ri ence to make a choice 
Perce ived extens ive cl inicia n-pati e nt power gap 
Persistently fearful and ill-equipped or overwhelmed 
Desire for greater participat ion in the dec ision-making process 
Perce ption of de nial of preferred role in decision-making 
I Why choices a re offered 
l Perceived as a get out clause if 'something goes wrong ' Avo idance of lit igation 
INFLUENCES OVER PATIENTS' RESPONSES TO BEING GIVEN A CHOICE OF TREATMENTS 
There were numerous influences over the way pat ients responded to be ing given a cho ice of 
These were defined by five factorsj personal factors ; clinicians' consultat ion sty le; treatment. 
exploration of information needs, treatment preferences and concerns; patients' percept ion of 
their role in decision-making; and time given for consideration . These are summarised in table 
7.2 . 
Personal factors 
Patients arrived at diagnosis either with an expectation of being provided with a treatment plan 
by the doctor (most patients) or with a sense of entitlement about choosing their treatment 
(minority). Their expectations were often associated with patient factors, in particular, prior 
knowledge and healthcare experiencesj both generally and those specific to breast cancer . 
All my life if I've needed to go to a doctor, I've followed instructions: "Take these tablets" 
or \\00 nothing" and whatever I've been advised I've always followed those directions. 
[Patient 57, BCT, age 44, low MR unit, P4-5] 
Some assigned their expectations to their age or generationj older patients being less likely to 
anticipate involvement in treatment selection . 
Maybe it's my generation, but you just think, "Well the doctors know best" ... 1 didn't 
particularly want to know worst case scenarios ... statistics .. . 1 just wanted to go and have it 
done and .. . move on from there. [Patient 43, BCT, age 6~, high MR unit, plO-n] 
This was especially relevant among a small minority for whom this was the second experience of 
finding a breast lump. 
Twenty years ago, I found a lump ... all I was told was that if it was found to be 
cancerous ... that I had to sign th is consent form and whilst I was under the operation, they 
were doing this frozen section, they would take the breast off, there and the n. That was 
the only information I was given ... . as it was it was just a benign lump ... all the 
information I was given this time is absolutely phenomenal. .. 1 just thought it was going to 
be the same procedure as then . [Patient 22, BCT, age 58, high MR unit, pl] 
Clinicians' consultation style 
Without exception the patients interviewed wanted to feel secure in the care of the ir expert 
clinicians, who had the knowledge and experience to optimally manage thei r cancer. However, 
clinicians' provision of information, consultation and communication skills also profoundly 
influenced how patients felt about being involved in decision-making . Participating in treatment 
decisions was expressed more positively among patients describing a more patient-centred 
consultation approach; where clear, understandable, tailored information was provided, along 
with the opportunity to express and explore their needs, concerns and preferences. 
He accepted the fact that I had a brain, I'd been looking at things and ... took my 
background into account ... we talked about things as a couple of adults . [Patient 6, BCT, 
age 56, medium MR unit, P7] 
Most needed support and encouragement of their clinicians to gain the confidence for engaging 
in more autonomous decision-making 
I felt a little bit ... alone .. . Not qualified ... to be making this decision myself.. .it was like 
stepping out into the unknown ... it was a big thing to take on. . .. But I was aware that 
everybody was there to help me. Everybody was on my side. [Patient 31, mastectomy, 
age 64, high MR unit, P7-8] 
Patients benefited from rece iving an explanation of why they were being offered a choice of 
treatments. If this style of consultation was not adopted, patients sometimes felt there was such 
a gap in experience, knowledge and power between themselves and their clinicians, that the 
expert was the only person who could assume control of treatment selection . Doctors seemed to 
have the capacity to exert the more disempowering influence with in the situation and 
relationship, and BCNs sometimes facilitated greater patient involvement in the discussion of 
options and decision-making. 
Rather than it be a discussion between us, I felt it was a one-sided d iscussion, ... there was 
two doctors in the room and I didn't have a nurse in with me .. . when I had a breast care 
nurse with me before, we were all involved in the conversat ion ... 1 felt I had my support 
with me .. [Patient 62, BCT, age 44, low MR unit, Pl1-12] 
The consultation style of cl inicians seen earlier in their j ourney to cancer diagnosis of could also 
influence patients ' expectations. 
Having not expected to have a choice [it] ... did th row me ./I [plO] " ... because [the doctor] 
previously ... had said usually [they usually] ... recommend ... mastectomy [in cases like 
mine]. .. [Patient 65, mastectomy, age 44, low MR un it , P7] 
Exploration of information needs, treatment preferences and concerns 
Although some patients preferred a less autonomous decision-making experience, t hey still often 
wanted their treatment plan to take into consideration their individual preferences, needs and 
concerns. Some vocalised the conundrum that, within the timeframe ava ilable, clin icians cou ld 
not be expected to get to know their patients sufficiently well to make individualised treatment 
decis ions. 
"Everything considered, I think that's what you should do." ... 1 think ... 1 wanted the 
consultant to say that to me .... [But] a consultant has never seen me before and doesn't 
have a detailed understanding of my medical history or my psychological state ... so I 
suppose 1 couldn't reasonably expect him to make that decision.' [Patient 29, 
mastectomy, age 48, high MR unit, P23] 
This realisation of th is, could lead naturally passive patients to become more willing to assume a 
more autonomous role. 
1 would say it would be nice for the experts to make a dec ision and tell you what they 
think you should have, and not give you a choice. Having said that, in hindsight, if I had 
been told that 1 was to have the lumpectomy 1 would have had a lumpectomy 
and .. . radiotherapy and 1 wouldn't have questioned it ... 1 would have been none the wiser 
about ... how quick and easy mastectomy is compared to it.' [p21-22] ' ... [and] 1 don't want 
to be coming back every day for radiotherapy for six week' because 1 had got .. . my son and 
his two children here ... And ... 1 take my duty as a surrogate parent seriously and I thought 
[radiotherapy] it's [very] time-consuming. [Patient 25, mastectomy, age 60, high MR 
unit, P7-8] 
The language style clinicians adopted affected patients' impression of their knowledge-base. 
Patients also described benefiting from clin icians' proactively checking thei r unde rstand ing of the 
information provided . Patients who felt they had sufficient time with their clin icians to gather 
information and gain confidence, described feeling more pos it ive about thei r part icipat ion in 
deciSion-making . Many patients found the repetition and re-explorat ion of information, an 
opportunity to both consolidate and opt imise their knowledge-base, and endow suffic ient 
confidence for engaging in dec ision-making . 
There always ... somebody to follow up, to ... ensure .. . yo u've unde rstood . And if you 
haven\ they ... go through it ... again ... until you do . [Patient 17, B(T, age 50, med ium MR 
unit, P23] 
Most patients interviewed found the time they spent with their BeN following their initia l 
consultation with the surgeon invaluable. This extra consultation provided patients w ith much 
needed psychological support, as well as providing an opportunity to further explore the available 
treatment options and their information needs. This aided their absorpt ion of information 
through reiteration and reinforcement, and provided an opportunity to explore their personal 
preferences. 
1 tried to research it a bit ... had a look on the internet ... discussed it with breast care nurse 
at various points on the telephone. [Patient 57, B(T, age 44, low MR unit, P4-5J 
Patients' challenge regarding decision making was often associated with their feeling of 
possessing insufficient information, decision support and time to comfortably make a choice . 
Some felt their clinicians' supply was inadequate. 
1 was floundering ... there was no information on which to make a cho ice. 1 wasn't being 
forced to make a choice on the spot .. .so ... 1 tried to research it a bit. [Patient 57, B(T, age 
44, low MR unit, P4-SJ 
They felt the solution was to spend more time with their clinicians to gather information and gain 
decision making confidence . 
I would have liked more time to have been able to absorb what I was being told and not 
just that hour slot ... if I could've had perhaps a couple of hours where I could have sat with 
somebody and they could have explained the operations in, more detail. [Patient 38, 
B(T, age 57, high MR unit, P24J 
Others felt the issue was purely their inability to absorb and process information at the time. 
It was limited information but ... 1 don't think I could have taken much more in anyway.' 
[Patient 6S, mastectomy, age 44, low MR unit, P12J 
While some absorbed the information, but found weighing up the pros and cons especia lly 
difficult, due to the high stakes but equal survival associated with the options. 
I don't consider me a person who .. . has problems making decisions and yet this was ... an 
impossible decision ... 1 wasn't educated to do it .. . 1 wasn't experienced .. . [and] I couldn 't 
even make it on psychological grounds as ... 1 didn't know at t he t ime of making the 
decision how I would feel. .. if there had been a benefit of one over the other ... there 
wouldn't have been the choice . [Patient 42, B(T, age 60, high MR unit, P23-24J 
Many who received an individualised diagram with synopsis of pert inent cancer and treatment 
information from their clinicians, described benefit from its provision; they used it t o simulate 
their recall of the consultation information and considerat ion during dec ision -ma ki ng . 
... my mind was ... not terribly clear at the time [of diagnosis appointment, 
useful to have it [diagram] when I came back [home] to look at it ... 
mastectomy, age So, medium MR unit, p6] 
so] ... it was 
[Patient 9, 
They also described benefitting from having someone with them in the consultation who was not 
part of the clinical team . This allowed them to effectively extend the consultation through later 
re-discussion, which facilitated their absorption of information. 
That's why you need somebody with you because I'll say something to [husband] and he'll 
say, \\Well you haven't understood what they've said" because he has obviously taken 
more in than I have, because I think you are in ... shock. [Patient 21., B(T, age 54, high MR 
unit, p1.o] 
Patients' perception oftheir role in decision-making 
Patients' responses to decision-making were also influenced by whether or not they perceived 
they were being offered a genuine opportun ity to choose their treatment. When clinicians 
presented options in a non-directed manner, patients were more likely to feel a genuine choice 
was available. 
They were very clear that this was going to be my choice and that they wouldn't push one 
against the other. They just simply presented all the facts about the two. [Patient 33, 
B(T, age 57, p6] 
In contrast, if patients were presented with a recommendation or treatment plan rather than 
options, they generally assumed they were not being offered a role in choosing their treatment . 
.. . at the end of the day you .. . Iisten to what they say and you think 'well he 's the one that 
knows what he's doing' and you sort of go with him ... unless you're dead set against it . 
[Patient 21., B(T, age 54, High MR unit, p6] 
When patients participated in decision making but felt their decisions were not accepted by their 
clinicians, they could feel insecure, frustrated or angry . 
[The] nurse on the ward .. . kept saying \\Well, [consultant]'s also mentioned ... wide local 
excision [B(T]" .. . then ... 2 or 3 hrs later one of the Breast (are Nurses came up and started 
going through the same thing again ... . [and I] started to get a bit wound up ... "What do 
you think I've spent the last two weeks deciding7 " [Patient 65, mastectomy, age 44, low 
MR unit, p1.8-1.9] 
Time given for consideration 
Patients often articulated that before they were able to mean ingfully engage in t reatment 
decision-making, they need time away from the clinical environment to recover from shock of 
their diagnosis . 
I bet it was a good ten days before I actually calmed down and just thought, quite 
calmly ... this is what I'm going to do. [Patient 42, BeT, age 60, high MR unit, P15] 
They needed time assimilate and explore the information they had received. 
All that information .. . gets crammed in your head ... you're awash with it until you can 
come home and then you've got that time to relax and chill and just let your mind unwind 
and then think about everything that's been said. [Patient 48, BeT, age 38, P33] 
They also required a realistic timeframe in which to make a decision; given this they could believe 
more autonomous decision-making was achievable. 
I was thinking from one to the other ... thinking \\My God, what a decision .. . " but knowing 
I'd got this fortnight.. .and being told two or three times I didn't have to make a decision 
there and then, I could leave it right 'til the morning of the operat ion .. . helped. So I didn't 
panic. [Patient 31, mastectomy, age 64, high MR unit, p8] 
However, if not provided with a clearly defined time frame in which to make their treatment 
decision, they tended to assume the decision was required immediately and that th is was not an 
unachievable objective . 
I found it a very hard decision .. . just couldn't decide, couldn't decide at all .. . I'd got to 
decide there and then . [Patient 51, BeT, age 51, low MR unit, P7] 
TABLE 7.2 Influences over patient responses to breast cancer treatment choices 
Prior knowledge and healthcare experiences (general or specific to breast services) 
Decision-making preferences; active, collaborative or passive 
Specific personal treatment option preferences 
• Accessibility of clinician and information 
Tailored dialogue vs. prescriptive approach 
Exploration of information needs, treatment preferences and concerns 
>. , 
. . . 
:',,' .. :..... ',' . . . 
• Opportunity to optimally explore information needs and reinforce knowledge 
• Sufficient clear, understandable, unambiguous information for informed decision-making 
Time to explore information and preferences 
• Provision of a genuine choice 
• Provision of a clear explanation of the rationale for treatment choices 
• Invitation, encouragement and support of patient decision-making 
Patient feels decision-making is achievable (information, support, time) 
Support and encouragement of more autonomous decision-making by clinicians 
• Sufficient time for reflection and consolidation 
Clearly defined timeframe for decision-making provided or not 
WHAT PATIENTS NEED FOR A POSITIVE DECISION-MAKING EXPERIENCE 
The three subthemes above generated eight factors which encompassed patients ' requirements 
for a positive decision-making experience. These are summarised in table 7.3 and the following 
quote highlights many of them . 
The choice ... to have it explained to you and to make sure that the patient knows at any 
time they can change the mind ... . And ... open communication ... being able to ring up the 
breast care nurses and ask anything about the operation because it is so much to take on 
board in what is possibly half an hour to an hour's appointment .. .. and then ... time to ... let 
your mind unwind and ... think about everything that's been said .. .. [and] having clear and 
precise information at all times. [Patient 48, BCT, age 38, low MR unit, P33] 
Across the interviews patients wanted to be prepared for their decision-making and cancer 
journey. They viewed the information, advice and guidance they received from their clinicians as 
a means of equipping them for this, and as a method to empower and take care of themselves 
physically and psychologically. This view was expressed independent of the treatment options 
they chose. Despite the fact that patients sometimes felt overwhelmed by the volume of 
information they were given and at times felt unable to absorb it all, most expressed the desire to 
be fully informed about their cancer and treatment. 
The key to a positive experience of decision making among the minority who were steadfastly 
passive, was the security of being issued with a specific treatment plan by the expert clinician. 
This group's needs were focussed on the clinician relaying a sense of caring, reassurance and 
empathy, rather than knowing the details of options. However, they still expressed the desire for 
information. The retrospective nature of the interviews permitted some to reflect that although 
they were happy to undergo BCT (which their clinicians usually recommended), some possessed 
quite crippling anxiety and concerns about local recurrence. With hindsight, this group talked 
about the desire for their clinicians to tailor their treatment plan or guidance to their individual 
needs and concerns. Some recognised this could be difficult. 
Although decision-making experiences varied, the majority of patients seemed satisfied . The 
reasons for satisfaction however varied. Those who participated more fully in decision-making 
and whose clinicians provided comprehensive information and supported their pat ients ' dec ision-
making, often expressed satisfaction related to the ir assumption of a role in choosing a treatment 
that felt appropriate for them as an individual, which also often increased their sense of control 
and empowerment. Those who were treated by clinicians who offered less choice and more 
treatment direction, often expressed satisfaction about the security they felt as a result of t he 
expert gUiding them or providing them with a treatment plan . 
He didn't ... say, "Which would you prefer?" but ... he 's the professional, he kn ows ... 1 was 
quite happy to take his word, I mean you've got to trust in them, haven 't you) [Pat ient 
63, B(T, age 59, low MR unit, P19-20] 
While those who expressed dissatisfaction with their decision-making experiences, were often 
those who felt they were forced to assume a greater or lesser role in decis ion-making than they 
desired, and whose clinicians adopted a prescriptive approach, only offering treatments which 
were incongruent with their patients' preferences. 
If I could give any doctor any feedback, it's .. . listen to what your patient's saying ... you 
might think, "Well, the best thing is this," but listen to why they don't want to go with 
that. [Patient 62, B(T, age 44, low MR unit, pll] 
The provision of patient-centred care was often central to how comfortable patients felt in the ir 
consultations, the decision-making process and their treatment. 
I was dealt with compassion and efficiency .. . treated as a person, not as a walking d isease . 
[Patient 14, B(T, age 60, medium MR unit, p16] 
They appreciated being provided with honest, tailored understandable information, and 
experiencing a supported decision-making process, and the sense of not being rushed . 
He went to great care to explain and ... you didn't feel he was rushing you . [Patient 20, 
B(T, age 58, medium MR unit, P14] 
We were on the same wavelength ... we were always working togethe r fo r my benefit . I 
didn't have to think, "Well he knows better than I do so I'll go with what he says" ... the re 
was never any confrontation, never any \l Well I'm not quite sure, but he must know best . 
[Patient 12, B(T, age 69, medium MR unit, p20] 
TABLE 7.3 Summary: What patients need for a positive shared decision-making experience 
Patients permitted to play the role they desire in decision-making* 
* but some are initially ignorant of a possible role, PDMS can change in response to information 
and support and some described benefiting from choices even though they initially held more 
passive preferences. 
~. • •. ,,' ,- " •• ~, .-~ ",' ~ ; ••. l,,' ','\ "', ,\ ...... ,,"'" ..... ":.' "f .::!l '.' ~ ... - .' ~. . . 
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• 
• 
• 
• 
• 
• 
Provision of a genuine choice 
Provision of a clear explanation the rationale for treatment choice 
Permission or invitation to participate in decision-making 
Encouragement and support to participate in decision-making 
Perception that decision-making is achievable (information/knowledge, support, time) 
Negative responses when choices which did not feel genuine 
Clear comprehensive, unambiguous information necessary for decision-making 
Opportunity to explore information needs 
Opportunity to build on knowledge (reiteration, reinforcement, re-exploration) 
Tailored patient-centred communication , 
With doctors and BCNs 
Freedom to explore information, preferences and barriers to shared decision-making/options 
• Accessibility for multiple consultations if necessary 
Accessibility of clinicians within consultationsj unrushed time, open tailored discussions 
Appropriate tailored decision-making support 
Knowledge 
Safety and acceptability of the option preferred or chosen 
Reassurance regarding support for decision-making 
Endorsement of option preferred or chosen by patient 
CONCLUSION 
This chapter describes a very strong emergent theme from the interviews with women identif ied 
by their breast team clinicians as given choices of breast cancer surgery, and increases our 
understanding of what patients feel about being asked to make treatment choices . In an era of 
change where patients are increasingly viewed as partners in healthcare decision-making, this 
information is crucial to optimising the quality of patients' healthcare decision-making 
experiences. 
Patients interviewed expressed varying desires for participation in decision-making, consistent 
with the active, collaborative and passive decision-making preferences described in the 
literature.(Degner et al. 1997b) These qualitative findings support the findings of recent 
questionnaire-based studies; and confirm that the DMS of patients has changed with time, the 
majority of patients now happy adopting more active or autonomous roles in healthcare 
decisions.(Beaver, Luker, Owens, Leinster, Degner, & Sloan 1996;Bilodeau & Degner 
1996;Degner, Sloan, & Venkatesh 1997b;Janz, Wren, Copeland, Lowery, Goldfarb, & Wilkins 
2004jLam, Fielding, Chan, Chow, & Ho 2oo3;Lantz, Janz, Fagerlin, Schwartz, Liu, Lakhani, Salem, 
& Katz 2ooSjLuker, Beaver, Leinster, & Owens 1996b;Mastaglia & Kristjanson 2001jSingh, Sloan, 
Atherton, Smith, Hack, Huschka, Rummans, Clark, Diekmann, & Degner 2010) However, the 
findings also highlight that certain contingencies exist to the way patients perceive treatment 
decision making and they provide additional detail to that possible from questionna iresj 
highlighting some subtleties involved . These include how preconceptions and initial responses 
are substantially modified by information, consultation styles and decision making support 
provided by clinicians, and how involvement in decision-making was presented to them . 
Most patients found being involved in breast cancer treatment decisions, either novel or a 
challenge . An unexpected majority had no expectation of being involved in choos ing their 
treatment. They anticipated the provision of a treatment plan at diagnosis instead. This meant 
they were often initially surprised by the offer of this role . Patients often described experiencing 
a number of personal responses they as they progressed through the decision making experience 
and had the opportunity to reflect on it. These often changed over timej initial responses often 
g iving way to later responses. 
Clinicians had a substant ial influence over how pat ients felt about involvement in th is hea lthcare 
decisionj patients' adaption seem ing to result from their interactions w ith the ir clinicians and the 
passage of time from the acuteness of their diagnosis. The process of adaption was described 
more fully and specifically among those experiencing more facilitative/less directive consultations 
and decision making. 
Many patients described needing time and the support of their clinicians to adjust, become 
sufficiently informed and feel appropriately supported to operate more comfortably in this role . 
They often described requiring and desiring the opportunity to receive information at multiple 
time points within and away from the clinical environment. This was necessary to absorb and 
process information, and reach a decision. This is where an additional consultation with BCNs 
was of great potential benefit. 
Patients' views were influenced by prior expectations and experiences, together with the 
acuteness of their diagnosis and awareness of their knowledge deficiency. Most patients' initial 
conceptions and responses adapted and the majority seem to accept and even embrace this role, 
once provided with the rationale for their involvement by their specialist clinicians, and provided 
with patient-centred explanations, information, time and support. For many, choosing their 
treatment became a positive aspect of their cancer experience and a chance to re-establish a 
sense of power and control denied at their cancer diagnosis. This was true for both many who 
found decision-making relatively uncomplicated, and those finding it more challenging. 
While decision-making experiences varied, most of the women interviewed expressed satisfaction 
with their particular decision-making experience. The reasons for their satisfaction were 
expressed irrespective of their treatment type, but differed according to their experience of 
consultation and decision-making. The provision of individualised patient-centred care, 
accessible information, tailored consultations and decision-making experiences, and the provision 
of appropriate decision support were often central to patients' satisfact ion with their decision-
making experiences. Those describing the provision of more comprehensive information and 
autonomous but supported roles in choosing their treatment often expressed satisfaction that 
they had received patient-centred care. They often ascribed their satisfaction to their clinicians 
treating them as partners in the process and frequently described how such engagement 
provided, not only the opportunity to select the treatment that was right for them as an 
individual, but also the opportunity to re-establish a sense of control and empowerment at a time 
of vulnerability. However, patients could equally be satisfied by the provis ion of a more directed 
approach from their clinical specialist or expert; provided they felt the ir opinions and needs were 
respected, and the option suggested was acceptable to them . This group often expressed their 
satisfaction residing in the reassurance and sense of security they gained from being under the 
care of an expert and receiving an expert's opinion. 
A powerful method of providing patients with reassurance, and optimising their satisfact ion w ith 
decision-making was the clinician's endorsement of the operation patients decided to undergo; 
whether this was articulated by the clinician or perceived by the patient. This was evident even 
amongst patients who had a fairly clear idea of their preferred treatment . Patients wanted 
reassurance they were making the right choice, a choice that was safe and acceptable to their 
clinicians. 
Dissatisfaction was expressed most markedly among those whose decision-making experiences 
and treatment were discordant with what they wanted : Those who felt forced to assume a more 
or less autonomous role in decision-making than they desired, and whose clinicians adopted a 
prescriptive approach, only offering treatments incongruent with their patients' preferences. 
A potential limitation of the study is that participants were interviewed following the completion 
of the decision-making experience. This raises the possibility of recall bias and post hoc 
justification influencing the findings. This is explored in the general discussion. The interviews 
however took place within a similar timeframe to other qualitative studies exploring decision-
making, and had the interviews had been conducted earlier; the information about how 
perceptions adapted overtime and what influenced this would have been absent. 
All participants were identified by their own specialist clinicians as hav ing been offered treatment 
choices. Despite this, some patients' descriptions of their experiences seemed inconsistent with 
the provision of options and a role in choosing their treatments. This might represent the belief 
of some clinicians that they are providing their patients with choices, when they are in fact 
offering much less autonomy. 
Chapter 8 
Review of findings 
This study investigates variation in hospital breast unit MRs from key stakeholder perspectives 
(patient, specialist doctor and BeN). It provides new information and a fuller understanding of 
the prelude to and interface between patients and clinicians, in situations where patients can be 
provided choices and treatment varies. 
Employing a mixed methodology multi-perspective study, we demonstrate variation MRs is not 
due to units' case-mix, but largely due to the impact of clinic ians' beliefs and preferences over 
decision making . These dictated which patient groups received genuine options, clinic ians' 
consultations and approach to decision making, and patients' decision making experiences. The 
breast units studied possessed different decision making cultures with a central ethos which was 
either focussed on a more facilitative or directive approach toward decision making. These were 
based on the central belief of what comprises optimum patient management; patients 
undergoing the treatment their expert clinicians deem preferable or patients deciding this for 
themselves, having been provided with the tools (knowledge and support) and time to do so . The 
differences between units with varying practice patterns are summarised in table 8.1 and 8.2. 
OBJECTIVES AND FINDINGS 
Finding Significant variation in breast cancer MRs persists when case-mix is excluded . 
5109 primary breast cancers detected over a six-year period (1997-2003) by the Trent reg ion 's 11 
breast screening units, were analysed at individual case level to ident ify whether case-m ix and 
case-load explained variation MRs observed at aggregate level . 
Expected case-m ix adjusted MRs were derived by log ist ic regress ion using the variables cancer 
size, site and grade, patient age and year of presentation (representing changes in evidence -
based practice) . The region 's overall case-mix adjusted practice was employed as t he reference 
population . Significant variation existed in breast unit MRs (range 25%-45%, p<O.OOOl), which 
persisted following case-mix adjustment (P<O.OOOl). Two-fold variat ion was demonstrated 
overall (observed to expected unit MR coefficient range 0.66-1.36). Variation increased to almost 
four-fold among the small diameter subgroup (observed to expected unit MR coefficient range 
0.55-1.95, among less than 15mm diameter cancers) . 
Neither case-m ix correct ion nor the available literature explains wide variat ion in MRs. Fu rther 
research is requ ired to investigate the other potential patient and clinician causative factors. 
Finding Clinicians possessed treatment preferences which despite agreed treatment 
guidelines, were also influenced by patient age and cl inicians' gender and 
occupational role. 
A quantitative cross-sectional postal survey ut ilising DCE methodo logy examined whether 
clinicians possessed preferences for breast cancer surgica l opt ions. Al l permanent specialist 
breast team cl inicians (doctors and nurses) from the 14 Trent breast units were invited to indicate 
the ir preference for su rgery (mastectomy, BCT or pat ient choice) over a series of hypothet ical 
scenarios randomly generated from a group of preoperatively available variables; patient age, bra 
cup size, cancer size, site and cancer centricity . 68/93 clinicians completed the survey (73% 
response rate) and data were analysed across the 25 scenarios (n=l,69S) using mult inom ial 
logistic regression with allowance for response clustering, comparing preference for choice, with 
preference for mastectomy or preference for BCT. 
Clinicians' treatment preferences were predominantly consistent with evidence-based breast 
cancer treatment guidelines, which recognise the boundaries of surv iva l equivalence and 
acceptable recurrence risks, while being flexible to patient preferences and therefore conta in few 
absolute indications or contra indications to specific treatment options. Clinicians' preference for 
mastectomy, over choice, over BCT, was positively correlated with increasing cancer size, 
reducing breast size, central cancer position and multi-centricity (P<O.OOl). However contrary to 
guidelines, clinician preferences were also significantly influenced by patient age; increasing 
patient age correlated with increased preference for mastectomy (P<O.OOl) . The age impact was 
less marked among those preferring BCT and in the oldest patient age groups. The DCE also 
demonstrated, clinicians preferring BCT or mastectomy had different thresholds for altering their 
preferences. Those preferring BCT shifted toward choice when cancers exceeded 20mm 
diameter and those preferring mastectomy shifted toward choice in cancers under 30mm 
diameter. 
Despite the clear demonstration of the impact of the patient and cancer characteristics over 
clinician preferences, the low pseudo R2 (0.29) indicates the factors examined within the DCE only 
account for 29% of the clinicians' responses. Something else is responsible for the majority . 
Clinician gender and occupation were also associated with thei r preferences: Female clinicians 
and nurses tended to prefer choice rather than mastectomy (P=O.OlS and P<O.OOl respective ly). 
Nurses were more likely to prefer cho ice than specific treatment options (P<O.OOl), and doctors 
were more likely to demonstrate specific treatment preferences (mastectomy or BCT) than prefer 
choice. 
Finding Breast teams/clinicians differed in who they provided with options. 
Qualitative methodology comprising semi-structured interviews, highlighted that variat ion in 
MRs was associated with differences in breast unit teams/clinicians identification of patients 
provided with options/choices, and how much direction and genuine choice patients were 
provided . Descriptions from the low MR unit differed from the more similar medium and high MR 
units. Among the units studied, lower MRs were associated with the offer of BeT rather than 
options to women with smaller cancers, and the provision of more directive information 
regarding BeT to those given options. 
Finding Breast teams within units possessed a decision making culture with a central 
ethos, based on the possession of particular beliefs. These influenced the 
information provided to patients; and their consultation and decision making 
approaches. 
Semi-structured interviews with 26 clinicians from the three breast units representing the 
spectrum of case-mix adjusted MRs from the region, demonstrated clinicians possessed 
treatment preferences and beliefs which were predominantly clustered by their breast unit. 
These consolidated within a unit ethos and were associated with the description of a particular 
unit decision making culture. The decision making cultures seemed self-perpetuating and were 
reinforced by the processes and practice adopted by individual cl inicians and as a team . The low 
MR unit ethos and culture differed from that of the other units . 
Despite the possession of a differing ethos, the primary underlying motivation was similar w ith in 
all units. They wanted to provide optimum management to their breast cancer patients and 
minimise the negative impact of the diagnosis. They diverged in their possession of a different 
set of beliefs about what the optimum management comprised . This was perceived to be 
informed patient decision making or a specific treatment. 
The ethos and practice of the low MR unit are termed outcome-based practice . The ir focus was 
on a particular treatment goal. They described the possession of the central bel ief that BeT was 
optimum and mastectomy should be avoided where possible . They concurrent ly possessed the 
predominant belief that most patients possessed a passive POMS, and were unable to assimilate 
and contemplate the volume of new information required to engage in informed decision making . 
They therefore expressed the trained expert, the clinician, was the most appropriate individual to 
determine the optimum treatment for their patients . Therefore BCT was un iversally 
recommended where not absolutely contraindicated . 
In contrast the medium and high MR unit clinicians' ethos and practice are termed process-based . 
Their focus was on a particular process of treatment decision-makingj more autonomous patient 
decision making. These clinicians described core beliefs that only individual patient could judge 
which particular treatment was right for them, and that patients were capable of making such 
decisions if provided with suitably understandable information, support and time. They described 
a reluctance to provide recommendationsj stating the desire to avoid their personal preferences 
exerting undue influence over patients' decisions. 
Despite the presence of a central ethos and particular decision making culture within breast units, 
some heterogeneity was described within them. There was some diversity in individual clinicians' 
beliefs and strength of adherence to them . However, clinicians' perception of the norm and the 
extent of diversity described were embedded within and dominated by the culture of their breast 
unit. Although some clinicians' beliefs seemed to have more in common with those from other 
units and they were outliers in the context oftheir unit norm, only small a few were true outl iers. 
Finding UK women want & achieve more autonomy in choosing their treatment than 
previously realised and this influences the choices women make 
A quantitative patient survey utilising validated instruments, was conducted with in the same 
three specialist breast units representing practice variation. Completed questionnaires were 
received from 356/697 consecutive eligible patients offered a choice between BCT and 
mastectomy (51% response rate) Respondents had a mean age of 58.5 yea rs (range 30.4-89.0) 
and completed the questionnaires a mean 6·9 weeks after their surgery (range 1.3-48.6). 74% 
underwent BCT (n=262) and 26% mastectomy (n=94) . 
High proportions of active decision-making (POMS and AOMS) were demonstratedj part icu larly 
among those choosing mastectomy (active AOMS 83% vs. 58%, P<O .OOl) and those t reated by 
the high MR unit (active ADMS 80% vs. 54% and 52%, P<0.001). Higher concordance of PDMS 
and ADMS was noted among active decision makers (91%, p<O.OO1) and there was a non-
significant trend for greater concordance among those choosing mastectomy (67% vs . 59%, 
P=0.070). 
Finding Patients' treatment choices are substantially influenced by breast-team 
influences; the options provided; content and portrayal of information; time 
given for decision-making; and degree of patient autonomy in decision making 
promoted and supported 
Qualitative interviews were conducted among a subgroup of 65 patients completing the OMS 
questionnaire phase of the programme of research . The women articulated different preferences 
for specific treatment options based on innate patient-specific factors consistent with known 
influences over breast cancer patients' decisions from existing literature; body image, recurrence 
fears, radiotherapy concerns, social commitments etc. Women from the different breast units did 
not possess fundamentally different preferences for treatment. However their treatment choices 
were influenced by three clinician/unit factors impacting these more innate patient factors 
associated the information provided by clinic ians; patients' perception of their options, the most 
reassuring treatment option and least disruptive treatment option. 
Patients' interactions with their cl inicians impacted their decisions in other ways. Clinicians' 
preferences (either for BCT or more autonomous decision making) were clearly communicated to 
their patients. These and the breast units' environment for decision making established by the 
decision making culture and reinforced by the un its' processes, had a substantial influence over 
patients' decisions. Differences were described in the information provided (content and 
portrayal) to women were about their cancer, the treatment options offered (choice of surgery or 
BCT), the level of promotion and support of more autonomous patient decision-making, and t he 
t ime provided for the process . 
The ethos of the low MR un it meant that some cl inicians deemed patients so clearly suitable for 
BCT, they did not consider providing options. While others considered suitable for choices they 
often read ily volunteered treatment recommendations. Correspond ingly, predominant 
descriptions of decision making among these patients were those guided by clinicians ' 
recommendations rather than those based on more comprehensive information and personal 
deliberation. Experiences among the other units contrasted with this . These were described as 
more deliberative and comprehensive; based on the consideration of patients' preferences in the 
context of more extensive expressed knowledge. This was consistent with the med ium and high 
MR units' descriptions of a process-based ethos focussed on facilitating shared decision making. 
Finding Patient satisfaction was influenced by patient-centred care; the provision of 
tailored, clear information and time; the receipt of reassurance; and 
involvement in decision-making with individualised support 
Patient satisfaction was influenced by the perception of the provision of patient-centred care. 
This encompassed the provision of clear tailored information, involvement in the decision-making 
process to the individual's level of preference, unrushed time within consultations and adequate 
time for decision-making. Despite the predominance of the active PDMS and ADMS among the 
patients, at diagnosis only a minority of those interviewed anticipated involvement in choosing 
their treatment. Satisfaction was influenced by patients' involvement in the decision-making 
process even if they did not possess an active PDMS. However, describing benefit and 
satisfaction from engaging in decision making was for most, contingent on patients feeling 
adequately informed, confident and supported in undertaking a more autonomous role . 
However a minority with a passive PDMS, viewed more autonomous engagement in decision 
making as a cause of sometimes extreme dissat isfaction; even w ith t he above prerequ isites met . 
Patients' satisfaction was also increased by the receipt of reassurance regard ing their treatmentj 
especially if this was readily volunteered by cl inicians . Th is included many of those descri bing 
more di rected and paternalistic experiences. Reassurances and a strong direction toward BeT 
could be viewed as sources of satisfaction, providing patients did not possess confl ict ing 
preferences for mastectomy and/or a more active DMS. 
THE BENEFITS OF ADOPTING A MIXED METHODOLOGY APPROACH 
The study design reflects the complexity of communication and decision making in healthcare . 
The adoption of a mUlti-perspective mixed methodology approach enhanced the find ings of the 
overall study. Utilising both qualitative and quantitative methods, enabled issues raised w ithin 
one section of the study to be explored from a different aspect in other sections of the study. The 
adoption of this more complex approach was considered important in permitting the generation 
of a more coherent picture of decision-making and the factors associated with variation in the 
surgical treatment of breast cancer. 
MISMATCHES IN RESULTS 
There are a few possible mismatches between the results of the DCE and clinician interviews. 
At a regional level, clinicians' responses to the hypothetica l DCE scenarios indicated different 
thresholds for the transference of their preferences from BCT and mastectomy to patient choice . 
Those preferring BCT shifted toward choice when cancers exceeded 20mm diameter and those 
preferring mastectomy shifted toward choice in cancers below 30mm. Interviews with the 
subgroup of clinicians from the three breast units reflecting practice variation were consistent 
with the possession of different thresholds for clinicians ' preferences. But the cancer diameter 
thresholds for the preference shift indicated by the DCE were less well clarified within the 
interviews. Most clinicians would consider cancers of these sizes sma ll j unless breast volume is 
also small. The specific thresholds demonstrated by the DCE may be the product of a dominant 
influence by one of the other variables. The DCE requires that ideally variables be independent . 
But breast volume and cancer size are not truly independent when the breast volume is sma ller, 
as the aesthetic outcome of BCT is compromised when over 20% of the breast volume is excised 
without volume replacement. 
This could represent a potential mismatch in the results of the different methodologies or res idua l 
gap in understanding clinician preferences. Specifically, the clarif ication of t he threshold for 
clinicians form the different breast units shifting from offering options to promoting mastectomy. 
As a group, medium and high MR clinicians described provid ing options to those not requiri ng 
mastectomy on clinical grounds. Theoretically they offered options to a much wider group than 
the low MR clinicians, who viewed small cancer size as a relative contra ind ication to choices . 
Some considered cancers up to 40mm diameter 'small'; especially if they were also located 
peripherally. However the specifics of clinicians from the different units bel ievi ng mastectomy 
was indicated on clinical grounds, was not fully explored. 
TABLE 8.1 Summary of themes associated with breast unit treatment variation . 
Ethos Avoidance of mastectomy where 
possible 
Options Choice for 'borderline' or larger 
cancers. BCT for smaller 
(especially peripheral) cancers 
Information Less comprehensive, more 
directive 
Communication More closed/clinician-centred 
consultation style 
Recommendations More active direction of choices & 
volunteering of clinician opinion 
Checking patient 
understanding 
Patient knowledge 
Patient autonomy 
Decision making 
culture 
Time for decision 
making 
Consent 
Overall impression 
Less extensive 
Narrower and less complete 
descriptions 
Support of autonomous patient 
decision making in selected 
subgroups; overtly active decision-
makers & some cancers borderline 
for BCT. 
Encourages acquiescence 
Short timescales and time-
pressure for decision making 
Consent early: At diagnosis or one 
week after diagnosis 
(,Informed ') compliance 
Promotion of more autonomous 
patient decision making where 
possible 
Choice for those suitable for BCT 
More comprehensive, less directive 
More open/patient-centred 
consultation style with active 
promotion of wider more extensive 
discussion (especially high MR unit) 
Reluctance to direct choice & less 
volunteering of clinician opinion 
More extensive (especially high MR 
unit) 
Broader and more complete 
descriptions (margins, & 
inevitability & details regarding 
radiotherapy with BeT) 
Routinely pro-active support and 
encouragement of autonomous 
patient decision making in all from 
early in the decision making 
process. 
Encourages autonomy 
Longer timescales and attempt to 
lessen time-pressure in decision 
making 
Consent later: At pre-assessment 
clinic or pre-operatively 
Informed consent 
FIGURE 8.l. Summary study findings. 
The key difference between clinicians' and the unit ethos is what they believed was 
optimum management; a specific treatment outcome (BeT in the low MR unit) or 
process of shared decision making (in t he medium and high MR units) 
This resulted in different groups of patients being considered eligible for choices in the 
different breast units & differences in information provision & decision making 
approaches. 
Prerequisites for patients' more autonomous engagement in decision making were; 
patients' perception of genuine options together with the possession of appropriate 
information, time and support by their specialist clinicians. 
• Patients want more autonomy in the selection of their breast cancer treatment 
than they did in the past. 
• Despite this, at diagnosis the maJonty still anticipate a paternalistic decision 
making encounter which impacts their decision making experiences, unless 
provided with options and the prerequisites for more autonomous decision making. 
• Patients' DMS are not necessarily pre-determined, obvious (even to patients) at 
diagnosis, orfixed . They are determined by the combination of patients' 
preconceptions of the decision making encounter and their experiences with 
clinicians. 
• The treatment patients undergo is substantially influenced by clinicians . In 
particular by clinicians' treatment preferences, the degree of autonomy they 
provide patients, and whether patients feel sufficiently informed and empowered 
to make such medical treatment decisions. 
• Despite variation in practice and decision-making experiences between breast 
units, providing patients underwent a treatment they were comfortable with or felt 
they received patient-centred care, the majority expressed sat isfaction. 
